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Abstract
Aspects of the mechanism of action of Ca2+-mobilizing agents, particularly the 
regulation of Ca2+ fluxes, have been examined in the perfused rat liver using a Ca2+-selective 
electrode and other relevant biochemical techniques.
The first area of study concerns agents whose actions in liver appear to be mediated by an 
interaction with non-parenchymal cells. Thus arachidonic acid, zymosan and lysolecithin 
(lysophosphatidylcholine) were found to induce Ca2+ flux changes, vasoconstrictive, respiratory and 
glycogenolytic effects when administered to the perfused rat liver. Also, the action of PAF (platelet 
activating factor) which previously had been shown to elicit vasoconstriction, glycogenolysis and 
changes in respiration, was also found to be accompanied by marked alterations in Ca2+ flux. The 
effects of these agents in the intact liver were found to be highly sensitive to inhibition by 
indomethacin (an inhibitor of cyclo-oxygenase) and bromophenacyl bromide (an inhibitor of 
phospholipase A2). This suggests an involvement of eicosanoids, prostaglandins in particular, in
mediating the action of these agents. Because the parenchymal cells (the hepatocytes) are not 
considered to be significant producers of eicosanoids, a model is proposed whereby the agents as well as 
eliciting responses by direct interaction with parenchymal cells and indirectly as a consequence of 
vasoconstriction (or associated anoxia/ischemia), are purported to elicit responses by inducing 
eicosanoid production and release in non-parenchymal cells (Kupffer and endothelial cells) within the
liver. This notion is supported by the finding that prostaglandins (PG) F2a , E2 and D2, and an
analogue of thromboxane A2, themselves elicit responses which mimic those induced by these agents.
The second area of study relates to those agents whose principal effects in liver have been shown 
to involve an interaction with hepatocytes. A characterization of the Ca2+ flux changes induced 
by the Ca2+-mobilizing agonists phenylephrine, vasopressin and angiotensin revealed that the agents 
have differing ability to stimulate Ca2+ flux movement, particularly Ca2+ influx. The 
co-administration of glucagon (or cyclic AMP) was found to stimulate Ca2+ uptake 
synergistically, leading to a large reversible accumulation of Ca2+ by the mitochondria. This has 
implicated mitochondria in the regulation of Ca2+ flux induced by hormones. Other agents like ATP,
ADP, EGF and PGF2a also have been found to induce Ca2+ flux changes, and to interact 
synergistically with cyclic AMP in stimulating Ca2+ influx. In all these instances the synergistic
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stimulation of Ca2+ influx is unaffected by verapamil, diltiazem and nifedipine (inhibitors of 
voltage-sensitive Ca2+ channels), but is completely inhibited by neomycin, and a lowering of the 
extracelluar pH to 6.8. The inability of these manipulations to significantly affect the influx of 
Ca2+ associated with the refilling of the intracellular hormone-sensitive pool of Ca2+, suggests that 
Ca2+ influx in liver may occur by at least two separate mechanisms.
The ability of an agonist to stimulate Ca2+ influx synergistically in the presence of cyclic AMP, 
appears to correlate with its reported ability to induce phosphoinositide hydrolysis and generation of 
the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. This suggests that either
one or more second messengers, or metabolites of these, may be involved in regulating Ca2+ 
influx. Phosphatidic acid, a metabolite previously proposed to act like a Ca2+-ionophore in 
some systems, is probably not involved in this effect since the responses elicited appear to be 
receptor-mediated, as assessed by its ability to induce responses and a mobilization of intracellular 
Ca2+ at both physiological and submicromolar Ca2+ concentrations of extracellular Ca2+. 
Preliminary studies with hepatocytes appear to support the view that is emerging from studies in 
other systems; that is, that inositol 1,3,4,5-tetrakisphosphate (IP4) which is synthesized from the 
second messenger IP3, is involved in the regulation of Ca2+ influx across the plasma membrane. 
The studies suggest that cyclic AMP can potentiate synergistically, the production of IP4 (induced by 
vasopressin) by synergistically activating IP3 kinase. Further confirmation that IP4 is involved in the 
regulation of Ca2+ influx by Ca2+-mobilizing agonists, and the precise details of how cyclic AMP and 
IP4 can promote the influx of Ca2+ in liver, awaits further study.
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Outline of Presentation
This thesis has been organised into three main sections. The first is an introductory review 
representing the current state of knowledge of the mechanism of action of Ca2+-mobilizing agents in 
liver. The review covers aspects of both intercellular communication within the liver (by considering 
agents whose actions appear to be mediated primarily through an interaction with non-parenchymal 
cells), and signal transduction within hepatocytes (that is, the role of second messengers in the 
regulation of Ca2+ flux). Established information, recent advances in these areas, and some of the 
findings made in the course of this study are juxtaposed, to allow an assessment of how the results of 
this study merge into the wider scope of this field of research.
The second part of this thesis consists of the experimental data and interpretations, obtained 
during this study. These are presented in the form of scientific papers which have been accepted in 
refereed journals. It is hoped that the relationship between these papers will become obvious from 
the introductory review, and from the introductions and discussions in each of the papers. It will be 
noted that the order of presentation is not necessarily the order in which the experiments were 
carried out.
The final section entitled 'Concluding Comments and Future Directions' is devoted largely to 
those issues or areas of study which seem crucial for future advances and a furthering of 
understanding in the field.
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4(A) INTRODUCTION
This work sets out to review recent findings on the mechanism of action of Ca2+-mobilizing 
agents in liver. Because much of the author's work comprises results obtained using the perfused liver, 
the review begins with a brief description of the perfused liver system. This approach serves as a 
prelude to the first part which deals with those agents whose action in the perfused liver appears to 
involve the non-parenchymal cells. Diverse events are reviewed such as phagocytosis, K+-induced 
depolarization, stimulation of the sympathetic nerves, and the increasing number of stimulating agents 
including arachidonic acid, platelet activating factor, lysolecithin (lysophosphatidylcholine) and phorbol 
esters, which are thought to elicit at least part of their action on liver parenchyma indirectly through an 
involvement of non-parenchymal cells. A hypothesis is presented in which these factors, as well as 
eliciting responses by interacting directly with hepatocytes, are proposed to induce whole-tissue Ca2+ 
flux changes and associated changes in liver metabolism indirectly, by the production and release of 
eicosanoids, particularly prostanoids, from non-parenchymal cells. On being released from these cells 
the eicosanoids are purported to induce effects in the liver parenchyma. Moreover, various stimulating 
factors and/or eicosanoids may also interact with vasoactive cells (eg. endothelial or smooth muscle 
cells) thereby eliciting vasoconstriction and physiological responses associated with anoxia and/or
ischemia in affected regions of the liver. It is proposed also that in some instances (eg. that of PGF2ot) 
the mechanism by which eicosanoids elicit their effects in hepatocytes is similar to that of the so-called 
Ca2+-mobilizing hormones.
The second part of the review deals with agonists whose effects are mediated primarily through an 
interaction with parenchymal cells. These can be largely distinguished from those that act on 
non-parenchymal cells by their insensitivity to inhibitors of the arachidonate cascade, notably 
bromophenacyl bromide and indomethacin, and possibly inhibitors of voltage-sensitive Ca2+ channels. 
This feature is exploited in the second part of this work which deals with the mechanism of action of 
agonists like adrenaline, vasopressin and angiotensin, whose principal effects in liver are brought about 
by an interaction with receptors on hepatocytes. A brief description of the structure of the different 
receptors whose activation are purported to be linked to the mobilization of cellular Ca2+ is given. 
Particular emphasis is given also, to the mechanism by which these agonists are able to stimulate the 
influx of Ca2+ across the plasma membrane. Recent evidence is reviewed which suggests that these 
agonists elicit their effects by stimulating phosphoinositide hydrolysis and the generation of the second 
messengers for the release of intracellular Ca2+ and the activation of protein kinase C. The mechanisms 
by which agonists are thought to bring about an activation of phospholipase C, and the mechanisms by 
which second messengers (produced as a consequence of phospholipase C activation) are thought to
5bring about an activation of protein kinase C and the release of Ca2+ from the endoplasmic reticulum, 
are discussed in detail. Also, the actions of hormones, and of other Ca2+-mobilizing agonists which 
induce Ca2+ flux changes and other responses in liver, are described. Apart from stimulating Ca2+ 
efflux, an important part of the action of agonists whose effects are linked to a receptor-mediated 
breakdown of phosphoinositides within the hepatocyte plasma membrane, is to stimulate Ca2+ influx 
into the cell. The various Ca2+ transport mechanisms proposed to be involved in Ca2+ entry across the 
plasma membrane of the liver cell therefore, are reviewed. In quantitative terms the influx of Ca2+ is 
stimulated synergistically in the presence of cyclic AMP or cyclic AMP-generating hormones like 
glucagon. Such potentiation has provided a useful tool with which to study the properties of the Ca2+ 
influx pathway(s) in liver, and therefore, a means with which to identify those receptor-mediated events 
that may be important in regulating Ca2+ influx. It is the elucidation of these regulatory mechanisms 
that form the main thrust of this review.
(B) THE PERFUSED RAT LIVER SYSTEM
Studies using the perfused rat liver have contributed significantly to our understanding of the 
mechanism of action of Ca2+-mobilizing agonists (for review see eg. Reinhart et al., 1984a). More 
specifically, the studies have provided information concerning ion flux changes, especially Ca2+ and
also have permitted the characterization of numerous physiological responses induced by agonists under 
various conditions. Since much of the work reviewed herein bears directly on results obtained using the 
perfused liver, it seems appropriate to begin this discussion with a brief description of this experimental 
system.
The perfused liver involves essentially a system in which the portal blood supply to the liver of an 
animal (usually the rat) is replaced with a physiological medium such as Krebs-Henseleit bicarbonate 
buffer (Krebs & Henseleit, 1932). The medium is kept at 37°C and oxygenated with O2 /CO2  (19:1); a
physiological pH of 7.4 is also maintained. Various agonists, antagonists, and other chosen 
compounds can be infused into the portal vein by pump-driven syringes at any time with only minimal 
disturbance to the tissue. The outflowing medium collected from the vena cava is passed through a 
chamber containing various electrodes for measuring the concentration of ions such as Ca2+ O2  and
pH. In addition, after passing through the electrode chamber, the outflowing medium can be collected 
for the assay of various metabolites, e.g. glucose, by other analytical procedures. The use of this 
technique, utilizing the intact, undisrupted tissue, permits a study of the effects of agonists under 
conditions which closely approximates the in vivo situation. Therefore, apart from its usefulness in the 
characterization of agonist-induced responses, studies with the perfused liver often have the potential to
6isolate those effects of agonists that arise solely as a consequence of tissue disruption, or the 
unphysiologic conditions under which in vitro experiments on cellular and subcellular components are 
sometimes conducted. It is not surprising therefore, that studies with the perfused tissue often have 
complemented and extended the interpretation of those findings made at the cellular, subcellular and 
molecular level. In essence, the technique allows one to help identify those effects or actions that may 
be considered to be of more physiological relevance to the whole animal.
The greater complexity of the whole liver relative to isolated cells is not itself without drawbacks. 
Notably, to date the technique permits only net whole-tissue changes of metabolites to be measured; 
there is no indication of the location of these changes among the different cell-types that may exist, or 
among cells in different regions of the tissue. Aspects of this problem are considered in the first part 
of this review.
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(C) NON-PARENCHYMAL CELLS AS MEDIATORS OF PHYSIOLOGICAL
RESPONSES IN LIVER
8(1) Introduction
The liver is the largest organ in the body, performing a variety of physiological and metabolic 
functions many of which are under strict control by hormones and other regulatory mechanisms (Arias 
et al., 1982). The basic functional unit of the liver is the acinus which consists of a small parenchymal 
mass formed about a vascular axis consisting of a terminal portal venule, hepatic arteriole, bile duct, 
lymph vessels and nerves (see eg. Rappaport et al., 1954; Rappaport, 1973; Campra & Reynolds, 
1982). Parenchymal cells are arranged in sheets or laminae that radiate out from terminal branches of 
the hepatic vein. These sheets interconnect to form a continuous 3-dimensional lattice structure. There 
is evidence that adjacent parenchymal cells are connected by gap-junctions of low electrical resistance 
(Gilula & Hertzberg, 1982), and that both parenchymal and non-parenchymal cells are innervated (Metz 
& Forssmann, 1980). Blood supply to the liver occurs through the hepatic artery and the portal vein; 
of these the latter is the major inflow system. The portal vein and hepatic artery branch repeatedly into 
smaller terminal divisions that eventually become continuous with sinusoids. Hepatic arteries run with 
branches of the portal vein forming arterioles and capillaries which empty into the terminal portal vein 
and sinusoids, thereby constituting the hepatic microcirculatory unit (Rappaport, 1973; Campra & 
Reynolds, 1982). Each sinusoid therefore receives blood from branches of the portal vein and hepatic 
artery and empties into terminal hepatic venules which are collected into the vena cava. The periportal 
regions of the liver include those parenchymal cells situated around the terminal portal venules which 
are the first to come in contact with the incoming blood. The cells in the perivenous regions are those 
situated around efferent terminal hepatic venules. Owing to the fact that exchange of substrate and 
metabolites would have occurred on passage through the periportal regions, these cells are therefore 
exposed to blood of different composition. It is clear also, that apart from stimulation via nerves, 
alteration in the composition of the blood (eg. the presence of hormones or other stimulating factors) 
and/or its rate of flow through the liver provide the principal means by which changes in the metabolic 
activity of the organ can be effected.
(2) Liver heterogeneity
It has been known for many years that liver is composed of different cell-types including: 
hepatocytes, endothelial cells, Kupffer cells and fat-storing cells (see eg. Blouin, 1977; Wisse & 
Knook, 1977). In rat liver, endothelial cells constitute 48%, Kupffer cells 39% and fat-storing cells 
approximately 13% of the non-parenchymal cells (Widmann et al., 1972; Blouin, 1977). The 
non-parenchymal cells make up approximately 35% of the total cell number, but because of their much 
larger size, the parenchymal cells (the hepatocytes) make up in excess of 90% of the total liver mass. 
Recent work suggests that the parenchymal cells of liver are themselves heterogenous with respect to
9the activities of a number of cellular enzymes depending on whether they are situated in periportal or 
perivenous regions in relation to blood flow (Jungermann & Katz, 1982; Sies, 1982, 1987; Thurman et 
al., 1986). The contribution of the different cell-types, and perhaps the location of the parenchymal cells 
themselves may be an important factor that needs to be taken into account when interpreting the effects 
that are observed on exposing the intact liver to a particular stimulating agent. A more detailed 
description of the structural organization of the liver in relation to these different cell-types therefore is 
warranted.
The sinusoids of liver are lined with fenestrated wall-forming endothelial cells and phagocytic 
Kupffer cells (see Fig. 1). The endothelial cells have an elongated shape and their fenestrations form 
sieve-like plates along the sinusoidal lining (Aterman, 1963; Fahimi, 1967; Fahimi, 1970; Widmann 
& Fahimi, 1975). The Kupffer cells are stellate in shape and are preferentially distributed in the 
sinusoids around the portal tract; they have morphological features that are typical of macrophages. The 
precise function of endothelial and Kupffer cells is not known; however it is known that they participate 
in the clearing of foreign material from the blood including senescent erythrocytes, micro-organisms and 
macromolecules (see eg. van Berkel, 1979). The Kupffer cells are highly efficient in phagocytozing 
large particles, whereas the endothelial cells have only a limited capacity for endocytosis of particulate 
matter (Widmann et al., 1972). It is thought that these sinusoidal cells constitute a co-ordinated defence 
system which can protect hepatocytes against injury. In addition to endothelial and Kupffer cells, the 
liver also contains fat-storing cells (Ito, 1973) which are located in the perisinusoidal space. These cells 
contain numerous lipid droplets and are thought to be involved in aspects of lipid metabolism and in the 
storage of vitamin A (Ikejeri & Tanikawa, 1977).
The parenchymal cells have long been known to be involved in a wide spectrum of metabolic 
activity including the storage and breakdown of glycogen, gluconeogenesis, amino acid and fatty acid 
metabolism. Although recent evidence suggests that some degree of specialization of these cells may 
exist among hepatocyte populations in different regions or 'zones' within the liver (Jungermann & Katz, 
1982; Sies, 1982, 1987; Thurman et al., 1986), it seems most likely that this type of specialization or 
heterogeneity is less important, in so far as this discussion is concerned, than that which occurs 
between the different cell-types (e.g. hepatocytes and Kupffer cells). It has been established that apart 
from making up the bulk of the liver, hepatocytes are the principal sites of glycogen storage, and 
contain more than 95% of mitochondria in liver (which therefore can account for a large proportion of 
the respiratory activity of the whole organ). Also, by comparison with the endothelial cells and Kupffer 
cells which are much smaller in volume, hepatocytes contribute a much greater total surface area of 
endoplasmic reticula. Both types of organelles (ie. mitochondria and endoplasmic reticula) are 
important for the regulation of intracellular Ca2+ which is important in the activation of physiological 
responses in liver by Ca2+-mobilizing agonists (for reviews see eg. Reinhart etal., 1984a,e;
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Fig. 1. Relationship betweeen the different cell types in liver.
The simplified diagram shows the structural relationship between the parenchymal 
cells (hepatocytes) and nonparenchymal cells (Kupffer and endothelial cells) in liver 
sinusoids. A cross-section of the sinusoid is shown in (a), and a longitudinal section 
is shown in (b). The illustrations are based on studies using electron microscopy 
(see Fahimi, 1967; Wisse & Knook, 1977).
(a)
HepatocytesSinusoid
Kupffer cell
Endothel ia l  cell
(b)
Hepatocytes
SinusoidEndothel ia l  cells K upffe r  cells
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Exton, 1985; Williamson et al., 1985). Also, since the mitochondria and the endoplasmic reticulum 
are believed to be the main stores of intracellular Ca2+, it is clear that the bulk of intracellular Ca2+ in 
liver is associated with hepatocytes. It is well established that the mobilization of this Ca2+, and also 
the activation of other messenger systems such as the adenyl cyclase generating cyclic AMP, can be 
effected by the activation of various receptors on the surface of the plasma membrane of hepatocytes, 
both in isolated hepatocyte preparations and in the perfused liver. This suggests that the metabolic 
activity of these cells can be influenced or controlled by hormones in the blood. Because hepatocytes 
sediment at lower g forces than either endothelial cells, or Kupffer cells, it also should be pointed out 
that hepatocyte preparations obtained from low-speed centrifugation of dispersed cells from whole liver 
contain an increased proportion of hepatocytes by comparison with the sinusoidal cells. This sometimes 
can provide a means of distinguishing those agonists or stimulating factors which act directly on 
hepatocytes from those whose actions are mediated by an interaction with sinusoidal cells.
(3) Evidence that non-parenchymal cells play a role in mediating the effects of 
various stimulating agents
In recent years evidence has accumulated which suggests that in some situations the effects induced 
by agents administered to the perfused rat liver cannot be explained solely in terms of an action on the 
liver parenchyma. For example, the infusion of heat-aggregated immunoglobulin G to the perfused rat 
liver was reported to induce vasoconstriction, changes in whole-tissue respiration and a stimulation of 
glycogenolysis (Buxton et al., 1984b; 1987). These responses were inhibited by pre-treatment of the 
liver with the cyclo-oxygenase inhibitor indomethacin, and could be mimicked by the infusion of 
prostaglandin E2 (Buxton et al., 1984b, 1987). Another area of recent considerable interest to many 
workers concerns the mechanism of action of the phosphoglyceride l-O-hexadecyl-2-acetyl-sn-glycero- 
3-phosphocholine, also called platelet activating factor (PAF) (Hanahan, 1986; Braquet et al., 1987). 
Studies by a number of workers (Shukla et al., 1983; Mendlovic et al., 1984; Buxton et al., 1984a, 
1986; Fisher et al., 1984, 1986) have shown that the administration of PAF to the perfused rat liver 
elicits powerful vasoconstrictive effects, changes in respiration, and a stimulation of glycogenolysis. 
Surprisingly, no effect of PAF could be observed in isolated hepatocytes (Fisher et al., 1984). This 
result cannot be readily explained, other than to propose that receptors for PAF are damaged or rendered 
non-functional during hepatocyte preparation (Fisher et al., 1984). An explanation for the action of 
PAF is further complicated by the apparent conflicting reports regarding the ability of PAF to stimulate 
phosphoinositide hydrolysis in isolated hepatocytes (Fisher et al., 1984; Charest et al., 1985a), and the
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finding that PAP elicits its effects without significant mobilization of Ca2+ in the perfused rat liver 
(Buxton et al., 1984a; Lapointe et al., 1987); but see later. A recent study suggests however, that in 
isolated hepatocytes PAP stimulates the breakdown of phosphoinositides by activation of 
phospholipase A2 rather than phospholipase C (Okayasu et al., 1987). This may explain the reported 
inability of PAF to stimulate glycogenolysis (Fisher et al., 1984) and the production of the second 
messenger inositol 1,4,5-trisphosphate in this system (Charest et al., 1985a). Another group of 
workers (Mendlovic et al., 1984), reported an inhibition of the vasoconstrictive and glycogenolytic 
effects of PAF by indomethacin, an inhibitor of cyclo-oxygenase. However, because of the apparent 
uncertainty that existed concerning the location of cyclo-oxygenase activity in liver, these results also 
were not readily interpretable.
Recently, studies with Kupffer cells and with endothelial cells isolated from rat liver suggest that 
when in short-term culture, both cell-types take up and metabolize arachidonic acid, and can be 
stimulated by agents such as Ca2+-ionophore A23187, phorbol esters and PAF (Birmelin & Decker, 
1984; Dieter et al., 1986; Schlayer et al., 1986). Stimulation of the cells by these agents has been 
shown to lead to the generation o f superoxide, and to the production of eicosanoids particularly
prostaglandins (PG) D 2> E2> F2a and I2 or prostacyclin (see refs above) as shown in Fig. 2. By
contrast, hepatocytes do not appear to be significant producers of eicosanoids (Decker, 1985; Tran-Thi et 
al., 1986). These observations are consistent also with the report that arachidonic acid-induced
production of thromboxane B 2 (TXB2), 6-keto-PGFja  and PGF2a , is more specific for the
non-parenchymal cells isolated from mouse liver (Spolarics et al., 1987). Another important 
observation utilized the ability of Kupffer cells to take up small particles by phagocytosis. Thus it has 
been shown that Kupffer cells take up and are stimulated by opsonized zymosan to produce various
eicosanoids including PGE2 PGF2a and thromboxane B2 (TXB2) (Birmelin & Decker, 1984; Dieter
et al., 1986). In most instances the stimulation of Kupffer cells and endothelial cells to produce 
eicosanoids can be blocked by inhibitors of phospholipase A2 and inhibitors of arachidonic acid 
metabolism (Birmelin & Decker, 1984; Decker, 1985; Dieter et al., 1986).
In view of the action of agents such as zymosan, arachidonic acid, and PAF on Kupffer and/or 
endothelial cells in culture, studies were conducted in this laboratory to determine the effects of 
administering these agents in the perfused liver. Exogenously-administered arachidonic acid and
opsonized zymoson, but not latex particles (1|jjv> diameter) were found to induce vasoconstriction 
(Dieter et al., 1987a), Ca2+ flux changes and a stimulation of oxygen uptake and glucose output 
(Dieter et al., 1987b). Because zymosan is taken up selectively by Kupffer cells and not by either 
endothelial cells or hepatocytes (Wisse & Knook, 1977), the findings provide strong evidence for the
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Fig. 2. The arachidonate cascade.
A simplified schematic diagram showing the likely mechanism by which eicosanoid 
production is elicited in liver sinusoidal cells (Kupffer and endothelial cells) by 
various stimulating agents, and the sites of action of various inhibitors described in 
the text.
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involvement of Kupffer cells in the action of this agent. It is noteworthy that the vasoactive effects of 
zymosan were inhibited 40-50% by indomethacin (an inhibitor of cyclo-oxygenase; Vane, 1971), 
nordihydroguaiaretic acid (an inhibitor of lipoxygenase; Chang et al., 1984) and bromophenacyl bromide 
(an inhibitor of phospholipase A2; Blackwell & Flower, 1983 , see Dieter et al. (1987aJ, whereas Ca2+ 
fluxes and other responses were significantly inhibited (70-80%) by bromophenacyl bromide and 
nordihydroguaiaretic acid (Dieter et al., 1987b). Also, the Ca2+ flux changes and associated responses 
induced by arachidonic acid were sensitive to inhibition by indomethacin, and hence indicated a possible 
involvement of prostanoids in mediating these effects. These data suggested, therefore, that the action 
of zymosan and arachidonic acid were at least partly mediated by eicosanoids (Needleman et al., 1986), 
products of cyclo-oxygenase and/or lipoxygenase produced within the liver.
Despite reports which suggest that the action of PAF is not associated with any Ca2+ flux changes 
at low perfusate Ca2+ (Buxton et al., 1984a), recent work from our laboratory indicates that PAF, and
also a structurally related compound lysolecithin (L-a-lysophosphatidylcholine), elicits marked changes 
in Ca2+ fluxes, particularly Ca2+ efflux, when administered to the liver perfused with media containing 
a physiological concentration (1.3mM) of Ca2+ (Altin et al., 1987b). This raises the possibility that 
these agents elicit their glycogenolytic effect by a mobilization of Ca2+ from intracellular stores in 
hepatocytes. However, because of the uncertainty of the effect of PAF on inositol 1,4,5-trisphosphate 
production in hepatocytes (Fisher et al., 1984; Charest et al., 1985a), the mechanism of Ca2+ release is 
unclear. Unlike Ca2+-mobilizing hormones (see eg. Altin & Bygrave, 1986) PAF and lysolecithin do 
not act synergistically with glucagon to stimulate Ca2+ influx in the perfused rat liver (Altin & 
Bygrave, unpublished observations). This suggests therefore that the mechanism of action of PAF and 
lysolecithin is different to the mechanism of action of the Ca2+-mobilizing hormones. The possibility 
that the action of PAF is mediated by eicosanoids, and prostaglandins in particular, was realized 
following the observation that under these conditions, the changes in Ca2+ flux, respiration, 
glycogenolysis and vasoconstriction were considerably inhibited by bromophenacyl bromide and 
indomethacin (Mendlovic et al., 1984; Altin et al., 1987b). Since hepatocytes appear to be involved in 
the degradation rather than in the synthesis of eiconasoids (Decker, 1985; Tran-Thi et al., 1986), the 
findings suggest that eicosanoids produced by non-parenchymal cells, also may be involved in the 
action of PAF and lysolecithin in the perfused rat liver. This notion is consistent with the finding that 
PAF stimulates the production of eicosanoids when added to Kupffer and endothelial cells in culture 
(Dieter et al., 1986; Schlayer et al., 1986), and also perhaps with the observation that PAF can act on 
cultured vascular endothelium in various blood vessels (Brock & Gimbrone, 1986). Because endothelial 
cells at the junction of sinusoids and portal venules have been proposed to play some role in the 
regulation of blood flow in sinusoids (McCuskey, 1966), and PAF has been reported to act directly on 
vascular endothelial cells in some systems (Hanahan, 1986; Braquet et al., 1987), we do not rule out the
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possibility that in liver also, PAF may act directly on these or other vasoactive cells (eg. smooth 
muscle) inducing vasoconstriction, and therefore responses associated with anoxia or ischemia within 
regions of the liver tissue (Buxton et al., 1986; Fisher et al., 1986; Hill & Olson, 1987).
Recently, a number of other studies utilizing the perfused liver have emerged which suggest that 
non-parenchymal cells may be involved in mediating responses in liver. Firstly, there are reports which 
suggest that the glycogenolytic effects of phorbol esters in the perfused liver are inhibited by 
indomethacin (Garcia-Sainz & Henandez-Sotomayer, 1985a; Patel, 1987). In this instance it was noted, 
however, that PMA administration did not alter production of PGE2 and 6-oxo-PGFla  (Patel, 1987).
Secondly, it has been reported (Taylor, van de Pol, van Heldon, Reinhart & Bygrave, 1985) that the 
exposure of livers to 60mM K+ (by partial substitution of the NaCl in the Krebs-Henseleit medium 
perfusing the liver) induces Ca2+-dependent responses including glycogenolysis, alterations in octanoate 
oxidation, and alterations in cytoplasmic and mitochondrial NADH/NAD ratios. The responses were 
not observed when the livers were perfused in the presence of Ca2+ channel blockers, or in the absence 
of added Ca2+. The results were therefore interpreted to reflect the existence of voltage-sensitive Ca2+ 
channels in hepatocytes. Subsequently, it was reported that the exposure of livers to depolarizing 
concentrations of K+ was also accompanied by marked vasoconstrictive effects (Hill et al., 1987). The 
vasoconstriction and other metabolic effects were inhibited by verapamil (a Ca2+ channel blocker) 
but were unaffected by indomethacin. It was proposed that the glycogenolytic and metabolic effects 
were secondary to vasoconstriction and associated anoxia within the liver tissue (Hill et al., 1987), a 
conclusion consistent with the observation that depolarization by extracellular K+ may lead to a 
contraction of endothelial cells at the junction of sinusoids and portal venules (McCuskey, 1966). 
Recent studies in our laboratory have revealed that the responses induced by depolarization with 60mM
K+ are inhibited 70-80% by a 15 min pretreatment with 20|i.M indomethacin, or with 20|iM 
bromophenacyl bromide (unpublished work). Because Ca2+ ionophore A23187 has been shown to 
stimulate production of eicosanoids in sinusoidal cells (Birmelin & Decker, 1984; Dieter et al., 1986), 
and since eicosanoid production by sinusoidal cells is dependent on extracellular Ca2+ (Decker & 
Birmelin, 1984), it may be argued that the effects of depolarizing concentrations of K+ may also 
involve the production of eicosanoids in these cells by activating Ca2+ influx through voltage-sensitive 
Ca2+-channels.
Thirdly, very recently it was reported that the action of sympathetic nerve stimulation on liver 
metabolism and hemodynamics are significantly inhibited by both bromophenacyl bromide and 
indomethacin (Iwai & Jungermann, 1987). Because eicosanoid production occurs principally in the 
Kupffer and endothelial cells (Decker, 1985; Dieter et al., 1986; Schlayer et al., 1986; Tran-Thi et al., 
1986; Spolarics et al., 1987), and hepatocytes and sinusoidal cells are reported to be innervated (Metz &
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Forssmann, 1980), this study suggests that the responses induced by nerve stimulation are at least
partly mediated or modulated by eicosanoid production, particularly prostanoids, in the sinusoidal cells.
■fUt _
Finally, it is of interest also, that^Caz+ ionophore A23187, which has been shown to elicit eicosanoid 
production in sinusoidal cells (Birmelin & Decker, 1984; Dieter et al., 1986), has been shown to induce
vasoconstriction and other responses in the perfused rat liver (Reinhart et al., 1983; Akerboom et al.,
1987).
(4) Effects of prostanoid administration to the perfused liver
The large body of evidence suggesting that eicosanoids, products of cyclo-oxygenase in particular, 
are involved in mediating physiological responses in liver, prompted us to examine the effects of 
exogenously administering various prostanoids to the perfused liver. These studies showed clearly that 
prostaglandins D2, E2 and particularly PGF2a induced marked stimulation of Ca2+ fluxes, and glucose
output (Altin & Bygrave, 1988). Moreover, PGF2a appeared to release Ca2+ from the same
intracellular stores as the a-agonist phenylephrine. Also, similar to other Ca2+-mobilizing agonists, 
PGF2a was found to interact synergistically with glucagon to stimulate extensive Ca2+ uptake by 
mitochondria (Altin & Bygrave, 1986, 1988). Similar results were obtained when the experiments were 
conducted with isolated hepatocytes. These results indicate that the mechanism of action of PGF2ot is
similar to that of phenylephrine and other Ca2+-mobilizing agents, and hence, suggest that PGF2a 
elicits its effects by stimulating phosphoinositide breakdown and production of inositol 
1,4,5-trisphosphate in hepatocytes. It should be pointed out that although the action of PGF2a was 
accompanied by vasoconstriction, presumably reflecting an action on endothelial and/or smooth muscle 
cells (Fukuo et al., 1986), the potency of PGF2a in inducing vasoconstriction was three orders of 
magnitude lower than, and the vasoconstrictive effect itself was smaller than (approx. 20%), that 
induced by PAF and the TXA2 analogue ONO-11113 (compare results in Altin et al., 1987b and Altin
& Bygrave, 1988). The administration of PGD2> and PGE2 also induced Ca2+ flux changes and a 
stimulation of respiration and glycogenolysis. However, comparable concentrations of these agents 
induced much smaller effects than those induced by PGF2ot. Similar results recently have been reported 
(Haussinger et al., 1987b). It was of interest to observe also that the general pattern of Ca2+ flux 
change and other responses induced by 5|iM PGF2a exhibited features similar to those induced by the
administration of lOOfiM arachidonic acid (Dieter et al., 1987b; Altin & Bygrave, 1987c, 1988). But, 
whereas the action of arachidonic acid was inhibited by indomethacin, the Ca2+ fluxes and other
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responses induced by PGF2a were not inhibited by this agent. These results show clearly that 
exogenously-administered prostaglandins elicit physiological responses in rat liver, and suggest that the 
action of arachidonic acid may be largely mediated by PGF2a .
The possible effects of the prostanoid thromboxane A2 (TXA2) in liver were studied using the
analogue ONO-11113. This agent was found to elicit marked vasoconstriction, Ca2+ flux changes, 
changes in respiration, and glycogenolysis (Altin & Bygrave, 1988). The general pattern of Ca2+ 
response was similar to that induced by PAF and lysolecithin (compare responses in Fig. 4 of Altin & 
Bygrave, 1988; with Figs 2 and 3 of Altin et al., 1987b). While studying the effects of U-46619, a 
different analogue of TXA2, Fisher et al. (1987) proposed that the induced glycogenolytic and metabolic 
effects were secondary to anoxia and ischemia induced as a consequence of vasoconstriction and a 
possible re-distribution of flow in different regions of the liver. In fact, there are suggestions that 
anoxia can stimulate glycogenolysis and alter metabolism in liver by increasing intracellular AMP 
(Hers, 1976; Hems & Whitton, 1980; Sharma, 1980). However, our observation that the action of 
ONO-11113 is associated with marked Ca2+ flux changes, raises the possibility also that at least part of 
the metabolic changes may occur as a consequence of Ca2+ mobilization in hepatocytes. Whether the 
Ca2+ release is induced directly by the action of ONO-11113 on hepatocytes, or indirectly as a 
consequence of vasoconstriction and associated anoxia, is unclear. The data show however, that the 
mechanism of Ca2+ release by ONO-11113 is probably different to that of the Ca2+-mobilizing 
agonists; moreover, similar to PAF and lysolecithin, the action of ONO-11113 is not synergistic with 
glucagon in stimulating Ca2+ influx (Altin & Bygrave, 1988). The possibility that Ca2+ release 
induced by ONO-11113 is secondary to anoxia needs to be considered because of the observed effects of 
ONO-11113 on vasoconstriction and inhibition o f whole-tissue oxygen uptake, and the established 
dependence of mitochondrial respiration on oxygen supply. In this regard preliminary experiments in 
our laboratory indicate that the action of ONO-11113 may be counteracted by the prostacyclin analogue 
Iloprost (ZK 36 374).
Because the administration of respiratory inhibitors to the perfused rat liver, or to isolated 
hepatocytes, is known to be associated with a release of Ca2+ from intracellular stores (which may 
include a loss of Ca2+ from both mitochondria and endoplasmic reticulum (see eg. Reinhart et al., 
1984a,e; Exton, 1985; Williamson et al., 1985), it seems possible also that the onset of anoxia could 
inhibit respiration similarly and result in the mobilization of such Ca2+. An alternative explanation is 
that the mobilization of Ca2+-induced by ONO-11113 could involve some form of coupling (perhaps 
through gap junctions or nerves) between cells responsive to ONO-11113 (e.g. endothelial and/or 
smooth muscle cells) and hepatocytes. As yet there is no evidence however to support this model.
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From these studies it is apparent that the mechanism by which ONO-11113 and perhaps other TXA2 
analogues [and possibly other agents such as UTP whose effects in liver are associated with significant 
vasoconstriction (Haussinger et al., 1987a)] induce their effects on parenchymal cells requires further 
investigation. However it is clear that the analogues themselves, and presumably the prostanoid TXA2, 
exert quite powerful effects in the perfused liver.
(5) Aspects of intercellular communication in liver- an integrated hypothesis
The possibility that eicosanoids produced by sinusoidal cells could modulate responses in 
hepatocytes was suggested by Decker (1985) following the observation that the cells can produce 
eicosanoids when stimulated in culture. Until recently, however, there was no direct experimental 
evidence to suggest that this could occur in the intact liver. A study of the action of agents like 
arachidonic acid, zymosan, PAF and lysolecithin, recently has led us to propose a model for the 
mechanism by which these agents elicit their effects in the perfused rat liver (Dieter et al., 1987a,b; 
Altin et al., 1987b). In light of recent findings, this model can now be extended to include the action of 
other stimulating factors (see Fig. 3). Essentially, the model proposes that in the perfused liver, a 
number of stimulating agents can exert their principal effects on sinusoidal cells leading to the 
production of eicosanoids within the liver, as well as interacting directly with hepatocytes. Eicosanoid 
production can be elicited by different routes including: phagocytosis (e.g. of particular immune 
aggregates and agents like zymosan by Kupffer cells), the interaction of agonists with specific receptors 
linked directly with activation of phospholipase A2 (Lapetina, 1982; Burgoyne et al., 1987; Chang et
al., 1987), indirect activation of phospholipase A2 by phorbol esters or by altering resting Ca2+ levels
(e.g. by A23187 and perhaps by K+-induced depolarization), the exogenous administration of 
arachidonic acid, and perhaps nerve stimulation (Iwai & Jungermann, 1987). Since particulate zymosan 
selectively interacts with Kupffer cells whereas exogenous arachidonic acid is metabolised by both 
Kupffer cells and endothelial cells, it is most likely also that each particular stimulating agent will 
differ in its ability to interact with Kupffer and endothelial cells. Therefore, as Kupffer and endothelial 
cells each produce a different spectrum of prostaglandins (Birmelin & Decker, 1984; Decker, 1985; 
Dieter et al., 1986; Schlayer et al., 1986), it is likely also that the spectrum of eicosanoids produced by 
different stimulants will differ by virtue of their differing ability to interact with each type of sinusoidal 
cell. These differences will therefore reflect the characteristics of the particular stimulating agent.
The eicosanoids released from the sinusoidal cells are presumed to interact with hepatocytes either 
through specific receptors on the plasma membrane, or by being taken up by the hepatocytes
themselves and metabolized. Also, specific eicosanoids such as PGF2a and TXA2 may also interact
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with vascular endothelial and smooth muscle cells (Fukuo et al., 1986; Dom II et al., 1987) to elicit 
vasoconstriction of the hepatic vasculature and/or a redistribution of blood flow in different regions of 
the liver. It is presumed that both these processes can induce physiological responses or alter the 
metabolic activity of parenchymal cells. Our work suggests that at least one prostaglandin, namely
PGF2a , which is purported to be produced by Kupffer and endothelial cells (Birmelin & Decker, 1984;
Decker, 1985; Dieter et al., 1986; Schlayer et al., 1986), elicits its effects on liver parenchyma by a 
mechanism which mimics that of other Ca2+-mobilizing agonists (Altin & Bygrave, 1988). This
suggests firstly, that hepatocytes possess receptors for PGF2a  , and secondly that, as with other
Ca2+-mobilizing agonists, the activation of these receptors leads to a stimulation of phosphoinositide 
hydrolysis and the production of second messengers for the mobilization of cellular Ca2+ (Berridge, 
1984; Williamson etal., 1985).
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PART II
(D) SECOND MESSENGERS AND THE REGULATION OF Ca2+ FLUX BY 
Ca2+-MOBILIZING AGONISTS IN RAT LIVER
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(I) MECHANISM OF ACTION OF Ca2+-MOBILIZING AGONISTS IN LIVER
(1) Receptors for Ca2+-mobilizing agonists in liver parenchyma
Apart from receptors that regulate cyclic AMP production, the liver parenchyma possess another 
major type of cell surface receptor , the activation of which mediate^effects via an increase in cytosolic 
Ca2+. These are generally referred to as Ca2+-mobilizing receptors and include those for the 
(Xji-adrenergic agonists such as phenylephrine, adrenaline and noradrenaline, and those for the peptide 
hormones vasopressin and angiotensin. Pharmacological studies have revealed that these receptors exist 
as distinct molecular entities on the plasma membrane of hepatocytes and that the action of the agonists 
are brought about by an interaction with their respective receptor (see eg. Campanile et al., 1982; Crane 
et al., 1982; Jard, 1983; Kirk et al., 1983; Goodhardt et al., 1984). Studies on the characterization of
the (Xj-receptor from rat liver suggests that it is a dimer of 85 KDa subunits (Venter & Fraser, 1983;
Venter et al., 1984a). The a^-receptor has been characterized also in a number of other tissues 
including smooth muscle (Lomasney et al., 1986), and has been shown to be structurally related to the 
otj-receptor from human platelets (Shreeve et al., 1985) and to the muscarinic cholinergic receptor in the 
nervous system (Venter et al., 1984b). In liver, vasopressin interacts with the Vj-vasopressin receptor
(reviewed in Kirk et al., 1983) which is a hydrophobic and highly asymmetrical molecule of 70-90 KDa 
(Guillon et al., 1980; Jard, 1983; Crause et al., 1984; Fishman et al., 1987). Recent studies suggest 
that the Vj-receptor is a glycoprotein (Dickey et al., 1987) and may exist as a dimer of 30 KDa and 38 
KDa subunits (Boer & Fahrenholz, 1985). Moreover, solubilization of the receptor has shown that it 
may exist coupled to a GTP-binding protein in rat liver plasma membranes (Bojanic & Fain, 1986; 
Fitzgerald et al., 1986; Dickey et al., 1987); the solubilized receptor has also been reconstituted into 
phospholipid vesicles (Aiyar et al., 1987; Dickey et al., 1987). Hitherto there has been only a 
preliminary characterization of the angiotensin Aj-receptor from rat liver (Campanile et al., 1982; 
Crane et al., 1982; Sen et al., 1983) and from kidney cortex (Douglas, 1987).
Although the peptide hormone glucagon traditionally has been regarded as a typical example of a 
hormone that acts solely via cyclic AMP, recent evidence suggests that liver cells possess two distinct 
receptors for this hormone; a GR-2 receptor linked to the activation of adenylate cyclase and a GR-1 
receptor which is linked to the mobilization of Ca2+ (Peterson & Bear, 1986; Wakelam et al., 1986; 
Houslay et al., 1987). Hitherto, it seems that neither of these receptors has been characterized.
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Other receptors thought to be linked to the mobilization of Ca2+ in liver include the P2-purinergic
receptor activated by both ADP and ATP (Sistare et al., 1985; Staddon & McGivan, 1985; Charest et 
al., 1985b; Keppens & De Wulf, 1986; Okajima et al., 1987; Altin & Bygrave, 1987a), and perhaps 
receptors for EGF (epidermal growth factor) (Johnson et al., 1986; Johnson & Garrison, 1987; Altin &
Bygrave, 1987a), phosphatidic acid (Altin & Bygrave, 1987c), PGF2a  (Altin & Bygrave, 1988), 
[Leu]enkephalin (Leach & Titheradge, 1986; Leach et al., 1986) and histamine (Garcia-Sainz et al., 
1987). Preliminary studies indicate that the P2-purinergic receptor from human platelets is a protein of 
100 KDa (Figures et al., 1986), and that the EGF receptor from rat liver is a protein of around 170 KDa 
(Taylor, Uhing, Blackmore, Prpic & Exton, 1985). Whilst phosphatidic acid, PGF2a , [Leu]enkephalin
and histamine have been shown to induce responses characteristic of Ca2+-mobilizing agonists (see refs 
above), in most instances it remains to be shown that the action of these agents in liver is 
receptor-mediated.
Whilst not many Ca2+-mobilizing receptors can be considered to be well-characterized in liver, and 
the structure of different receptors and their affinity for a particular agonist often differs widely as judged 
from studies in a number of tissues, all Ca2+-mobilizing receptors appear to be linked to a common 
signal transduction mechanism which leads to the mobilization of cellular Ca2+, and to the induction of 
Ca2+-dependent (and perhaps also Ca2+-independent) physiological responses. Such responses include a 
stimulation of glycogenolysis, respiration, and alterations in the cytosolic and mitochondrial 
oxidation-reduction ratios (see eg. Williamson et al., 1981, 1985; Reinhart et al., 1982a,c, 1984a,c; 
Exton, 1985; Taylor et al., 1983a, 1986; Patel, 1986). Moreover, a considerable body of evidence now 
exists which suggests that a characteristic feature of the Ca2+-mobilizing receptors is their ability to 
stimulate the hydrolysis of phosphoinositides in the plasma membrane (see eg. Creba et al., 1983; 
Berridge, 1984, 1987; Charest et al., 1985a). In some instances (eg. that of EGF, phosphatidic acid,
PGF2a , [Leu]enkephalin and histamine) the existence of a specific receptor and/or an effect of the 
agonist on phosphoinositide hydrolysis in liver remains to be established. However, there is 
compelling experimental evidence which indicates that the activation of receptors for a-agonists, 
vasopressin and angiotensin, induces a receptor-mediated hydrolysis of phosphoinositides which 
generates second messengers for the mobilization of cellular Ca2+ (Creba et al., 1983; Joseph et al., 
1984a; Berridge, 1984), the induction of Ca2+-dependent responses (Williamson et al., 1981, 1985, 
1986; Reinhart et al., 1984a,e; Exton, 1985), and responses brought about by an activation of protein 
kinase C (Nishizuka, 1983, 1984, 1986; Berridge, 1984). These receptor-mediated events will be 
discussed in more detail in following sections of this work.
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(2) Polyphosphoinositides and the generation of second messengers by 
Ca2 +-mobilizing agonists - an overview
In recent years it has been established that in liver as well as in a number of other tissues, the 
mechanism of signal transduction for Ca2+-mobilizing agonists involves changes in the metabolism of 
the membrane phospholipids phosphatidylinositol 4-phosphate (PIP) and phosphatidylinositol 
4,5-bisphosphate (PIP2). These lipids are collectively referred to as phosphoinositides and have been
shown to constitute a minor proportion (1-2%) of the total phospholipids in eukaryotic cells. Under 
resting conditions the levels of each of the phosphoinositides are in equilibrium. The binding of a 
Ca2+-mobilizing agonist to its receptor on the plasma membrane leads to the activation of a 
PIP2'Specific phospholipase C (Downes & Michell, 1981) which stimulates the phosphodiesteratic
hydrolysis of PIP2 to yield 1,2-diacylglycerol and inositol 1,4,5-trisphosphate (IP3) as illustrated in
Fig. 4 (see also Berridge, 1983, 1984; Creba et al., 1983; Charest et al., 1985a; Lynch et al., 1985b; 
Williamson et al., 1985; Williamson & Hansen, 1987). Whilst the identity of the coupling factor(s) 
between the receptor and phospholipase C remains to be established, current evidence suggests that a 
GTP-binding protein(s) may be involved, a situation somewhat analogous to the receptor-activation of 
adenylate cyclase (Litosch & Fain, 1986; Taylor & Merritt, 1986). The two metabolites diacylglycerol 
and IP3 have been shown to serve as intracellular second messengers. Thus, diacylglycerol activates 
protein kinase C in the presence of phosphatidylserine and Ca2+ (Nishizuka, 1983, 1984, 1986), and 
the water-soluble product IP3 has been shown to stimulate the release of Ca2+ from intracellular stores,
namely the endoplasmic reticulum (Streb et al., 1983; Joseph et al., 1984a, Burgess et al., 1984a,b; 
Thomas et al., 1984; Prentki et al., 1984a). Because protein kinase C exerts positive and negative 
feedback controls on this receptor-linked diacylglycerol/^ generating system (Nishizuka, 1984, 1986),
and because Ca2+ is involved in the activation of Ca2+-dependent responses (for reviews see 
Williamson et al., 1981, 1985, 1986; Reinhart et al., 1984a,e; Exton, 1985), both branches of the 
pathway often are necessary for the full expression of the final cellular response.
The metabolism of IP3 occurs either through the stepwise degradation to I(1,4)P2,1(4)P, and I by 
the successive phosphatase action of a phosphomonoesterase(s) (Berridge, 1983, 1984; Storey et al., 
1984; Tennes et al., 1987; Shears et al., 1987a). Or alternatively, as illustrated in Fig. 5, IP3 can be
phosphorylated to inositol 1,3,4,5-tetrakisphosphate (IP4) (Batty et al., 1985; Burgess et al., 1985; 
Downes et al., 1986; Hansen et al., 1986) and other inositol phosphates (eg. different isomers of IP4, 
IP5 and possibly IPß, see also Nahorski & Batty, 1986; Michell, 1986a; Downes, 1986; Vallejo et al., 
1987) by the action of specific kinases such as the Ca2+/calmodulin-dependent I(1,4 ,5)P3 kinase
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Fig. 4. The role o f polyphosphoinositide hydrolysis in the mechanism o f action o f 
Ca2+-mobilizing agonists.
Occupation of Ca2+-mobilizing receptors on the outer surface of the plasma 
membrane leads to the activation of phospholipase C (PLC) which hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIP2) on the inner surface of the plasma 
membrane. The receptor is coupled to PLC via a putative GTP-binding protein 
(GTP-bp) not yet identified, but which appears to be tissue- and receptor-specific. The 
hydrolysis of PIP2 by PLC produces inositol 1,4,5-trisphosphate (IP3) and
1,2-diacylglycerol (DG). IP3 has been shown to release Ca2+ from the endoplasmic 
reticulum, thereby increasing the cytosolic Ca2+ concentration and eliciting 
Ca2+-dependent responses. IP3 can be metabolized by different routes (see Fig. 5) to
produce other inositol phosphates (which themselves may have second messenger 
function) and free inositol (I). DG has been shown to activate protein kinase C 
(PKC) which can phosphorylate cellular proteins thereby eliciting other physiological 
responses or modulating or complimenting those mediated by the increased 
cytoplasmic Ca2+ concentration. DG can also be phosphorylated by diacylglycerol 
kinase (DGK) to produce phosphatidic acid (PA) which is transported to the 
endoplasmic reticulum (ER) for the synthesis of phosphatidylinositol (PI). PI is 
transported to the plasma membrane and undergoes successive phosphorylations to 
produce PIP and to regenerate the receptor substrate PIP2. Activation of
Ca2+-mobilizing receptors also has been shown to induce alterations in Ca2 + 
transport across the plasma membrane, especially Ca2+ influx; however the 
mechanism by which this occurs is not yet understood. The enzymes catalyzing the 
reactions denoted by letters are: a, PI kinase; b, PIP kinase; c, IP3-3-kinase;
d, IP3-5-phosphomonoesterase; e, I(l,3,4,5)-5-phosphomonoesterase; f, 1(1,3,4)-
a.
1-phosphomonoesterase; g, IP2-phosphomonoesterse; h, IP-phosphatase.
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Fig. 5. The Metabolism of inositol phosphates.
The receptor-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) 
generates diacylglycerol (DG ) and inositol 1,4,5-trisphosphate [1(1,4,5)P3]. 
I(1,4,5)P3, the signal which stimulates the release of Ca2+ from the endoplasmic 
reticulum, has been proposed to be degraded by at least two separate routes. Firstly, it 
can be dephosphorylated to I(1,4)P2,1(4)P, and free inositol by the successive action 
of specific phosphatases. Secondly, it can be phosphorylated by specific kinases to 
produce other inositol phosphates such as I(1,3,4,5)P4, IP5 and possibly IPg. These
inositol phosphates may also have second messenger functions. Thus, IP4 has been
proposed to be involved in the regulation of Ca2+ influx across the plasma 
membrane. The inositol phosphates can be degraded by dephosphorylation to give rise 
to other isomers of inositol phosphates including I(1,3,4)P3, I(3,4)P2 and I(3)P 
before producing free inositol. Other pathways of degradation and/or interconversion 
of inositol phosphates may also exist.
Agonist
I(l,3,4,5)P4
PIR
PIP I(1,4)P2 I(3,4)P2
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(Irvine et al., 1986a; Biden & Wollheim, 1986; Biden et al., 1987; Ryu et al., 1987c). Although these 
inositol phosphates can be metabolised by different pathways by the action of phosphatases and/or 
kinases, it appears that the principal route of degradation for IP4 is that which produces I(1,3,4)P3,
I(3,4)P2,1(3)P and I (Shears et al., 1987a,b; Inhom et al., 1987; Bansal et al., 1987; Connolly et al.,
1987; Emeux et al., 1987; Hansen et al., 1987; Williamson & Hansen, 1987; Moyer et al., 1987). 
The usual route of diacylglycerol metabolism in liver is by phosphorylation to phosphatidic acid in the 
plasma membrane by diacylglycerol kinase (Hokin & Hokin, 1959; Kanoh & Ohno, 1981). However, 
in many tissues diacylglycerol is known to be acted upon by a diacylglycerol-specific lipase releasing 
arachidonic acid (Bell et al., 1979; Prescott & Majerus, 1983), an agent proposed to be released also by 
the action of a phosphatidic acid-specific lipase on phosphatidic acid (Billah et al., 1981; Lapetina, 
1982). Cytidine triphosphate is added to the phosphatidic acid in the endoplasmic reticulum yielding 
cytidine diphosphate-diacylglycerol the general precursor for phospholipid synthesis which can react 
with inositol (I) to produce PI (see Fig. 4). The PI can then undergo successive phosphorylations by 
specific kinases to yield PIP and PIP2 (Tou et al., 1970; Cockcroft et al., 1985; Lundberg et al., 1985,
1986; Cochet & Chambaz, 1986; Verhoeven et al., 1987). This sequence of events therefore, serves 
both in the production and degradation of second messenger signals, and also as a source of inositol for 
the supply or resynthesis of receptor substrate PIP2, for the continued production of signals and/or 
restoration of the receptor-signalling mechanism (see Fig. 4 and Berridge, 1983, 1984).
(3) Characteristics of phospholipase C
Since the second messengers IP3 and diacylglycerol that are produced can transmit the signal of 
receptor occupation to the cell interior, by virtue of a mobilization of Ca2+ and an activation of protein 
kinase C, respectively, the activation of a PIP2-specific phospholipase C is a crucial step in the cellular
responses to Ca2+-mobilizing agonists. Despite its central role in transmembrane signalling, however,
there has been only a limited characterization of the enzyme. Isolation of a receptor-regulated
PIP2-specific phospholipase C has been difficult owing to an apparent heterogeneity in the molecular
weight, calcium dependence, pH optima, and isoelectric point of phospholipase C from different tissues
£
(Hirasawa et al., 1982; Low et al., 1984), and because of the heterogenous distribution of the enzyme in 
subcellular fractions. Evidence suggests that in most tissues phospholipase C exists in both cytosolic 
and membrane-bound forms (see eg. Takenawa & Nagai, 1981; Nakanishi et al., 1985; Carter & Smith, 
1987; Kozawa et al., 1987; Lee et al., 1987; Katan & Parker, 1987). Moreover, multiple forms of the 
soluble enzyme have been reported in many tissues including bovine brain (Ryu et al., 1987a,b), 
and porcine lymphocytes (Carter & Smith, 1987). The precise relationship between the 
membrane-bound and soluble phospholipase C activities remains to be elucidated, although there is
33
evidence which suggests that a membrane-bound form of phospholipase C which hydrolyzes PIP2 can 
be activated by Ca2+-mobilizing agonists in plasma membrane preparations from various cell types 
(Smith etal., 1985; Uhing etal., 1986; Straub & Gershengom, 1986).
Hitherto it appears that only a cytosolic form of phospholipase C has been isolated from rat liver 
(Takenawa & Nagai, 1981; Nakanishi et al., 1985); this enzyme has a molecular weight of 70 KDa, 
specifically hydrolyzes phosphatidylinositol, and requires Ca2+ for activity (Takenawa & Nagai, 1981). 
Although a PIP2-specific phospholipase C associated with rat liver plasma membranes has been 
reported (Melin et al., 1986), to date it appears that the enzyme itself has not yet been isolated. By 
comparison, the soluble and particulate forms of PIP2-specific phospholipase C in bovine brain have 
molecular masses of 140-160 KDa (Lee et al., 1987; Katan & Parker, 1987; Kozawa et al., 1987; Ryu 
et al., 1987a,b), however in this tissue a soluble form of the enzyme of much lower molecular mass 
(85-88 KDa) also has been found (Rebecchi & Rosen, 1987; Ryu et al., 1987b). Whilst among early 
studies there was some controversy as to whether phospholipase C activity in liver is Ca2+-dependent 
(Creba et al., 1983; Prpic, et al., 1982; Rhodes et al., 1983), recently the use of Quin-2 techniques for 
monitoring and clamping the cytosolic Ca2+ to fixed levels, has shown that a PIP2-specific
phospholipase C in intact hepatocytes is partially dependent on Ca2+ at low intracellular Ca2+ 
concentrations, but is essentially unaffected by intracellular Ca2+ levels above 190nM (Renard et al., 
1987). It should be noted however, that the Ca2+-dependence of phospholipase C activity may also 
depend on the Mg2+ concentration (see Uhing et al., 1986). Relevant also are findings that in some 
tissues such as sheep seminal vesicular gland (Majerus et al., 1985,1986) and human platelets (Manne 
& Kung, 1987), a soluble phospholipase C has been isolated which requires millimolar concentrations
of Ca2+ for PI hydrolysis, but only pM concentrations of Ca2+ for PIP2 hydrolysis. Of especial 
interest are the reports that a soluble phosphoinositide-specific phospholipase C from human platelets 
(Baldassare & Fisher, 1986; Deckmyn et al., 1986), and a PIP2-specific phospholipase C activity
associated with rat liver plasma membranes (Melin et al., 1986; Taylor & Exton, 1987) can be activated 
by non-hydrolyzable GTP analogues. This result supports a growing body of evidence which suggests 
that a GTP-binding protein is involved in the receptor-induced activation of phospholipase C.
(4) GTP-binding protein and the activation of phospholipase C
At present relatively little is known about the molecular mechanisms by which receptors activate 
phospholipase C. However, although the putative GTP-binding protein remains to be isolated, there is 
much evidence which suggests that the coupling of the PIP2-specific phospholipase C to cell surface 
receptors occurs by a GTP-binding protein somewhat analogous to the receptor-mediated regulation of
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adenylate cyclase (see eg. Litosch & Fain, 1986; Taylor & Merritt, 1986; Guillon et al., 1987). The 
activity of phospholipase C is thus thought to be modulated by a membrane GTP-binding protein 
which acts as a transducer to couple the phospholipase C which is presumably associated with the inner 
surface of the plasma membrane, to specific receptors on the outer surface of the cell (for recent reviews 
see eg. Taylor & Merritt, 1986; Litosch & Fain, 1986; Cockcroft, 1987; Gilman, 1987). The 
regulation of adenylate cyclase appears to involve two binding proteins Gj and Gs that interact with the 
enzyme to either inhibit or stimulate its activity (Levitzki, 1982; Helmreich & Pfeuffer, 1985). The 
enzymes are sensitive to activation by fluoride which interacts with the GDP situated on the a-subunit. 
Also, the bacterial toxins, pertussis and cholera toxin, each have been shown to bring about an 
activation of adenylate cyclase by catalyzing ADP-ribosylation of Gj and Gs, respectively (see eg.
Helmreich & Pfeuffer, 1985). These properties have been useful in identifying G-protein-mediated 
reactions in many tissues (see above refs).
The possibility that guanine nucleotides may be involved in the regulation of signal transduction 
for Ca2+-mobilizing receptors was perhaps first realized with the demonstration that guanine nucleotides 
could promote secretion in mast cells (Gomperts, 1983; Cockcroft & Gomperts, 1985), and stimulate 
the formation of diacylglycerol in permeabilized platelets (Haslam & Davidson, 1984). More recently, 
fluoride was shown to lead to a stimulation of IP3 formation in intact hepatocytes (Blackmore et al,
1985). This was followed by observations that GTP-y-S could activate phospholipase C in rat liver 
plasma membranes (Wallace & Fain, 1985; Uhing et al., 1986; Cockcroft & Taylor, 1987), and that 
fluoride can activate phospholipase C and Ca2+ flux in isolated hepatocytes (Blackmore et al., 1985; 
Cockcroft & Taylor, 1987; Hughes & Barritt, 1987). In addition, fluoride has been shown to activate 
phospholipase C in other systems including GH3 cells (Martin, et al., 1986), WRK1 cell membranes 
(Guillon et al., 1986), and rat cerebral-cortical membranes (Litosch, 1987). Further support for the 
notion that the activation of phospholipase C by fluoride reflects an involvement of a G-protein and not 
a direct activation of the enzyme, stems from the observation that in liver plasma membranes, GDP-ß-S
which can inhibit the activation of phospholipase C by both GTP-y-S or GTP plus agonist, also 
inhibits activation by fluoride (Cockcroft & Taylor, 1987).
Despite the many parallels that appear to exist between the adenylate cyclase and phospholipase C 
transmembrane signalling mechanism, studies with pertussis and cholera toxin in a variety of systems 
have failed to implicate the presently well-characterized G-proteins Gj and Gs in any universal system of
agonist-induced phospholipase C activation. In particular, although cholera toxin recently has been 
reported to inhibit phosphoinositide labelling in rat liver plasma membranes (Biffen & Martin, 1987), 
there appears to be an uncertainty regarding the involvement of these G-proteins in the activation of
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phospholipase C in liver. In cells such as neutrophils where pertussis has been found to inhibit 
agonist-induced activation of phospholipase C, the G-protein involved has been shown to be 
immunochemically different to Gj (Gierchik et al., 1986). This has led to the possibility proposed by 
Michell & Kirk (1986) that different but closely related G-proteins may mediate the link between 
receptor occupation and phospholipase C activation in different cells and/or at different receptors. The 
recent reports of other G-proteins of as yet unknown function (e.g. the G0 protein purified from brain,
Sternweis & Robishaw, 1984; Rouot et al., 1987) has served to increase the size of the family of 
G-proteins which are implicated in signal transduction (see eg. Lo & Hughes, 1987). Thus, although 
G-proteins have been implicated recently in many areas of signal transduction including the regulation 
of ion channels (see eg. Barns, 1986; Bochaert et al., 1987; Dunlap et al., 1987; Litosch, 1987; 
Gilman, 1987; Scott & Dolphin, 1987), it seems that the nature and identity of the particular 
G-protein(s) involved in the receptor-induced activation of Pff^-specific phospholipase C in liver, as in 
other tissues^ yet to be resolved.
(5) Diacylglycerol and the activation of protein kinase C
Diacylglycerol, a neutral lipid produced at the plasma membrane as a consequence of PIP2
hydrolysis, has been shown to have second messenger functions in the activation of protein kinase C 
(Takai et al., 1977; Nishizuka, 1983). The activation of this enzyme is thought to constitute the 
second pathway of signal transduction for Ca2+-mobilizing agonists (reviewed in Nishizuka, 1983, 
1984, 1986). Protein kinase C requires diacylglycerol, Ca2+ and phosphatidylserine for maximum 
activity (Kishomoto et al., 1980), and has a broad substrate specificity which differs from that of the 
cyclic nucleotide and Ca2+/calmodulin-dependent protein kinases (reviewed in Nishizuka, 1986). 
Protein kinase C has been found to alter the activity of cellular proteins in vitro through 
phosphorylation of serine and threonine residues. Characterization of protein kinase C from rat brain 
(Kikkawa et al., 1982, 1987) and rat liver (Azhar et al., 1987) suggests that the enzyme may exist in 
multiple forms; the enzyme occurs as a monomeric protein of 64-90 KDa. A form of the protein from 
brain (perhaps the richest source of protein kinase C) has been shown to contain a hydrophobic domain 
which interacts with Ca2+ and phospholipid, and a hydrophilic domain which is catalytically active 
(Kikkawa et al., 1982). The presence of diacylglycerol has been shown to lead to a large reduction in 
the affinity of the enzyme for Ca2+, such that the enzyme is activated even at physiological 
(intracellular) Ca2+ concentrations (Yamamishi et al., 1983; Kikkawa et al., 1986). This observation 
has led some workers to suggest that the activation of Ca2+-mobilizing receptors and consequent 
increase in diacylglycerol levels at the plasma membrane could activate protein kinase C even without 
the prior mobilization of Ca2+ (Kishomoto et al., 1980; Marme & Matzen-Auer, 1985).
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Whilst the mechanism by which diacylglycerol leads to an activation of protein kinase C is not 
yet well understood, it is generally believed that in unstimulated cells the enzyme is localized in the 
cytosol in an inactive state. The production of diacylglycerol that accompanies the stimulation of 
Ca2+-mobilizing receptors is thought to promote an association of the enzyme with the plasma 
membrane probably by binding to phosphatidylserine (Drust & Martin, 1985; Hirota et al., 1985; 
Hemandez-Sotomayer & Garcia-Sainz, 1988). This process is thought to shift the Ca2+-dependence of 
the enzyme and to bring about its activation. Protein kinase C can be activated also by synthetic 
diacylglycerols and by tumour-promoting phorbol diesters (Niedel et al., 1983; Castagna et al., 1982). 
These agents have been employed extensively as tools for investigating aspects of the role of the 
diacylglycerol-activated protein kinase C pathway in intact cells. For example, studies in platelets using 
phorbol 12-myristate 13-acetate in conjunction with Ca2+ ionophore A23187 have indicated that in this 
system protein kinase C and Ca2+ may act synergistically in eliciting the full expression of the platelet 
physiological response, namely aggregation (Kaibuchi et al., 1983; Rink et al., 1983). By contrast, in 
several other systems phorbol esters have been shown to inhibit insulin and EGF binding probably by 
promoting the phosphorylation of these receptors (Jacobs et al., 1983; Davis & Czech, 1985). These 
and other similar findings have led to the conclusion that activation of protein kinase C forms an 
integral component of the signalling mechanism for Ca2+-mobilizing receptors, which is necessary for 
the full expression of physiological responses, but which in some systems may also provide a negative 
feedback signal to down-regulate or de-sensitize receptors to the continued presence of an agonist.
Perhaps the first evidence for a role of protein kinase C in the action of Ca2+-mobilizing agonists 
in liver came from the work of Garrison et al. (1984) who showed that pre-treatment of hepatocytes 
with phorbol 12-myristate 13-acetate increased the phosphorylation state of 3 of the 10 cytosolic 
enzymes normally affected by vasopressin or angiotensin, in the absence of any observable stimulation 
of Ca2+ flux. Moreover, the treatment of hepatocytes with Ca2+ ionophore A23187 was found to 
mimic the effects of the hormones on the phosphorylation of the remaining 7 substrates. It is 
noteworthy also, that activation of protein kinase C did not seem to obligatorily involve the 
mobilization of intracellular Ca2+. These observations provided evidence that in this system both 
signalling mechanisms, the diacylglycerol-protein kinase C and the IPß-Ca24", are required for the full 
expression of the responses induced by Ca2+-mobilizing agonists.
More recently, the pretreatment of hepatocytes with phorbol esters has been shown to abolish the 
subsequent response to a-adrenergic agonists (Corvera & Garcia-Sainz, 1984; Garcia-Sainz et al., 
1985c; Cooper et al., 1985) through a protein kinase C-mediated inhibition of a-receptor binding 
(Lynch et al., 1985a; Corvera et al., 1986), and probably through a phosphorylation and uncoupling of 
the a-receptor to phospholipase C (Leeb-Lundberg et al., 1985). Further evidence for the involvement
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of protein kinase C in this effect is provided by the observation that the refractoriness to a-adrenergic 
agonists induced by phorbol esters, and also by vasopressin and angiotensin, can be blocked by 
inhibitors of protein kinase C (Garcia-Sainz & Hemandez-Sotomayor, 1987). Recent studies with 
phorbol esters suggest that other actions of protein kinase C in hepatocytes may include: an inhibition 
of cyclic AMP phosphodiesterase (Irvine, Pyne & Houslay, 1986), an inhibition of the effect of 
glucagon on IP3 production and Ca2+ mobilization (Blackmore & Exton, 1986; Staddon & Hansford,
1986, 1987), and an alteration of the activity of the Na+/K+-ATPase (Lynch et al., 1986; 1987) and 
possibly that of the Na+/H+ exchange (Berridge, 1984). There is evidence also, that protein kinase C 
may be involved in the inactivation of hepatic glycogen synthase (Blackmore et al., 1986; Nakabayashi 
et al., 1987), and that protein kinase C may phosphorylate a 27 KDa protein component of rat liver gap 
junctions in vitro (Takeda et al., 1987). These findings provide an illustration of the broad substrate 
specificity of protein kinase C, and further support the notion that in liver and in many other systems 
diacylglycerol plays a second messenger role in signal transduction for Ca2+-mobilizing agonists.
(6) Inositol 1,4,5-trisphosphate: the second messenger in the release 
of intracellular Ca2 +
First evidence that IP3, a water-soluble product of PIP2 hydrolysis, may be the second messenger 
for the mobilization of intracellular Ca2+ was obtained from the observation that IP3 stimulates the 
release of Ca2+ from a non-mitochondrial Ca2+ pool in permeabilised pancreatic acinar cells (Streb et 
al., 1983). The use of mitochondrial inhibitors in this system suggested that the source of Ca2+ was 
the endoplasmic reticulum; a result consistent with the showing that the endoplasmic reticulum was the 
sole source of ^ - in d u c e d  Ca2+ release from subcellular fractions (Prentki et al., 1984a).
Subsequently, IP3 was found to induce Ca2+ release in permeabilized cells and microsomal preparations
from a wide variety of tissues including pancreatic ß-cells (Biden et al., 1984; Joseph et al., 1984b; 
Streb et al., 1985; Prentki et al., 1985) human and rabbit neutrophils (Prentki et al., 1984b; Spat et al., 
1986a), human platelets (Authi & Crawford, 1985; Adunyah & Dean, 1985; O'Rourke et al., 1985) and 
hepatocytes (Joseph et al., 1984a; Burgess et al., 1984a, 1984b; Dawson & Irvine, 1984; Muallem et 
al., 1985; Spat et al., 1986b).
Supporting evidence that IP3 functions as the second messenger in the release of intracellular Ca2+
followed from the observation that the dose-response for the initial rate of increase of cytosolic free 
Ca2+ concentration induced by the action of vasopressin in intact hepatocytes correlated with the initial 
rates of PIP2 breakdown and production of IP3 (Thomas et al., 1984; Williamson et al., 1985). In this
system the peak elevation of cytosolic Ca2+ concentration occurred when the IP3 concentration was
38
0.6pM (Thomas et al., 1984). Because maximal concentrations of vasopressin (12nM) were estimated 
to produce cytosolic IP3 levels in the range of 10-20fiM (see also Lynch et al., 1985b; Charest et al., 
1985a), it follows that only a fraction (<5%) of the IP3 produced by vasopressin under these conditions
is required to induce a near-maximal increase in the cytosolic Ca2+ concentration and activation of 
phosphorylase (Lynch et al., 1985b; Charest et al., 1985a; Williamson et al., 1985). A significant 
proportion of the apparent IP3 levels produced by agonists however,most probably represented the
inactive isomer inositol 1,3,4-trisphosphate which is produced more slowly than inositol 
1,4,5-trisphosphate (Irvine et al., 1984a,b, 1985; Burgess et al., 1985; Hansen et al., 1986; Williamson 
& Hansen, 1987). Moreover, the maximum amount of ff^-releasable Ca2+ from permeabilized
guinea-pig hepatocytes was around 0.5nmol/mg dry weight of protein (or approx. 50% of the total 
calcium content of the endoplasmic reticulum); this is in good agreement with the amount of Ca2+ 
released from intact hepatocytes (Burgess et al., 1984b) and also from the perfused rat liver (Reinhart et
al., 1982c), in response to oij-agonists. Recently, other important properties of IP3 consistent with a
second messenger role in mediating Ca2+ release in response to Ca2+-mobilizing agonists in liver have 
been revealed. These are: firstly, that the production of IP3 in hormonally-stimulated hepatocytes 
precedes or coincides with the rise in cytosolic Ca2+ concentration (Charest et al., 1985a; Williamson 
et al., 1985), and secondly, that IP3 can be degraded rapidly upon removal of the Ca2+-mobilizing
agonist (Joseph et al., 1984a; Seyfred et al., 1984; Joseph & Williams, 1985; Hansen et al., 1986; 
Shears et al., 1987a,b; Tennes et al., 1987).
(7) Mechanism of Ca2+-release from the endoplasmic reticulum
The molecular mechanism by which IP3 induces Ca2+-release from the endoplasmic reticulum is
not known. However, because Ca2+ transport across the endoplasmic reticulum membrane consists of 
a Ca2+ sequestering mechanism, Ca2+-ATPase (or Ca2+-pump) as well as a mechanism for passive 
Ca2+ efflux (see eg. Bygrave, 1978a; Epping & Bygrave, 1984a,b), it is conceivable that the action of 
IP3 in releasing Ca2+ from the endoplasmic reticulum could involve an interaction with one or both of
these pathways. The finding that IP3 still induced a rapid release of Ca2+ under conditions in which the 
Ca2+ pump was totally inhibited by vanadate suggests that the action of IP3 is to stimulate passive 
Ca2+ release, rather than to inhibit Ca2+ uptake (Prentki et al., 1984b). Moreover, the temperature 
insensitivity of the ^ -in d u ced  Ca2+ release in permeabilized macrophages (Hirata et al., 1985a), 
cultured vascular smooth muscle cells (Smith et al., 1985) and hepatocytes (Joseph & Williamson, 
1986) suggests that IP3 activates a Ca2+ channel; the activation of this channel involves
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ligand-binding, but does not involve the metabolism of either ATP or IP3. Studies on the effects of 
different organic and inorganic channel-blockers on the IP3-mediated Ca2+ release from permeabilized rat 
hepatocytes indicate that the IP3-gated Ca2+ channel does not resemble voltage-gated Ca2+ channels 
(Joseph & Williamson, 1986). Of especial note, also, are the findings that in this system IP3-induced
Ca2+ release from the endoplasmic reticulum has a requirement for K+ ions (although it appears that 
other monovalent cations such as Li+ can also substitute for K+ at least in vitro), and that Ca2+ efflux 
is inhibited by permeant anions such as Cl", B r, I" and S042'  (Muallem et al., 1985; Joseph &
Williamson, 1986). These properties suggest that in hepatocytes the IP3-induced Ca2+ release from the 
endoplasmic reticulum requires the movement of a counter-ion, namely K+, to prevent the build up of 
charge and hence maintain electrical neutrality. In some systems it appears that the effect of IP3 on 
Ca2+ release is enhanced by increasing the pH from 6.7 to 7.5 (Brass & Joseph, 1985; Clapper & Lee, 
1985). By contrast Joseph & Williamson (1986) observed no effect of pH in the range 6.5-8.0 on the 
IP3-induced Ca2+ release from permeabilized hepatocytes.
Evidence for the existence of specific binding sites for IP3 was obtained from the observation that 
in guinea-pig hepatocytes, Ca2+ release from the endoplasmic reticulum is specific for IP3 (Burgess et 
al., 1984b), though similar molecules with phosphates on the 4 and 5 position of the inositol moe^ty 
were also active (specificity: inositol l,4,5-P3>inositol 2,4,5-P3>inositol 4,5-P2. see also Irvine et al., 
1984a). In addition, Hirata et al. (1985b) developed a photo-affinity label (an acrylazide derivative of 
IP2) which caused the irreversible inhibition of IP3-induced release of Ca2+ in saponin-permeabilized, 
photo-irradiated macrophages. Under these conditions the irreversible inhibition was prevented if the 
cells were incubated with a 10-fold excess of IP3. More recently, Spat and co-workers used
32P-Ins(l,4,5)P3 to show specific, saturable and specific binding of the radiolabel in permeabilized
guinea-pig hepatocytes and rabbit neutrophils (Spat et al., 1986a), and in microsomal fractions of rat 
liver (Spat et al., 1986b) and bovine pituitary (Spat et al., 1987). These characteristics are consistent 
with the existence of a specific receptor for IP3. Moreover, very recently the solubilization,
purification and characterization of an inositol trisphosphate receptor protein from rat cerebellar 
membranes has been reported (Supattapone et al., 1988). Recent work by Worley et al. (1987) indicates 
that IP3 receptor binding in rat cerebellar membranes displays a high sensitivity and selectivity for IP3
(Kpj of 40nM, by comparison with a Kj of 10|iM for both IP and IP4), is strongly inhibited by 
submicromolar Ca2+, and is considerably increased by slightly alkaline pH. Relevant also are the 
reports that glucose 6-phosphate increases Ca2+ loading into IP3-releasable pools in permeabilized 
hepatocytes and in fractions of liver endoplasmic reticulum (Benedetti et al., 1985, 1986, 1987).
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These findings suggest that regulation of IPj-receptor binding and/or Ca2+ release may occur through 
the physiological alteration of Ca2+, pH and glucose 6-phosphate in the local intracellular environment.
Another aspect of the mechanism of Ca2+ release from the endoplasmic reticulum concerns a 
possible role for adenine and guanine nucleotides. Preliminary studies by Dawson (1985) suggested a 
requirement for GTP in the release of Ca2+ by IP3 from rat liver microsomes. Using detergent- 
permeabilized NDE-115 neuroblastoma cells, Gill et al. (1986) subsequently revealed that a partial 
release of the IPj-releasable Ca2+ could be induced by exposure to GTP. This release was thought to 
involve GTP hydrolysis since non-hydrolyzable analogues of GTP were ineffective. Also, unlike the 
Ca2+ release by IP3 which occurs in the absence of polyethylene glycol, the GTP-mediated Ca2+
release had an absolute requirment for polyethylene glycol in the incubation medium (but see Nicchitta 
et al., 1987). The addition of GTP to pituitary microsomes (Kiesel et al., 1987) and to rat liver 
microsomes (Dawson et al., 1986) after they had been allowed to accumulate Ca2+, was found to induce 
both a release of Ca2+ and a potentiation of ^ -in d u ced  Ca2+ release. However, studies using 
saponin-permeabilized N1E-115 neuronal cells (Chueh & Gill, 1986), and preparations of endoplasmic 
reticula from pancreatic islets (Wolf et al., 1987) indicate that the effect of GTP and IP3 on Ca2+ 
release is additive, and hence that the two mechanisms of Ca2+ release are different.
Very recently, Dawson et al. (1987) used electron microscopy to show that GTP-treatment of 
microsomal vesicles promotes the fusion of small vesicles and the formation of larger vesicular 
structures. These authors suggest further, that the observed effect of GTP in inducing Ca2+ release, and 
in enhancing release of Ca2+ by IP3 may be attributable to GTP-dependent changes in vesicular 
structure. Evidence has been presented also which suggests that in rat liver microsomes GTP-dependent 
phosphorylation is not required for Ca2+ release by IP3 (Lukacs et al., 1987). Hence the relevance of 
the GTP mechanism of Ca2+ release from the endoplasmic reticulum seems physiologically difficult to 
evaluate, and is probably completely different to the mechanism of Ca2+ release by IP3. It is apparent 
therefore, that there is still considerable uncertainty concerning the possible role of GTP, and the 
mechanism by which IP3 induces Ca2+ release from the endoplasmic reticulum.
(8) Perspective on the role of Ca2+ in the mechanism of action 
of Ca2 + -mobilizing agonists in liver
Historically, the study of the mechanism of action of Ca2+-mobilizing agonists has been closely 
related to the study of the processes which effect cellular Ca2+ homeostasis. The notion that the level 
of intracellular Ca2+ plays a key role in the action of certain agonists in liver arose largely from the
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observations that the responsiveness of hepatocytes to Ca2+-mobilizing hormones diminish after 
prolonged incubation in low Ca2+ containing media, that the addition of the hormones to hepatocytes 
leads to alterations in 45Ca2+ fluxes, and that Ca2+-ionophore A23187 can mimic some of the effects 
induced by the hormones (for reviews see Williamson et al., 1981; Exton, 1982; Reinhart et al., 1983, 
1984a,e). The observations were also consistent with the knowledge that changes in the activities of 
cytoplasmic enzymes can occur through phosphorylation by Ca2+-dependent protein kinases (Cohen, 
1982, 1984), the best-studied of which is phosphorylase b kinase, a key enzyme involved in the 
glycogenolytic cascade. A total of about 7 cytosolic enzymes have been shown since to be activated by 
phosphorylation following an increase in cytosolic Ca2+ (Garrison et al., 1984; Connelly et al., 1987). 
More direct evidence that the action of the hormones were associated with an increase in the cytosolic 
Ca2+ concentration was provided by studies using the Ca2+-sensitive dye Quin-2. By monitoring 
changes in Quin-2 fluorescence, Charest et al. (1983) and subsequently Berthon et al. (1984), showed 
that the cytosolic Ca2+ concentration increases rapidly from a basal level of around 0.2jiM to approx.
0.6pM within seconds of the addition of adrenaline and other Ca2+-mobilizing agonists to hepatocytes 
loaded with the indicator. These and similar studies by other workers established that the rise in 
cytosolic Ca2+ induced by hormones preceded the onset of physiological responses such as the 
activation of phosphorylase (Charest et al., 1985a; Williamson et al., 1985; Exton, 1985).
An area of interest to many workers concerns the nature of the Ca2+ flux change responsible for 
the elevation of the cytosolic Ca2+ concentration by hormones. Because of the sometimes diverse 
experimental techniques and conditions employed by different workers however, this has not been easy 
to establish. For example, early experiments with 45Ca2+ suggested that hormones stimulated the 
uptake of the radiolabel (Foden & Randle, 1978; Poggioli et al., 1980; Barritt et al., 1981a), and 
therefore were interpreted to reflect a stimulation of Ca2+ influx. By contrast, experiments with 
hepatocytes prelabelled with 45Ca2+ (Kimura et al., 1982), and with the perfused liver incorporating a 
Ca2+-selective electrode (Reinhart et al., 1982c), indicated that hormones stimulate Ca2+ efflux. 
Interpretation of these findings was made easier by the showing that in the perfused rat liver, as well as 
stimulating net Ca2+ efflux, the hormones also stimulate the rate of "Ca2+-cycling" across the plasma 
membrane (Reinhart et al., 1984d). Moreover, differences in the pattern of Ca2+ flux induced by 
different agonists also have been reported (Altin & Bygrave, 1985). The finding that responses which 
were "sustained" at physiological concentrations of extracellular Ca2+ became transient when the 
extracellular Ca2+ was omitted, showed clearly that extracellular Ca2+ was necessary for the full 
expression of the hormone-induced responses (see eg. Fig. 6a and Reinhart et al., 1984c). Moreover, 
the observation that the onset of Ca2+ efflux and also the onset of physiological responses induced by 
hormones was unaffected by a lowering of the extracellular Ca2+ concentration to submicromolar levels 
using EGTA, or even by the removal of Ca bound to the outside of the plasma membrane by using
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Fig. 6. Extracellular Ca2 + is required to sustain the increase in cytosolic 
Co2* concentration induced by Ca2 +-mobilizing agonists.
(a) shows that glucose output induced by phenylephrine is dependent on 
extracellular Ca2+. Rat livers were perfused with Krebs-Henseleit media containing 
1.3mM Ca2+. At 10 min, the perfusate concentration was either maintained at
1.3mM (o-----o) or reduced to O.ljiM (•——•). At 15 min of perfusion
phenylephrine (2|iM, thick line) was infused as indicated; 1.3mM Ca2+ was also 
infused where indicated. [For other details see Reinhart et al., 1984c.]
(b) shows the changes in cytosolic Ca2+ concentration induced by the addition of 
vasopressin to Quin-2-loaded hepatocytes, as determined by changes in Quin-2 
fluorescence. The hepatocytes were loaded with the Ca2+ indicator Quin-2 and
incubated in a medium containing either 1.3mM Ca2+ (-----) or 20pM Ca2+ (—  ),
and then lOnM vasopressin was added as indicated. For the experiment conducted at 
20|iM Ca2+, 1.3mM Ca2+ was also added as shown. [For other details see 
Williamson et al., 1985.]
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an excess of EGTA, provided evidence for the existence of an intracellular hormone-sensitive pool of 
Ca2+ (Reinhart et al., 1982c, 1984c,d). This pool, which was estimated to contain approx. 160 nmol 
calcium/g wet weight of liver, is depleted upon administration of the hormone, and is subsequently 
refilled in the presence of extracellular Ca2+ when the hormone is removed. The triggering of 
physiological responses by hormones therefore was envisaged to involve mainly a release of 
intracellular Ca2+, whilst an influx of extracellular Ca2+ was considered to be necessary in the later 
stages in order to sustain the responses when the intracellular stores are depleted (Reinhart et al., 1982c, 
1984a,c). This scheme is consistent with observations that in Quin-2 loaded hepatocytes, agonists 
induce a transient increase in cytosolic Ca2+ when the cells are incubated in media containing low Ca2+ 
concentrations, but a sustained increase in cytosolic Ca2+ when the cells were incubated in media 
containing 1.3mM Ca2+ (see Fig. 6b, and Charest et al., 1985a; Williamson et al., 1985).
The knowledge that an action of the hormones is to mobilize Ca2+ from an intracellular 
hormone-sensitive store has raised questions relating to its intracellular location. It has been shown that 
hepatocytes contain approximately 2|imol calcium/gm wet weight, most of which is located in discrete 
cellular compartments namely, the extracellular space, the cytoplasm, the mitochondrial matrix and the 
lumen of the endoplasmic reticulum (Claret-Berthon et al., 1977; Borle, 1981). Moreover, it is known 
that only a small fraction (<2%) of the calcium in each of these compartments actually exists in the free 
ionized form (Ca2+) that can activate enzymes; the remainder is bound to membranes, macromolecules 
or complexed with anions such as phosphate. The Ca2+ located on the outside of the plasma membrane 
which constitutes a large fraction (approx. 40%) of the total calcium content of liver, is unlikely to be 
involved in the initial triggering of physiological responses since the onset of these responses is not 
significantly reduced when this calcium is largely removed by treatment with an excess amount of 
EGTA (Reinhart et al., 1984c). Further, the calcium associated with the cytoplasm and the inner surface 
of the plasma membrane is known to be largely bound to proteins such as the Ca2+-ATPase or 
membrane-bound calmodulin, and while in close equilibrium with the cytosolic Ca2+ concentration, has 
not yet been established as a component of the hormone-sensitive Ca2+ store.
The notion that the mitochondria and/or the endoplasmic reticulum may be the main sources of 
hormone-sensitive Ca2+ was based on early studies which suggested that these organelles contain a 
significant store of the total cell calcium content (mitochondria 40%, endoplasmic reticulum 20%), and 
also the knowledge that these organelles possess well-developed Ca2+ transport systems across their 
respective membranes (Bygrave, 1978a,b; Becker et al., 1980). Furthermore, fractionation studies using 
45Ca2+ pre-labelled cells (Kimura et al., 1982), and rapid fractionation of the liver utilizing Percoll 
density gradients (Reinhart et al., 1982b,c) suggested that the calcium content of mitochondria and 
endoplasmic reticulum enriched fractions is decreased following the administration of hormones to 
isolated cells or to the perfused liver. More recent studies however, suggest that the in vivo calcium
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content of mitochondria may be much lower than previous estimates obtained using conventional 
fractionation techniques, and that under physiological conditions, the mitochondria may not play a 
major role in the elevation of cytosolic Ca2+ by hormones (Burgess et al., 1983; Joseph et al., 1983; 
Joseph & Williamson, 1983; Reinhart et al., 1984b; Somlyo et al., 1985; Kleineke & Soling, 1985). 
These considerations, and reports that the calcium content of mitochondria increases after 
phenylephrine, or vasopressin stimulation (Shears & Kirk, 1984a,b), have added support to the findings 
that the Ca2+ concentration of the mitochondrial matrix increases following stimulation with 
Ca2+-mobilizing hormones, and to the notion that the Ca2+-translocation cycle across the inner 
mitochondrial membrane may be a target for the regulation of the activity of Ca2+-activated respiratory 
dehydrogenases and other intramitochondrial enzymes by hormones (Denton & McCormack, 1985; 
McCormack, 1985a,b,c; Moreno-Sanchez, 1985; Hansford, 1985; Assimacopoulus-Jeannet et al., 1986; 
McCormack & Denton, 1986; Johnson & Brand, 1987).
A problem that puzzled researchers for a number of years, concerned the nature of the signal that is 
transmitted into the cell following the interaction of the agonist with its receptor on the plasma 
membrane, and which is involved in signalling the release of intracellular Ca2+ (Williamson et al., 
1981; Exton, 1980, 1982; Michell & Kirk, 1981; Taylor et al., 1983b; Reinhart et al., 1984a). As 
described previously, this phenomenon is now understood in terms of a receptor-mediated breakdown of 
phosphoinositides which generates the second messenger IP3, the signal which triggers the release of 
Ca2+ from the endoplasmic reticulum. Whilst the mechanism by which hormones regulate the various 
Ca2+ transport processes in cells is still the subject of much current research, the observation that 
alterations in cytoplasmic Ca2+ are an integral part of the action of many agonists serve to illustrate 
not only the important role of Ca2+ in hormone action, but also the fact that while the action of 
different Ca2+-mobilizing agonists may be brought about by the physical interaction with different 
receptors, the mechanism(s) involved in generating the receptor-mediated Ca2+ signal may be shared by 
different agonists. This is consistent with our current understanding that in liver (and other tissues) the 
action of Ca2+-mobilizing agents is linked with a receptor-mediated breakdown of phosphoinositides in 
the inner leaflet of the plasma membrane which generates second messengers such as IP3 which is
involved in the release of Ca2+ from the endoplasmic reticulum (e.g. Williamson et al., 1985, 1986; 
Williamson & Hansen, 1987), and possibly other messengers for the regulation of Ca2+ influx across 
the plasma membrane (Irvine & Moor, 1987). The remainder of this work therefore focuses on the 
Ca2+ flux changes induced by the agonists, and on the identification of those events or signals which 
may be important in regulating Ca2+ flux movement, particularly Ca2+ influx across the liver cell 
plasma membrane.
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(E) REGULATION OF Ca2+ FLUX BY Ca2+-MOBEJZING AGONISTS
(1) Stimulation of net Ca2 + flux by Ca2 + -mobilizing agonists
A technique that has proved very useful for monitoring the Ca2+ flux changes induced by hormones 
has been the incorporation of a Ca2+-selective electrode in the perfused rat liver system (Reinhart et al., 
1982c). Using this technique it was shown initially that the administration of phenylephrine to the liver 
perfused with media containing 1.3mM Ca2+ induces a transient efflux of Ca2+ from the liver, and that 
net Ca2+ uptake occurs only after the removal of the agent when there is a refilling of the intracellular 
hormone-sensitive Ca2+ pool (see Reinhart et al., 1982c, and Fig. 7a of this work). Subsequently, a 
further characterization of the Ca2+ flux changes induced by phenylephrine and also by vasopressin and 
angiotensin in our laboratory, has revealed that in livers perfused with physiological concentrations of 
Ca2+ these hormones differ in their ability to induce net Ca2+ flux movements - particularly Ca2+ 
influx (see Fig. 7, and Altin & Bygrave, 1985). Whilst these results do not necessarily indicate that 
these agonists have a different mechanism of action, the results do suggest that apart from differences in 
the receptors themselves, there may be differences either in the signal transduction process which lead to 
the production of second messengers and/or in the coupling of the activated receptors to the Ca2+ 
transporters across the plasma membrane. In this regard it is noteworthy that near-maximal 
concentrations of phenylephrine, vasopressin and angiotensin also have been reported to differ in their 
ability to induce metabolic responses in the presence of insulin (Garcia-Sainz & Hemandez-Sotomayer, 
1985b; Huerta-Bahena & Garcia-Sainz, 1985); and to differ in their ability to induce increases in 
cytosolic Ca2+ levels (Berthon et al., 1984; Binet et al., 1985; Kleineke & Soling, 1987), to stimulate 
phosphoinositide breakdown and the production of the second messengers IP3 and diacylglycerol (Lynch 
et al., 1985b; Bocckino et al., 1985; Pickford et al., 1987).
The more complex pattern of Ca2+ flux changes induced by vasopressin and angiotensin (ie. Ca2+ 
efflux and Ca2+ influx both occur during hormone administration (see Fig. 7) suggests also a more 
complex interpretation of these changes in terms of the intracellular regulatory signals, by comparison 
with phenylephrine. Clearly, the observation that the hormones all induce Ca2+ efflux at low 
extracellular Ca2+ is consistent with the knowledge that they all induce phosphoinositide hydrolysis and 
the production of IP3, the signal for the release of Ca2+ from the endoplasmic reticulum. Because these
Ca2+-mobilizing hormones have been shown to stimulate the unidirectional influx of 45Ca2+ (Barritt 
et al., 1981a; Parker et al., 1983; Mauger et al., 1984; Reinhart et al., 1984d; Poggioli et al., 1985), 
and since the stimulation of Ca2+ influx simultaneously with Ca2+ efflux will result in an apparent 
reduction of the net amount of Ca2+ efflux as measured by the Ca2+ electrode (since only net Ca2+
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Fig. 7. Ca2+fluxes induced by phenylephrine, vasopressin and angiotensin.
Each trace in (a), (b) and (c) was obtained from a separate experiment in which 
phenylephrine (2pM), vasopressin (lOnM) or angiotensin (lOnM), respectively, was 
administered to a rat liver perfused with Krebs-Henseleit bicarbonate media containing 
1.3mM Ca2+. In each instance the liver was pre-perfused for 15 min before the 
administration of the hormone which was infused continuously for the time indicated 
(arrows). Each trace is a representative of 3 to 5 independent experiments. [For 
further details see Altin & Bygrave, 1985.]
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movements are measured), it would seem that differences in the responses observed could be explained 
solely on the basis of a difference in the ability to stimulate Ca2+ influx. Moreover, this notion is 
supported by the observation that even at 1.3mM extracellular Ca2+, the Ca2+ influx response can be 
inhibited completely by pretreating the liver with inhibitors of mitochondrial respiration; whereas the 
total net efflux of Ca2+ under these conditions is increased (J.G. Altin & F.L. Bygrave, unpublished 
observations). The observation that the spontaneous influx of Ca2+ (ie. the hormone-dependent Ca2+ 
uptake that occurs in the presence of the hormone, see Fig. 7b & 7c) induced by vasopressin and 
angiotensin is inhibited by respiratory inhibitors is consistent with the finding that the administration 
of vasopressin to isolated hepatocytes results in an increase in the calcium content of the subsequently 
isolated mitochondria (Shears et al., 1984b). This suggests that at least with vasopressin and 
angiotensin as agonists, the mitochondria may play a role as an intracellular sink for Ca2+ which in 
turn may regulate Ca2+ influx into the cell across the plasma membrane.
On the other hand, the observation that no net uptake of Ca2+ occurs after removal of vasopressin 
and angiotensin (cf. the removal of phenylephrine, see Fig. 7) probably reflects the affinity of the 
hormone-receptor binding, and the rate of dissociation of these hormones from their respective receptors. 
For example, a slower rate of dissociation of vasopressin and angiotensin from their respective receptors 
could be expected to result in a slower rate of termination of the signal for production of second 
messengers, by comparison with phenylephrine. This could mean that the stimulation of Ca2+ influx 
upon removal of these hormones occurs over a longer period of time (by comparison with 
phenylephrine) such that the Ca2+ influx response associated with the refilling of the intracellular Ca2+ 
pool may be smaller and undetectable using this system. Alternatively, it may be possible that in these 
instances a partial refilling of the endoplasmic reticulum Ca2+ pool occurs intracellularly, from a loss 
and/or redistribution of the Ca2+ previously accumulated by the mitochondria (Shears et al., 1984b).
Of considerable interest also are the findings that other agonists such as ATP, ADP, EGF, 
phosphatidic acid and PGF2a also induce Ca2+ flux changes in the perfused rat liver (Altin & Bygrave,
1987a,c). In some instances complimentary work with these agents has also been carried out with 
isolated hepatocytes (Sistare et al., 1985; Staddon & McGivan, 1985; Charest et al., 1985b; Altin & 
Bygrave, 1988). A noteworthy feature of the Ca2+ flux changes induced by these agents is that although 
the magnitude of the response induced by each agent has characteristics of its own, especially in so far 
as dose-response relationship is concerned, in most instances the pattern of response induced by each 
agent resembles or lies intermediate between those induced by vasopressin and angiotensin on the one 
hand, and those induced by phenylephrine on the other (cf. results in Altin & Bygrave, 1985; 1987a,c, 
1988).
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(2) Ca2 + homeostasis in the liver cell
The area of Ca2+ homeostasis recently has been reviewed in detail (see eg. Carafoli & Penniston, 
1985; Carafoli, 1987) so that only a brief mention will be given here. In the unstimulated cell the free 
Ca2+ concentration in the cytoplasm is usually maintained at very low levels (approximately 0.2pM) 
by the net effect of Ca2+ transport through transporters across the plasma membrane, and across the 
membranes of intracellular Ca2+-sequestering organelles such as the endoplasmic reticulum and 
mitochondria (see Fig. 8). These Ca2+ transporters form three separate Ca2+-translocation cycles across 
the respective membranes, and establish an equilibrium between the cytosolic free Ca2+ concentration 
and Ca2+ bound to regulatory proteins and other macromolecules within the cell (Bygrave, 1978a,b; 
Reinhart et al., 1984a; Carafoli & Penniston, 1985; Hughes et al., 1987; Carafoli, 1987). Although 
some aspects of the hormonal regulation of cytosolic Ca2+ by the endoplasmic reticulum has been 
discussed already in relation to the production of the second messenger IP3, it is clear that regulation of
cytoplasmic Ca2+ levels by hormones may involve changes in the activities also of the Ca2+ 
transporters in the mitochondria and at the plasma membrane.
(3) Intracellular Ca2+ transport
In addition to its role in the storage of hormone-mobilizable Ca2+, it seems that the endoplasmic 
reticulum may be involved in other aspects of cytoplasmic Ca2+ regulation. In many tissues including 
liver, the endoplasmic reticulum has been shown to possess a high-affinity, Ca2+-sequestering 
mechanism^the Ca2+-ATPase. This Ca2+ transporter is structurally related to the Ca2+-ATPase in the 
sarcoplasmic reticulum in skeletal muscle whose structure is known in some detail (see eg. Maurer et
al., 1987). It has a high affinity for Ca2+ (Km 0.15-0.2pM) and requires both Ca2+ and Mg2+-ATP for
activity. The energy for Ca2+ transport is derived from the hydrolysis of ATP and the Ca2+ transport 
process is inhibited by high concentrations of vanadate (Dawson & Fulton, 1983; Epping & Bygrave, 
1984a,b; Schanne & Moore, 1986), but stimulated by oxalate (Dawson, 1982; Epping & Bygrave, 
1984b), calmodulin (Moore & Kraus-Friedmann, 1983; but see Schutze & Soling, 1987) and glucose 
6-phosphate (Benedetti et al., 1985, 1986, 1987). On the other hand, Ca2+ uptake by mitochondria
occurs through the Ca2+ uniporter (Km for Ca2+ uptake of 2-10|iM) in the inner mitochondrial
membrane (Bygrave, 1978a). In this instance, electrogenic Ca2+ uptake is an energy-dependent process 
driven by the electro-chemical gradient across the membrane (Bygrave, 1978a, Brand & Murphy, 1987). 
Apart from its regulation by Pj (Bygrave, 1978a) it appears that this Ca2+ transport process may also
be regulated by spermine (Nicchitta & Williamson, 1984; Lenzen et al., 1986). Mitochondrial Ca2+ 
efflux is not energy-dependent and can occur by passive diffusion of the ion through pores down the 
large concentration gradient that exists across the membrane, or by electroneutral exchange via the
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Fig. 8. Ca2+ transport systems likely to be involved in the regulation of the cytosolic Ca2+ 
concentration.
The simplified diagram shows that in the unstimulated cell the cytosolic Ca2 + 
concentration (~0.2pM) is maintained by the active and passsive transport of Ca2+ 
across the plasma membrane, and across the membranes of the intracellular 
Ca2+-sequestering organelles such as the endoplasmic reticulum and mitochondria. 
These Ca2+ transport processes (represented by the arrows) constitute three separate 
Ca2+ translocation "cycles" across the respective membranes (see text). Moreover, the 
cytosolic free Ca2+ is also in rapid equilibrium with intracellular bound Ca2+ (not 
shown). Elevations in the cytosolic Ca2+ concentration by Ca2+-mobilizing 
hormones (the signal for the induction of various physiological responses) have been 
shown to involve a release of Ca2+ from the endoplasmic reticulum, and an increase 
in the Ca2+ permeability of the plasma membrane. As well, it seems that the 
hormones may alter the activities of other Ca2+-transporters including those in the 
mitochondria.
CytoplasmExtracellular
space
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2Na+/Ca2+ antiport system (Bygrave, 1978a; Bemardi & Azzone, 1983; Bemardi, 1984; Brand, 
1985a,b; Rizzuto et al., 1987). These transport processes constitute a mitochondrial 
'Ca2+-translocation cycle’ across the mitochondrial membrane (Bygrave, 1978a,b).
(4) Ca2+ transport across the plasma membrane
The influx and efflux of Ca2+ into and out of the cell is dependent upon the transport of Ca2+ 
across the plasma membrane. In the unstimulated liver cell, Ca2+ influx is presumed to occur by 
diffusion of the ion through carriers or channels down the large concentration gradient that exists across 
the membrane. Hitherto, these transporter(s) have remained largely uncharacterized. However, recent 
evidence suggests that these 'basal' Ca2+ transporters are different from the Ca2+ influx transporters) 
activated by hormones (Hughes et al., 1986b; Altin & Bygrave, 1987a). Recent studies on the 
ATP-independent Ca2+ transport in rat liver plasma membrane vesicles suggests that this Ca2+ 
transporter displays characteristics of a protein carrier; Ca2+ transport is temperature-dependent, and 
sensitive to inhibition by a number of metal ions (Bygrave et al., 1988, unpublished work). It is 
interesting that the kinetics of this basal Ca2+ transport process are similar to those of the Ca2+ influx 
which occurs during the refilling of the hormone-sensitive Ca2+ pool after the removal of 
phenylephrine (Reinhart et al., 1982c, 1984d). Under physiological conditions, the high Ca2+ gradient
across the plasma membrane (1.3mM outside, 0.2|iM inside) is maintained by an outwardly-directed 
Ca2+-transport system^the plasma membrane Ca2+-Mg2+ ATPase, an active Ca2+ transport mechanism 
which moves Ca2+ against the concentration gradient by coupling this movement to the hydrolysis of 
Mg2+-ATP (Lotersztajn et al., 1981; Iwasa et al., 1982; Pavoine et al, 1987). The transporter has a
high affinity for Ca2+ on the intracellular side of the membrane (Km of 0.01-0.2|iM); it has no 
requirement for exogenous Mg2+, is not stimulated by calmodulin (Epping & Bygrave, 1984b), and 
very sensitive to inhibition by vanadate (Chan & Junger, 1983; Lin, 1985; Schanne & Moore, 1986; 
but see Epping & Bygrave, 1984b). Purification of the Ca2+-Mg2+ ATPase from rat liver plasma 
membrane vesicles suggest that it has a molecular weight of around 118-200 KDa (Lin & Fain, 1984; 
Lin, 1985). Although Ca2+ efflux in other tissues such as muscle (Miller & Moisescu, 1976), adrenal 
medulla (Douglas, 1968), pancreas (Rubin, 1970), and brain (Baker, 1976), may also occur through a 
Na+/Ca2+ exchange (for reviews see Philipson, 1985; Carafoli, 1987), andNa+/Ca2+ exchange activity 
has been reported to exist in rat liver plasma membrane vesicles (Kraus-Friedmann et al., 1982), the 
physiological relevance of this Ca2+ efflux pathway in liver remains to be demonstrated.
(5) Regulation of the cytosolic Ca2+ concentration by hormones 
Under resting conditions the relative importance of the various Ca2+ transporters in the regulation of 
the cytosolic Ca2+ concentration is determined by the relative affinities of the transporters for Ca2+.
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Therefore, since the resting levels of intracellular Ca2+ ( 0.2jiM) are closer to the Km of the Ca2+
pumping ATPases in the endoplasmic reticulum and the plasma membrane, it seems likely that these 
would be the more important Ca2+ transporters which determine the 'resting' cytosolic Ca2+ 
concentration. Also, the endoplasmic reticulum, which has a high affinity for Ca2+ but a small 
capacity for Ca2+ storage, appears suited for only short-term cytosolic Ca2+ regulation. On the other
hand the mitochondria are endowed with a lower affinity for Ca2+ (Km l-2|j.M) but a much larger
capacity for Ca2+ storage. This suggests a posssible role for mitochondria in the buffering of elevated 
cytosolic Ca2+ levels. By contrast, the large Ca2+ gradient that exists across the plasma membrane and 
the large capacity of the extracellular space suggests that both the Ca2+ influx transporter(s) and the 
high affinity Ca2+-ATPase at the plasma membrane, are likely to be the more important Ca2+ 
transporters for determining the resting or long-term cytosolic Ca2+ concentration.
It is conceivable that, apart from inducing a release of Ca2+ from the endoplasmic reticulum, 
hormones may regulate cytosolic Ca2+ levels by altering the activity of other Ca2+ transport processes 
either at the plasma membrane or in the mitochondria. In particular, it seems possible that hormones 
could increase cytosolic Ca2+ simply by inhibiting Ca2+ efflux via the Ca2+-ATPase at the plasma 
membrane (see Fig. 8). Some workers in fact report an inhibition of the ATP-dependent Ca2+-transport 
activity of plasma membrane vesicles prepared from hormone-treated hepatocytes, presumably indicative 
of an inhibitory effect of the hormones on the Ca2+-ATPase (see eg. Lin et al., 1983; Prpic et al., 
1984; Lotersztajn et al., 1985). It has been reported also that increased Ca2+ inflow across the plasma 
membrane of Ca2+-deprived hepatocytes does not increase cytosolic Ca2+ concentration unless 
accompanied by an inhibition of Ca2+ efflux (Hughes et al., 1986a). On the other hand there is much 
evidence which suggests that in intact hepatocytes and the perfused liver the hormones stimulate a 
unidirectional influx of Ca2+ as determined by the removal of 45Ca2+ (Barritt et al., 1981a; Reinhart et 
al., 1984d; Mauger et al., 1984). Furthermore, Ca2+ efflux is stimulated under these conditions 
(Reinhart et al., 1982c; 1984d). It seems therefore that at present there is still considerable uncertainty 
regarding the precise role of the Ca2+-ATPase in either increasing or prolonging the increase in 
cytosolic Ca2+ concentration as a consequence of hormone action in liver. Although original 
suggestions that the mitochondria are the source of hormone-mobilizable Ca2+ have subsided with the 
finding that their in vivo calcium content is too low for regulation of cytosolic Ca2+ (Reinhart et al., 
1984b; Somlyo et al., 1985), and the finding that IP3 induces a release of Ca2+ from the endoplasmic 
reticulum (see eg. Joseph et al., 1984a), recent evidence suggests that following the co-administration 
of glucagon and a Ca2+-mobilizing agonist, mitochondria can accumulate quite large amounts of Ca2+ 
(Altin & Bygrave, 1986). This has provided direct evidence that under physiological conditions the 
mitochondria play at least some role in regulating cytosolic Ca2+ levels, albeit in the buffering of the 
increase in the cytosolic Ca2+ concentration that is induced by hormones.
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A characteristic feature of the action of Ca2+-mobilizing agonists is that following the initial 
period of Ca2+ mobilization from intracellular stores, extracellular Ca2+ is required to maintain 
intracellular Ca2+ at elevated levels (see Fig. 6, and Reinhart et al., 1984c; Berthon et al., 1984; Binet 
et al., 1985; Charest et al., 1985a). Under these conditions there is a pronounced increase in the rate of 
45Ca2+ removal from the extracellular medium which is thought to reflect a stimulation of 
unidirectional Ca2+ influx (Barritt et al., 1981a; Parker et al., 1983; Reinhart et al., 1984d; Mauger et 
al., 1984). Despite the importance of this Ca2+ influx in sustaining the responses induced by 
Ca2+-mobilizing agonists however, the nature of the Ca2+ influx pathway(s) itself and the mechanisms 
by which it is regulated, hitherto remain uncharacterized. It is clear therefore, that a knowledge of the 
way in which hormones may regulate Ca2+ inflow across the plasma membrane is necessary for an 
understanding of the mechanism of action of Ca2+-mobilizing agonists, especially after depletion of the 
intracellular Ca2+ stores.
Recently, the use of aequorin to measure free Ca2+ levels in single isolated rat hepatocytes has 
suggested that the increase in cytosolic Ca2+ levels induced by Ca2+-mobilizing agonists may occur as 
a series of repetitive transients or oscillations whose amplitude vary from resting free Ca2+ levels of 
around 200nM to the stimulated level of over 600nM (Woods et al., 1986, 1987a). The duration of 
each transient was dependent on the nature of the agonist but usually ranged from 7-15s; whereas the 
frequency ranged from 20s to several minutes and depended on the agonist concentration (Woods et al., 
1987a). Moreover, the transients induced by phenylephrine and vasopressin were found to be inhibited 
by phorbol esters (Woods et al., 1987b). Interestingly, under suitable conditions oscillations in 
perfusate Ca2+ levels have been observed also in the perfused rat liver following the administration of 
Ca2+-mobilizing hormones (Graf et al., 1987; also Altin & Bygrave, unpublished work). It has been 
proposed that the transient nature of the increase in cytosolic Ca2+ levels may result from the cyclical 
production of second messengers such as IP3 in individual cells (Woods et al., 1987a). Oscillations of 
intracellular free Ca2+ levels also have been reported following the internal perfusion of 
voltage-clamped guinea-pig isolated hepatocytes with IP3 (Capiod et al., 1987), and as a result of
spontaneous action potentials in pituitary cells (Schlegel et al., 1987). However, at present neither the 
underlying mechanism by which the transients are produced, nor their significance in terms of hormone 
action, is known. Although such studies may lead to a better understanding of the precise nature of the 
increase in cytosolic Ca2+ levels in individual cells as a consequence of hormone action, it seems 
unlikely that such studies will seriously alter our understanding of the importance of the various Ca2+ 
transport processes just described, including the agonist-stimulated influx of Ca2+ into the cell.
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(HI) PROPOSED MECHANISMS FOR Ca2+ INFLUX
(1) Voltage-sensitive Ca2+ channels
In excitable tissues such as nerve, skeletal, cardiac, smooth muscle, and neurosecretory cells, Ca2+ 
influx occurs through voltage-sensitive Ca2+ channels located in the plasma membrane (Hagiwara & 
Byerly, 1981; Reuter, 1983; Levitan et al., 1983). Recent studies using electrophysiological and 
pharmacological techniques have defined three different types of voltage-sensitive channels: the 
T-(transient), N-(neuronal) and L-(long lasting) (reviewed in Hofmann et al., 1987). These channels 
generally are activated by events that lead to a depolarization of the plasma membrane, although their 
activity can be modulated also by hormones, neurotransmitters and other agents. Because the existence 
of N-type channels has been reported only for neurones, and the T-type channels have been associated 
with rapid Ca2+ transients only, it seems that these two types of channels are unlikely to be of major 
importance in liver. The L-channel in cardiac muscle can be regulated by cyclic AMP-dependent 
phosphorylation which stimulates the Ca2+ transport activity by increasing the number of functional 
channels and/or by increasing the probability of a given channel to be in the open state (Reuter, 1983; 
Cachelin et al., 1983; Trautwein & Hofmann, 1983; Bean et al., 1984). The activity of the L-channel 
is inhibited by cyclic GMP which is thought to act either by lowering cyclic AMP through the 
activation of a cyclic GMP-stimulated, cyclic AMP phosphodiesterase (Hartzell & Fischmeister, 1986), 
or through the cyclic GMP-dependent phosphorylation of a specific site on the channel itself (Bkaily & 
Sperelakis, 1985; Sperelakis et al., 1985; Hartzel & Fischmeister, 1986). Although there may be 
tissue- and species-specific differences, and different classes of voltage-sensitive Ca2+ channels may 
exist (Spedding, 1987; Hofmann et al., 1987), it seems that the characteristic features of classical ’slow' 
or L-type voltage-sensitive channels are their activation by membrane depolarization, and their 
sensitivity to inhibition by organic Ca2+ channel blockers such as verapamil, diltiazem and nifedipine 
(Glossmann et al., 1982; Nayler & Horowitz, 1983; Godfraind et al., 1986). Another property of these 
channels is that Ca2+ influx can be blocked by metal ions such as Ni2+, La3+, Cd2+, Co2+, Mn2+, 
and Mg2+ (Hagiwara & Byerly, 1981). The predicted sequence for the dihydropyridine receptor [the 
binding site for a specific subgroup of Ca2+ channel blockers (see Towart & Schramm, 1984; 
Spedding, 1985)] in rabbit skeletal muscle, suggests that the L-channel is a peptide of 212 KDa which 
can act both as a voltage sensor and a Ca2+ channel (Tanabe et al., 1987).
Evidence for the existence of voltage-sensitive Ca2+ channels in liver arose largely from the 
observation that at 1.3mM extracellular Ca2+ the exposure of rat liver to depolarizing concentrations of 
K+ induces physiological responses, including glycogenolysis and respiratory changes, which are 
sensitive to inhibition by blockers of the voltage-sensitive Ca2+ channels (Taylor, van de Pol, van
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Helden, Reinhart & Bygrave, 1985). Subsequently, it was shown that exposure of the perfused liver to 
depolarizing concentrations of K+ was accompanied by an increase in portal pressure indicative of 
hepatic vasoconstriction (Hill et al., 1987). Because both vasoconstrictive and the glycogenolytic 
effects of depolarization are inhibited by verapamil, diltiazem, Sr2+, and La2+ (Hill et al., 1987), and
also by bromophenacyl bromide and indomethacin (each at 20 pM, Altin & Bygrave, unpublished 
observations) the possibility exists that vasoconstriction and/or prostanoid production by 
non-parenchymal cells may be involved in mediating the responses induced (see PART I of this work). 
These findings suggest therefore, that whereas voltage-sensitive Ca2+ channels may be present in the 
non-parenchymal cells of the liver, they are unlikely to be present in the parenchymal cells, or 
hepatocytes. This notion is supported by the finding that depolarizing concentrations of K+ is 
ineffective in inducing glycogenolysis and other responses in isolated hepatocytes (Hill et al., 1987). 
Although some workers report inhibition of hormonally-induced Ca2+ movements in hepatocytes (eg. 
Blackmore et al., 1984; Joseph et al., 1985), such studies usually employ very high concentrations of 
the Ca2+ channel blockers verapamil and diltiazem. Nominal concentrations of these agents do not 
have any significant effect on the stimulation of Ca2+ influx induced by the removal of phenylephrine, 
or by the co-administration to the perfused liver of glucagon and a Ca2+-mobilizing agonist such as 
vasopressin (Altin & Bygrave, 1987a). In fact, at high concentrations (>250 |iM diltiazem, >50 pM 
verapamil) the administration of these agents was accompanied by a stimulation of respiration and 
glycogenolysis, and were found to reduce the responsiveness of the liver to Ca2+-mobilizing hormones 
(Altin & Bygrave, 1987a). It would seem therefore, that the observed effects of high concentrations of 
these agents on Ca2+ influx (Blackmore, et al., 1984; Joseph et al., 1985), is not due to an inhibition 
of voltage-sensitive Ca2+ channels per se, but instead may be related to their toxicity and/or and 
interference with hormone receptors (Naylor & Horowitz, 1983).
(2) Receptor-operated Ca2+ channels and Ca2+ influx regulated by metabolites 
of phosphoinositide hydrolysis
In many cells the influx of Ca2+ induced by the action of Ca2+-mobilizing agonists has been 
proposed to occur through a specific class of channels called receptor-operated Ca2+ channels (Bolton, 
1979; Van Breemen et al., 1979). The mechanisms underlying this form of Ca2+ entry is unknown, 
although recently a number of proposals have been made (see eg. Meldolesi & Pozzan, 1987). A recent 
study reported the existence of a receptor-operated Ca2+ channel in smooth muscle which is directly 
activated by the ligand ATP (Benham & Tsien, 1987), and another has suggested that in hepatocytes the 
regulation of Ca2+ influx by vasopressin and EGF does not require an increase in inositol trisphosphate 
but involves a GTP-binding regulatory protein sensitive to pertussis toxin (Hughes et al., 1987).
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However, a number of other studies in a variety of tissues have suggested an association of 
receptor-stimulated Ca2+ influx with the hydrolysis of membrane phospholipids and the generation of 
second messengers (see eg. Michell, 1975; Berridge & Fain, 1979; Kuno & Gardner, 1987; but see 
Cockcroft, 1981). These are probably better described as second messenger operated Ca2+ channels (see 
Meldolesi & Pozzan, 1987). Among the metabolites proposed to be involved in the receptor-mediated
Ca2+ influx mechanism include phosphatidic acid, and more recently, IP3 and IP4. Evidence for the 
involvement of each of these agents will be reviewed separately.
(i) Phosphatidic acid
Perhaps the first metabolite implicated in the stimulation of Ca2+ influx by Ca2+-mobilizing 
agonists is phosphatidic acid, a metabolite which is produced rapidly as a consequence of 
phosphoinositide hydrolysis (Berridge, 1984; Godfrey & Putney, 1984; Seyfred & Wells, 1984; but see 
also Bocckino et al., 1987). Phosphatidic acid was reported to possess Ca2+ ionophoretic properties in 
some systems (Tyson et al., 1976; Putney et al., 1980; Serhan et al., 1981; Harris et al., 1981), to 
increase cellular Ca2+, and to evoke physiological responses when added exogenously to cells (e.g. 
Barritt et al., 1981b; Ohsako & Deguchi, 1981). These observations led to suggestions that 
phosphatidic acid could be involved in mediating Ca2+ influx by Ca2+-mobilizing agonists (e.g. 
Putney et al., 1980; Harris et al., 1981). By contrast, recent work by Moolenaar et al. (1986) suggests 
that in human A341 carcinoma cells, phosphatidic acid elicits its effects not by stimulating Ca2+ influx 
ionophoretically, but by triggering the breakdown of phosphoinositides and a release of Ca2+ from 
intracellular stores. A similiar effect was observed when phosphatidic acid was administered to the 
perfused rat liver (Altin & Bygrave, 1987c). In this instance phosphatidic acid (up to 200 pM) did not
induce any net Ca2+ influx but instead induced Ca2+ efflux, at both high (1.3mM) and low (10 pM) 
extracellular Ca2+ concentrations, and a pattern of physiological responses similar to those induced by 
the a-agonist phenylephrine. In addition, and similar to other Ca2+-mobilizing agonists (see e.g. 
Altin & Bygrave, 1986, 1987c), phosphatidic acid interacted synergistically with glucagon (or cyclic 
AMP) in stimulating Ca2+ influx (Altin & Bygrave, 1987c). These responses were essentially 
unaffected by indomethacin, suggesting that phosphatidic acid interacted primarily with hepatocytes. As 
yet the possibility that phosphatidic acid might have some Ca2+-ionophoretic-like action in liver 
cannot be totally excluded, and it is noteworthy that the temporal accumulation of phosphatidic acid in 
the plasma membrane of hepatocytes stimulated with vasopressin (Seyfred & Wells, 1984; Bocckino et 
al., 1987) seems to correlate well with the onset of Ca2+ influx when both vasopressin and glucagon or 
cyclic AMP are co-administered (Altin & Bygrave, 1986).
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However, our observation that in liver the action of phosphatidic acid (including Ca2+ efflux) 
mimics that of phenylephrine, supports the findings of Moolenaar et al. (1986) that phosphatidic acid 
elicits its effects by stimulating phosphoinositide hydrolysis, and suggests that the action of 
exogenously added phosphatidic acid in liver may be receptor-mediated, and not mediated by stimulating 
Ca2+ influx ionophoretically. It is noteworthy that Holmes & Yoss (1983) also failed to demonstrate 
any Ca2+ influx on the addition of phosphatidic acid, albeit in phosphatidylcholine-containing 
membrane vesicles. Although it appears that the existence of receptors for phosphatidic acid on the 
hepatocyte plasma membrane remains to be established, it may be relevant that phosphatidic acid 
recently has been reported to induce receptor-like effects (the production of IP3 and other inositol
phosphates, and inhibition of adenylate cyclase) also in 3T3 fibroblast cells (Murayama & Ui, 1987). 
These considerations argue against the notion that phosphatidic acid, generated as a consequence of the 
activation of Ca2+-mobilizing receptors, is involved in the stimulation of Ca14 influx by an 
ionophoretic process.
Another area in which phosphatidic acid has been suggested to play a role in stimulating Ca2+ 
influx, at least in cardiac tissue, is in the stimulation of Na+/Ca2+ exchange. Thus it has been shown 
that phospholipid hydrolysis induced by the mild treatment of sarcolemmal vesicles with phospholipase 
C increases passive permeability to Ca2+ and stimulated Na+/Ca2+ exchange (Philipson et al., 1983). 
The stimulation of Na+/Ca2+ exchange was proposed to occur through an effect exerted by the 
accumulation of negatively-charged phospholipids in the membranes. A stimulation of Na+/Ca2+ 
exchange was also observed when the vesicles were treated with phospholipase D (Philipson & 
Nishimoto, 1984), which therefore raises the possibility that phosphatidic acid generated as a 
consequence of receptor-induced phosphoinositide hydrolysis could similarly regulate Ca2+ influx by 
this mechanism. Although Na+/Ca2+ exchange has been postulated in liver by some workers (Racker, 
1980; Williamson et al., 1981; Kraus-Friedmann et al., 1982), its properties remain largely 
uncharacterized and its regulation by phosphatidic acid produced as a consequence of a receptor-induced 
hydrolysis of phosphoinositides, remains to be demonstrated.
Of especial note are the recent findings that as well as activating phospholipase C, Ca2+-mobilizing 
agonists may also lead to a direct activation of phospholipase D, an action which has been proposed to 
be the principal route of phosphatidic acid production in liver (Bocckino et al., 1987). This suggests 
that phosphatidic acid could play some role in the action of these agonists. The possibility needs to be 
considered therefore, that the effect of phosphatidic acid produced intracellularly may be different to that 
evoked when added exogenously. It is clear that the precise role of phosphatidic acid in hormone action 
remains to be identified.
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(ii) Inositol l y4y5-trisphosphate (IP3)
Another hypothesis to explain the stimulation of Ca2+ influx by Ca2+-mobilizing agonists that 
has attracted much attention recently, concerns an involvement of the immediate product of 
phosphoinositide hydrolysis, IP3. Recently, Putney (1986) proposed that the second messenger IP3
which is involved in the release of Ca2+ from the endoplasmic reticulum, may also be involved in the 
regulation of Ca2+ influx across the plasma membrane. Central to this model is the notion that parts 
of the endoplasmic reticulum membrane are in close aposition with the plasma membrane (or 
alternatively that contact can be induced by some action of the Ca2+-mobilizing agent) such that the 
removal of Ca2+ from the endoplasmic reticulum by IP3 leads to an increase in the Ca2+ permeability
of the plasma membrane (see Fig. 9a). Preliminary evidence for this has been provided by fractionation 
studies with islet cells which suggests that a small proportion of the endoplasmic reticulum membrane 
is closely associated with fractions of plasma membrane vesicles (Dunlop, 1987). Evidence has been 
presented also for the existence in rat liver endoplasmic reticulum of a specialised protein of 63 KDa 
which has structural and Ca2+-binding properties similar to calsequestrin from skeletal muscle 
sarcoplasmic reticulum (Damiani et al.y 1988); it is not yet known whether this protein is associated 
with a specialised organelle or component of the endoplasmic reticulum which may represent the 
non-muscle counterpart of the sarcoplasmic reticulum. Because this so-called capacitative-coupling 
model proposes that a fall in the Ca2+ concentration within the endoplasmic reticulum (as a 
consequence of the release of Ca2+ into the cytosol) stimulates Ca2+ influx directly from outside the 
cell, Ca2+ influx is presumed to occur for as long as the hormone stimulation is continued. Similarly, 
according to this model the intracellular hormone-sensitive Ca2+ store (within the endoplasmic 
reticulum) could, upon removal of hormonal stimulation, be refilled directly with Ca2+ from the 
extracellular space. This model is attractive because it fits well with observations that Ca2+ influx 
associated with the refilling of the hormone-sensitive pool of Ca2+ is not accompanied by any 
significant increase in the cytosolic Ca2+ concentration in rat parotid gland (Putney, 1977; Aub et al.y 
1982), or stimulation of glycogenolysis in the perfused liver (Reinhart et al.y 1982c).
By contrast, the model is not easily reconciled with our recent observations that in liver, Ca2+ 
influx into intracellular stores is regulated differently from, and therefore may involve a Ca2+ influx 
pathway which is different to, that which mediates a massive influx of Ca2+ upon simultaneous 
stimulation with glucagon and vasopressin (Altin & Bygrave, 1986). Evidence suggests that the 
former pathway is relatively insensitive to inhibition by neomycin and acidification of the 
extracellular medium, whereas the latter is very sensitive to inhibition by both types of manipulations.
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Fig. 9. The capacitative model for the regulation ofCa2+ influx across the plasma membrane by 
Ca2+-mobilizing agonists.
The interaction of a Ca2+-mobilizing agonist with its receptor (R) activates 
phospholipase C (PLC) via a putative GTP-binding protein (G), which stimulates the 
hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). This generates the
second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG). The
diagrams illustrate two current models by which these agonists are proposed to 
stimulate Ca2+ influx across the plasma membrane.
According to the model first proposed by Putney (1986), the endoplasmic reticulum 
(ER) exists in close apposition with the plasma membrane. The receptor-induced 
production of IP3 releases Ca2+ from the ER into the cytosol. It is proposed that the
consequent lowering of the Ca2+ concentration within the ER lumen increases the 
Ca2+ permeability of regions of the plasma membrane in contact with the ER, 
allowing Ca2+ to enter the cytoplasm through the ER, as illustrated in (a). Removal 
of agonist is purported to result in a closing of the IP3-gated channel in the ER, and a
refilling of the ER Ca2+ pool directly from outside the cell. [For other details see 
Putney et al., 1986.]
The capacitative model was modified by Irvine et al. (1987) to incorporate the 
observations that in some systems Ca2+ influx requires both IP3 and IP4. The
modification proposes that IP4 (produced by phosphorylation of IP3) promotes the
formation of contacts or Ca2+ channels (somewhat analogous to gap junctions) 
between the ER and the plasma membrane. It is through these channels that Ca2+ 
influx into the cell is proposed to occur, as shown in (b). [For other details see Irvine 
et al., 1987.]
(a)
Agonist
PLC
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Therefore, because Ca2+ influx into intracellular stores is not inhibited under conditions where the 
hormonally stimulated net influx of Ca2+ is fully inhibited (Altin & Bygrave, 1987a), it seems that in 
each instance the pathway for Ca2+ influx into the cells is different, and hence that the capacitative 
hypothesis can be accommodated only on the assumption that different pathways for Ca2+ influx exist, 
at least in liver. In this regard it is noteworty that the existence of separate pathways for Ca2+ inflow 
in liver has been proposed also by Hughes et al. (1986b). It should be pointed out nonetheless, that in 
liver there is as yet no direct evidence to suggest that the influx of Ca2+ into the cell occurs through a 
putative endoplasmic reticulum-plasma membrane transporter as required by this model.
(iii) Inositol 1,3,4^-tetrakisphosphate (IP4)
Recently, another mechanism for the stimulation of Ca2+ entry into the cell [a modification of 
the model proposed by Putney (1986)] has been proposed which involves both IP3 and another inositol 
phosphate, IP4 (Irvine & Moor, 1987). It has been established that production of IP4 accompanies the 
increase in IP3 that occurs on receptor activation, and is produced through one of the two pathways 
known to metabolize IP3. In most tissues, I(1,3,4,5)P4 is produced by phosphorylation of I(1,4,5)P3 
by the action of I(1,4,5)P3 kinase (IP3 kinase), an enzyme which is largely associated with the plasma 
membrane and is regulated by Ca2+ and calmodulin (Biden et al., 1987). Because IP4 is rapidly 
produced upon activation of receptors, and rapidly degraded on removal of stimulation, many workers 
have proposed that IP4 may have a second messenger function. Recently, a number of workers have
shown that the microinjection of IP3 into sea urchin eggs (Whitaker & Irvine, 1984; Turner, et al.,
1986; Slack et al., 1986) caused a raising of the fertilization envelope, a process that depends on the 
presence of extracellular Ca2+ (Slack, et al., 1986). Evidence was presented also that other inositol 
phosphates such as I(1,3,4)P3, I(2,4,5)P3 or 1(1,2 cyclic-4,5)P3 which are less potent than IP3, but 
nonetheless effective in releasing intracellular Ca2+ (Irvine et al., 1986b; Dixon & Hokin, 1987), could 
not substitute for IP3 in raising the fertilization envelope (Irvine & Moor, 1986). On the other hand,
the envelope could be raised by co-injecting IP4 with 1(2,4,5)P3 (Irvine & Moor, 1986), but not by 
injecting IP4 in conjunction with an elevation of intracellular Ca2+ with the use of ionomycin (Irvine 
& Moor, 1987). Because IP3 can be converted to IP4, these results were interpreted to suggest firstly, 
that IP4 is involved in regulating Ca^+ entry across the plasma membrane, and secondly, that IP4 
requires the action of IP3 (or some other inositol-phosphate capable of releasing Ca2+ from the 
endoplasmic reticulum) in order for these regulatory effects to be expressed. These observations have 
led Irvine & Moor (1987) to propose a model in which IP4 promotes coupling of the endoplasmic
64
reticulum and plasma membranes, by forming a channel somewhat analoguous to a gap-junction 
through which Ca2+ can enter the endoplasmic reticulum directly from the outside. This model, 
illustrated in Fig. 9b, fits well with the observation that both IP3 and IP4 are necessary to evoke a 
sustained increase in Ca2+-activated K+ current (which is dependent on extracellular Ca2+) in perfused 
voltage-clamped lacrimal acinar cells (Morris et al., 1987). In this regard it is also interesting that 
calcium entry has been correlated with the levels of IP3 and IP4 induced by the action of substance P
and carbachol in rat parotid acinar cells (Merritt & Rink, 1987a,b), and that specific binding of IP4 has 
been demonstrated in rat cerebellar membranes (Theibert et al., 1987).
Although the model has attracted the attention of many workers recently, direct evidence that Ca2+ 
entry occurs through this mechanism, especially in liver is still scant, or nonexistent. It is worth 
pointing out, nonetheless, that the model bears on a number of observations in liver that are worthy of 
consideration. Firstly, it has been shown that hepatocytes possess IP3 kinase activity, and that IP4 
levels increase following the treatment of hepatocytes with vasopressin (Hansen et al., 1986). 
Secondly, both vasopressin and angiotensin which produce greater increases in EP3 and presumably IP4
levels by comparison with phenylephrine in hepatocytes (Charest et al., 1985a; Lynch et al., 1985b; 
Williamson et al., 1986), also have been shown to induce a greater stimulation of net Ca2+ influx 
(Altin & Bygrave, 1985). Moreover, in permeabilized hepatocytes IP4 has been shown to prolong the
Ca2+ release induced by IP3, probably by inhibiting hydrolysis of IP3 (Joseph et al., 1987). Thirdly, 
in isolated hepatocytes the co-administration of glucagon (or cyclic AMP) and vasopressin, which 
induces a synergistic stimulation of Ca2+ influx (see later), has been shown also to elicit a synergistic 
increase in I(1,4,5)P3 kinase activity by comparison with the administration of each hormone alone 
(Biden et al., 1988).
(3) H+/C a 2+ Exchange
The existence of a H+/Ca2+ exchange in liver was suggested by the observation that in the perfused 
liver Ca2+ influx can be stimulated by agents which increase intracellular pH (eg. nupercaine, see 
Friedmann, 1972), and that changes in extracellular pH can affect the calcium content of isolated 
hepatocytes following the separate administration of glucagon, vasopressin and angiotensin 
(Kraus-Friedmann, 1982; Blackmore et al., 1984). Moreover, the net influx of Ca2+ induced by the 
administration of vasopressin to the perfused rat liver is abolished at pH 6.8, but stimulated at pH 8.0 
(Altin & Bygrave, 1987a). Similarly, in both isolated hepatocytes and the perfused liver the influx of 
Ca2+ induced by the co-administration of glucagon and a Ca2+-mobilizing agonist (to be discussed
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later) is completely inhibited at extracellular pH 6.8, but is stimulated at pH 8.0 (Morgan et al., 1983; 
Altin & Bygrave, 1987a). In this instance, however, the stimulation of Ca2+ influx by the hormones 
was not directly proportional to the increase in the efflux of H+ as determined by measurement of 
extracellular pH (Altin & Bygrave, 1987a). Assuming that under these conditions the changes in 
extracellular pH are not significantly affected by mechanisms other than H+/Ca2+ exchange, the results 
suggest that whilst the synergistic stimulation of Ca2+ influx is pH-sensitive, the Ca2+ influx 
mechanism itself is unlikely to involve a simple H+/Ca2+ exchange.
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(IV) SYNERGISTIC INTERACTION BETWEEN GLUCAGON 
AND Ca2+-MOBILIZING AGONISTS
(1) Synergistic stim ulation of Ca2+ fluxes
Of potential relevance to our understanding of the mechanism by which Ca2+-mobilizing agonists 
regulate Ca2+ fluxes, are the findings that the Ca2+-mobilizing action of noradrenaline can be 
potentiated by the cyclic AMP-producing hormone glucagon and exogenous dibutyryl cyclic AMP. 
Work by Morgan et al. (1983) indicates that with no added extracellular Ca2+, the pre-addition of 
glucagon or cyclic AMP potentiates the action of noradrenaline in raising cytosolic Ca2+ levels in 
isolated hepatocytes, and leads to a synergistic increase in the ability of noradrenaline to elicit Ca2+ 
efflux in both isolated hepatocytes and in the perfused liver. Since the binding of 3H-noradrenaline was 
found to be increased under these conditions, the potentiation effects were generally attributed to a cyclic 
AMP-mediated increase in the available binding sites for the hormone (Morgan et al., 1983; 1985). It 
should be pointed out nonetheless, that cyclic AMP also has been proposed to increase the sensitivity 
of the endoplasmic reticulum to the Ca2+-releasing action of IP3 (Burgess et al., 1986).
Of especial interest, however, were the observations that at physiological concentrations of 
extracellular Ca2+, glucagon or cyclic AMP could significantly alter the overall pattern of Ca2+ flux 
changes that are induced by the Ca2+-mobilizing hormones in liver. In particular, at physiological 
concentrations of extracellular Ca2+, the co-administration of glucagon (or cyclic AMP) and a 
Ca2+-mobilizing agent such as phenylephrine, vasopressin or angiotensin to isolated hepatocytes 
(Morgan et al., 1983; Mauger et al., 1985; Mauger & Claret, 1986; Poggioli et al., 1986) or to the 
perfused rat liver (Morgan et al., 1983; Altin & Bygrave, 1986), was accompanied by a synergistic 
stimulation of unidirectional 4^Ca2+ influx or net Ca2+ uptake. The synergistic effect was greatest 
when glucagon (or cyclic AMP) was administered a few minutes before the Ca2+-mobilizing agent, and 
was apparent also at physiological concentrations of the hormones suggesting that the effect has 
physiological relevance (Mauger et al., 1985; Mauger & Claret, 1986; Altin & Bygrave, 1986). 
Subcellular fractionation studies revealed that the influxed Ca2+ was accumulated by the mitochondria 
(Morgan et al., 1983; Altin & Bygrave, 1986). The co-administration of maximal concentrations of 
glucagon and vasopressin (lOnM for each) to the perfused rat liver resulted in an extensive uptake of 
Ca2+ by the liver, (approx. 4,000 nmol/g of liver) over a period of 20 min (see Fig. 10 and 
Altin & Bygrave, 1986). Under these conditions the calcium content of mitochondria was found to 
increase some 20 to 50-fold (see Fig. 11, and Altin & Bygrave, 1986). Removal of the hormones was 
followed by a more gradual efflux of Ca2+ over a period of about 30 min (see Fig. 10). After this time 
the response could be repeated, therefore suggesting that the system was still functional (not shown).
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Very recently, studies using electron probe analysis on sections of rat liver rapidly frozen in vivo 
have failed to detect any increase in the calcium content of mitochondria (or indeed whole cell calcium) 
following the injection of glucagon and vasopressin into the anterior mesenteric vein (Bond et al., 
1987). We have no explanation for those results. We point out, however, that the observed increase in 
both mitochondrial cellular calcium content in liver following the administration of glucagon and a 
Ca2+-mobilizing agent is supported by a number of independent observations. Firstly, the calcium 
content of the mitochondrial fraction obtained from hormone-treated liver is increased by comparison 
with the mitochondrial fraction from control livers, and this increase can be prevented by inhibitors of 
mitochondrial respiration (Morgan et al., 1983; Altin & Bygrave, 1986). Secondly, the administration 
of these hormones has been shown to induce a synergistic stimulation of unidirectional 4^Ca2+ uptake 
in isolated hepatocytes (Mauger et al., 1985; Mauger & Claret, 1986; Poggioli et al., 1986) and the 
perfused liver (Altin & Bygrave, 1987d). Furthermore, a brief administration (for 5 min) of 4-5Ca2+ to 
the perfused livers during the Ca2+ uptake response results in a large increase (approx. 10-fold increase 
with respect to controls carried out in the absence of hormones) in the accumulation of label in the 
mitochondrial fraction upon subsequent subfractionation of the liver. This is observed despite the fact 
that extracellular Ca2+ is largely removed by perfusion with media containing no added extracellular 
Ca2+, but an excess of EGTA, for a 2 min period before liver subfractionation (Altin & Bygrave, 
1987d). Thirdly, the increase in mitochondrial calcium content can be correlated with the removal of 
Ca2+ from the perfusate as determined by atomic absorption spectroscopy (Morgan et al., 1983) and 
also by Ca2+-selective electrode measurements (Altin & Bygrave, 1986) in the perfused liver. 
Moreover, this is reflected also in an observed increase in the calcium content of the complete liver 
homogenate (Altin & Bygrave, 1986) and the total cell calcium content of hepatocytes as measured by 
atomic absorption spectroscopy (Morgan et al., 1983).
Clearly, many of these observations are completely independent of cell fractionation 
studies, and therefore are not subject to inaccuracies that may be associated with ion re-distribution (see 
eg. Reinhart et al., 1984b). The failure of Bond et al. (1987) to detect any increase in mitochondrial or 
total cell calcium content must therefore reflect the different experimental systems that are used. 
More specifically, it may be possible that that the injection of glucagon and vasopressin in vivo results 
in a partial inactivation of these agents by binding or protease activity in plasma. Alternatively, it 
would appear that there may be inaccuracies inherent in the ion-probe method currently being used, and 
hence the suitability of the experimental method itself could be seriously questioned.
In addition to the synergistic effects observed with glucagon and phenylephrine, vasopressin and 
angiotensin, similar interactions were observed also on the co-administration of glucagon with other 
Ca2+-mobilizing agents purportedly linked to the breakdown of phosphoinositides. Thus ATP, ADP, 
EGF and agents such as PGF2a  , and phosphatidic acid, were all found to stimulate Ca2+ influx
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synergistically in the liver perfused with media containing 1.3mM Ca2+ (Altin & Bygrave, 1987a; 
1987c; 1988). In each instance net Ca2 + influx was insensitive to inhibition by nominal 
concentrations of the voltage-sensitive Ca2+-channel blockers verapamil, diltiazem and nifedipine. By 
contrast, the influx was completely inhibited by lOmM neomycin, and by a lowering the extracellular 
pH to 6.8 (Altin & Bygrave, 1987a). These manipulations however, did not effect the ability of these 
agonists to induce a release of Ca2+ from intracellular stores. The findings suggest that under these 
conditions all these agents share similar mechanisms for the regulation of Ca2+ influx. Moreover, 
whilst the ability of glucagon (or cyclic AMP) to induce a mobilization of intracellular Ca2+ when 
administered alone recently has been attributed to an effect on phosphoinositide hydrolysis (reviewed in 
Williamson et al., 1986; but see Rashed & Patel, 1987), it seems clear that the potential for cyclic 
AMP to alter Ca2+ flux, especially when in the presence of Ca2+-mobilizing hormones, may well 
include other mechanisms.
(2) The nature of the synergism between cyclic AMP and Ca2+-mobilizing agonists
An important question regarding the mechanism for the synergistic stimulation of Ca2+ influx by 
cyclic AMP and Ca2+-mobilizing agonists concerns the location of the control point for Ca2+ influx 
into the cell. That is, does the primary event for the synergistic stimulation of Ca2+ influx by cyclic 
AMP and Ca2+-mobilizing hormones occur at the level of the mitochondria (since these accumulate 
Ca2+), or the plasma membrane? It has been reported that the administration of glucagon to rats leads to 
an increased ability of subsequently isolated mitochondria to accumulate Ca2+ (Hughes & Barritt, 1978; 
Andia-Waltenbaug et al. 1978, 1981; Prpic & Bygrave, 1980; Taylor et al, 1980). It may be argued, 
therefore, that under these conditions cyclic AMP may exert its effects through a modification of the 
Ca2+ transport systems in the mitochondria, presumably through phosphorylation of the Ca2+ 
transporters for mitochondrial Ca2+ uptake by stimulating Ca2+ uptake and/or inhibiting Ca2+ efflux, 
and thereby lowering the set point for Ca2+ uptake by mitochondria. As a consequence of this, one 
might expect that in the presence of cyclic AMP the action of a Ca2+-mobilizing agonist on the liver 
cell would induce an increase in cytosolic Ca2+ concentration which is lower than that induced by the 
administration of a Ca2+-mobilizing agonist alone. However, recent work suggests that the 
co-administration of cyclic AMP and Ca2+-mobilizing agents leads to a greater increase in the cytosolic 
Ca2+ concentration than that which is achieved by the addition of the hormones singly (Combettes et 
al., 1986; Williamson et al., 1986). Because the mitochondria are known to take up Ca2+ under these 
conditions, this finding contradicts the notion that the primary action of cyclic AMP is to lower the set 
point for Ca2+ uptake by the mitochondria. Instead, taken in conjunction with the findings that the 
co-administration of the hormones leads to a stimulation of unidirectional Ca2+ influx^Mauger et al., 
1985; Mauger & Claret, 1986; Poggioli et al., 1986; Altin & Bygrave, 1987d), under conditions where
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cytosolic Ca2+ is presumed to be further increased (Combettes et al., 1986; Williamson et al., 1986), it 
appears that the simplest interpretation of the results would require that the primary action of cyclic 
AMP is to affect changes in Ca2+ influx across the plasma membrane.
It should be pointed out nonetheless, that because the Ca2+ influx is sensitive to inhibition by 
inhibitors of mitochondrial respiration, and because the capacity of the mitochondria to store Ca2+ 
though large, is finite, it seems possible that a regulatory or feedback effect on Ca2+ influx into the cell 
might exist under these conditions. It is envisaged that such an effect could include an inhibition of the 
plasma membrane Ca2+ influx pathway by Ca2+ (see Poggioli et al., 1985) as a consequence of an 
excessive increase in cytosolic Ca2+ concentration that might occur under conditions where the ability 
of mitochondria to buffer cytoplasmic Ca2+ is reduced.
(3) The role of cyclic AMP
In order to gain insights into the mechanism by which glucagon (or cyclic AMP) can synergistically 
potentiate the influx of Ca2+ induced by Ca2+-mobilizing agonists, it is essential to establish the site 
at which cyclic AMP acts in this system. The administration of glucagon or dibutyryl cyclic AMP 
alone to isolated hepatocytes has been shown to lead to a cyclic AMP-dependent phosphorylation of a 
number of cytosolic, mitochondrial, and plasma membrane proteins (see eg. Vargas et al., 1982). 
However, it is not known whether any of the proteins presently known to be phosphorylated by 
glucagon bears any relationship to the synergistic stimulation of Ca2+ influx described. There is 
considerable evidence that protein phosphorylation by the catalytic subunit of cyclic AMP-dependent 
protein kinase can alter the gating properties of voltage-sensitive Ca2+ channels in tissues such as 
cardiac muscle. As discussed previously, however, the existence of voltage-sensitive channels and their 
activation by Ca2+-mobilizing agonists remains to be demonstrated in rat liver. It is not known 
therefore, whether the action of cyclic AMP in liver is to phosphorylate a specific class of Ca2+ 
channels or Ca2+ influx pathway, or whether phosphorylation is simply an early step in some cascade 
of events involved in the production of messengers which leads ultimately to the modulation of channel 
activity.
Studies in our laboratory indicate that the administration of glucagon or cyclic AMP alone to the 
perfused liver does not lead to any significant stimulation of net Ca2+ influx (Altin & Bygrave, 1986). 
Moreover, the rate of Ca2+-cycling across the plasma membrane is only slightly stimulated by 
glucagon administration under these conditions (Reinhart et al., 1984d). Our data show also that the 
stimulation of net Ca2+ influx is always preceded by a stimulation of a small amount of Ca2+ efflux 
from intracellular stores (see eg. Fig. 10). There are indications also that a positive correlation may 
exist between the ability of a Ca2+-mobilizing agent to induce PIP2 hydrolysis as measured by other
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workers (eg. Lynch et al., 1985b; Charest et al., 1985a), and its ability to interact synergistically with 
glucagon (or cyclic AMP) to stimulate Ca2+ influx (Altin & Bygrave, 1986, 1987a). In this regard it 
is noteworthy also, that both vasopressin and angiotensin, which induce a greater stimulation of PIP2
breakdown and production of IP3 by comparison with the a-agonist phenylephrine, are also more 
effective than phenylephrine in stimulating Ca2+ influx when each agent is administered alone (Altin & 
Bygrave, 1985). Although the synergistic potentiation of Ca2+ influx requires the presence of both 
cyclic AMP and a Ca2+-mobilizing agonist, it should be pointed out that once established, the 
continuation of Ca2+ influx induced by the co-administration of glucagon (or cyclic AMP) and a 
Ca2+-mobilizing agonist is more sensitive to the continued presence of the Ca2+-mobilizing agonist, 
than to the presence of cyclic AMP. This is evident from the fact that removal of the Ca2+-mobilizing 
agonist results in a more rapid cessation of the Ca2+ inflow compared with the removal of glucagon or 
cyclic AMP (see Fig. 12, and Altin & Bygrave, 1987d). Moreover, efflux of the accumulated Ca2+ does 
not occur until removal of the Ca2+-mobilizing agonist, but still occurs in the presence of cyclic AMP 
after the removal of the Ca2+-mobilizing agonist. These findings suggest that cyclic AMP is involved 
in some form of 'priming' step which requires events subsequent to the occupation of the 
Ca2+-mobilizing receptor for stimulation of Ca2+ influx.
It seems therefore, that cyclic AMP is involved either in 'priming' the Ca2+ transporter itself which 
requires also the interaction of a metabolite of phosphoinositide hydrolysis for activation, or 
alternatively, cyclic AMP either directly or indirectly through cyclic AMP-dependent protein 
phosphorylation, affects the activity of enzymes involved in the production of some signal or 
metabolite derived from phosphoinositide hydrolysis, and which is involved in the regulation of Ca2+ 
influx. These conclusions are consistent also with the observation that the synergistic stimulation of 
Ca2+ influx is sensitive to inhibition by neomycin (Altin & Bygrave, 1987a), an agent reported to 
inhibit the action of phospholipase C in some systems.
(4) Possible interaction of cyclic AMP with second messengers
If the synergistic interaction of cyclic AMP and Ca2+-mobilizing agonists in the stimulation of 
Ca2+ influx is due to the interaction of cyclic AMP and products of phosphoinositide breakdown on the 
Ca2+ inflow mechanism, then it seems that the second messengers diacylglycerol and IP3 (and
metabolites of these) should be considered as possible candidates for the regulation of Ca2+ influx. 
Because diacylglycerol activates protein kinase C (Nishizuka, 1983, 1984) it is clear also, that a 
possible synergistic effect between cyclic AMP and protein kinase C needs to be considered in this 
context. There are reports which suggest that the pre-treatment of hepatocytes with phorbol esters 
abolishes the Ca2+ fluxes and other responses induced by glucagon (Williamson et al., 1986).
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Fig. 12. The effect of glucagon, and phenylephrine, separately on the Ca2+ response induced by 
the co-administration of glucagon and phenylephrine to the perfused rat liver.
Glucagon (lOnM, thick lines) and 4 min later phenylephrine (2|iM, thin lines) were 
co-infused as indicated. Trace (a) shows the Ca2+ responses obtained when both 
glucagon and phenylephrine were removed simultaneously. The response obtained 
when the administration of either glucagon or phenylephrine, was continued beyond 
the period of co-administration, is shown in (b) and (c), respectively. [For further 
details see Altin & Bygrave, 1987d.]
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Conversely, the pre-administration of cyclic AMP does not result in a synergistic stimulation of net 
Ca2+ influx upon subsequent administration of phorbol 12-myristate 13-acetate to isolated hepatocytes 
or to the perfused liver (Altin & Bygrave, unpublished observations). Similar results are obtained also 
with the membrane-permeable synthetic diacylglycerol (l-oleoyl-2-acetylglycerol) instead of phorbol 
12-myristate 13-acetate. This suggests that the activation of protein kinase C and the presence of cyclic 
AMP alone, are not sufficient to stimulate Ca2+ influx synergistically. A similar conclusion was 
reached by Burgess et al. (1986) while studying the interactions between cyclic AMP and Ca2+ 
mobilization by angiotensin in guinea pig hepatocytes.
In many systems diacylglycerol can be phosphorylated by a diacylglycerol-specific kinase to form 
phosphatidic acid, or alternatively, it can be hydrolysed by a diacylglycerol-specific lipase to form 
monoacylglycerol and arachidonic acid. Because phosphatidic acid already has been implicated in Ca2+ 
inflow, and arachidonic acid is an established precursor of eicosanoids, it was of interest to examine a 
possible synergistic effect of glucagon with phosphatidic acid and arachidonic acid in the stimulation of 
Ca2+ influx. Experiments using the perfused rat liver suggest however, that both metabolites, when 
administered exogenously, interact synergistically with glucagon (or cyclic AMP) in stimulating Ca2+ 
influx. Such action is unlikely to be mediated by a direct effect of these agents per se, but is more 
likely to occur through the stimulation of phosphoinositide hydrolysis. Thus, phosphatidic acid elicited 
Ca2+ efflux and other responses that are characteristic of the activation of Ca2+-mobilizing receptors 
(Altin & Bygrave, 1987c; see also Moolenaar et al., 1986); and arachidonic acid elicited responses 
which were inhibited by indomethacin and therefore presumably reflecting an involvement of 
non-parenchymal cells (see Part I of this review and Altin & Bygrave, 1987c). Assuming that these 
findings obtained by the exogenous administration of phosphatidic acid and arachidonic acid can be 
extrapolated to represent the situation whereby these agents are produced intracellularly by the activation 
of Ca2+-mobilizing receptors, it would seem that neither phosphatidic acid or arachidonic acid, nor 
events or metabolites produced from these, are involved in the synergistic stimulation of Ca2+ influx in 
the presence of cyclic AMP. In light of these observations it would seem that the second messenger 
IP3, or other metabolites derived from this are the more likely candidates for the synergistic effects of
cyclic AMP and Ca2+-mobilizing agonists on Ca2+ influx. However, although various inositol 
phosphates have already been successfully injected into sea urchin eggs for studying their possible 
involvement in the regulation of Ca2+ influx, to date it appears that studies in which IP3, IP4 or other
inositol phosphates are introduced into viable hepatocytes for examining a possible synergistic 
interaction with cyclic AMP, have not yet been reported.
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(5) Effect of cyclic AMP on phosphinositide breakdown 
and inositol phosphate metabolism
The possibility that the action of cyclic AMP is to increase the production of metabolites or second 
messenger involved in the stimulation of Ca2+ influx, has to date not been thoroughly investigated. 
Preliminary studies by Poggioli et al. (1986) indicated that the presence of glucagon and a 
Ca2+-mobilizing agent (either vasopressin or phenylephrine) had no synergistic effect on 
phosphoinositide hydrolysis and production of I(1,4,5)P3, in hepatocytes. These workers concluded 
therefore, that the synergistic stimulation of Ca2+ influx was not due to any change in the coupling of 
the receptors to this signal transduction process. As pointed out by Whipps et al. (1987) however, in 
their experiments Poggioli et al. (1986) did not conduct a time course of phosphoinositide breakdown 
and IP3 accumulation, but made measurements at relatively short times (30 s) after administration of
the hormones. This time is relatively short to study on the possible synergistic effect of glucagon and 
Ca2+-mobilizing agents on Ca2+ influx, as the maximum net rate of Ca2+ influx as measured in the 
perfused liver is reached only after 90 s of vasopressin administration (Altin & Bygrave, 1986). In this 
regard it is interesting that Whipps et al. (1987) report that the presence of glucagon enhances the 
stimulation of both PIP2 phosphodiesterase and phosphatidylinositol kinase activities when measured at
later times in isolated rat hepatocytes. It also has been reported that the administration of both 
glucagon and vasopressin to hepatocytes induced a greater increase in diacylglycerol levels than that 
induced by vasopressin alone (Bocckino et al., 1985). This result indicates that cyclic AMP either 
increases phospholipase C activation or inhibits diacylglycerol kinase. Studies in lymphocytes, red 
cells and platelets also indicate increased 32P-labelling of phosphoinositides byAcatalytic subunit of 
cyclic AMP-dependent protein kinase (Enyedi et al., 1983); however it appears that in some systems 
including platelets, cyclic AMP can inhibit phospholipase C activity (Watson et al., 1984). It seems 
therefore, that the effect of cyclic AMP on the stimulation of phosphoinositide hydrolysis by 
Ca2+-mobilizing hormones in liver, as in other tissues, remains to be clarified.
From the preceding discussion it seems that in so far as Ca2+ influx is concerned, the effect of 
cyclic AMP is more likely to result in the alteration of the production and/or metabolism of IP3 rather 
than that of diacylglycerol. For this reason we have recently studied possible effects of cyclic AMP on 
the metabolism of IP3 by I(1,4,5)P3 kinase, the enzyme involved in the production of IP4. This area
is especially important in light of other recent findings which suggest that IP4 may be involved in the
gating of Ca2+ influx as described previously. Preliminary studies in our laboratory using hepatocytes 
pre-incubated with 3H-inositol suggest that whereas glucagon (or cyclic AMP) only slightly increases 
the recovery of label in IP4 when added alone, the pre-addition of glucagon synergistically increases the
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label recovered in IP4 following the addition of vasopressin (Biden et al., 1988). Apart from 
establishing a role for cyclic AMP in stimulating I(1,4 ,5)P3 kinase in liver, these observations also add 
further support to the findings that IP4 may be involved in regulating Ca2+ entry (Irvine & Moor,
1987). In this context the events that may be important for the regulation of Ca2+ influx by the 
synergistic action of glucagon and Ca2+-mobilizing agonists are summarised in Fig. 13.
(6) Ion fluxes associated with Ca2+ influx
Because the Ca2+ ion carries a net positive charge and the co-administration of glucagon and 
Ca2+-mobilizing agonists to rat liver induces a large influx of Ca2+, the question arises as to what other 
ion movement if any, is necessary in order to maintain the electrical charge balance of the cell. It 
remains to be established whether in this system Ca2+ influx is dependent on either the 
counter-transport of some cation, or alternatively, the co-transport of some anion. Apart from 
stimulating the movement of Ca2+, the action of glucagon and Ca2+-mobilizing hormones has been 
associated with a stimulation of other ion transport processes such as Na+/K +-ATPase 
(Radominska-Pyrek et al., 1982; Berthon et al., 1985; Lynch et al., 1986, 1987) and Na+/H+-exchange 
(McGivan & Moule, 1987). However, the activation of these has not yet been shown to be obligatory 
for stimulation of Ca2+ influx. Although Friedmann (1972) reported a stimulation of both K+ and 
Na+ fluxes in perfused rat liver following stimulation with glucagon, no studies were conducted to 
determine the ion fluxes induced by the presence of both glucagon and a Ca2+-mobilizing agonist; that 
is, under conditions where there is a synergistic stimulation of Ca2+ influx. In guinea pig liver it has 
been reported that the co-administration of <X - and ß -agonists induces a K+ loss which is greater than 
the additive effect of the agonists administered separately (Jenkinson & Koller, 1977; Cocks et al., 
1984). Whilst differences in the K+ permeability properties of guinea-pig and rat liver have been 
well-documented (eg. Burgess et al., 1981; Coats, 1985), we also detect a synergistic loss of K+ 
following the administration of glucagon and phenylephrine to the perfused rat liver. This K+ loss does 
not occur however, when vasopressin, which induces an even greater influx of Ca2+ by comparison 
with phenylephrine under these conditions, is used as the Ca2+-mobilizing agonist (Altin & Bygrave, 
unpublished observations). It would seem therefore, that in the main, K+ efflux is not directly linked 
with the synergistic influx of Ca2+ that occurs following the co-administration of glucagon and a 
Ca2+-mobilizing agonist to rat liver. To our knowledge there has not yet been any study on the Na+ 
flux changes that may occur upon the co-administration of glucagon and Ca2+-mobilizing agonists in
rat liver.
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Fig. 13. The regulation o f Ca2+ influx by the synergistic action o f glucagon and 
Ca2+-mobilizing agonists.
This simplified diagram illustrates some of the possible sites of regulation of Ca2+ 
influx by cyclic AMP and Ca2+-mobilizing agonists. Ca2+-mobilizing agonists have 
been shown to induce PIP2 breakdown generating second messengers such as 
diacylglyceroi (DG) which activates protein kinase C, and IP3 which releases Ca2+
from the endoplasmic reticulum (see Fig. 4 and relevant sections of the text). The 
co-administration of glucagon (or cyclic AMP) and a Ca2+-mobilizing agonist has 
been shown to induce a large stimulation of unidirectional Ca2+ influx into the liver 
cell, resulting in an extensive accumulation of Ca2+ by the mitochondria (bold 
arrow). Although the mechanism by which the Ca2+ influx is regulated is not 
known and may involve some form of direct coupling of the receptor with the Ca2+ 
transporter itself, the Ca2+ influx appears to require both cyclic AMP (or steps 
involving phosphorylation by cyclic AMP-dependent protein kinase) and a 
metabolite(s) of PIP2 hydrolysis. The role of cyclic AMP in this system is not clear 
but may involve a direct or indirect stimulation of the Ca2+ influx transporter itself, 
or an alteration in the rate of production of the signal(s) that is involved in the 
regulation of Ca2+ influx. Although only some posssible sites of regulation are 
illustrated in the diagram, cyclic AMP may also lead to changes in the activities of 
other Ca2+-transporters in the plasma membrane, the mitochondria, and possibly the 
endoplasmic reticulum (ER). There is some evidence which suggests that cyclic AMP 
may alter the metabolism of the phosphoinositides, and that in liver cyclic AMP 
may regulate the production of IP4 by stimulating the activity of IP3 kinase.
Although recent studies in other tissues suggest that IP3 and IP4 may be involved in 
the regulation of Ca2+ influx, it remains to be established whether this mechanism
occurs in liver.
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Studies on the effects of administering glucagon and vasopressin, either singly or together, to the 
perfused rat liver, followed by estimations of the total calcium and inorganic phosphate (Pj) content of 
the mitochondria obtained by rapid Percoll density subfractionation of the liver, suggest that the 
synergistic stimulation of Ca2+ influx and accumulation of Ca2+ by mitochondria is accompanied by a 
synergistic increase in the Pj content of mitochondria (F.L. Bygrave & J.G. Altin, unpublished
observations). These findings are compatible with the observations that the presence of Pj enhances
the uptake of Ca2+ by rat liver mitochondria in vitro (Bygrave, 1978a), and that the administration of 
glucagon, and to a lesser extent phenylephrine, vasopressin and angiotensin, to isolated hepatocytes 
leads to an increase in the cellular Pj content (Siess et al., 1984). Since an increase in the Pj content of 
mitochondria by the co-administration of the hormones was not observed under conditions of low 
extracellular Ca2+ (ie. when no net Ca2+-influx occurs), the results also suggest that Pj uptake is 
secondary to Ca2+ influx and Ca2+ accumulation. It is presumed therefore, that this could reflect a 
requirement of Pj in neutralizing the build up of a positive charge within the mitochondria, and also 
perhaps in the storage of the quite large amounts of Ca2+ that accumulate in the mitochondria under 
these conditions. It is noteworthy also, that whereas the accumulation of Ca2+ and Pj by mitochondria
could be correlated with a fall in the perfusate concentrations of Ca2+ and Pj, Ca2+ influx into the cell 
and into mitochondria were not obligatorily dependent on perfusate Pj, since Ca2+ uptake was 
unaffected by lowering the perfusate Pj concentration to around 20 f±M (J.G. Altin & F.L. Bygrave, 
unpublished observations). Presumably under these conditions Pj for transport into mitochondria can 
be provided by the relatively high resting concentration of Pj in the cytosol. From these considerations 
it would seem that whereas the electrical balance for Ca2+ transport into the mitochondria may be met 
by the transport of Pj, the electrical balance for Ca2+ entry into the cell may involve the transport of 
other ions apart from Pj. Clearly, this area requires further study.
(7) Effect of membrane depolarization on Ca2+ influx
Of potential relevance to our understanding of the regulation of Ca2+ influx in liver are the 
observations that the administration of glucagon, and of phenylephrine, is accompanied by membrane 
hyperpolarization in both the perfused rat liver (Friedmann et al., 1971; Friedmann & Dambach, 1980) 
and in isolated segments of mouse liver (Graf & Petersen, 1978). Also, whereas the co-administration
of both a -  and ß-agonists leads to a synergistic stimulation of Ca2+ influx in rat liver, the 
administration of these agonists has been shown to lead to a synergistic increase in membrane potential
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in guinea-pig liver (Jenkinson & Koller, 1977; Cocks et al., 1984). Because it has been reported that 
IP3 can stimulate Ca2+ influx in Xenopus oocytes on hyperpolarization (Parker & Miledi, 1987), it
seemed possible also, that membrane hyperpolarization could play some role in the synergistic 
stimulation of Ca2+ influx that occurs in rat liver following the co-administration of glucagon and 
Ca2+-mobilizing agonists. Preliminary studies suggest that hyperpolarization of the rat liver by 
valinomycin (Friedmann & Dambach, 1980) does not result in the synergistic stimulation of Ca2+ 
influx upon the administration of either glucagon or vasopressin (Altin & Bygrave, unpublished). 
However, in both the perfused rat liver and in isolated hepatocytes the synergistic stimulation of Ca2+ 
influx induced by the co-administration of glucagon and vasopressin was sensitive to inhibition by a 
depolarization of the plasma membrane induced by exposure to lOOmM K+. Although we did not 
check the ability of vasopressin to stimulate phosphoinositide hydrolysis under these conditions, it is 
noteworthy that because extracellular pH can effect membrane potential and K+ efflux in rat liver 
(Henderson et al., 1987), the inhibition of Ca2+ influx by membrane depolarization may also provide 
an explanation for the mechanism by which Ca2+ influx is inhibited under conditions in which the 
extracellular medium is acidified (Blackmore et al., 1984; Altin & Bygrave, 1987a). Whilst Ca2+ 
influx through voltage-sensitive Ca2+ channels in excitable tissues is stimulated by membrane 
depolarization, it appears therefore, that the hormonal stimulation of Ca2+ influx in rat liver may be 
inhibited by membrane depolarization. This clearly reflects the different properties of these Ca2+ influx 
mechanisms.
(V) SUMMARY
Knowledge of the mechanism of action of Ca2+-mobilizing agonists in liver has progressed 
considerably following the discovery that their interaction with specific receptors on the plasma 
membrane is accompanied by the hydrolysis of PIP2 and the generation of the second messengers 
diacylglycerol and IP3 for the activation of protein kinase C and the mobilization of intracellular 
Ca2+, respectively. Although the second messenger functions of diacylglycerol and IP3 in these
actions seem well established, it is not yet clear how the agonists are able to regulate Ca2+ influx 
across the plasma membrane, an event which is crucial for those actions of the agonists which are 
dependent on the maintenance of an elevated level of cytosolic Ca2+. Whilst there is evidence for the 
existence of more than one pathway for Ca2+ influx in liver, it appears that in each instance the Ca2+ 
influx process is regulated differently to the Ca2+ influx through the voltage-sensitive Ca2+ channels 
that is known to occur in excitable tissues. At present it is not clear whether any of the Ca2+ influx
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pathways in liver is regulated by direct coupling to the agonist receptor mechanism on the outer surface 
of the plasma membrane, or whether the regulation involves the production of some second 
messenger(s). However, indirect evidence from a number of tissues appears to favour the 
involvement of both IP3 and IP4 in the regulation of Ca2+ influx. The mechanism by which IP3 and
IP4 may regulate Ca2+ influx remains to be established, but it has been proposed that Ca2+ entry into
the cell occurs through a pathway connecting the plasma membrane and the endoplasmic reticulum, 
following the release of intracellular Ca2+ from the lumen of the endoplasmic reticulum.
Although it is not yet known whether glucagon (or cyclic AMP) activates the same pathway for 
Ca2+ influx as Ca2+-mobilizing agonists, the marked potentiation by cyclic AMP of the Ca2+ influx 
induced by Ca2+-mobilizing agonists has provided a powerful system with which to study the 
regulation of Ca2+ influx in liver. Whether this Ca2+ influx process occurs through some ion 
exchange mechanism (such as Ca2+/Na+ exchange) remains to be determined. Results from this study 
suggest that the Ca2+ influx is inhibited by neomycin, acidic pH, and a depolarization of the plasma 
membrane. The observation that cyclic AMP synergistically potentiates the influx of Ca2+ induced by 
Ca2+-mobilizing agonists, that this influx appears to correlate with the reported ability of these 
agonists to induce PIP2 hydrolysis and accumulation of IP3, and that cyclic AMP synergistically
potentiates the production of IP4 by vasopressin, are all consistent with the notion that IP3 and IP4 
are involved in regulating Ca2+ influx. Whilst little is known about the Ca2+ transport process itself, 
these studies coupled with the recent finding that Ca2+ influx into the liver cell can occur through 
different pathways, seem set to lead to a better understanding of this important process in the 
near future.
85
(E) REFERENCES
ADUNYAH, S.E. & DEAN, W.L. (1985). Inositol trisphosphate-induced Ca2+-release from human platelet 
membranes. Biochemical and Biophysical Research Communications 128,1274-1280.
AIYAR, N., NAMBI, P., STASSEN, F. & CROOKE, S.T. (1987). Solubilization and reconstitution of 
vasopressin Vi receptors of rat liver. Molecular Pharmacology 32, 34-36.
AKERBOOM, T., LENZEN, R., SCHNEIDER, I. & SIES, H. (1987). Cholestasis and changes in the 
microcirculation of perfused rat liver caused by the calcium ionophore A23187 and type 1 
antiarrhythmic drugs. Biochemical Pharmacology 36, 3037-3042.
ALTIN, J.G. & BYGRAVE, F.L. (1985). The Ca2+-mobilizing actions of vasopressin and angiotensin
differ from those of the a-adrenergic agonist phenylephrine in the perfused rat liver.
Biochemical Journal 232,911-917.
ALTIN, J.G. & BYGRAVE, F.L. (1986). Synergistic stimulation of Ca2+ uptake by glucagon and 
Ca2+-mobilizing hormones in the perfused rat liver. A role for mitochondria in long-term Ca2+ 
homeostasis. Biochemical Journal 238,653-661.
ALTIN, J.G. & BYGRAVE, F.L. (1987a). The influx of Ca2+ induced by the administration of glucagon 
and Ca2+-mobilizing agents to the perfused rat liver could involve at least two separate pathways. 
Biochemical Journal 242,43-50.
ALTIN, J.G., DIETER, P. & BYGRAVE, F.L. (1987b). Evidence that Ca2+ fluxes and respiratory, 
glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and
L-a-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase 
pathway. Biochemical Journal 245, 145-150.
ALTIN, J.G. & BYGRAVE, F.L. (1987c). Phosphatidic acid and arachidonic acid each interact 
synergistically with glucagon to stimulate Ca2+ influx in the perfused rat liver.
Biochemical Journal 247,613-619.
ALTIN, J.G. & BYGRAVE, F.L. (1987d). Ca2+ uptake stimulated by the synergistic action of glucagon 
and Ca2+-mobilizing agents in the perfused rat liver occurs through the activation of a unidirectional 
Ca2+ influx pathway.
Biochemical and Biophysical Research Communications 142,745-753.
ALTIN, J.G. & BYGRAVE, F.L. (1988). Prostaglandin F2a  and the thromboxane A2 analogue
ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that 
prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.
Biochemical Journal 249,677-685.
ANDIA-WALTENBAUGH, A.M., KIMURA, S., WOOD, J. DIVAKARAN, P. & FRIEDMANN, N. 
(1978). Effects of glucagon, insulin and cyclic AMP on mitochondrial calcium uptake in the liver.
Life Sciences 23, 2437-2444.
86
ANDIA-WALTENBAUGH, A.M., TATE, C.A. & KRAUS-FRIEDMANN, N. (1981). The effect of 
glucagon on the kinetics of hepatic mitochondrial calcium uptake.
Molecular and Cellular Biochemistry 36, 177-184.
ARIAS, I., POPPER, H„ SCHÄCHTER, D. & SHAFRITZ, D.A. (eds) (1982).
The Liver: Biology and Pathobiology. Raven Press, New York.
ASSIMACOPOULUS-JEANNET, F., McCORMACK, J.G. & JEANRENAUD, B. (1986).
Vasopressin and/or glucagon rapidly increases mitochondrial calcium and oxidative enzyme activities in 
the perfused rat liver. Journal of Biological Chemistry 261, 8799-8804.
ATERMAN, K. (1963). The structure of the liver sinusoids and the sinusoidal cells. In: The Liver, 
Morphology, Biochemistry, Physiology (ed. C. Rouiller) pp. 61-136,
Academic Press, New York.
AUB, D.L., McKINNEY, J.S. & PUTNEY, J.W.Jr. (1982). Nature of the receptor-regulated calcium pool 
in the rat parotid gland. Journal of Physiology (London) 331, 557-565.
AUTHI, K.S. & CRAWFORD, N. (1985). Inositol 1,4,5-trisphosphate induced-release of sequestered Ca2+ 
from highly purified human platelet intracellular membranes. Biochemical Journal 230,247-253. 
AZHAR, S., BUTTE, J. & REAVEN, E. (1987). Calcium-activated, phospholipid-dependent protein 
kinases from rat liver: subcellular distribution, purification, and characterization of multiple forms. 
Biochemistry 26, 7047-7057.
BAKER, P.F. (1976). Regulation of intracellular Ca and Mg in squid axons.
Federation Proceedings 35,2589-2595.
BALDASSARE, J.J. & FISHER, G.J. (1986). Regulation of membrane-associated and cytosolic 
phospholipase C activities in human platelets by guanosine triphosphate.
Journal of Biological Chemistry 261, 11942-11944.
BANSAL, V.S., INHORN, R.C. & MAJERUS, P.W. (1987). The metabolism of inositol 
1,3,4-trisphosphate to inositol 1,3-bisphosphate.
Journal of Biological Chemistry 262, 9444-9447.
BARNS, D.M. (1986). How cells respond to signals. Science 234, 286-288.
BARRITT, G.J., PARKER, J.C. & WADSWORTH, J.C. (1981a). A kinetic analysis of the effects of 
adrenaline on calcium distribution in isolated rat liver parenchymal cells.
Journal of Physiology (London) 312, 29-55.
BARRITT, G J., DALTON, K.A. & WHITING, J.A. (1981b). Evidence that phosphatidic acid stimulates 
the uptake of calcium by liver cells but not calcium release from mitochondria.
FEBS Letters 125, 137-140.
BATTY, I.R., NAHORSKI, S.R. & IRVINE, R.F. (1985). Rapid formation of inositol 
1,3,4,5-tetrakisphosphate following muscarinic receptor stimulation of rat cerebral cortical slices. 
Biochemical Journal 232,211-215.
87
BEAN, B.P., NOWYCKY, M.C. & TSIEN, R.W. (1984). ß-adrenergic modulation of calcium channels in 
frog ventricular heart cells. Nature (London) 307, 371-375.
BECKER, G.L., FISKUM, G. & LEHNINGER, A.L. (1980). Regulation of free Ca2+ by liver 
mitochondria and endoplasmic reticulum. Journal o f Biological Chemistry 255,9009-9012.
BELL, R.L., KENNERLY, D.A., STANFORD, N. & MAJERUS, P.W. (1979). Diglyceride lipase: a 
pathway for arachidonate release from human platelets.
Proceedings of the National Academy of Science (USA) 76, 3238-3241.
BENEDETTI, A., FULCERI, R. & COMPORTI, M. (1985). Calcium sequestration in rat liver 
microsomes. Evidence for a cooperation of calcium transport with glucose-6-phosphatase.
Biochimica et Biophysica Acta 816,267-277.
BENEDETTI, A., FULCERI, R., FERRO, M. & COMPORTI, M. (1986). On the possible role of 
glucose-6-phosphatase in the regulation of liver cell cytosolic concentration.
Trends in Biochemical Sciences 11,284-285.
BENEDETTI, A., FULCERI, R., ROMANI, A. & COMPORTI, M. (1987). Stimulatory effect of glucose 
6-phosphate on the non-mitochondrial Ca2+ uptake in permeabilized hepatocytes and Ca2+ release by 
inositol trisphosphate. Biochimica et Biophysica Acta 928, 282-286.
BENHAM, C.D. & TSIEN, R.W. (1987). A novel receptor-operated Ca2+-permeable channel activated by 
ATP in smooth muscle. Nature (London) 328, 275-278.
BERNARDI, P. & AZZONE, G.F. (1983). Regulation of Ca2+ efflux in rat liver mitochondria: role of 
membrane potential. European Journal o f Biochemistry 134, 377-383.
BERNARDI, P. (1984). Modulation of Ca2+ efflux and rebounding Ca2+ transport in rat liver 
mitochondria. Biochimica et Biophysica Acta 766, 277-282.
BERRIDGE, MJ. & FAIN, J.N. (1979). Inhibition of phosphatidylinositol synthesis and the inactivation 
of calcium entry after prolonged exposure of the blowfly salivary gland to 5-hydroxytryptamine. 
Biochemical Journal 178,59-69.
BERRIDGE, M.J. (1983). Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse 
polyphosphoinositides instead of phosphatidylinositol. Biochemical Journal 212, 849-858. 
BERRIDGE, M.J. (1984). Inositol trisphosphate and diacylglycerol as second messengers.
Biochemical Journal 220, 345-360.
BERRIDGE, M.J. (1987). Inositol trisphosphate and diacylglycerol: two interacting second messengers. 
Annual Review o f Biochemistry 56, 159-193.
BERTHON, B., BINET, A., MAUGER, J-P. & CLARET, M. (1984). Cytosolic free Ca2+ in isolated rat 
hepatocytes as measured by quin 2: effects of noradrenaline and vasopressin.
FEBS Letters 167, 19-24.
BERTHON, B., CAPIOD, T. & CLARET, M. (1985). Effects of noradrenaline, vasopressin and 
angiotensin on the Na-K pump in rat isolated liver cells.
British Journal o f Pharmacology 86,151-161.
88
BIDEN, T.J., PRENTKI, M., IRVINE, R.F., BERRIDGE, M.J. & WOLLHEIM, C.B. (1984). Inositol
1.4.5- trisphosphate mobilizes intracellular Ca2+ from permeabilized insulin-secreting cells. Biochemical 
Journal 223,467-473.
BIDEN, T.J. & WOLLHEIM, C.B. (1986). Ca2+ regulates the inositol tris/tetrakisphosphate pathway in 
intact and broken preparations of insulin-secreting RINm5F cells.
Journal o f Biological Chemistry 261,11931-11934.
BIDEN, T.J., COMTE, M., COX, J.A. & WOLLHEIM, C.B. (1987). Calcium-calmodulin stimulates 
inositol 1,4,5-trisphosphate kinase activity from insulin-secreting RINm5F cells.
Journal o f Biological Chemistry 262,9437-9440.
BIDEN, T.J., ALTIN , J.G. & BYGRAVE, F.L. (1988). Regulation of hepatic inositol (1,4,5)P3 kinase.
Australian Societies for Experimental Biology, Bicentennial Meeting, Abstract 5.6.
BIFFEN, M. & MARTIN, B.R. (1987). Polyphosphoinositide labeling in rat liver plasma membranes is 
reduced by preincubation with cholera toxin. Journal o f Biological Chemistry 262,7744-7750. 
BILLAH, M.M., LAPETINA, E.G. & CUATRECASAS, P. (1981). Phospholipase A2 activity specific
for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets.
Journal of Biological Chemistry 256, 5399-5403.
BINET, A., BERTHON, B. & CLARET, M. (1985). Hormone-induced increase in free cytosolic calcium 
and glycogen phosphorylase activation in rat hepatocytes incubated in normal and low-calcium media. 
Biochemical Journal 228, 565-574.
BIRMELIN, M. & DECKER, K. (1984). Synthesis of prostanoids and cyclic nucleotides by phagocytosing 
rat Kupffer cells. European Journal of Biochemistry 142,219-225.
BKAILY, G. & SPERELAKIS, N. (1985). Injection of guanosine 5 '-cyclic monophosphate into heart cells 
blocks calcium slow channels. American Journal of Physiology 248, H745-H749.
BLACKMORE, P.F., WAYNICK, L.E., BLACKMAN, G.E., GRAHAM, C.W. & SHERRY, R.S.
(1984). a- and ß-adrenergic stimulation of parenchymal cell Ca2+ influx. Influence of extracellular pH. 
Journal o f Biological Chemistry 259,12322-12325.
BLACKMORE, P.F., BOCCKINO, S.B., WAYNICK, L.E. & EXTON, J.H. (1985). Role of a guanine 
nucleotide-binding regulatory protein in the hydrolysis of hepatocyte phosphophatidylinositol
4.5- bisphosphate by calcium-mobilizing hormones and the control of cell calcium. Studies utilizing 
aluminium fluoride. Journal of Biological Chemistry 260,14477-14483.
BLACKMORE, P.F. & EXTON, J.H. (1986). Studies on the hepatic calcium-mobilizing activity of 
aluminium fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate.
Journal of Biological Chemistry 261, 11056-11063.
BLACKMORE, P.F., STRICKLAND, W.G., BOCCKINO, S.B. & EXTON, J.H. (1986). Mechanism of 
hepatic glycogen synthase inactivation induced by Ca2+-mobilizing hormones. Studies using 
phospholipase C and phorbol myristate acetate. Biochemical Journal 237,235-242.
89
BLACKWELL, G.J. & FLOWER, RJ. (1983). Inhibition of phospholipase.
British Medical Bulletin 39, 260-264.
BLOUIN, A. (1977). Morphometry of liver sinusoidal cells. In: Kupffer Cells and Other Liver Sinusoidal 
Cells, (ed. E. Wisse and K.L. Knook) pp. 61-71. Elsevier, New York.
BOCCKINO, S.B., BLACKMORE, P.F. & EXTON, J.H. (1985). Stimulation of 1,2-diacylglycerol 
accumulation in hepatocytes by vasopressin, epinephrine, and angiotensin II.
Journal of Biological Chemistry 260, 14201-14207.
BOCCKINO, S.B., BLACKMORE, P.F., WILSON, P.B. & EXTON, J.H. (1987). Phosphatidate 
accumulation in hormone-treated hepatocytes via a phospholipase D mechanism.
Journal of Biological Chemistry 262, 15309-15315.
BOCKAERT, J., HOMBURGER, V. & ROUOT, B. (1987). GTP binding proteins: a key role in cellular 
communication. Biochimie 69, 329-338.
BOER, R. & FAHRENHOLZ, F. (1985). Photoaffinity labeling of the vasopressin receptor in plasma
membranes from rat liver. Journal of Biological Chemistry 260, 15051-15054.
BOJANIC, D. & FAIN, J.N. (1986). Guanine nucleotide regulation of [3H]vasopressin binding to liver 
plasma membranes and solubilized receptors. Evidence for the involvement of a guanine nucleotide 
regulatory protein. Biochemical Journal 240, 361-365.
BOLTON, T.B. (1979). Mechanisms of action of transmitters and other substances on smooth muscle. 
Physiological Reviews 59, 606-718.
BOND, M„ VADASZ, G., SOMLYO, A.V. & SOMLYO, A.P. (1987). Subcellular calcium and 
magnesium mobilization in rat liver stimulated in vivo with vasopressin and glucagon.
Journal of Biological Chemistry 262, 15630-15636.
BORLE, A.B. (1981). Control, modulation and regulation of cell calcium.
Reviews of Physiological and Biochemical Pharmacology 90,13-153.
BRAND, M.D. (1985a). Pathways of Ca2+ efflux from liver and heart mitochondria.
Biochemical Society Transactions 13, 688-689.
BRAND, M.D. (1985b). Electroneutral efflux of Ca2+ from liver mitochondria.
Biochemical Journal 225,413-419.
BRAND, M.D. & MURPHY, M.P. (1987). Control of electron flux through the respiratory chain in 
mitochondria and cells. Biological Reviews 62, 141-193.
BRAQUET, P., TOUQUI, L., SHEN, T.Y. & VARGAFTIG, B.B. (1987). Perspectives in 
platelet-activating factor research. Pharmacological Reviews 39, 97-145.
BRASS, L.F. & JOSEPH, S.K. (1985). A role for inositol trisphosphate in intracellular Ca2 + 
mobilization and granule secretion in platelets.
Journal of Biological Chemistry 260, 15172-15179.
BROCK, T.A. & GIMBRONE, M.A.Jr. (1986). Platelet activating factor alters calcium homeostasis in 
cultured vascular endothelial cells. American Journal of Physiology 250, H1086-H1092.
90
BURGESS, G.M., CLARET, M. & JENKINSON, D.H. (1981). Effects of quinine and apamin on the 
calcium-dependent potassium permeability of mammalian hepatocytes and red cells.
Journal o f Physiology (London) 317, 67-90.
BURGESS, G.M., McKINNEY, J.S., FABIATO, A., LESLIE, B.A. & PUTNEY, J.W.Jr. (1983). 
Calcium pools in saponin-permeabilized guinea pig hepatocytes.
Journal o f Biological Chemistry 258, 15336-15345.
BURGESS, G.M., GODFREY, P.P., McKINNEY, J.S., BERRIDGE, M.J., IRVINE, R.F. & PUTNEY, 
J.W. Jr. (1984a). The second messenger linking receptor activation to internal Ca2+ release in liver. 
Nature (London) 309,63-66.
BURGESS, G.M., IRVINE, R.F., BERRIDGE, M.J., McKINNEY, J.S. & PUTNEY, J.W. Jr. (1984b). 
Actions of inositol phosphates on Ca2+ pools in guinea-pig hepatocytes.
Biochemical Journal 224,741-746.
BURGESS, G.M., McKINNEY, J.S., IRVINE, R.F. & PUTNEY, J,W. Jr. (1985). Inositol 
1,4,5-trisphosphate and inositol 1,3,4-trisphosphate formation in Ca2+-mobilizing-hormone-activated 
cells. Biochemical Journal 232,237-243.
BURGESS, G.M., DOOLEY, R.K., McKINNEY, J.S., NANBERG, E. & PUTNEY, J.W.Jr. (1986). 
Further studies on the interactions between the calcium mobilization and cyclic AMP pathways in 
guinea pig hepatocytes. Molecular Pharmacology 30, 315-320.
BURGOYNE, R.D., CHEEK, T.R. & O'SULLIVAN, A.J. (1987). Receptor-activation of phospholipase 
A2 in cellular signalling. Trends in Biochemical Sciences 12, 332-333.
BUXTON, D.B., SHUKLA, S.D., HANAHAN, D.J. & OLSON, M.S. (1984a). Stimulation of hepatic 
glycogenolysis by acetylglyceryl ether phosphorylcholine.
Journal o f Biological Chemistry 259, 1468-1471.
BUXTON, D.B., HANAHAN, D.J. & OLSON, M.S. (1984b). Stimulation of glycogenolysis and 
platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver. 
Journal o f Biological Chemistry 259,13758-13761.
BUXTON, D.B., FISHER, R.A., HANAHAN, D.J. & OLSON, M.S. (1986). Platelet-activating 
factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Journal of Biological Chemistry 261, 644-649.
BUXTON, D.B., FISHER, R.A., BRISENO, D.L., HANAHAN, D.J. & OLSON, M.S. (1987) 
Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin 
E2 in the perfused rat liver. Biochemical Journal 243,493-498.
BYGRAVE, F.L. (1978a). Mitochondria and the control of intracellular calcium.
Biological Reviews 53, 43-79.
BYGRAVE, F.L. (1978b). Calcium movements in cells.
Trends in Biochemical Sciences 3, 175-178.
91
BYGRAVE, F.L., KARJALAINEN, A. & ALTIN, J.G. (1988). ATP-independent calcium uptake by 
plasma membrane vesicles isolated from rat liver. (Submitted).
CACHELIN, A.B., de PEYER, J.E., KOKUBUN, S. & REUTER, H. (1983). Ca2+ channel modulation 
by 8-bromocyclic AMP in cultured heart cells. Nature (London) 304,462-464.
CAMPANILE, C.P., CRANE, J.K., PEACH, M.J. & GARRISON, J.C. (1982). The hepatic angiotensin 
II receptor. I. Characterization of the membrane-binding site and correlation with physiological response 
in hepatocytes. Journal of Biological Chemistry 257,4951-4958.
CAMPRA, J.L. & REYNOLDS, T.B. (1982). The hepatic circulation. In: The Liver: Biology and 
Pathobiology, (ed. I. Arias, H. Popper, D. Schächter & D.A. Shafritz) pp. 627-645.
Raven Press, New York.
CAPIOD, T., FIELD, A.C., OGDEN, D.C. & SANDFORD, C.A. (1987). Internal perfusion of 
guinea-pig hepatocytes with buffered Ca2+ or inositol 1,4,5-trisphosphate mimics noradrenaline 
activation of K+ and Cl' conductances. FEBS Letters 217,247-252.
CARAFOLI, E. & PENNISTON, J.T. (1985). The calcium signal.
Scientific American 253 (No. 5), 50-58.
CARAFOLI, E. (1987). Intracellular calcium homeostasis.
Annual Review of Biochemistry 56, 395-433.
CARTER, H.R. & SMITH, A.D. (1987). Resolution of the phosphoinositide-specific phospholipase C 
isolated from porcine lymphocytes into multiple species. Partial purification of two isoenzymes. 
Biochemical Journal 244,639-645.
CASTAGNA, M., TAKAI, Y., KAIBUCHI, K., SANO, K., KIKKAWA. U. & NISHIZUKA, Y. (1982). 
Direct activation of Ca2+-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol 
esters. Journal of Biological Chemistry 251,7847-7851.
CHAN, K-M. & JUNGER, K.D. (1983). Calcium transport and phosphorylated intermediate of (Ca2+ + 
Mg2+)-ATPase in plasma membranes of rat liver.
Journal of Biological Chemistry 258,4404-4410.
CHANG, J., SKOWRONEK, M.D., CHERNEY, M.L. & LEWIS, A.J. (1984). Differential effects of 
putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations. 
Inflammation 8, 143-155.
CHANG, J., MUSSER, J.H. & McGREGOR, H. (1987). Phospholipase A2'. function and pharmacological
regulation. Biochemical Pharmacology 36, 2429-2436.
CHAREST, R„ BLACKMORE, P.F., BERTHON, B. & EXTON, J.H. (1983). Changes in free cytosolic
Ca2+ in hepatocytes following o^-adrenergic stimulation. Studies on quin-2-loaded hepatocytes. 
Journal of Biological Chemistry 258, 8769-8773.
CHAREST, R., PRPIC, V., EXTON, J.H. & BLACKMORE, P.F. (1985a). Stimulation of inositol 
trisphosphate formation in hepatocytes by vasopressin, adrenaline and angiotensin II and its relationship 
to changes in cytosolic free Ca2+. Biochemical Journal 227,79-90.
92
CHAREST, R., BLACKMORE, P.F. & EXTON, J.H. (1985b). Characterization of responses of isolated 
rat hepatocytes to ATP and ADP. Journal of Biological Chemistry 260, 15789-15794.
CHUEH, S-H. & GILL, D.L. (1986). Inositol 1,4,5-trisphosphate and guanine nucleotides activate calcium 
release from endoplasmic reticulum via distinct mechanisms.
Journal o f Biological Chemistry 261, 13883-13886.
CLAPPER, D.L. & LEE, H.C. (1985). Inositol trisphosphate induces calcium release from 
nonmitochondrial stores in sea urchin egg homogenates.
Journal of Biological Chemistry 260, 13947-13954.
CLARET-BERTHON, B., CLARET, M. & MAZET, J.L. (1977). Fluxes and distribution of calcium in rat 
liver cells: kinetic analysis and identification of pools.
Journal o f Physiology (London) 272, 529-552.
COATS, R.A. (1985). The effects of adrenoceptor agonists and antagonists on plasma potassium 
concentration in anaesthetized guinea-pigs, rabbits and rats.
British Journal o f Pharmacology 86, 827-836.
COCHET, C. & CHAMBAZ, E.M. (1986). Catalytic properties of a purified phosphatidylinositol- 
4-phosphate kinase from rat brain. Biochemical Journal 237,25-31.
COCKCROFT, S. (1981). Does phosphatidylinositol breakdown control the Ca2+-gating mechanism? 
Trends in Pharmacological Sciences 9, 340-342.
COCKCROFT, S. & GOMPERTS, B.D. (1985). Role of guanine nucleotide binding protein in the 
activation of polyphosphoinositide phosphodiesterase. Nature (London) 314, 534-536.
COCKCROFT, S., TAYLOR, J.A. & JUDAH, J.D. (1985). Subcellular localisation of inositol lipid 
kinases in rat liver. Biochimica et Biophysica Acta 845, 163-170.
COCKCROFT, S. (1987). Polyphosphoinositide phosphodiesterase: regulation by a novel guanine 
nucleotide binding protein, Gp. Trends in Biochemical Sciences 12, 75-78.
COCKCROFT, S. & TAYLOR, J.A. (1987). Fluoroaluminates mimic guanosine 5’-[y-thio]triphosphate in 
activating the polyphosphoinositide phosphodiesterase of hepatocyte membranes. Role for the guanine 
nucleotide regulatory protein Gp in signal transduction. Biochemical Journal 241,409-414.
COCKS, T.M., JENKINSON, D.H. & KOLLER, K. (1984). Interactions between receptors that increase 
cytosolic calcium and cyclic AMP in guinea-pig liver cells.
British Journal o f Pharmacology 83,281-291.
COHEN, P. (1982). The role of protein phosphorylation in neural and hormonal control of cellular activity. 
Nature (London) 296,613-620.
COHEN, P. (1984). Hormones, second messengers and the reversible phosphorylation of proteins: 
an overview. BioEssays 2, 63-68.
COMBETTES, L., BERTHON, B., BINET, A. & CLARET, M. (1986). Glucagon and vasopressin 
interactions on Ca2+ movements in isolated hepatocytes. Biochemical Journal 237,675-683.
93
CONNELLY, P.A., SISK, R.B., SCHULMAN, H. & GARRISON, J.C. (1987). Evidence for the 
activation of the multifunctional Ca2+/calmodulin-dependent protein kinase in response to hormones 
that increase intracellular Ca2+. Journal of Biological Chemistry 262,10154-10163.
CONNOLLY, T.M. BANSAL, V.S., BROSS, T.E., IRVINE, R.F. & MAJERUS, P.W. (1987). The 
metabolism of tris- and tetraphosphate of inositol by 5-phosphomonoesterase and 3-kinase enzymes. 
Journal of Biological Chemistry 262,2146-2149.
COOPER, R.H., COLL, K.E. & WILLIAMSON, J.R. (1985). Differential effects of phorbol ester on 
phenylephrine and vasopressin-induced Ca2+ mobilization in isolated hepatocytes.
Journal of Biological Chemistry 260, 3281-3288.
CORVERA, S. & GARCIA-SAINZ, J.A. (1984). Phorbol esters inhibit alpha^adrenergic stimulation of 
glycogenolysis in isolated rat hepatocytes.
Biochemical and Biophysical Research Communications 119,1128-1133.
CORVERA, S., SCHWARZ, K.R., GRAHAM, R.M. & GARCIA-SAINZ, J.A. (1986). Phorbol esters
inhibit a  ^ adrenergic effects and decrease the affinity of liver cell a  ^ -adrenergic receptors for
(-)-epinephrine. Journal o f Biological Chemistry 261, 520-526.
CRANE, J.K., CAMPANILE, C.P. & GARRISON, J.C. (1982). The hepatic angiotensin II receptor.
II. Effect of guanine nucleotides and interaction with cyclic AMP production.
Journal of Biological Chemistry 257,4959-4965.
CRAUSE, P., BOER, R. & FAHRENHOLZ, F. (1984). Determination of functional molecular size of 
vasopressin isoreceptors. FEBS Letters 175,383-386.
CREBA, J.A., DOWNES, C.P., HAWKINS, P.T., BREWSTER, G., MICHELL, R.H. & KIRK, C.J. 
(1983). Rapid breakdown of phosphatidylinositol 4-phosphate and phosphatidyl-inositol 
4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other Ca2+-mobilizing hormones. 
Biochemical Journal 212,733-747.
DAMIANI, E., SPAMER, C., HEILMANN, C., SALVATORI, S. & MARGRETH, A. (1988). 
Endoplasmic reticulum of rat liver contains two proteins closely related to skeletal sarcoplasmic 
reticulum Ca2+-ATPase and calsequestrin. Journal of Biological Chemistry 263, 340-343.
DAVIS, R.J. & CZECH, M.P. (1985). Tumor-promoting phorbol diesters cause the phosphorylation of 
epidermal growth factor receptors in normal human fibroblasts at threonine-654.
Proceedings o f the National Ac adamy o f Sciences (USA) 82,1974-1978.
DAWSON, A.P. (1982). Kinetic properties of the Ca2+-accumulation system of a rat liver microsomal 
fraction. Biochemical Journal 206, 73-79.
DAWSON, A.P. & FULTON, D.V. (1983). Some properties of the Ca2+-stimulated ATPase of a rat liver 
microsomal fraction. Biochemical Journal 210,405-410.
DAWSON, A.P. & IRVINE, R.F. (1984). Inositol trisphosphate-promoted Ca2+ release from microsomal 
fractions of rat liver. Biochemical and Biophysical Research Communications 120, 858-864.
94
DAWSON, A.P. (1985). GTP enhances inositol trisphosphate-stimulated Ca2+ release from rat liver 
microsomes. FEBS Letters 185, 147-150.
DAWSON, A.P., COMERFORD, J.G. & FULTON, D.V. (1986). The effect of GTP on inositol 
1,4,5-trisphosphate-stimulated Ca2+ efflux from a rat liver microsomal fraction. Is a GTP-dcpendent 
protein phosphorylation involved? Biochemical Journal 234, 311-315.
DAWSON, A.P., HILLS, G. & COMERFORD, J.G. (1987). The mechanism of action of GTP on Ca2+ 
efflux from rat liver microsomal vesicles. Biochemical Journal 244, 87-92.
DECKER, K. & BIRMELIN, M. (1984). Ca2+ mediates phagocytosis-evoked eicosanoid synthesis in 
Kupffer cells. In: Prostaglandins and Membrane Ion Transport (ed. P. Braquet) pp. 113-118.
Raven Press. New York.
DECKER, K. (1985). Eicosanoids, signal molecules of liver cells.
Seminars in Liver Disease 5, 175-190.
DECKMYN, H., TU, S-M. & MAJERUS, P.W. (1986). Guanine nucleotides stimulate soluble 
phosphoinositide-specific phospholipase C in the absence of membranes.
Journal of Biological Chemistry 261, 16553-16558.
DENTON, R.M. & McCORMACK, J.G. (1985). Ca2+-transport by mammalian mitochondria and its role 
in hormone action. American Journal o f Physiology 249, E543-E554.
DICKEY, B.F., FISHMAN, J.B., FINE, R.E. & NAVARRO, J. (1987). Reconstitution of the rat liver 
vasopressin receptor coupled to guanine nucleotide-binding proteins.
Journal of Biological Chemistry 262, 8738-8742.
DIETER, P., SCHULZE-SPECKING, A. & DECKER, K. (1986). Differential inhibition of prostaglandin 
and superoxide production by dexamethasone in primary cultures of rat Kupffer cells.
European Journal of Biochemistry 159,451-457.
DIETER, P., ALTIN, J.G. & BYGRAVE, F.L. (1987a). Possible involvement of prostaglandins in 
vasoconstriction induced by zymosan and arachidonic acid in the perfused rat liver.
FEBS Letters 213, 174-178.
DIETER, P., ALTIN, J.G., DECKER, K. & BYGRAVE, F.L. (1987b). Possible involvement of 
eicosanoids in the zymosan and arachidonic acid-induced oxygen uptake, glycogenolysis and Ca2+ 
mobilization in the perfused rat liver. European Journal of Biochemistry 165,455-460.
DIXON J.F. & HOKIN, L.E. (1987). Inositol 1,2-cyclic 4,5-trisphosphate concentration relative to inositol 
1,4,5-trisphosphate in pancreatic minilobules on stimulation with carbamylcholine in the absence of 
lithium. Journal o f Biological Chemistry 262, 13892-13895.
DORN II, G.W., SENS, D., CHAIKHOUNI, A., MAIS, D. & HALUSHKA, P.V. (1987). Cultured 
human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of
U-46619-induced 45calcium efflux. Circulation Research 60,952-956.
DOUGLAS, W.W. (1968). The First Gaddum Memorial Lecture. Stimulus-secretion coupling: the concept 
and clues from chromaffin and other cells. British Journal of Pharmacology 34,451-474.
95
DOUGLAS, J.G. (1987). Angiotensin receptor subtypes of the kidney cortex.
American Journal of Physiology 253, F1-F7.
DOWNES, C.P. & MICHELL, R.H. (1981). The polyphosphoinositide phosphodiesterase of erythrocyte 
membranes. Biochemical Journal 198,133-140.
DOWNES, C.P., HAWKINS, P.T. & IRVINE, R.F. (1986). Inositol 1,3,4,5-tetrakisphosphate and not 
phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in 
agonist-stimulated parotid gland. Biochemical Journal 238, 501-506.
DOWNES, C.P. (1986). Inositol phosphates: concord or confusion?
Trends in Neurosciences 9,394-396.
DRUST, D.S. & MARTIN, T.FJ. (1985). Protein kinase C translocates from cytosol to membrane upon 
hormone activation: effects of TRH in GH3 cells.
Biochemical and Biophysical Research Communications 128, 531-537.
DUNLAP, K. HOLZ, G.G. & RANE, S.G. (1987). G proteins as regulators of ion channel fuction.
Trends in Neuroscience 10, 241-244.
DUNLOP, M. (1987). Agonist and inositol 1,4,5-trisphosphate-sensitive Ca2+ mobilization from islet cell 
membranes. Proceedings of the Australian Biochemical Society 19, S29.
ENYEDI, A., FARAGO, A., SARKADI, B., SZASZ, I. & GARDOS, G. (1983). Cyclic AMP-dependent 
protein kinase stimulates the formation of polyphosphoinoditides in the plasma membranes of different 
blood cells. FEBS Letters 161, 158-162.
EPPING, R.J. & BYGRAVE, F.L. (1984a). A procedure for rapid isolation from rat liver of plasma 
membrane vesicles exhibiting Ca2+-transport and Ca2+-ATPase activities.
Biochemical Journal 223,733-745.
EPPING, R.J. & BYGRAVE, F.L. (1984b). Inhibition by orthovanadate of ATP-dependent calcium 
transport in microsomes isolated from rat liver. Membrane Biochemistry 5, 167-180.
ERNEUX, C., DELVAUX, A., MOREAU, C. & DUMONT, J.E. (1987). The dephosphorylation pathway 
of D-myo-inositol 1,3,4,5-tetrakisphosphate in rat brain. Biochemical Journal 247, 635-639.
EXTON, J.H. (1980). Mechanisms involved in a-adrenergic phenomena: role of calcium ions in actions of 
catecholamines in liver and other tissues. American Journal of Physiology 238, E3-E12.
EXTON, J.H. (1982). Molecular mechanisms involved in -adrenergic responses.
Trends in Pharmacological Sciences 3, 111-115.
EXTON, J.H. (1985). Mechanisms involved in a-adrenergic phenomena.
American Journal of Physiology 248, E633-E647.
FAHIMI, H.D. (1967). Perfusion and immersion fixation of rat liver with glutaraldehyde.
Laboratory Investigation 16, 736-750.
FAHIMI, H.D. (1970). The fine structural localization of endogenous and exogenous peroxidase activity in 
Kupffer cells of rat liver. Journal of Cell Biology 47, 247-262.
96
FIGURES, W.R., SCEARCE, L.M., WACHTFOGEL, Y., CHEN, J., COLMAN, R.F. & COLMAN,
R.W. (1986). Platelet ADP receptor and a 2-adrenoreceptor interaction. Evidence for an ADP
requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding. 
Journal of Biological Chemistry 261, 5981-5986.
FISHER, R.A., SHUKLA, S.D., DEBUYSERE, M.S., HANAHAN, D.J. & OLSON, M.S. (1984). The 
effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 
4,5-bisphosphate metabolism in rat hepatocytes.
Journal o f Biological Chemistry 259, 8685-8688.
FISHER, R.A., KUMAR, R., HANAHAN, D.J. & OLSON, M.S. (1986). Effects of ß-adrenergic 
stimulation on l-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and 
glycogenolysis in the perfused rat liver. Journal of Biological Chemistry 261, 8817-8823.
FISHER, R.A., ROBERTSON, S.M. & OLSON, M.S. (1987). Stimulation of glycogenolysis and 
vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619.
Journal of Biological Chemistry 262,4631-4638.
FISHMAN, J.B., DICKEY, B.F. & FINE, R.E. (1987). Purification and characterization of the rat liver 
vasopressin (V^ receptor. Journal of Biological Chemistry 262, 14049-14055.
FITZGERALD, T.J., UHING, R.J. & EXTON, J.H. (1986). Solubilization of the vasopressin receptor 
from rat liver plasma membranes. Evidence for a receptor GTP-binding protein complex.
Journal of Biological Chemistry 261, 16871-16877.
FODEN, S. & RANDLE, P.J. (1978). Calcium metabolism in rat hepatocytes.
Biochemical Journal 170,615-625.
FRIEDMANN, N., SOMLYO, A.V. & SOMLYO, A.P. (1971). Cyclic adenosine and guanosine 
monophosphates and glucagon: effect on liver membrane potentials. Science 171,400-402. 
FRIEDMANN, N, (1972). Effects of glucagon and cyclic AMP on ion fluxes in the perfused liver. 
Biochimica et Biophysica Acta 274,214-225.
FRIEDMANN, N. & DAMBACH, G. (1980). Antagonistic effect of insulin on glucagon-evoked 
hyperpolarization. A correlation between changes in membrane potential and gluconeogenesis. 
Biochimica et Biophysica Acta 596, 180-185.
FUKUO, K., MORIMOTO, S., KOH, E., YUKAWA, S., TSUCHIYA, H., IMANAKA, S., 
YAMAMOTO, H., ONISHI, T. & KUMAHARA, Y. (1986). Effects of prostaglandins on the 
cytosolic free calcium concentration in vascular smooth muscle cells.
Biochemical and Biophysical Research Communications 136,247-252.
GARCIA-SAINZ, J.A. & HERNANDEZ-SOTOMAYOR, S.M.T. (1985a). Stimulation of hepatic 
glycogenolysis by 12-0-tetradecanoyl-phorbol-13-acetate (TPA) via cyclo-oxygenase products. 
Biochemical and Biophysical Research Communications 132,204-209.
97
GARCIA-SAINZ, J.A. & HERNANDEZ-SOTOMAYOR, S.M.T. (1985b). Adrenergic regulation of
gluconeogenesis: possible involvement of two mechanisms of signal transduction in a  ^ adrenergic
action. Proceedings of the National Acadamy ofScience{USA) 82, 6727-6730.
GARCIA-SAINZ, J.A., MENDLOVIC, F. & MARTINEZ-OLMEDO, M.A. (1985c). Effects of phorbol
esters on a^adrenergic-mediated and glucagon-mediated actions in isolated rat hepatocytes.
Biochemical Journal 228,277-280.
GARCIA-SAINZ, J.A. & HERNANDEZ-SOTOMAYER, S.M.T. (1987). Inhibitors of protein kinase C 
block the a 1-adrenergic refractoriness induced by phorbol 12-myristate 13-acetate, vasopressin and
angiotensin II. European Journal of Biochemistry 163,417421.
GARCIA-SAINZ, J.A., De La GARZA, M.C., CONTRERAS-RODRIGUEZ, J.L. & 
NAJERA-ALVARADO, A. (1987). Effects of histamine on the metabolism of isolated rat hepatocytes: 
roles of Hj- and H2-histamine receptors. Molecular Pharmacology 31,253-258.
GARRISON, J.C., JOHNSEN, D.E. & CAMPANILE, C.P. (1984). Evidence for the role of 
phosphorylase kinase, protein kinase C, and other Ca2+-sensitive protein kinases in the response of 
hepatocytes to angiotensin II and vasopressin.
Journal of Biological Chemistry 259, 3283-3292.
GIERCHIK, P., FALLOON, J., MILLIGAN, G., PINES, M., GALLIN, J.I. & SPIEGEL, A. (1986). 
Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils.
Journal of Biological Chemistry 261, 8058-8062.
GILL, D.L., UEDA, T., CHUEH, S-H. & NOEL, M.W. (1986). Ca2+ release from endoplasmic reticulum 
is mediated by a guanine nucleotide regulatory mechanism. Nature (London) 320,461-464.
GILMAN, A.G. (1987). G proteins: transducers of receptor-generated signals.
Annual Reviews of Biochemistry 56, 615-649.
GILULA, N.B. & HERTZBERG, E.L. (1982). Communication and gap junctions. In: The Liver: Biology 
and Pathobiology (ed. I. Arias, H. Popper, D. Schächter, & D.A. Shafritz) pp. 615-623.
Raven Press, New York.
GLOSSMANN, H., FERRY, D.R., LÜBBECKE, F., MEWES, R. & HOFMANN, F. (1982). Calcium 
channels: direct identification with radioligand binding studies.
Trends in Pharmacological Sciences 5,431 -437.
GODFRAIND, T., MILLER, R. & WIBO, M. (1986). Calcium antagonism and calcium entry blockade. 
Pharmacological Reviews 38, 321-416.
GODFREY, P.P. & PUTNEY, J.W.Jr. (1984). Receptor-mediated metabolism of the phosphoinositides 
and phosphatidic acid in rat lacrimal ancinar cells. Biochemical Journal 218, 187-195.
GOMPERTS, B.D. (1983). Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by 
receptors. Nature (London) 306, 64-66.
98
GOODHARDT, M., FERRY, N., AGGERBECK, M. & HANOUNE, J. (1984). The hepatic 
Alpha^adrenergic receptor. Biochemical Pharmacology 33, 863-868.
GRAF, J., & PETERSEN, O.H. (1978). Cell membrane potential and resistence in liver.
Journal of Physiology 284, 105-126.
GRAF, P., vom DAHL, S. & SIES„ H. (1987). Sustained oscillations in extracellular calcium 
concentrations upon hormonal stimulation of perfused rat liver Biochemical Journal 241,933-936.
GUILLON, G., COURAUD, P.O., BUTLEN, D., CANTAU, B. & JARD, S. (1980). Size of vasopressin 
receptors from rat liver and kidney. European Journal of Biochemistry 111, 287-294.
GUILLON, G., BALESTRE, M-N., MOUILLAC, B. & DEVILLIERS, G. (1986). Activation of 
membrane phospholipase C by vasopressin: a requirement for guanyl nucleotides.
FEBS Utters 196, 155-159.
GUILLON, G., BALESTRE, M-N., MOUILLAC, B., BERRADA, R. & KIRK, C.J. (1987). Mechanisms 
of phospholipase C activation: a comparison with the adenylate cyclase system.
Biochemie 69, 351-363.
HAGIWARA, S. & BYERLY, L. (1981). Calcium channel. Annual Review of Neuroscience 4, 69-125.
HANAHAN, D.J. (1986). Platelet activating factor: a biologically active phosphoglyceride.
Annual Reviews of Biochemistry 55,483-509.
HANSEN, C.A., MAH, S. & WILLIAMSON, J.R. (1986). Formation and metabolism of inositol 
1,3,4,5-tetrakisphosphate in liver. Journal of Biological Chemistry 261, 8100-8103.
HANSEN, C.A., JOHANSON, R.A., WILLIAMSON, M.T. & WILLIAMSON, J.R. (1987). Purification 
and characterization of two types of soluble inositol phosphate 5-phosphomonoesterases from rat brain. 
Journal of Biological Chemistry 262,17319-17326.
HANSFORD, R.G. (1985). Relation between mitochondrial calcium transport and control of energy 
metabolism. Reviews of Physiology, Biochemistry and Pharmacology 102,1-72.
HARRIS, R.A., SCHMIDT, J., HITZEMANN, B.A. & HITZEMANN, R.J. (1981). Phosphatidate as a 
molecular link between depolarization and neurotransmitter release in the brain.
Science 212, 1290-1291.
HARTZELL, H.C. & FISCHMEISTER, R. (1986). Opposite effects of cyclic GMP and cyclic AMP on 
Ca2+ current in single heart cells. Nature (London) 323,273-275.
HASLAM, R.J. & DAVIDSON, M.M. (1984). Receptor-induced diacylglycerol formation in permeabilized 
platelets: possible role for a GTP-binding protein. Journal of Receptor Research 4,605-629.
HAUSSINGER, D., STEHLE, T. & GEROK, W. (1987a). Actions of extracellular UTP and ATP in 
perfused rat liver: a comparative study. European Journal of Biochemistry 167,65-71.
99
HAUSSINGER, D„ STEHLE, T., TRAN-THI, T-A., DECKER, K. & GEROK, W. (1987b). 
Prostaglandin responses in isolated perfused rat liver: Ca2+ and K+ fluxes, hemodynamic and metabolic 
effects. Biological Chemistry Hoppe-Seyler 368,1509-1513.
HELMREICH, E.J.M. & PFEUFFER, T. (1985). Regulation of signal transduction by ß-adrenergic 
hormone receptors. Trends in Pharmacological Sciences 6,438-443.
HENDERSON, R.M., GRAF, J. & BOYER, J.L. (1987). Na-H exchange regulates intracellular pH in 
isolated rat hepatocyte couplets. American Journal of Physiology 252, G109-G113.
HEMS, D.A. & WHITTON, P.D. (1980). Control of hepatic glycogenolysis.
Physiological Reviews 60, 1-50.
HERNANDEZ-SOTOMAYOR, S.M.T. & GARCIA-SAINZ, J.A. (1988). Phorbol esters and 
calcium-mobilizing hormones increase membrane-associated protein kinase C activity in rat 
hepatocytes. Biochimica et Biophysica Acta 968, 138-141.
HERS, H.G. (1976). The control of glycogen metabolism in the liver.
Annual Review of Biochemistry 45,167-189.
HILL, C.E., PRYOR, J.S., OLSON, M.S. & DAWSON, A.P. (1987). Potassium-mediated stimulation of 
hepatic glycogenolysis. Journal of Biological Chemistry 262,6623-6627.
HILL, C.E. & OLSON, M.S. (1987). Stimulation of uric acid release from the perfused rat liver by platelet 
activating factor or potassium. Biochemical Journal 247, 207-214.
HIRASAWA, K., IRVINE, R.F. & DAWSON, R.M.C. (1982). Heterogeneity of the calcium-dependent 
phosphatidylinositol phosphodiesterase in rat brain. Biochemical Journal 205, 437-442.
HIRATA, M., KUKITA, M., SASAGURI, T., SUEMATSU, E., HASHIMOTO, T. & KOGA, T. 
(1985a). Increase in Ca2+ permeability of intracellular Ca2+ store membrane of saponin-treated guinea 
pig peritoneal macrophages by inositol 1,4,5-trisphosphate.
Journal of Biochemistry (Tokyo) 97, 1575-1582.
HIRATA, M., SASAGURI, T., HAMACHI, T., HASIMOTO, T., KUKITA, M. & KOGA, T. (1985b). 
Irreversible inhibition of Ca2+ release in saponin-treated macrophages by the photoaffinity derivative of 
inositol-1,4,5-trisphosphate. Nature (London) 317, 723-725.
HIROTA, K., HIROTA, T., AGUILERA, G. & CATT, K.J. (1985). Hormone-induced redistribution of 
calcium-activated phospholipid-dependent protein kinase in pituitary gonadotrophs.
Journal of Biological Chemistry 260, 3243-3246.
HOFMANN, F., NASTAINCZYK, W., ROHRKASTEN, A., SCHNEIDER, T. & SIEBER, M. (1987).
Regulation of the L-type calcium channel. Trends in Pharmacological Sciences 8, 393-398.
HOKIN, L.E. & HOKIN, M.R. (1959). The presence of phosphatidic acid in animal tissues.
Journal of Biological Chemistry 234, 800-804.
HOLMES, R.P. & YOSS, N.L. (1983). Failure of phosphatidic acid to translocate Ca2+ across 
phosphatidylcholine membranes. Nature (London) 305,637-638.
100
HOUSLAY, M.D., WAKELAM, MURPHY, G.J., GAWLER, D.J. & PYNE, N.J. (1987).
Glucagon stimulates adenylate cyclase through GR2 glucagon receptors: a process which can be 
attenuated by glucagon stimulating inositol phospholipid metabolism through GR1 glucagon receptors. 
Biochemical Society Transactions 15,21-24.
HUERTA-BAHENA, J. & GARCIA-SAINZ, J.A. (1985). Possible involvement of two mechanisms of 
signal transduction in -adrenergic action. Selective effect of cycloheximide.
Biochimica et Biophysica Acta 845, 131-137.
HUGHES, B.P. & BARRITT, G.J. (1978). Effects of glucagon and N60 2 -dibutyryladenosine 3':5'cyclic 
monophosphate on calcium transport in isolated rat liver mitochondria.
Biochemical Journal 176,295-304.
HUGHES, B.P., MILTON, S.E. & BARRITT, G.J. (1986a). Effects of vasopressin and La3+ on 
plasma-membrane Ca2+ inflow and Ca2+ disposition in isolated hepatocytes. Evidence that vasopressin 
inhibits Ca2+ disposition. Biochemical Journal 238, 793-800.
HUGHES, B.P., MILTON, S.E., BARRITT, G.J. & AULD, A.M. (1986b). Studies with verapamil and 
nifedipine provide evidence for the presence in the liver cell plasma membrane of two types of Ca2+ 
inflow transporter which are dissimiliar to potential-operated Ca2+ channels.
Biochemical Pharmacology 35, 3045-3052.
HUGHES, B.P., AULD, A.M. & BARRITT, G.J. (1987a). Effect of extracellular Ca2+ on plasma 
membrane Ca2+ inflow and cytoplasmic free Ca2+ in isolated hepatocytes.
Biochimica et Biophysica Acta 928, 208-216.
HUGHES, B.P., CROFTS, J.N., AULD, A.M., READ, L.C. & BARRITT, G.J. (1987b). Evidence that a 
pertussis-toxin-sensitive substrate is involved in the stimulation by epidermal growth factor and 
vasopressin of plasma-membrane Ca2+ inflow in hepatocytes. Biochemical Journal 248, 911-918.
HUGHES, B.P. & BARRITT, G.J. (1987). The stimulation by sodium fluoride of plasma-membrane Ca2+ 
inflow in isolated hepatocytes. Biochemical Journal 245,41-47.
IKEJERI, N. & TANIKAWA, K. (1977). Effects of vitamin A and estrogen on the sinusoidal cells in the 
rat liver. In: Kupffer Cells and Other Liver Sinusoidal Cells (ed. E. Wisse & D.L. Knook) pp. 83-93, 
Elsevier, Amsterdam.
INHORN, R.C., BANSAL, V.S. & MAJERUS, P.W. (1987). Pathway for inositol 1,3,4-trisphosphate 
and 1,4-bisphosphate metabolism.
Proceedings of the National Academy of Science (USA) 84, 2170-2174.
IRVINE, F., PYNE, N.J. & HOUSLAY, M.D. (1986). The phorbol ester TPA inhibits cyclic AMP 
phosphodiesterase activity in intact hepatocytes. FEBS Letters 208,455-459.
IRVINE, R.F., BROWN, K.D. & BERRIDGE, M.J. (1984a). Specificity of inositol trisphosphate-induced 
calcium release from permeabilized Swiss-mouse 3T3 cells. Biochemical Journal 221, 269-272.
101
IRVINE, R.F., LETCHER, A.J., LANDER, D.J. & DOWNES, C.P. (1984b). Inositol trisphosphates in 
carbachol-stimulated rat parotid glands. Biochemical Journal 223,237-243.
IRVINE, R.F., ANGGARD, E.E., LETCHER, A.J. & DOWNES, C.P. (1985). Metabolism of inositol 
1,4,5-trisphosphate and inositol 1,3,4-trisphosphate in rat parotid glands.
Biochemical Journal 229, 505-511.
IRVINE, R.F., LETCHER, A.J., HESLOP, J.P. & BERRIDGE, M.J. (1986a). The inositol 
tris/tetrakisphosphate pathway - demonstration of Ins(l,4,5)P3 kinase activity in animal tissues. Nature 
(London) 320, 631-634.
IRVINE, R.F., LETCHER, A.J., LANDER, D.J. & BERRIDGE, M.J. (1986b). Specificity of inositol 
phosphate-stimulated Ca2+ mobilization from Swiss-mouse 3T3 cells.
Biochemical Journal 240,301-304.
IRVINE, R.F. & MOOR, R.M. (1986). Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea 
urchin eggs by a mechanism dependent on external Ca2+. Biochemical Journal 240,917-920.
IRVINE, R.F. & MOOR, R.M. (1987). Inositol (l,3,4,5)tetrakisphosphate-induced activation of sea urchin 
eggs requires the presence of inositol trisphosphate.
Biochemical and Biophysical Research Communications 146,284-290.
ITO, T. (1973). Recent advances in the study of the fine structure of the hepatic sinusoidal wall. A review. 
Gunmar Rep. Medical Science 6, 119-163.
IWAI, M. & JUNGERMANN, K. (1987). Possible involvement of eicosanoids in the actions of 
sympathetic hepatic nerves on carbohydrate metabolism and hemodynamics in perfused rat liver.
FEBS Letters 221, 155-160.
I WAS A, Y., IWASA, T., HIGASHI, K., MATSUI, K. & MIYAMOTO, E. (1982). Demonstration of a 
high affinity Ca2+-ATPase in rat liver plasma membranes.
Biochemical and Biophysical Research Communications 105,488-494.
JACOBS, S., SAHYOUN, N.E., SALTIEL, A.R. & CUATRECASAS, P. (1983). Phorbol esters 
stimulate the phosphorylation of receptors for insulin and somatomedin C.
Proceedings of the National Academy o f Science (USA) 80, 6211-6213.
JARD, S. (1983). Vasopressin: mechanisms of receptor activation. In: The neurohypophysis: Structure, 
Function and Control, Progress in Brain Research,
Vol. 60 (ed. B.A. Cross & G. Leng) pp. 383-394.
JENKINSON, D.H. & KOLLER, K. (1977). Interactions between the effects of a- and ß-adrenoceptor 
agonists and adenine nucleotides on the membrane potential of cells in guinea-pig liver slices.
British Journal of Pharmacology 59,163-175.
JOHNSON, R.M., CONNELLY, P.A., SISK, R.B., POBINER, B.F., HEWLETT, E.L. & GARRISON, 
J.C. (1986). Pertussis toxin or phorbol 12-myristate 13-acetate can distinguish between epidermal 
growth factor- and angiotensin-stimulated signals in hepatocytes.
Proceedings of the National Acadamy of Science (USA) 83,2032-2036.
102
JOHNSON, R.M. & GARRISON, J.C. (1987). Epidermal growth factor and angiotensin II stimulate 
formation of inositol 1,4,5- and inositol 1,3,4-trisphosphate in hepatocytes. Differential inhibition by 
pertussis toxin and phorbol 12-myristate 13-acetate.
Journal o f Biological Chemistry 262, 17285-17293.
JOHNSTON, J.D. & BRAND, M.D. (1987). Stimulation of the respiration rate of rat liver mitochondria 
by sub-micromolar concentrations of extramitochondrial Ca2+.
Biochemical Journal 245,217-222.
JOSEPH, S.K., COLL, K.E., COOPER, R.H., MARKS, J.S. & WILLIAMSON, J.R. (1983). 
Mechanisms underlying calcium homeostasis in isolated hepatocytes.
Journal of Biological Chemistry 258, 731-741.
JOSEPH, S.K. & WILLIAMSON, J.R. (1983). The origin, quantitation, and kinetics of intracellular 
calcium mobilization by vasopressin and phenylephrine in hepatocytes.
Journal o f Biological Chemistry 258, 10425-10432.
JOSEPH, S.K., THOMAS, A.P., WILLIAMS, R.J., IRVINE, R.F. & WILLIAMSON, J.R. (1984a). 
Myo-inositol 1,4,5-trisphosphate: a second messenger for the hormonal mobilization of intracellular 
Ca2+ in liver. Journal of Biological Chemistry 259, 3077-3081.
JOSEPH, S.K., WILLIAMS, R.J., CORKEY, B.E., MATSCHINSKY, F.M. & WILLIAMSON, J.R. 
(1984b). The effect of inositol trisphosphate on Ca2+ fluxes in insulin-secreting tumor cells.
Journal o f Biological Chemistry 259, 12952-12955.
JOSEPH, S.K., COLL, K.E., THOMAS, A.P., RUBIN, R. & WILLIAMSON, J.R. (1985). The role of 
extracellular Ca2+ in the response of the hepatocyte to Ca2+-dependent hormones.
Journal of Biological Chemistry 260, 12508-12515.
JOSEPH, S.K. & WILLIAMS, R.J. (1985). Subcellular localization and some properties of the enzymes 
hydrolysing inositol polyphosphates in rat liver. FEBS Letters 180, 150-154.
JOSEPH, S.K. & WILLIAMSON, J.R. (1986). Characteristics of inositol trisphosphate-mediated Ca2+ 
release from permeabilized hepatocytes. Journal of Biological Chemistry 261,14658-14664.
JOSEPH, S.K., HANSEN, C.A. & WILLIAMSON, J.R. (1987). Inositol 1,3,4,5-tetrakisphosphate 
increases the duration of the inositol 1,4,5-trisphosphate-mediated Ca2+ transient.
FEBS Letters 219, 125-129.
JUNGERMANN, K. & KATZ, N, (1982). In: Metabolic Compartmentation (ed. H. Sies) pp. 411-435. 
Academic Press, London.
KAIBUCHI, K., TAKAI, Y., SAWAMURA, M., HOSHIJIMA, M., FUJIKURA, T. & NISHIZUKA, Y. 
(1983). Synergistic functions of protein phosphorylation and calcium mobilization in platelet 
activation. Journal o f Biological Chemistry 258, 6701-6704.
KANOH, H. & OHNO, K. (1981). Partial purification and properties of diacylglycerol kinase from rat liver 
cytosol. Archives of Biochemistry and Biophysics 209, 266-275.
103
KATAN, M. & PARKER, PJ. (1987). Purification of phosphoinositide-specific phospholipase C from a 
particulate fraction of bovine brain. European Journal of Biochemistry 168,413-418.
KEPPENS, S. & DE WULF, H. (1986). Characterization of the liver P2-purinoceptor involved in the
activation of glycogen phosphorylase. Biochemical Journal. 240,367-371.
KIESEL, L., LUKACS, G.L., EBERHARDT, L, RUNNEBAUM, B. & SPAT, A. (1987). Effect of 
inositol 1,4,5-trisphosphate and GTP on calcium release from pituitary microsomes.
FEBS Letters 111, 85-88.
KIKKAWA, U., TAKAI, Y., MINAKUCHI, R., INOHARA, S. & NISHIZUKA, Y. (1982). 
Calcium-activated phospholipid-dependent protein kinase from rat brain. Subcellular distribution, 
purification and properties. Journal of Biological Chemistry 257, 13341-13348.
KIKKAWA, U., GO, M., KOUMOTO, J. & NISHIZUKA, Y. (1986). Rapid purification of protein kinase 
C by high performance liquid chromatography.
Biochemical and Biophysical Research Commumications 135,636-643.
KIKKAWA, U ., OGITA, K., ONO, Y., ASAOKA, Y., SHEARMAN, M.S., FUJII, T., ASE, K., 
SEKIGUCHI, K., IGARASHI, K. & NISHIZUKA, Y. (1987). The common structure and activities of 
four subspecies of rat brain protein kinase C family. FEBS Letters 223, 212-216.
KIMURA, S., KUGAI, N., TADA, R., KOJIMA, I., ABE, K. & OGATA, E. (1982). Sources of calcium
mobilized by a-adrenergic stimulation in perfused rat liver.
Hormone and Metabolic Research 14,133-138.
KIRK, C.J., CREBA, J.A., HAWKINS, P.T. & MICHELL, R.H. (1983). Is vasopressin-stimulated 
inositol lipid breakdown intrinsic to the mechanism of Ca2+-mobilization at Vj vasopressin receptors?
In: The Neurohypophysis: Structure, Function and Control, Progress in Brain Research. Vol. 60 (ed. 
B.A. Cross & G. Leng) pp. 405-411.
KISHOMOTO, A., TAKAI, Y., MORI, T„ KIKKAWA, U. & NISHIZUKA, Y. (1980). Activation of 
calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to 
phosphatidylinositol turnover. Journal of Biological Chemistry 255, 2273-2276.
KLEINERE, J. & SOLING, H-D. (1985). Mitochondrial and extramitochondrial Ca2+ pools in the perfused 
rat liver. Mitochondria are not the origin of calcium mobilized by vasopressin.
Journal of Biological Chemistry 260, 1040-1045.
KLEINERE, J. & SOLING, H-D. (1987). The Ca2+-dependent actions of the a-adrenergic agonist 
phenylephrine on hepatic glycogenolysis differ from those of vasopressin and angiotensin.
European Journal of Biochemistry 162, 143-150.
KOZAWA, O., HOSHIJIMA, M., TANIMOTO, T., OHMORI, T. & TAKAI, Y. (1987). Similiar 
physical and kinetic properties of rat brain synaptic membrane and cytosol phosphoinositide 
phospholipases C. Biochemical and Biophysical Research Communications 145,218-227.
104
KRAUS-FRIEDMANN, N., BIBER, J„ MURER, H. & CARAFOLI, E. (1982). Calcium uptake in 
isolated hepatic plasma-membrane vesicles. European Journal of Biochemistry 129, 7-12.
KREBS, H.A. & HENSELEIT, K. (1932). Untersuchungen über die Harnstoffbildung im Tierkorper.
Hoppe-Seyler’s Z. Physiological Chemistry 210, 33-66.
KUNO, M. & GARDNER, P. (1987). Ion channels activated by inositol 1,4,5-trisphosphate in plasma 
membrane of human T-lymphocytes. Nature (London). 326,301-304.
LAPETINA, E.G. (1982). Regulation of arachidonic acid production: role of phospholipases C and A2 . 
Trends in Pharmacological Sciences 3,115-118.
LAPOINTE, D.S., HANAHAN, D.J. & OLSON, M.S. (1987). Mobilization of hepatic calcium pools by 
platelet activating factor. Biochemistry 26,1568-1574.
LEACH, R.P. & TITHERADGE, M.A. (1986). The stimulation of glycogenolysis in isolated hepatocytes 
by opioid peptides. Biochemical Journal 238, 531-535.
LEACH, R.P., SHEARS, S.B., KIRK, C.J. & TITHERADGE, M.A. (1986). Changes in free cytosolic 
calcium and accumulation of inositol phosphates in isolated hepatocytes by [Leujenkephalin. 
Biochemical Journal 238, 537-542.
LEE, K-Y., RYU, S.H., SUH, P-G., CHOI, W.C. & RHEE, S.G. (1987). Phospholipase C associated 
with particulate fractions of bovine brain.
Proceedings of the National Acadamy of Science (USA) 84, 5540-5544.
LEEB-LUNDBERG, L.M .F., COTECCHIA, S., LOM ASNEY, J.W ., DeBERNARDIS, J.F.,
LEFKOWITZ, R.J. & CARON, M.G. (1985). Phorbol esters promote aj-adrenergic receptor
phosphorylation and receptor uncoupling from inositol phospholipid metabolism.
Proceedings of the National Acadamy of Science (USA) 82, 5651-5655.
LENZEN, S., HICKETHIER, R. & PANTEN, U. (1986). Interactions between spermine and Mg2+ on 
mitochondrial Ca2+ transport. Journal of biological Chemistry 261, 16478-16483.
LEVITAN, I.B., LEMOS, J.R. & NOVAK-HOFER, I. (1983). Protein phosphorylation and the regulation 
of ion channels. Trends in Neurosciences 6,496-499.
LEVITZKI, A. (1982). Activation and inhibition of adenylate cyclase by hormones: mechanistic aspects. 
Trends in Pharmacological Sciences 3,203-208.
LIN, S-H., WALLACE, M.A. & FAIN, J.N. (1983). Regulation of Ca2+-M g2+-ATPase activity in 
hepatocyte plasma membranes by vasopressin and phenylephrine. Endocrinology 113,2268-2275.
LIN, S-H. & FAIN, J.N. (1984). Purification of (Ca2+-Mg2+)-ATPase from rat liver plasma membranes. 
Journal of Biological Chemistry 259, 3016-3020.
LIN, S-H. (1985). Novel ATP-dependent calcium transport component from rat liver plasma membranes. 
The transporter and the previously reported (Ca2+-Mg2+)-ATPase are different proteins.
Journal of Biological Chemistry 260, 7850-7856.
105
LITOSCH, I. & FAIN, J.N. (1986). Regulation of phosphoinositide breakdown by guanine nucleotides. 
Life Sciences 39, 187-194.
LITOSCH, I. (1987). Regulatory GTP-binding proteins: emerging concepts on their role in cell function. 
Life Sciences 41,251-258.
LO, W.W.Y. & HUGHES, J. (1987). Receptor-phosphoinositidase C coupling: multiple G-proteins?
FEBS Letters 224, 1-3.
LOMASNEY, J.W., LEEB-LUNDBERG, L.M.F., COTECCHIA, S., REGAN, J.W., DeBERNARDIS,
J.F., CARON, M.G. & LEFKOWITZ, R.J. (1986). Mammalian o^-adrenergic receptor: purification
and characterization of the native receptor ligand binding subunit.
Journal o f Biological Chemistry 261, 7710-7716.
LOTERSZTAJN, S., HANOUNE, J. & PECKER, F. (1981). A high affinity calcium-stimulated 
magnesium-dependent ATPase in rat liver plasma membranes. Dependence on an endogenous protein 
activator distinct from calmodulin. Journal o f Biological Chemistry 256,11209-11215. 
LOTERSZTAJN, S., EPAND, R., MALLAT, A., PAVOINE, C. & PECKER, F. (1985). The liver 
plasma membrane Ca2+ pump: hormonal sensitivity. Biochimie 67, 1169-1176.
LOW, M.G., CARROLL, R.C. & WEGLICKI, W.B. (1984). Multiple forms of phosphoinositide-specific 
phospholipase C of different relative molecular masses in animal tissues. Evidence for modification of 
the platelet enzyme by Ca2+-dependent proteinase. Biochemical Journal 221, 813-820.
LUKACS, G.L., HAJNOCZKY, G., HUNYADY, L. & SPAT, A. (1987). The effect of inositol 
1,4,5-trisphosphate and GTP on calcium-release from rat liver microsomes.
Biochimica et Biophysica Acta 931,251-254.
LUNDBERG, G.A., JERGIL, B. & SUNDLER, R. (1985). Subcellular localization and enzymatic 
properties of rat liver phosphatidylinositol 4-phosphate kinase.
Biochimica et Biophysica Acta 846, 379-387.
LUNDBERG, G.A., JERGIL, B. & SUNDLER, R. (1986). Phosphatidylinositol-4-phosphate kinase from 
rat brain: activation by polyamines and inhibition by phosphatidylinositol 4,5-bisphosphate.
European Journal o f Biochemistry 161,257-262.
LYNCH, C.J., CHAREST, R„ BOCCKINO, S.B., EXTON, J.H. & BLACKMORE, P.F. (1985a). 
Inhibition of hepatic a^-adrenergic effects and binding by phorbol myristate acetate.
Journal o f Biological Chemistry 260,2844-2851.
LYNCH, C.J., BLACKMORE, P.F., CHAREST, R. & EXTON, J.H. (1985b). The relationships between 
receptor binding capacity for norepinephrine, angiotensin II, and vasopressin and release of inositol 
trisphosphate, Ca2+ mobilization, and phosphorylase activation in rat liver.
Molecular Pharmacology 28,93-99.
LYNCH, C.J., WILSON, P.B., BLACKMORE, P.F. & EXTON, J.H. (1986). The hormone-sensitive 
hepatic Na+-pump. Evidence for regulation by diacylglycerol and tumor promoters.
Journal of Biological Chemistry 261, 14551-14556.
106
LYNCH, C.J., BOCCKINO, S.B., BLACKMORE, P.F. & EXTON, J.H. (1987). Calcium-mobilizing 
hormones and phorbol myristate acetate mediate heterologous desensitization of the hormone-sensitive 
hepatic Na+/K+ pump. Biochemical Journal 248, 807-813.
MAJERUS, P.W., WILSON, D.B., CONNOLLY, T.M., BROSS, T.E. & NEUFELD, E.J. (1985). 
Phosphoinositide turnover provides a link in stimulus-response coupling.
Trends in Biochemical Sciences 10, 168-171.
MAJERUS, P.W., CONNOLLY, T.M., DECKMYN, H., ROSS, T.S., BROSS, T.E., ISHII, H., 
BANSAL, V.S. & WILSON, D.B. (1986). The metabolism of phosphoinositide-derived messenger 
molecules. Science 234, 1519-1526.
MANNE, V. & KUNG, H-F. (1987). Characterization of phosphoinositide-specific phospholipase C from 
human platelets. Biochemical Journal 243, 763-771.
MARME, D. & MATZEN-AUER, S. (1985). Protein kinase C and polyphosphoinositide metabolites: 
their role in cellular signal transduction. In: Calcium and Cell Physiology (ed. D. Marme) pp. 377-386. 
Springer-Verlag, New York.
MARTIN, T.F.J., LUCAS, D.O., BAJJALIEH, S.M. & KOWALCHYK, J.A. (1986). 
Thyrotropin-releasing hormone activates a Ca2+-dependent polyphosphoinositide phosphodiesterase in
permeable GH3 cells. GTP-y-S potentiation by a cholera and pertussis toxin-insensitive mechanism. 
Journal o f Biological Chemistry 261, 2918-2927.
MAUGER, J-P., POGGIOLI, J., GUESDON, F. & CLARET, M. (1984). Noradrenaline, vasopressin and 
angiotensin increase Ca2+ influx by opening a common pool of Ca2+ channels in isolated rat liver 
cells. Biochemical Journal 221,121-127.
MAUGER, J-P., POGGIOLI, J. & CLARET, M. (1985). Synergistic stimulation of the Ca2+ influx in rat 
hepatocytes by glucagon and the Ca2+-linked hormones vasopressin and angiotensin II.
Journal o f Biological Chemistry 260, 11635-11642.
MAUGER, J-P. & CLARET, M. (1986). Mobilization of intracellular calcium by glucagon and cyclic 
AMP analogues in isolated rat hepatocytes. FEBS Letters 195,106-110.
MAURER, A., TU, A.T. & VOLPE, P. (1987). Crystallization of the Ca2+-ATPase of skeletal muscle 
sarcoplasmic reticulum. Inhibition by myotoxin a. FEBS Letters. 224, 89-96.
McCORMACK, J.G. (1985a). Evidence that adrenaline activates key oxidative enzymes in rat liver by 
increasing intramitochondrial [Ca2+]. FEBS Letters 180,259-264.
McCORMACK, J.G. (1985b). Characterization of the effects of Ca2+ on the intramitochondrial 
Ca2+-sensitive enzymes from rat liver and within intact rat liver mitochondria.
Biochemical Journal 231, 581-595.
McCORMACK, J.G. (1985c). Studies on the activation of rat liver pyruvate dehydrogenase and 
2-oxoglutarate dehydrogenase by adrenaline and glucagon. Role of increases in intramitochondrial Ca2+ 
concentration. Biochemical Journal 231, 597-608.
107
McCORMACK, J.G., & DENTON, R.M. (1986). Ca2+ as a second messenger within mitochondria. 
Trends in Biochemical Sciences 11,258-262.
McCUSKEY, R.S. (1966). A dynamic and static study of hepatic arterioles and hepatic sphincters. 
American Journal of Anatomy 119,455-478.
McGIVAN, J.D. & MOULE, S.K. (1987). Stimulation of Na+/H+ antiport in plasma membrane vesicles 
from rat liver perfused with dibutyryl cyclic AMP. Journal o f Physiology (London), 391, 102P. 
MELDOLESI, J. & POZZAN, T. (1987). Pathways of Ca2+ influx at the plasma membrane: voltage-, 
receptor-, and second messenger-operated channels. Experimental Cell Research 171,271 -283.
MELIN, P-M., SUNDLER, R. & JERGIL, B. (1986). Phospholipase C in rat liver plasma membranes: 
phosphoinositide specificity and regulation by guanine nucleotides and calcium.
FEBS Letters 198, 85-88.
MENDLOVIC, F., CORVERA, S. & GARCIA-SAINZ, J.A. (1984). Possible involvement of 
cyclo-oxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the 
vasular effects of epinephrine in perfused rat liver.
Biochemical and Biophysical Research Communications 123, 507-514.
MERRITT, J.E. & RINK, T.J. (1987a). The effects of substance P and carbachol on inositol tris- and 
tetrakisphosphate formation and cytosolic free calcium in rat parotid acinar cells. A correlation between 
inositol phosphate levels and calcium entry.
Journal of Biological Chemistry 262, 14912-14916.
MERRITT, J.E. & RINK, T.J. (1987b). Regulation of cytosolic free calcium in fura-2-loaded rat parotid 
acinar cells. Journal o f Biological Chemistry 262, 17362-17369.
METZ, W. & FORSSMANN, W.G. (1980). Innervation of the liver in guinea pig and rat.
Anatomical Embryology 160, 239-252.
MICHELL, R.H. (1975). Inositol phospholipids and cell surface receptor function.
Biochimica et Biophysica Acta 415, 81-147.
MICHELL. B. (1986). Inositol phosphates: profusion and confusion. Nature (London) 319, 176-177. 
MICHELL, R.H. & KIRK, C.J. (1981). Why is phosphatidylinositol degraded in reponse to stimulation of 
certain receptors? Trends in Pharmacological Sciences 2, 86-89.
MICHELL, B. & KIRK, C. (1986). G-protein control of inositol phosphate hydrolysis.
Nature (London) 323, 112-113.
MILLER, D.J. & MOISESCU, D.G. (1976). The effects of very low external calcium and sodium 
concentrations on cardiac contractile strength and calcium-sodium antagonism.
Journal o f Physiology (London) 259, 283-308.
MOOLENAAR, W.H., KRUIJER, W., TILLY, B.C., VERLAAN, L, BIERMAN, A.J. & De LAAT, 
S.W. (1986). Growth factor-like action of phosphatidic acid. Nature (London) 323, 171-173.
MOORE, P.B. & KRAUS-FRIEDMANN, N. (1983). Hepatic microsomal Ca2+-dependent ATPase. 
Calmodulin-dependence and partial purification. Biochemical Journal 214,69-75.
108
MORENO-SANCHEZ, R. (1985). Regulation of oxidative phosphorylation in mitochondria by external 
free Ca2+ concentrations. Journal o f Biological Chemistry 260,4028-4034.
MORGAN, N.G., BLACKMORE, P.F. & EXTON, J.H. (1983). Modulation of the 0 4 -adrenergic control
of hepatocyte calcium redistribution by increases in cyclic AMP.
Journal of Biological Chemistry 258, 5110-5116.
MORGAN, N.G., CHAREST, R., BLACKMORE, P.F. & EXTON, J.H. (1985). Cyclic AMP-dependent 
modulation of 0^ -adrenergic responses in rat liver.
Biochemical Society Transactions 13, 217-218.
MORRIS, A.P., GALLACHER, D.V., IRVINE, R.F. & PETERSEN, O.H. (1987). Synergism of 
inositol trisphosphate and tetrakisphosphate in activating Ca2+-dependent K+ channels.
Nature (London) 330, 653-655.
MOYER, J.D., REIZES, O., DEAN, N.M. & MALINOWSKI, N. (1987). D-m yo-inositol 
(l,4)-bisphosphate 1-phosphatase. Partial purification from rat liver and characterization.
Biochemical and Biophysical Research Communications 146,1018-1026.
MU ALLEM, S., S CHOEFFIELD, M., PANDOL, S. & SACHS, G. (1985). Inositol trisphosphate 
modification of ion transport in rough endoplasmic reticulum.
Proceedings of the National Academy of Science (USA) 82,4433-4437.
MURAYAMA, T. & UI, M. (1987). Phosphatidic acid may stimulate membrane receptors mediating 
adenylate cyclase inhibition and phospholipid breakdown in 3T3 fibroblasts.
Journal of Biological Chemistry 262, 5522-5529.
NAHORSKI, S.R. & BATTY, I. (1986). Inositol tetrakisphosphate: recent developments in 
phosphoinositide metabolism and receptor function.
Trends in Pharmacological Sciences 7, 83-85.
NAKABAYASHI, H., CHAN, K-F.J. & HUANG, K-P. (1987). Role of protein kinase C in the regulation 
of rat liver glycogen synthase. Archives o f Biochemistry and Biophysics 252, 81-90.
NAKANISHI, H., NOMURA, H., KIKKAWA, U. KISHIMOTO, A. & NISHIZUKA, Y. (1985). Rat 
brain and liver soluble phospholipase C: resolution of two forms with different requirements for 
calcium. Biochemical and Biophysical Research Communications 132, 582-590.
NAYLER, W.G. & HOROWITZ, J.D. (1983). Calcium antagonists: a new class of drugs.
Pharmacology and Therapeutics 20,203-262.
NEEDLEMAN, P., TURK, J., JAKSCHIK, B.A., MORRISON, A.R. & LEFKOWITH, J.B. (1986).
Arachidonic acid metabolism. Annual Reviews of Biochemistry 55, 69-102.
NICCHITTA, C.V. & WILLIAMSON, J.R. (1984). Spermine: a regulator of mitochondrial calcium 
cycling. Journal of Biological Chemistry 259,12978-12983.
NICCHITTA, C.V., JOSEPH, S.K. & WILLIAMSON, J.R. (1987). GTP-mediated Ca2+ release in rough 
endoplasmic reticulum. Correlation with a GTP-sensitive increase in membrane permeability. 
Biochemical Journal 248, 741-747.
109
NIEDEL, J.E., KUHN, L.J. & VANDENBARK, G.R. (1983). Phorbol diester receptor copurifies with 
protein kinase C. Proceedings of the National Acadamy of Science (USA) 80,36-40.
NISHIZUKA, Y. (1983). Phospholipid degradation and signal translation for protein phosphorylation. 
Trends in Biochemical Sciences 8,13-16.
NISHIZUKA, Y. (1984). Protein kinases in signal transduction.
Trends in Biochemical Sciences 9,163-166.
NISHIZUKA, Y. (1986). Studies and perspectives of protein kinase C. Science 233, 305-312.
OHSAKO, S. & DEGUCHI, T. (1981). Stimulation by phosphatidic acid of calcium influx and cyclic 
GMP synthesis in neuroblastoma cells. Journal of Biological Chemistry 256,10945-10948.
OKAJIMA, F., TOKUMITSU, Y., KONDO, Y. & UI, M. (1987). P2-purinergic receptors are coupled to 
two signal transduction systems leading to inhibition of cAMP generation and to production of inositol 
trisphosphate in rat hepatocytes. Journal of Biological Chemistry 262,13483-13490.
OKAYASU, T., HASEGAWA, K. & ISHIBASHI, T. (1987). Platelet-activating factor stimulates 
metabolism of phosphoinositides via phospholipase A2 in primary cultured rat hepatocytes.
Journal of Lipid Research 28,760-767.
O’ROURKE, F.A., HALENDA, S.P., ZOVOICO, G.B. & FEINSTEIN, M.B. (1985). Inositol 
1,4,5-trisphosphate releases Ca2+ from a Ca2+-transporting membrane vesicles fraction derived from 
human platelets. Journal of Biological Chemistry 260,956-962.
PARKER, J.C., BARRITT, G.J. & WADSWORTH, J.C. (1983). A kinetic investigation of the effects of 
adrenaline on 45Ca2+ exchange in isolated hepatocytes at different Ca2+ concentrations, at 20 °C and in 
the presence of inhibitors of mitochondrial Ca2+ transport. Biochemical Journal 216,51-62.
PARKER, I. & MDLEDI, R.(F.R.S.) (1987). Inositol trisphosphate activates a voltage-dependent calcium 
influx in Xenopus oocytes. Proceedings of the Royal Society of London 231,27-36.
PATEL, T.B. (1986). Hormonal regulation of the tricarboxylic acid cycle in the isolated perfused rat liver. 
European Journal of Biochemistry 159,15-22.
PATEL, T.B. (1987). Stimulation of hepatic glycogenolysis by phorbol 12-myristate 13-acetate. 
Biochemical Journal 241,549-554.
PAVOINE, C., LOTERSZTAJN, S., MALLAT, A. & PECKER, F. (1987). The high affinity 
(Ca2+-Mg2+)-ATPase in liver plasma membranes is a Ca2+ pump. Reconstitution of the purified 
enzyme into phospholipid vesicles. Journal of Biological Chemistry 262,5113-5117.
PETERSEN, O.H. & BEAR, C. (1986). Two glucagon transducing systems. Nature (London) 323, 18.
PHILIPSON, K.D., FRANK, J.S. & NISHIMOTO, A.Y. (1983). Effects of phospholipase C on the 
Na+-Ca2+ exchange and Ca2+ permeability of cardiac sarcolemmal vesicles.
Journal of Biological Chemistry 258, 5905-5910.
PHILIPSON, K.D. & NISHIMOTO, A.Y. (1984). Stimulation of Na+-Ca2+ exchange in cardiac 
sarcolemmal vesicles by phospholipase D. Journal of Biological Chemistry 259,16-19.
110
PHILIPSON, K.D. (1985). Sodium-calcium exchange in plasma membrane vesicles.
Annual Reviews o f Physiology 47, 561-571.
PICKFORD, L.B., POLVERINO, A.J. & BARRITT, G.J. (1987). Evidence from studies employing 
radioactively labelled fatty acids that the stimulation of flux through the diacylglycerol pool is an early 
action of vasopressin on hepatocytes. Biochemical Journal 245,211-216.
POGGIOLI, J., BERTHON, B. & CLARET, M. (1980). Calcium movements in in situ mitochondria 
following activation of -adrenergic receptors in rat liver cells. FEBS Letters 115, 243-246. 
POGGIOLI, J„ MAUGER, J-P., GUESDON, F. & CLARET, M. (1985). A regulatory calcium-binding 
site for calcium channel in isolated rat hepatocytes.
Journal of Biological Chemistry 260, 3289-3294.
POGGIOLI, J., MAUGER, J-P. & CLARET, M. (1986). Effect of cyclic AMP-dependent hormones and 
Ca2+-mobilizing hormones on the Ca2+ influx and polyphosphoinositide metabolism in isolated rat 
hepatocytes. Biochemical Journal 235,663-669.
PRENTKI, M., BIDEN, T.J., JANJIC, D., IRVINE, R.F., BERRIDGE, M.J. & WOLLHEIM, C.B. 
(1984a). Rapid mobilization of Ca2+ from rat insulinoma microsomes by inositol-1,4,5-trisphosphate. 
Nature (London) 309, 562-564.
PRENTKI, M., WOLLHEIM, C.B. & LEW, P.D. (1984b). Ca2+ homeostasis in permeabilized human 
neutrophils. Characterization of Ca2+-sequestering pools and the action of inositol 1,4,5-trisphosphate. 
Journal o f Biological Chemistry 259, 13777-13782.
PRENTKI, M., CORKEY, B.E. & MATSCHINSKY, F.M. (1985). Inositol 1,4,5-trisphosphate and the 
endoplasmic reticulum Ca2+ cycle of a rat insulinoma cell line.
Journal of Biological Chemistry 260, 9185-9190.
PRESCOTT, S.M. & MAJERUS, P.W. (1983). Characterization of 1,2-diacylglycerol hydrolysis in 
human platelets. Demonstration of an arachidonoyl-monoglycerol intermediate.
Journal of Biological Chemistry 258, 764-769.
PRPIC, V. & BYGRAVE, F.L. (1980). On the inter-relationship between glucagon action, the 
oxidation-reduction state of pyridine nucleotides, and calcium retention by rat liver mitochondria. 
Journal o f Biological Chemistry 255,6193-6199.
PRPIC, V., BLACKMORE, P.F. & EXTON, J.H. (1982). Phosphatidylinositol breakdown induced by 
vasopressin and epinephrine in hepatocytes is calcium-dependent.
Journal of Biological Chemistry 257, 11323-11331.
PRPIC, V., GREEN, K.C., BLACKMORE, P.F. & EXTON, J.H. (1984). Vasopressin-, angiotensin II-, 
and o^-adrenergic-induced inhibition of Ca2+ transport by rat liver plasma membrane vesicles.
Journal of Biological Chemistry 259, 1382-1385.
PUTNEY, J.W.Jr. (1977). Muscarinic, a-adrenergic and peptide receptors regulate the same calcium influx 
sites in the parotid gland. Journal o f Physiology (London) 268, 139-149.
I l l
PUTNEY, J.W.Jr. WEISS, S.J., Van De WALLE, C.M. & HADDAS, R.A. (1980). Is phosphatidic acid a 
calcium ionophore under neurohumoral control? Nature (London) 284, 345-347.
PUTNEY, J.W.Jr. (1986). A model for receptor-regulated calcium entry. Cell Calcium 7,1-12.
RACKER, E. (1980). Fluxes of Ca2+ and concepts. Federation Proceedings 39,2422-2426. 
RADOMINSKA-PYREK, A., KRAUS-FRIEDMANN, N., LESTER, R. LITTLE, J. & DENKINS, Y. 
(1982). Rapid stimulation of Na+, K+-ATPase by glucagon, epinephrine, vasopressin and cAMP in 
perfused rat liver. FEBS Letters 141, 56-58.
RAPPAPORT, A.M., BOROWY, Z.J., LOUGHEED, W.M. & LOTTO, W.N. (1954). Subdivision of 
hexagonal liver lobules into a structural and functional unit: role in hepatic physiology and pathology. 
Anatomical Record 119, 11-27.
RAPPAPORT, A.M. (1973). The microcirculatory hepatic unit. Microvascular Research 6, 212-228. 
RASHED, H.M. & PATEL, T.B. (1987). Glucagon-stimulated calcium efflux in the isolated perfused rat 
liver is dependent on the cellular redox potential. Journal o f Biological Chemistry 262,15953-15958. 
REBECCHI, M.J. & ROSEN, O.M. (1987). Purification of a phosphoinositide-specific phospholipase C 
from bovine brain. Journal of Biological Chemistry 262,12526-12532.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1982a). Studies on a-adrenergic-induced 
respiration and glycogenolysis in perfused rat liver.
Journal o f Biological Chemistry 257, 1906-1912.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1982b). A procedure for the rapid preparation of 
mitochondria from rat liver. Biochemical Journal 204,731-735.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1982c). Calcium ion fluxes induced by the
action of a-adrenergic agonists in perfused rat liver. Biochemical Journal 208,619-630.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1983). The effect of ionophore A23187 on 
calcium ion fluxes and a-adrenergic agonist action in perfused rat liver.
Biochemical Journal 214,405-412.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1984a). The mechanism of a-adrenergic agonist 
action in liver. Biological Reviews 59, 511-557.
REINHART, P.H., van de POL, E., TAYLOR, W.M. & BYGRAVE, F.L. (1984b). An assessment of the 
calcium content of rat liver mitochondria in vivo. Biochemical Journal 218,415-420.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1984c). The contribution of both extracellular
and intracellular calcium to the action of a-adrenergic agonists in perfused rat liver.
Biochemical Journal 220,35-42.
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1984d). The action of a-adrenergic agonists on 
plasma-membrane calcium fluxes in perfused rat liver. Biochemical Journal 220,43-50.
112
REINHART, P.H., TAYLOR, W.M. & BYGRAVE, F.L. (1984e). The role of calcium ions in the 
mechanism of action of a-adrenergic agonists in rat liver. Biochemical Journal 223,1-13.
RENARD, D., POGGIOLI, J., BERTHON, B. & CLARET, M. (1987). How far does phospholipase C 
activity depend on the cell calcium concentration? A study in intact cells.
Biochemical Journal 243, 391-398.
REUTER, H. (1983). Calcium channel modulation by neurotransmitters, enzymes and drugs.
Nature (London) 301, 569-573.
RHODES, D., PRPIC, V., EXTON, J.H. & BLACKMORE, P.F. (1983). Stimulation of 
phosphatidylinositol 4,5-bisphosphate hydrolysis in hepatocytes by vasopressin.
Journal o f Biological Chemistry 258, 2770-2773.
RINK, T.J., SANCHEZ, A. & HALLAM, T.J. (1983). Diacylglycerol and phorbol ester stimulate 
secretion without raising cytoplasmic free calcium in human platelets.
Nature (London) 305,317-319.
RIZZUTO, R., BERNARDI, P., FAVERON, M. & AZZONE, G.F. (1987). Pathways for Ca2+ efflux in 
heart and liver mitochondria. Biochemical Journal 246,271-277.
ROUOT, B., BRABET, P., HOMBURGER, V., TOUT ANT, M. & BOCKAERT, J. (1987). G0, a major
brain GTP binding protein in search of a function: purification, immunological and biochemical 
characteristics. Biochimie 69, 339-349.
RUBIN, R.P. (1970). The role of calcium in the release of neurotransmitter substances and hormones. 
Pharmacological Reviews 22,389-428.
RYU, S.H., CHO, K.S., LEE, K-Y., SUH, P-G. & RHEE, S.G. (1987a). Purification and characterization 
of two immunologically distinct phosphoinositide-specific phospholipase C from bovine brain.
Journal o f Biological Chemistry 262, 12511-12518.
RYU, S.H., SUH, P-G., CHO, K.S., LEE, K-Y. & RHEE, S.G. (1987b). Bovine brain cytosol contains 
three immunologically distinct forms of inositolphospholipid-specific phospholipase C.
Proceedings o f the National Acadamy of Science (USA) 84,6649-6653.
RYU, S.H., LEE, S.Y., LEE, K-Y. & RHEE, S.G. (1987c). Catalytic properties of inositol trisphosphate 
kinase: activation by Ca2+ and calmodulin. FASEB Journal 1, 388-393.
SCHANNE, F.A.X. & MOORE, L. (1986). Liver plasma membrane calcium transport: evidence for a 
Na+-dependent Ca2+ flux. Journal o f Biological Chemistry 261, 9886-9889.
SCHLAYER, H.J., LEUTHNER, R., WOORT-MENKER, M. & DECKER, K. (1986). Characterization 
of sinusoidal endothelial cells in monolayer culture.
Biological Chemistry Hoppe-Seyler 367, Suppl. 380.
SCHLEGEL, W., WINIGER, B.P., MOLLARD, P., VACHER, P„ WUARIN, F., ZAHND, G.R., 
WOLLHEIM, C.B. & DUFY, B. (1987). Oscillations of cytosolic Ca2+ in pituitary cells due to action 
potentials. Nature (London) 329, 719-721.
113
SCHUTZE, S. & SOLING, H-D. (1987). Does a calmodulin-dependent Ca2+-regulated Mg2+-dependent 
ATPase contribute to hepatic microsomal calcium uptake? Biochemical Journal 243, 729-737.
SCOTT, R.H. & DOLPHIN, A.C. (1987). Activation of a G protein promotes agonist responses to 
calcium channel ligands. Nature (London) 330,760-762.
SEN, L, JIM, K.F. & SOFFER, R.L. (1983). Solubilization and characterization of an angiotensin II 
binding protein from liver. European Journal o f Biochemistry 136, 41-49.
SERHAN, C., ANDERSON, P., GOODMAN, E., DUNHAM, P. & WEISSMANN, G. (1981). 
Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenarzo III in 
liposomes. Journal o f Biological Chemistry 256, 2736-2741.
SEYFRED, M.A. & WELLS, W.W. (1984). Subcellular site and mechanism of vasopressin-stimulated 
hydrolysis of phosphoinositides in rat hepatocytes.
Journal of Biological Chemistry 259, 7666-7672.
SEYFRED, M.A., FARRELL, L.E. & WELLS, W.W. (1984). Characterization of D-myo-inositol- 
1,4,5-trisphosphate phosphatase in rat liver plasma membranes.
Journal of Biological Chemistry 259, 13204-13208.
SHARMA, R.J., RODRIGUES, L.M., WHITTON, P.D. & HEMS, D.A. (1980). Control mechanisms in 
the acceleration of hepatic glycogen degradation during hypoxia.
Biochimica et Biophysica Acta 630,414-424.
SHEARS, S.B. & KIRK, C.J. (1984a). Determination of mitochondrial calcium content in hepatocytes by 
a rapid cellular-fractionation technique, a-adrenergic agonists do not mobilize mitochondrial Ca2+. 
Biochemical Journal 219, 383-389.
SHEARS, S.B. & KIRK, C.J. (1984b). Determination of mitochondrial calcium content in hepatocytes by 
a rapid cellular fractionation technique. Vasopressin stimulates mitochondrial Ca2+ uptake.
Biochemical Journal 220,417-421.
SHEARS, S.B., STOREY, D.J., MORRIS, A.J., CUBITT, A.B., PARRY, J.B., MICHELL, R.H. & 
KIRK, C.J. (1987a). Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 
1,3,4-trisphosphate. Biochemical Journal 242, 393-402.
SHEARS, S.B., PARRY, J.B., TANG, E.K.Y., IRVINE, R.F., MICHELL R.H. & KIRK, C.J. (1987b). 
Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel 
isomer of myo-inositol tetrakisphosphate. Biochemical Journal 246, 139-147.
SHREEVE, S.M., FRASER, C.M. & VENTER, J.C. (1985). Molecular comparison of (Xj-and
o^-adrenergic receptors suggests that these proteins are structurally related 'isoreceptors'.
Proceedings of the National Acadamy of Science (USA) 82,4842-4846.
SHUKLA, S.D., BUXTON, D.B., OLSON, M.S. & HANAHAN, D.J. (1983). Acetylglyceryl ether 
phosphorylcholine: a potent activator of hepatic phosphoinositide metabolism and glycogenolysis. 
Journal o f Biological Chemistry 258, 10212-10214.
114
SIES, H. (1982). In.Metabolic Compartmentation (ed. H. Sies) pp. 1-6, Academic Press, London.
SIES, H. (1987). Liver heterogeneity: Intercellular and intracellular.
Biochemical Society Transactions 621st Meeting, London, 15: 359-360.
SIESS, E.A., KIENTSCH-ENGEL, R.I., FAHIMI, F.M. & WIELAND, O.H. (1984). Possible role of ^
supply in mitochondrial actions of glucagon. European Journal of Biochemistry 141, 543-548. 
SISTARE, F.D., PICKING, R.A. & HAYNES, R.C.Jr. (1985). Sensitivity of the response of cytosolic 
calcium in Quin-2-loaded rat hepatocytes to glucagon, adenine nucleosides, and adenine nucleotides. 
Journal o f Biological Chemistry 260,12744-12747.
SLACK, B.E., BELL, J.E. & BENOS, D.J. (1986). Inositol-1,4,5-trisphosphate injection mimics 
fertilization potentials in sea urchin eggs. American Journal o f Physiology 250, C340-C344.
SMITH, J.B., SMITH, L. & HIGGINS, B.L. (1985). Temperature and nucleotide dependence of calcium 
release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells.
Journal of Biological Chemistry 260, 14413-14416.
SOMLYO, A.P., BOND, M. & SOMLYO, A.V. (1985). Calcium content of mitochondria and 
endoplasmic reticulum in liver frozen rapidly in vivo. Nature (London) 314,622-625.
SPAT, A., BRADFORD, P.G., McKINNEY, J.S., RUBIN, R.P. & PUTNEY, J.W.Jr. (1986a). A 
saturable receptor for 22P-inositol-1,4,5-trisphosphate in hepatocytes and neutrophils.
Nature (London) 319, 514-516.
SPAT, A., FABIATO, A. & RUBIN, R.P. (1986b). Binding of inositol trisphosphate by a liver 
microsomal fraction. Biochemical Journal 233,929-932.
SPAT, A., LUKACS, G.L., EBERHARDT, L, KIESEL, L. & RUNNEBAUM, B. (1987). Binding of 
inositol phosphates and induction of Ca2+ release from pituitary microsomal fractions.
Biochemical Journal 244,493-496 
SPEDDING, M. (1985). Calcium antagonist subgroups.
Trends in Pharmacological Sciences 6,109-114.
SPEDDING, M. (1987). Three types of Ca2+ channel explain discrepancies.
Trends in Pharmacological Sciences 8,115-117.
SPERELAKIS, N., WÄHLER, G.M. & BKAILY, G. (1985). Properties of myocardial calcium slow 
channels and mechanisms of action of calcium antagonistic drugs.
Current Topics in Membranes and Transport 25,43-76.
SPOLARICS, Z., MUCHA, L, MANDL, L, MACHOVICH, R., BANHEGYI, G., ANTONI, F. & 
GARZO, T. (1987). Prostanoid synthesis in isolated parenchymal and non-parenchymal mouse liver 
cells in the presence of arachidonic acid.
Prostaglandins Leukotrienes and Medicine 29, 113-127.
STADDON, J.M. & McGIVAN, J.D. (1985). Evidence indicating that ATP addition to rat hepatocytes 
causes increases in cytoplasmic free Ca2+ and oxoglutarate dehydrogenase activity: comparison with 
effects of adenosine. Biochemical Society Transactions 13, 742-743.
115
STADDON, J.M. & HANSFORD, R.G. (1986). 4-ß-phorbol 12-myristate 13-acetate attenuates the 
glucagon-induced increase in cytoplasmic free Ca2+ concentration in isolated rat hepatocytes. 
Biochemical Journal 238,737-743.
STADDON, J.M. & HANSFORD, R.G. (1987). The glucagon-induced activation of pyruvate 
dehydrogenase in hepatocytes is diminished by 4ß-phorbol 12-myristate 13-acetate. A role for 
cytoplasmic Ca2+ in dehydrogenase regulation. Biochemical Journal 241, 729-735.
STERNWEIS, P.C. & ROBISHAW, J.D. (1984). Isolation of two proteins with high affinity for guanine 
nucleotides from membranes of bovine brain.
Journal o f Biological Chemistry 259, 13806-13813.
STOREY, D.J., SHEARS, S.B., KIRK, C.J. & MICHELL, R.H. (1984). Stepwise enzymatic 
dephosphorylation of inositol 1,4,5-trisphosphate to inositol in liver. Nature (London) 312, 374-376.
STRAUB, R.E., & GERSHENGORN, M.C. (1986). Thyrotropin-releasing hormone and GTP activate 
inositol trisphosphate formation in membranes isolated from rat pituitary cells.
Journal of Biological Chemistry 261, 2712-2717.
STREB, H., IRVINE, R.F., BERRIDGE, M.J. & SCHULZ, I. (1983). Release of Ca2+ from a 
nonmitochondrial intracellular store in pancreatic acinar cells by inositol 1,4,5-trisphosphate.
Nature (London) 306, 67-69.
STREB, H., HESLOP, J.P., IRVINE, R.F., SCHULZ, I. & BERRIDGE, M.J. (1985). Relationship 
between secretagogue-induced Ca2+ release and inositol polyphosphate production in permeabilized 
pancreatic acinar cells. Journal o f Biological Chemistry 260,7309-7315.
SUPATTAPONE, S., WORLEY, P.F., BAR AB AN, J.M. & SNYDER, S.H. (1988). Solubilization , 
purification, and characterization of an inositol trisphosphate receptor.
Journal o f Biological Chemistry 263, 1530-1534.
TAKAI, Y., KISHIMOTO, A., INOUE, M. & NISHIZUKA, Y. (1977). Studies on a cyclic 
nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and 
characterization of an active enzyme from bovine cerebellum.
Journal of Biological Chemistry 252, 7603-7609.
TAKEDA, A., HASHIMOTO, E., YAMAMURA, H. & SHIMAZU, T. (1987). Phosphorylation of liver 
gap junction protein by protein kinase C. FEBS Letters 210, 169-172.
TAKENAWA, T. & NAGAI, Y. (1981). Purification of phosphatidylinositol-specific phospholipase C 
from rat liver. Journal o f Biological Chemistry 256, 6769-6775.
TANABE, T., TAKESHIMA, H., MIKAMI, A., FLOCKERZI, V., TAKAHASHI, H., KANGAWA, K., 
KOJIMA, M., MATSUO, H., HIROSE, T. & NUMA, S. (1987). Primary structure of the receptor for 
calcium channel blockers from skeletal muscle. Nature (London) 328, 313-318.
TAYLOR, S.J. & EXTON, J.H. (1987). Guanine-nucleotide and hormone regulation of polyphospho­
inositide phospholipase C activity of rat liver plasma membranes. Bivalent-cation and phospholipid 
requirements. Biochemical Journal 248,791-799.
116
TAYLOR, C.W. & MERRITT, J.E. (1986). Receptor coupling to polyphosphoinositide turnover: a 
parallel with the adenylate cyclase system. Trends in Pharmacological Sciences 7,238-242.
TAYLOR, D., UHING, R.J., BLACKMORE, P.F., PRPIC, V. & EXTON, J.H. (1985). Insulin and 
epidermal growth factor do not affect phosphoinositide metabolism in rat liver plasma membranes and 
hepatocytes. Journal o f Biological Chemistry 260, 2011-2014.
TAYLOR, W.M., REINHART, P.H., HUNT, N.H. & BYGRAVE, F.L. (1980). Role of 3',5'-cyclic AMP 
in glucagon-induced stimulation of ruthenium red-insensitive calcium transport in an endoplasmic 
reticulum-rich fraction of rat liver. FEBS Letters 112, 92-96.
TAYLOR, W.M., REINHART, P.H. & BYGRAVE, F.L. (1983a). Stimulation by cx-adrenergic agonists 
of Ca^+ fluxes, mitochondrial oxidation and gluconeogenesis in perfused rat liver.
Biochemical Journal 212, 555-565.
TAYLOR, W.M., REINHART, P.H. & BYGRAVE, F.L. (1983b). On the role of calcium in the 
mechanism of action of a-adrenergic agonists in rat liver. Pharmacology and Therapeutics 21,125-141.
TAYLOR, W.M., Van De POL, E., van HELDEN, D.F., REINHART, P.H. & BYGRAVE, F.L. (1985). 
Effect of depolarizing concentrations of potassium on calcium uptake and metabolism in rat liver. 
FEBS Letters 183,70-74.
TAYLOR, W.M., Van De POL, E. & BYGRAVE, F.L. (1986). The stimulation of tricarboxylic acid-cycle 
flux by a-adrenergic agonists in perfused rat liver. Biochemical Journal 233, 321-324.
TENNES, K.A., McKINNEY, J.S. & PUTNEY, J.W.Jr. (1987). Metabolism of inositol 
1,4,5-trisphosphate in guinea-pig hepatocytes. Biochemical Journal 242, 797-802.
THEIBERT, A.B., SUPATTAPONE, S., WORLEY, P.F., BARABAN, J.M., MEEKJ.L. & SNYDER, 
S.H. (1987). Demonstration of inositol 1,3,4,5-tetrakisphosphate receptor binding.
Biochemical and Biophysical Research Communications 148,1283-1289.
THOMAS, A.P., ALEXANDER, J. & WILLIAMSON, J.R. (1984). Relationship between inositol 
polyphosphate production and the increase of cytosolic free Ca2+ induced by vasopressin in isolated 
hepatocytes. Journal of Biological Chemistry 259, 5574-5584.
THURMAN, R.G., KAUFFMAN, F.C. & JUNGERMANN, K. (eds) (1986). Regulation o f Hepatic 
Metabolism, Plenum Press, New York.
TOU, J-S., HURST, M.W., HIGGINS, C.G. & FOOR, W.E. (1970). Biosynthesis of triphosphoinositide 
in rat kidney cortex. Archives of Biochemistry and Biophysics 140,492-502.
TOWART, R. & SCHRAMM, M. (1984). Recent advances in the pharmacology of the calcium channel. 
Trends in Pharmacological Sciences 5,111-113.
TRAN-THI, T.A., HENNINGER, H.P., BUSSE, R. & DECKER, K. (1986). Hepatocytes in primary 
culture degrade prostanoids that are produced by stimulated Kupffer cells.
Biological Chemistry Hoppe-Seyler 367, suppl. 298.
117
TRAUTWEIN, W. & HOFMANN, F. (1983). Activation of calcium current by injection of cAMP and 
catalytic subunit of cAMP-dependent protein kinase.
Proceedings of the International Union of Pysiological Science 15, 75.
TURNER, P.R., JAFFE, L.A. & FEIN, A. (1986). Regulation of cortical vesicle exocytosis in sea urchin 
eggs by inositol 1,4,5-trisphosphate and GTP-binding protein.
Journal o f Cell Biology 102, 70-76.
TYSON, C.A., ZANDE, H.V. & GREEN, D.E. (1976). Phospholipids as ionophores.
Journal of Biological Chemistry 251, 1326-1332.
UHING, R.J., PRPIC, V., JIANG, H. & EXTON, J.H. (1986). Hormone-stimulated polyphosphinositide 
breakdown in rat liver plasma membranes. Roles of guanine nucleotides and calcium.
Journal o f Biological Chemistry 261, 2140-2146.
VALLEJO, M., JACKSON, T., LIGHTMAN, S. & HANLEY, M.R. (1987). Occurrence of extracellular 
actions of inositol pentakis- and hexakisphosphate in mammalian brain.
Nature (London) 330, 656-658.
Van BERKEL, T.J.C. (1979). The role of non-parenchymal cells in liver metabolism.
Trends in Biomedical Sciences 4,202-205.
Van BREEMEN, C. AARONSON, P. & LOUTZENHISER, R. (1979). Sodium-calcium interactions in 
mammalian smooth muscle. Pharmacological Reviews 30, 167-208.
VANE, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. 
Nature (New Biology) 231,232-235.
VARGAS, A.M., HALESTRAP, A.P. & DENTON, R.M. (1982). The effects of glucagon, phenylephrine 
and insulin on the phosphorylation of cytoplasmic, mitochondrial and membrane-bound proteins of 
intact liver cells from starved rats. Biochemical Journal 208, 221-229.
VENTER, J.C. & FRASER, C.M. (1983). The structure of a- and ß-adrenergic receptors.
Trends in Pharmacological Sciences 4,256-258.
VENTER, J.C., HORNE, P., EDDY, B., GREGUSKI, R. & FRASER, C.M. (1984a). Alpha!-adrenergic
receptor structure. Molecular Pharmacology 26, 196-205.
VENTER, J.C., EDDY, B., HALL, L.M. & FRASER, C.M. (1984b). Monoclonal antibodies detect the 
conservation of muscarinic cholinergic receptor structure from Drosophila to human brain and detect
possible structural homology with a!-adrenergic receptors.
Proceedings o f the National Acadamy of Science (USA) 81, 272-276.
VERHOEVEN, A.J.M., TYSNES, O-B., AARBAKKE, G.M., COOK, C.A. & HOLMSEN, H. (1987). 
Turnover of the phosphomonoester groups of polyphosphoinositol lipids in unstimulated human 
platelets. European Journal of Biochemistry 166, 3-9.
WAKELAM, M.J.O., MURPHY, G.J., HRUBY, V.J. & HOUSLAY, M.D. (1986). Activation of two 
signal-transduction systems in hepatocytes by glucagon. Nature (London) 323, 68-71.
118
WALLACE, M.A. & FAIN, J.N. (1985). Guanosine 5'-0-thiotriphosphate stimulates phospholipase C 
activity in plasma membranes of rat hepatocytes.
Journal of Biological Chemistry 260, 9527-9530.
WATSON, S.P., McCONNELL, R.T. & LAPETINA, E.G. (1984). The rapid formation of inositol 
phosphates in human platelets by thrombin is inhibited by prostacyclin.
Journal of Biological Chemistry 259, 13199-13203.
WHIPPS, D.E., ARMSTON, A.E., PRYOR, H.J. & HALESTRAP, A.P. (1987). Effects of glucagon and 
C a2+ on the metabolism of phosphatidylinositol 4-phosphate and phosphatidylinositol 
4,5-bisphosphate in isolated rat hepatocytes and plasma membranes.
Biochemical Journal 241, 835-845.
WHITAKER, M. & IRVINE, R.F. (1984). Inositol 1,4,5-trisphosphate microinjection activates sea urchin 
eggs. Nature (London) 312,636-639.
WIDMANN, J-J., COTRAN, R.S. & FAHIMI, H.D. (1972). Mononuclear phagocytes (Kupffer cells) and 
endothelial cells. Identification of two functional cell types in rat liver sinusoids by endogenous 
peroxidase activity. Journal of Cell Biology 52, 159-170.
WIDMANN, J-J. & FAHIMI, H.D. (1975) Proliferation of mononuclear phagocytes (Kupffer cells) and 
endothelial cells in regenerating rat liver. American Journal of Pathology 80, 349-366.
WILLIAMSON, J.R., COOPER, R.H. & HOEK, J.B. (1981). Role of calcium in the hormonal regulation 
of liver metabolism. Biochimica et Biophysica Acta 639, 243-295.
WILLIAMSON, J.R., COOPER, R.H., JOSEPH, S.K. & THOMAS, A.P. (1985). Inositol trisphosphate 
and diacylglycerol as intracellular second messengers in liver.
American Journal of Physiology 248, C203-C216.
WILLIAMSON, J.R., HANSEN, C.A., VERHOEVEN, A., COLL, K.E., JOHANSON, R., 
WILLIAMSON, M.T. & FILBURN, C. (1986). Mechanisms involved in receptor-mediated changes of 
intracellular Ca2+ in liver. In: Cellular Calcium and the Control of Membrane Transport 
(ed. D.C. Eaton and L.J. Mandel) Rockefeller Press, New York, 1986.
WILLIAMSON, J.R. & HANSEN, C.A. (1987). Signalling systems in stimulus-response coupling. In: 
Biochemical Actions of Hormones (ed. G. Litwack),
Vol. 14, Academic Press, New York, in press.
WISSE, E. & KNOOK, D.L. (eds) (1977). Kupffer Cells and Other Liver Sinusoidal Cells.
Elsevier, Amsterdam.
WOLF, B.A., FLORHOLMEN, J., COLCA, J.R. & McDANIEL, M.L. (1987). GTP mobilization of 
Ca2+ from the endoplasmic reticulum of islets. Comparison with myo-inositol 1,4,5-trisphosphate. 
Biochemical Journal 242,137-141.
WOODS, N.M., CUTHBERTSON, K.S.R. & COBBOLD, P.H. (1986). Repetitive transient rises in 
cytoplasmic free calcium in hormone-stimulated hepatocytes. Nature (London) 319, 600-602.
119
WOODS, N.M., CUTHBERTSON, K.S.R. & COBBOLD, P.H. (1987a). Agonist-induced oscillations in 
cytoplasmic free calcium concentration in single rat hepatocytes. Cell Calcium 8, 79-100.
WOODS, N.M., CUTHBERTSON, K.S.R. & COBBOLD, P.H. (1987b). Phorbol-ester-induced alterations 
of free calcium ion transients in single rat hepatocytes. Biochemical Journal 246, 619-623.
WORLEY, P.F., BARABAN, J.M., SUPATTAPONE, S., WILSON, V.S. & SNYDER, S.H. (1987). 
Characterization of inositol trisphosphate receptor binding in brain: regulation by pH and calcium. 
Journal of Biological Chemistry 262,12132-12136.
YAMANISHI, J., TAKAI, Y., KAIBUCHI, K., SANO, K., CASTAGNA, M. & NISHIZUKA, Y. (1983). 
Synergistic functions of phorbol ester and Ca2+ in serotonin release from human platelets.
Biochemical and Biophysical Research Communications 112, 778-786.
Section B
PUBLICATIONS
Volume 213, number 1, 174-178 FEB 04494 March 1987
Possible involvement of prostaglandins in vasoconstriction 
induced by zymosan and arachidonic acid in the perfused
rat liver
Peter Dieter*, Joseph. G. Altin and Fyfe L. Bygrave
Department o f  Biochemistry, The Faculty o f  Science, Australian National University, Canberra, A C T  2600, Australia
Received 22 December 1986
Exposure of perfused livers to zymosan, arachidonic acid or phenylephrine but not to latex particles, stimu­
lates hepatic constriction. The effects of arachidonic acid are rapid, reach a maximum after 2-3 min and 
then decline. They are blocked by the cyclooxygenase inhibitor indomethacin but not by the lipoxygenase 
inhibitor nordihydroguaiaretic acid. This suggests a role for prostaglandins in this action. Zymosan progres­
sively increases hepatic pressure after a lag time of about 1 min. Perfusion of bromophenacyl bromide, indo­
methacin and nordihydroguaiaretic acid only partially inhibits the zymosan-induced vasoconstriction. None 
of these inhibitors affect the phenylephrine-induced response. Repeated infusion of arachidonic acid leads 
to homologous desensitization of the response whereas the response of the liver to phenylephrine is unaf­
fected. The present data indicate that prostaglandins, produced and released within the liver, affect vasocon­
striction in this organ.
Arachidonic acid; Latex particle; Prostaglandin; Vasoconstriction; (Perfused liver)
1. INTRODUCTION
It is known that blood flow through the hepatic 
vasculature can be regulated by constriction of the 
portal venules and by sinusoids [1-3]. 
Mechanisms, including those induced by hormones 
such as catecholamines, a -  and /^-adrenergic 
agonists, serotonin, dopamine, angiotensin and 
vasopressin are known to regulate the hepatic 
blood flow [4], The role of eicosanoids, which are 
known to be vasoactive in other systems [5], has 
not been investigated in the liver to any great ex­
tent. In 1939 Von Euler [6] showed that a crude 
prostaglandin preparation increases portal venous
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pressure in anesthetized cats. A vasodilatory action 
of PGE2 in the hepatic arterial vascular bed of the 
dog has been described [7], Later Mendlovic and 
co-workers [8] presented some evidence that the 
action of platelet-activating factor (PAF) on 
hepatic blood flow may be mediated by 
eicosanoids. However the origin of the eicosanoids 
remained totally unclear.
It is well established that the liver consists of 
several cell types with hepatocytes, endothelial 
cells, Kupffer cells and fat storing cells being the 
most predominant. Of these, the sinusoidal cells, 
namely the Kupffer and endothelial cells, are 
known to produce eicosanoids [9-11]. By contrast, 
the parenchymal cells appear to be involved more 
in the degradation rather than in the synthesis of 
eicosanoids [12,13].
Here, we have examined the vascular effects of 
phagocytosable material like zymosan and latex 
particles in perfused rat liver; these are known to 
interact rather selectively with Kupffer cells [14].
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TWe have also examined the vascular effects of 
arachidonic acid which is converted to eicosanoids 
by both Kupffer and endothelial cells [10,11]. The 
results described are consistent with the notion that 
prostaglandins are produced and released within 
the liver and that they mediate the vascular effect 
induced by zymosan and arachidonic acid.
2. EXPERIMENTAL
2.1. Animals and perfusion
Wistar-strain albino rats (250-350 g body wt) 
having free access to food were anaesthetized with 
sodium pentobarbitone (50 mg/kg). Livers were 
perfused with Krebs-Henseleit bicarbonate medi­
um [15] containing 1.3 mM CaCE and equilibrated 
with O2/CO 2 (19:1) in a flow-through mode as in 
C [16]. After a preperfusion of 15 min, stimuli 
were infused for the appropriate times. Any in­
hibitors tested were infused 15 min before the ad­
ministration of the stimuli and thereafter for the 
duration of the experiment.
2.2. Analytical procedures
Perfusate oxygen concentrations were con­
tinuously monitored with a Clark-type oxygen 
electrode as detailed [16]. Portal vein pressure, 
which can be used as an index of intrahepatic 
pressure or vasoconstriction [17,18], was deter­
mined by measuring the changes in the level of the 
perfusion buffer in an open glass capillar tube 
(4 mm 0 )  connected to the portal inflow. Basal 
portal perfusion pressure was 3.3 ± 0.3 mmHg. A 
difference of 10 mmHg was determined to corre­
spond to a change in flow rate of about 8 ml/min 
at constant pressure. The uptake of zymosan and 
latex particles by the liver was assessed by measur­
ing the differences in absorbances at 540 nm of the 
inflow and outflow media. Perfusion experiments 
shown are representative experiments that were 
selected from at least two to five experiments 
which gave essentially identical results.
2.3. Chemicals and materials
Zymosan, latex particles (1 pm  0 ) ,  arachidonic 
acid, phenylephrine, indomethacin, nordihydro- 
guaiaretic acid (NDGA), bovine serum albumin 
(fraction V), catalase and superoxide dismutase 
were obtained from Sigma (St. Louis, USA). 
Bromophenacyl bromide (BPB) was purchased
from Aldrich (Milwaukee, USA). All other 
chemicals were of analytical grade.
Zymosan suspensions were kept at 95°C for 
30 min to destroy endogenous phospholipase A2 
activity. Bovine serum albumin was made fatty 
acid-free as described [19]. Arachidonic acid was 
diluted in perfusion buffer containing 10% bovine 
serum albumin and sonicated for 2-3  min. NDGA 
was dissolved in DMSO and infused directly. In­
domethacin and BPB were dissolved in DMSO and 
slowly added to the perfusion buffer containing 
0.1 % bovine serum albumin. Perfusion with 
DMSO (final concentration 0.03%) or bovine 
serum albumin (0.1%) alone did not induce any 
change in hepatic pressure.
3. RESULTS
3.1. Effect o f  arachidonic acid, zymosan and latex 
particles on hepatic portal pressure
The change in hepatic portal pressure induced by 
infusion of arachidonic acid (100 /^M), zymosan 
(150/^g/min), latex particles (150/*g/min) and 
phenylephrine (2 /<M) into the perfused rat liver is 
shown in fig .l. Phenylephrine induces a rapid in­
crease in hepatic pressure which remains elevated 
until the hormone is removed and then declines 
very rapidly to the original level. The pressure 
changes induced by arachidonic acid during the
2 0  2 5  3
Perfusion Time (min)
Fig.l. Effects of phenylephrine, arachidonic acid, 
zymosan and latex particles on hepatic portal pressure. 
Rat livers were perfused for 10 min (arrowed) in the 
presence of 2 /*M phenylephrine ( a ), 100
arachidonic acid (■), lOO^g/min zymosan (•) and 
lOO^g/min latex particles (O). For further details see 
section 2.
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first 2-3 min of infusion are very similar to those 
induced by phenylephrine. However a notable dif­
ference is that the pressure increase induced by 
arachidonic acid decreases after about 3 min even 
though it is still being infused. The pressure then 
remains constant until the arachidonic acid is 
removed and then declines to the original level. 
Zymosan infusion leads to a significant increase in 
hepatic portal pressure after a lag period of 
0.5-1 min; thereafter the hepatic pressure in­
creases constantly up to 10 min of infusion. 
Removal of zymosan leads to a rapid decline in 
hepatic pressure, but in contrast to the removal of 
arachidonic acid and phenylephrine, the hepatic 
pressure does not return to its original level after 
the removal of zymosan. Although about 71 ± 12 
and 84 ± 5% of zymosan and latex particles, 
respectively, are taken up by the liver, no signifi­
cant pressure change was induced by the latter.
3.2. Effects o f various inhibitors on the 
arachidonic acid- and zymosan-induced 
change in hepatic portal pressure
To determine whether cyclooxygenase and/or 
lipoxygenase products are involved in the observed 
pressure changes, the livers were perfused with in­
hibitors of these enzymes prior to the addition of 
the stimuli. Perfusion with the inhibitors alone did 
not result in any significant change in pressure. 
Also the overall shape of the curves as shown in 
fig.l is not altered by preperfusion with the in­
hibitors (not shown). Fig.2a shows that the infu­
sion of BPB, a phospholipase A2 inhibitor [20], 
indomethacin, a cyclooxygenase inhibitor [21], 
NDGA, a lipoxygenase inhibitor [22], or the com­
bination of these two inhibitors, does not alter the 
pressure changes induced by phenylephrine. The 
changes in hepatic pressure induced by zymosan 
are inhibited to 40-50% by each of these com­
pounds (fig.2b). In contrast to its effects on 
zymosan, BPB does not inhibit the change in por­
tal pressure induced by arachidonic acid (fig.2c). 
However after the infusion of indomethacin, or in­
domethacin plus NDGA, arachidonic acid is no 
longer able to induce any change in hepatic 
pressure. NDGA alone, in contrast to in­
domethacin alone, produces a stimulatory effect 
on the hepatic pressure change induced by 
arachidonic acid (fig.2c).
Since it is known that zymosan also induces a
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Fig.2. Effect o f various inhibitors on the increase in 
hepatic portal pressure induced by phenylephrine (a), 
zymosan (b) and arachidonic acid (c). 100 n M BPB (B), 
1 0 indomethacin (C), 50 /xM NDGA (D) or 
indomethacin and NDGA together (D) were infused 
15 min prior to the infusion of the stimuli and thereafter 
for the duration of the experiment. A represents the 
maximal response induced by the stimuli alone as in 
fig .l. 100% corresponds to a maximal portal pressure 
change of 2.2, 5.1 and 3.0 mmHg/10 g liver induced by 
phenylephrine, zymosan and arachidonic acid, 
respectively. Values are means ± SE for 2 -4  
experiments. For further details see section 2.
release of superoxide in cultured Kupffer cells 
[10,23] we attempted to assess whether this anion 
is involved in the zymosan-induced pressure 
changes. In these experiments, superoxide 
dismutase (50 U/min) and catalase (50 U/min), 
which together convert 0 2 into 0 2 and H20 , were 
infused 2 min prior to and together with zymosan. 
No significant change in the zymosan-induced 
pressure increase was observed suggesting that 
superoxide anions are not involved in this action of 
zymosan.
3.3. Effect o f repeated administrations o f 
phenylephrine, zymosan and arachidonic acid 
on the hepatic portal pressure 
The results in fig.2 suggest that the mechanisms 
by which phenylephrine, zymosan and arachidonic 
acid induce hepatic vasoconstriction may be dif­
ferent. To assess this, repeated infusions with 
phenylephrine, arachidonic acid and zymosan were
176
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P e r f u s i o n  T i m e  ( m i n )
Fig.3. Effect of repeated infusions of phenylephrine, 
arachidonic acid and zymosan on the hepatic portal 
pressure. Phenylephrine, zymosan and arachidonic acid 
were infused initially for 5 min in a, b, c respectively 
(thin arrow); corresponding responses: ( A)  phenyl­
ephrine, (•) zymosan, (■) arachidonic acid. At 30 min 
either the same agent, or one of the other two agents (as 
indicated), was infused for a further 5 min (thick 
arrow). For further details see section 2.
carried out. For these experiments one of these 
agents was infused for 5 min and subsequently 
either the same or one of the other two agents was 
infused for 5 min after an intervening recovery 
period of 10 min. Fig.3a shows that the initial in­
fusion with phenylephrine does not alter the 
hepatic portal pressure increase induced by a 
subsequent infusion of phenylephrine, arachidonic 
acid or zymosan. When zymosan is infused first, 
the subsequent phenylephrine-induced change in 
portal pressure is not altered. Moreover the change 
in hepatic pressure induced by a subsequent infu­
sion with zymosan or arachidonic acid, is inhibited 
by 25-35 and 40-60%, respectively (fig.3b). An 
initial infusion with arachidonic acid also does not 
lead to a change in the response induced by a 
subsequent infusion of phenylephrine (fig.3c). 
However almost no change in portal pressure can 
be measured after a subsequent infusion of 
arachidonic acid, whereas the response induced by 
a subsequent infusion of zymosan is inhibited by 
40-60% (fig.3c).
4. DISCUSSION
Infusion of zymosan and arachidonic acid into 
rat liver produces an increase in portal vein 
pressure. Since it has been shown that portal vein 
pressure is directly related to hepatic constriction 
[15,16], these results suggest that zymosan and 
arachidonic acid induce constriction of the hepatic 
vasculature. Our results also suggest that the 
mechanism of action of these agents is most 
probably different from that induced by a'-adre- 
nergic agonists like phenylephrine. In contrast to 
the zymosan- and arachidonic acid-induced in­
crease in portal pressure, the increase in pressure 
induced by phenylephrine is not affected by the in­
hibitors BPB, indomethacin and NDGA (fig.2). 
Repeated infusions of phenylephrine result in the 
pressure changes also being repeated, whereas 
those induced by subsequent infusions with zymo­
san and arachidonic acid show marked desensitiza­
tion (fig.3).
The ability of indomethacin to block almost 
totally the arachidonic acid-induced response sug­
gests a role for prostaglandins in this action. This 
assumption is strongly strengthened by the fact 
that administration of NDGA, a lipoxygenase in­
hibitor, led to an increase in the arachidonic acid- 
induced pressure change. Arachidonic acid itself 
seems to be vasoinactive since in the presence of in­
domethacin almost no pressure change could be 
observed during infusion with arachidonic acid 
alone.
In contrast to the arachidonic acid-induced in­
crease in portal pressure, that induced by zymosan 
is only partially inhibited by indomethacin, but is 
inhibited to about the same extent by BPB and 
NDGA (fig.2). This suggests that only a part of the 
pressure change induced by zymosan is mediated 
by eicosanoids. The other part may be due to a 
direct effect of zymosan on the perfusion flow 
and/or to a shape change of the Kupffer cells 
which is known to occur after phagocytosis of 
zymosan [14].
These data thus suggest a role of prostaglandins 
in the action of zymosan and arachidonic acid. 
However the origin of the prostaglandins remains 
to be clarified. We suggest that zymosan and 
arachidonic acid act primarily in Kupffer cells and 
endothelial cells. These cells would release pros­
taglandins after contact with these agents which in
177
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turn would react with the hepatic vasculature in­
ducing the observed pressure changes. The follow­
ing findings are in agreement with this hypothesis: 
(i) Cultured Kupffer cells and endothelial cells are 
able to release eicosanoids after contact with 
zymosan or with arachidonic acid [9-11]. (ii) 
Supernatant fractions of zymosan-stimulated 
Kupffer cells are able to contract rabbit femoral 
arteries [13]. (iii) In contrast to Kupffer cells and 
endothelial cells, hepatocytes seem to be more in­
volved in the degradation rather than in the syn­
thesis and release of eicosanoids [12,13]. (iv) 
Zymosan and latex particles (^0.8 fiM) are selec­
tively taken up by Kupffer cells [14]. (v) Latex par­
ticles which were vasoinactive (fig. 1) also do not 
lead to a pronounced release of eicosanoids in 
cultured Kupffer cells (Dieter, P., unpublished), 
although they are taken up by the liver and Kupf­
fer cells [10,14]. (vi) Prostaglandins directly in­
fused into the liver show vasoactivity [6,7]. Further 
investigations are required to establish which 
prostaglandins mediate the vasoconstriction in­
duced by zymosan and arachidonic acid.
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Possible involvement of eicosanoids in the zymosan and arachidonic acid-induce 
oxygen uptake, glycogenolysis and Ca2+ mobilization in the perfused rat liver.
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Possible involvement of eicosanoids in the zymosan
and arachidonic-acid-induced oxygen uptake, glycogenolysis
and Ca2 + mobilization in the perfused rat liver
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Exposure of perfused rat livers to zymosan, arachidonic acid and phenylephrine, but not to latex particles, 
induces pronounced oxygen uptake, glycogenolysis and Ca2+ mobilization. The oxygen uptake induced by 
arachidonic acid and by zymosan remains elevated even after the agents have been removed. NaN3 was found to 
be much more effective in inhibiting the oxygen uptake induced by phenylephrine than that induced by zymosan 
or arachidonic acid.
Glucose release induced by zymosan and by arachidonic acid reaches a maximum after about 2 min and then 
declines very rapidly even while the agents are still being infused. In contrast, glucose release induced by 
phenylephrine remains elevated for the duration of the infusion.
Ca2+ fluxes induced by arachidonic acid are similar to those induced by phenylephrine in that efflux occurs 
when the agent is administered and influx occurs only when the agent is removed. This contrasts to the Ca2+ flux 
changes induced by zymosan where both Ca2+ efflux and Ca2+ influx occur even while zymosan is still being 
infused.
Glucose release induced by zymosan is inhibited by bromophenacylbromide and nordihydroguaiaretic acid, 
but not by indomethacin. Indomethacin, however inhibits the arachidonic-acid-induced glucose release which is 
also inhibited by nordihydroguaiaretic acid but not by bromophenacylbromide. Indomethacin inhibits also the 
arachidonic-acid-induced Ca2+ flux changes whereas the zymosan- and the phenylephrine-induced Ca2+ flux 
changes are not inhibited by the cyclooxygenase inhibitor.
The data presented in this paper suggest that in the perfused rat liver the zymosan-induced glycogenolysis, as 
well as the Ca2+ flux changes and glycogenolysis induced by arachidonic acid, are mediated by eicosanoids.
It is well established that the liver consists of several cell 
types. The most predominant are hepatocytes, endothelial 
cells, Kupffer cells and fat-storing cells. Of these, only 
(cultured) Kupffer and endothelial cells reportedly are able to 
produce eicosanoids [1—3], Endothelial cells can synthesise 
and release eicosanoids from exogenously added arachidonic 
acid but not after treatment with zymosan [3]. Kupffer cells 
on the other hand respond to both agents by releasing 
eicosanoids [2], In contrast to these sinusoidal cells, paren­
chymal cells as hepatocytes seem to be more involved in the 
degradation rather than in the synthesis of eicosanoids 
[4-6],
There is evidence for the existence of individual and mul­
tiple receptors for different eicosanoids on eukaryotic mem-
Correspondence to P. Dieter, Biochemisches Institut, Albert- 
Ludwigs Universität, Hermann Herder Straße 7, D-7800 Freiburg, 
Federal Republic of Germany
Abbreviations. NDGA, nordihydroguaiaretic acid; Me2S 0 4, 
dimethylsulfoxide.
Enzymes. Catalase or hydrogen-peroxide oxidoreductase (EC 
1.11.1.6); cyclooxygenase or arachidonate:oxygen oxidoreductase 
(cyclizing) (EC 1.14.99. — ); lipoxygenase or arachidonate:oxygen 
oxidoreductase (EC 1.13.11. —); phospholipase A 2 or phosphatidyl­
choline 2-acylhydrolase (EC 3.1.1.4); superoxide dismutase or 
superoxide:superoxide oxidoreductase (EC 1.15.1.1).
branes including those of hepatocytes [7 — 9]. It has been re­
ported also that eicosanoids are able to induce cellular Ca2 + 
movements in different eucaryotic cells [10—12],
In this paper we have examined the effect of 
phagocytosable material like zymosan and latex particles on 
oxygen uptake, glycogenolysis and Ca2+ flux changes in the 
perfused rat liver; these particles are known to be taken up 
rather selectively by Kupffer cells [13]. As well, we have ex­
amined the effect of arachidonic acid on oxygen uptake, 
glycogenolysis and Ca2+ flux changes.
EXPERIMENTAL PROCEDURES 
Animals and perfusion
Wistar-strain albino rats (250 — 350 g body wt) having free 
access to food were anaesthetized with sodium pentobarbitone 
(50 mg/kg). Livers were perfused with Krebs-Henseleit bi­
carbonate medium [14] containing 1.3 mM CaCl2 and 
equilibrated with 0 2/C 02 (19:1) in a flow-through mode as 
in [15]. After a pre-perfusion period of 15 min, stimuli were 
infused by an infusion syringe for the appropriate times. Any 
inhibitors tested were administered 15 min before the infusion 
of any stimuli and thereafter continued for the duration of 
the experiment.
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Analytical procedures
Perfusate oxygen concentrations were continuously 
monitored with a Clark-type oxygen electrode as detailed [15]. 
Glucose release by the liver was determined by the glucose 
oxidase/peroxidase method as previously described [15]. The 
perfusate Ca2+ concentration was continuously monitored 
exactly as in [16]. The uptake of zymosan and latex particles 
by the liver was assessed by the difference in the absorbance 
at 540 nm of the outflow and the inflow media. Perfusate 
experiments shown are representive from at least three which 
gave essentially identical results.
Chemicals and materials
Zymosan (cell wall particles from yeast), latex particles 
(1-pm diameter), arachidonic acid, phenylephrine, indo- 
methacin, NDGA, salicylic acid, bovine serum albumin 
(fraction V), catalase, superoxide dismutase and the glucose 
assay kit were obtained from Sigma (St. Louis, USA). 
Bromphenacylbromide was purchased from Aldrich 
Chemical Company, Inc. (Milwaukee, USA). All other 
chemicals were of analytical grade.
Zymosan suspensions were kept at 95 °C for 30 min to 
destroy endogenous phospholipase A2 activity. Bovine serum 
albumin was made fatty-acid-free as described [17]. 
Arachidonic acid was diluted in perfusion buffer containing 
10% bovine serum albumin and sonicated for 2 —3 min. 
NDGA was dissolved in Me2SO and administered by infusion 
syringe. Indomethacin and bromophenacylbromide were dis­
solved in Me2S 04 and slowly added to the perfusion buffer 
containing 0.1% bovine serum albumin. All other agents were 
directly dissolved in perfusion buffer. Perfusion with Me2S 0 4 
(final concentration 0.03%) or bovine serum albumin (0.1%) 
did not induce any significant changes in oxygen uptake, 
glucose release and perfusate Ca2+ concentrations.
RESULTS
Preliminary experiments indicated that a concentration of 
150 pg/ml of zymosan infused into the perfused rat liver elicits 
near-maximal responses. Half-maximal effect was obtained 
with about 20 pg/ml whereas no effect was obtained with a 
zymosan concentration of less than 2 pg/ml. Although higher 
concentrations of arachidonic acid induced larger effects, 
a concentration of 100 pM was used in all experiments. 
Quantitative comparisons between the zymosan- and the 
arachidonic-acid-induced responses were not carried out. In­
fusion with zymosan or latex particles did not induce any 
release of the cytoplasmic enzyme lactate dehydrogenase into 
the perfusate. Similarly no loss of lactate dehydrogenase activ­
ity occurred in homogenates from livers treated with these two 
agents. This indicated that the liver cells were not damaged by 
the infusion of these agents.
Effect o f arachidonic acid, zymosan and latex particles 
on oxygen uptake in the perfused rat liver
Fig. 1 shows the oxygen uptake induced by the infusion of 
zymosan, latex particles, arachidonic acid and phenylephrine 
into the perfused rat liver. Although monitoring of the 
absorbance of the perfusate medium indicated that 71 ±  12% 
and 84 + 5% of zymosan and latex particles, respectively, 
were taken up by the liver, only zymosan was found to induce 
a pronounced oxygen uptake. Even at 10-fold higher concen-
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Fig. 1. Effect o f phenylephrine, zymosan, latex particles and 
arachidonic acid on oxygen consumption in the perfused rat liver. Livers 
were perfused exactly as described in Experimental Procedures. Where
indicated (arrowed) 2 pM phenylephrine (--------), 150 pg/ml zymosan
(---------), 150 pg/ml latex particles (--------), 100 pM arachidonic acid
(.......) were infused for 5 min and the consumption of oxygen continu­
ously monitored
trations, the latex particles did not induce a more pronounced 
oxygen uptake (data not shown). The stimulation of oxygen 
uptake induced by zymosan took place after a lag period of 
0.5 — 1 min and then increased almost constantly during the 
time of zymosan infusion. The stimulation of oxygen uptake 
by arachidonic acid was more rapid than that of zymosan; 
after about 1—2 min of arachidonic acid infusion an elevated 
plateau was reached which remained constant until the 
arachidonic acid was removed. After the removal of either 
zymosan or arachidonic acid the oxygen consumption de­
creased slowly, but in each instance did not decline to the pre­
stimulated value even 30 min after removing the agents (data 
not shown). This contrasts significantly with the oxygen 
uptake induced by phenylephrine which returned rapidly to 
the original value immediately after removal of the hormone.
NaN3, an inhibitor of the mitochondrial respiratory chain 
was used to differentiate between mitochondrial and non- 
mitochondrial oxygen uptake. Fig. 2 shows that a pre­
perfusion with NaN3 (5 mM) almost completely inhibited the 
phenylephrine-induced response. In contrast the zymosan- 
and arachidonic acid-induced oxygen uptake was inhibited by 
only about 15 ±  5% and 35 ±  5%, respectively, indicating that 
a large component of the oxygen uptake is non-mitochondrial.
Effect o f arachidonic acid, zymosan and latex particles 
on glucose release in the perfused rat liver
Because it is known that zymosan and arachidonic acid, 
but not latex particles, induce a release of eicosanoids from 
liver sinusoidal cells [2] (and P. Dieter, unpublished data), the 
effect of these agents on the release of glucose in the perfused 
rat liver was investigated. Fig. 3 shows that infusion of 
zymosan stimulated glucose release. Following a lag period 
of about 1 — 1.5 min, the glucose release induced by zymosan 
reached a maximum after about 3 min of zymosan infusion 
and thereafter declined very rapidly even when zymosan was
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Fig. 2. Effect o f NaN3 on oxygen consumption in the perfused rat liver 
induced by phenylephrine (Phe), zymosan (Zy)  and arachidonic acid 
( AA) .  5 mM N aN 3 (hatched blocks) was infused from 5 min prior to 
the addition of the stimuli until the end of the experiment. The stimuli 
were infused for 5 min as in Fig. 1. Values are means ±  SE of three 
experiments. The peak of the curve (cf. Fig. 1) was determined as the 
maximal oxygen consumption
Per f us i on  Time (min)
Fig. 3. Glucose release induced by phenylephrine, zymosan, latex 
particles and arachidonic acid in the perfused rat liver. The experimental 
procedure was exactly as in Fig. 1.2 pM phenylephrine (■ ) , 150 pg/ml 
zymosan ( • ) ,  150 pg/ml latex particles (O ) or 100 pM arachidonic 
acid (□ )  were infused for 5 min as indicated (arrowed) and glucose 
measured in aliquots of the perfusate collected at the times indicated. 
The basal glucose release corresponding to the value of 0 was around 
1.5 pmol/g x min
still being infused. Although the onset of the glucose release 
was more rapid with arachidonic acid than with zymosan, a 
similar response was obtained with arachidonic acid. If both 
zymosan and arachidonic acid were infused for a further 
10 min, the decline in the glucose release was about the same 
as shown in Fig. 3 (data not shown). Latex particles had only 
a very small effect on glycogenolysis, even at 10-fold higher 
concentrations (data not shown). In contrast to the glucose 
release induced by zymosan and arachidonic acid, the 
phenylephrine-induced glucose release remained elevated 
during the time of phenylephrine infusion. Only after removal 
of the hormone did the rate of glucose output decrease 
towards the prestimulated value.
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Fig. 4. Effect o f phenylephrine, zymosan, latex particles and 
arachidonic acid on the perfusate Ca2+ concentration. The ex­
perimental procedure was exactly as described in Fig. 1. 2 pM
phenylephrine (--------), 150 pg/ml zymosan (---------), 150 pg/ml latex
particles (------- ) or 100 pM arachidonic acid (....... ) were infused for
5 min as indicated (arrowed) and the concentration of Ca2+ in the 
perfusate continuously monitored with the Ca2 +-selective electrode
Effect o f arachidonic acid, zymosan and latex particles 
on the perfusate Ca2 + concentration
Since it has been shown that glucose release can be 
mediated by Ca2+ [18], and since it has been reported that 
eicosanoids are able to induce cellular Ca2+ mobilization in 
several eukaryotic cells [10 — 12], it seemed relevant to study 
the effects of latex particles, arachidonic acid and zymosan 
on the perfusate Ca2+ concentration. As in the experiments 
measuring oxygen uptake and glucose release, latex particles 
did not lead to a pronounced change also in the perfusate 
Ca2+ concentration (Fig. 4). Arachidonic acid infusion how­
ever led to a rapid onset of Ca2+ efflux which thereafter 
declined and was no longer detectable after about 2 — 3 min. 
After removal of arachidonic acid, a similar amount of Ca2 + 
was taken up by the liver. Similar to phenylephrine, there was 
almost no change in the total amount of Ca2 + in the liver since 
the amount of Ca2+ released from the liver (89 ±  5 nmol/g) 
and the amount of Ca2+ taken up by the liver (75 ± 8 nmol/ 
g) were about the same. It can be seen also in Fig. 4 that the 
Ca2+ flux changes induced by zymosan differed from those 
induced by phenylephrine and arachidonic acid. The onset of 
the response after zymosan infusion took place after a lag 
period of about 1 min. Thereafter there was an initial Ca2 + 
efflux followed by a spontaneous Ca2+ influx even while 
zymosan was still being administered. After removal of 
zymosan, Ca2+ was released by the liver. This again is in 
contrast to phenylephrine and arachidonic acid where Ca2 + 
was taken up by the liver only after removal of the agents. 
Flowever, similar to the actions of phenylephrine and 
arachidonic acid, zymosan did not lead to a change in the 
total amount of Ca2+ in the liver; 51 + 18 nmol Ca2 + /g liver 
were released in the First peak, which was followed by a Ca2 + 
uptake of 172 + 32 nmol/g liver and by a second release of 
Ca2 + of 114 + 24 nmol/g liver.
Effect o f various inhibitors on glucose release and Ca2+ flux 
changes induced by zymosan and arachidonic acid
Because zymosan and arachidonic acid induce eicosanoid pro­
duction in liver sinusoidal cells [1 —3], it seemed relevant to 
determine whether cyclooxygenase and/or lipoxygenase prod-
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Fig. 5. Effect o f various inhibitors on the glucose release induced by 
phenylephrine (a), zymosan (b) and arachidonic acid (c) in the perfused 
rat liver. The experiments were carried out as in Fig. 3 but 100 pM 
bromophenacylbromide (B), 10 pM indomethacin (C), 50 pM NDGA 
(D) or indomethacin and NDGA together (E) were infused 15 min 
prior to the addition of the stimuli and thereafter throughout the 
experiment. (A) The peak of glucose release induced by the stimuli. 
100% corresponds to a glucose release of 2.7, 3.6, and 2.5 pmol/ 
g x min for phenylephrine, zymosan and arachidonic acid, respective­
ly. Values are means + SE of three to six experiments
ucts are involved in the observed zymosan- and arachidonic 
acid-induced responses. For these experiments, livers were 
perfused for 15 min prior to the addition of the agents with 
100 pM bromophenacylbromide (a phospholipase A2 in­
hibitor [19]), with 10 pM indomethacin (a cyclooxygenase 
inhibitor [20]) or with 50 pM NDGA (a lipoxygenase inhibitor 
[21]).
Since the administration of bromophenacylbromide or 
NDGA alone resulted in a stimulation of oxygen consumption 
by the liver, quantitative studies on the effect of these inhibi­
tors on oxygen uptake could not be made. Also a transient 
stimulation of glucose release was observed following the 
administration of each of these inhibitors but the original level 
of glucose release was reached 5 — 10 min before infusion of 
the stimuli. In contrast to bromophenacylbromide and 
N DG A, the infusion of indomethacin did not cause a stimula­
tion of oxygen uptake or glucose release by the liver. However, 
the preadministration of indomethacin inhibited the oxygen 
consumption following the infusion of zymosan and 
arachidonic acid by about 60 — 80% (data not shown).
None of the inhibitors was found to have any significant 
effect on the glucose release induced by phenylephrine 
(Fig. 5 a). The zymosan-induced glucose release was inhibited 
by 75 ± 10% by bromophenacylbromide and NDGA 
(Fig. 5 b). Indomethacin had no significant effect on the 
zymosan-induced glucose release (Fig. 5 b), even at a concen­
tration of 100 pM (data not shown). Glucose release induced 
by arachidonic acid however, was inhibited by 85 ± 6%. The 
magnitude of inhibition of the arachidonic acid-induced 
glucose release with NDGA was about the same as with 
indomethacin, whereas bromophenacylbromide had no sig­
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Fig. 6. Effect o f indomethacin on the Ca2+ response induced by 
phenylephrine (a), zymosan (b) and arachidonic acid (c) in the perfused 
rat liver. The experiments were carried out as in Fig. 4 but either no
(------- ) or 10 pM indomethacin (------- ) was infused 15 min prior to
the addition of the stimuli and then throughout the experiment. 
The stimuli were infused for 5 min as indicated (arrowed) and the 
concentration of Ca2+ in the perfusate continously monitored with 
the Ca2 +-selective electrode
nificant effect on this response (Fig. 5c). The combination of 
both indomethacin and NDGA resulted in a more pro­
nounced inhibition for both the zymosan- and the arachidonic 
acid-induced responses (Fig. 5b and 5c). Aspirin (500 pM) 
had very similar effects to indomethacin, although the inhibi­
tion of the arachidonic-acid-induced glucose release was less 
pronounced (data not shown).
The effect of a 15-min preperfusion with indomethacin on 
the Ca2+ flux changes induced by phenylephrine, zymosan 
and arachidonic acid is shown in Fig. 6. It can be seen that 
indomethacin did not affect the Ca2+ response induced by 
phenylephrine (Fig. 6a). However the Ca2+ response induced 
by arachidonic acid was almost completely inhibited (Fig. 6c). 
By contrast, indomethacin was found to stimulate rather than 
to inhibit Ca2+ efflux induced by zymosan. An inhibitory 
effect of indomethacin was seen only on the zymosan-induced 
Ca2+ influx and on the Ca2+ efflux which followed after 
removal of zymosan (Fig. 6 b). The Ca2+ responses induced 
by zymosan, arachidonic acid, phenylephrine and also by 
vasopressin were inhibited by about 50% by bromophenacyl­
bromide and NDGA (data not shown). However, since an 
involvement of eicosanoids in the two latter reactions has not 
been demonstrated, a nonspecific effect of the two inhibitors 
on the Ca2+ flux changes cannot be eliminated.
As it is known that zymosan also induces a release of 
superoxide in cultured Kupffer cells [2, 22], we attempted to 
assess whether this anion is involved in the zymosan-induced 
glucose release. In these experiments, superoxide dismutase 
(50 units/min) and catalase (50 units/min) were infused 2 min 
prior and together with zymosan. No significant change in 
glucose release was observed suggesting that superoxide 
anions are not involved in this reaction.
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DISCUSSION
This paper reveals that the administration of zymosan and 
arachidonic acid, but not latex particles, leads to a stimulation 
of oxygen uptake, glucose release and Ca2 + flux changes in the 
perfused rat liver. Furthermore, inhibitors of the arachidonate 
cascade were found to prevent glucose release induced by 
zymosan, as well as the glucose release and the Ca2+ flux 
changes induced by arachidonic acid. These results suggest 
that eicosanoids may be involved in mediating these reactions. 
The fact that the phenylephrine-induced responses were 
unaffected by these inhibitors implies that in the perfused rat 
liver the mechanism of action of phenylephrine is different 
from that of arachidonic acid and zymosan in inducing the 
above-mentioned responses.
Since it has been reported that zymosan is taken up rather 
selectively by Kupffer cells [13] and that both zymosan and 
arachidonic acid are able to induce the release of eicosanoids 
in sinusoidal cells [2, 3], we suggest that in the present system 
(i.e. liver) these cells would release eicosanoids after contact 
with these agents. The released eicosanoids in turn would 
then react with hepatocytes and thereby induce the observed 
responses. The following Findings reported elsewhere are in 
agreement with this hypothesis, (a) In contrast to Kupffer and 
endothelial cells, hepatocytes seem to be involved more in 
the degradation rather than in the synthesis and release of 
eicosanoids [4 — 6], In fact, no eicosanoid release is observed 
after treatment of cultured hepatocytes with zymosan or 
arachidonic acid (T.A. Tran-Thi, personal communication), 
(b) There is evidence for individual and multiple receptors for 
different eicosanoids in eukaryotic cells including hepatocytes 
[7 — 9], (c) It has been shown that eicosanoids are able to 
induce cellular Ca2+ movements in several eucaryotic cells 
[10 — 12]. The following results presented in this paper with 
the perfused liver provide further support for this hypothesis. 
First, bromophenacylbromide and NDGA, but not indo- 
methacin inhibited the zymosan-induced glucose release 
(Fig. 5 b) and the zymosan-induced Ca2+ flux changes 
(Fig. 6 b). This suggests a role for lipoxygenase products in 
the mechanism of action of zymosan. However, since bromo­
phenacylbromide and NDGA also affected the Ca2 + response 
induced by phenylephrine or vasopressin, we cannot rule out 
a possible effect of these inhibitors on sites other than the 
arachidonate cascade. In contrast to bromophenacylbromide 
and NDGA, indomethacin had no effect on the Ca2 + response 
induced by phenylephrine (Fig. 6a) or vasopressin. However 
indomethacin inhibited glucose release (Fig. 5c) and the Ca2 + 
flux changes (Fig. 6c) induced by arachidonic acid. The fact 
that these responses are almost totally blocked by in­
domethacin suggests that arachidonic acid itself is inactive and 
that the observed responses are induced by cyclooxygenase 
products. This is in contrast to the arachidonic-acid-induced 
Ca2+ release from pancreatic islets which is reported to be 
induced by arachidonic acid and not by metabolites of 
arachidonic acid [23]. The second Finding consistent with the 
hypothesis is the inability of the latex particles to induce any 
response in the perfused liver (Figs 1, 3 and 4), a Finding that 
most likely reflects the inability of these particles to induce a 
pronounced release of eicosanoids in cultured Kupffer cells 
(P. Dieter, unpublished data). Last, the substantial NaN3- 
insensitive component of the oxygen consumption induced by 
zymosan and arachidonic acid (Fig. 2) is also suggestive of 
the formation of superoxide and eicosanoids. This suggestion 
is consistent with the fact that in cultured Kupffer cells NaN3 
does not affect the zymosan-induced release of superoxide
[22] or the zymosan-induced release of eicosanoids (P. Dieter, 
unpublished data).
After this work was completed we became aware of a very 
recent report [24] in which it is suggested that the metabolic 
effects of zymosan in the perfused rat liver are mediated by 
platelet-activating factor. The following Findings, however, 
argue against this proposal. First, we have shown in this paper 
that indomethacin does not inhibit the responses induced by 
zymosan. Second, the data of Mendlovic and coworkers [25] 
show that the vasoconstriction and glycogenolysis induced by 
platelet-activating factor in perfused rat liver are inhibited by 
indomethacin and bromophenacylbromide. Third, we have 
shown additionally that indomethacin also inhibits Ca2+ flux 
changes induced by platelet-activating factor [26].
At the moment it remains unclear, however, why the Ca2 ' 
flux changes induced by zymosan and arachidonic acid are 
different (cf. Figs 4 and 6). It is possible that these differences 
arise as a consequence of these agents acting on different 
target cells within the liver. As already mentioned, zymosan 
is known to interact most selectively with Kupffer cells [13] 
whereas exogenously added arachidonic acid can be converted 
to eicosanoids by Kupffer and endothelial cells [2, 3], Further­
more it has been shown recently that both cell types are able 
to release a different spectrum of eicosanoids [3, 5] which may 
in turn have different effects on hepatocytes. Further studies 
will be necessary to establish which eicosanoids are involved 
in glucose release and Ca2+ flux changes induced by zymosan 
and arachidonic acid in the perfused rat liver.
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Evidence that Ca2+ fluxes and respiratory, glycogenolytic and 
vasoconstrictive effects induced by the action of platelet-activating 
factor and L-a-lysophosphatidylcholine in the perfused rat liver 
are mediated by products of the cyclo-oxygenase pathway
Joseph G. ALTIN,* Peter DIETERf and Fyfe L. BYGRAVE*
*Department of Biochemistry, Faculty of Science, The Australian National University, Canberra, A.C.T. 2601, Australia, and 
fBiochemisches Institut, Albert-Ludwigs Universität, Hermann Herder Strasse 7, D-7800 Freiburg, West Germany
The administration o f 1 acetylglyceryl ether phosphorylcholine’ (AGEPC, also known as platelet-activating 
factor) and L-a-lysophosphatidylcholine (LPC) to rat livers perfused with media containing 1.3 mM-Ca2+ 
was followed by a concentration-dependent efflux of Ca2+ from the liver. Near-maximal response was 
observed at 100 nM-AGEPC and 50 /im-LPC, and resulted in a net efflux of approx. 130 nmol of Ca2+/g 
of liver. Onset of Ca2+ efflux occurred about 10 s after AGEPC and LPC administration, reached a 
maximum after about 50 s (the maximum rate of efflux was approx. 180 nmol/min per g) and thereafter 
decreased rapidly, and was sometimes followed by a much smaller influx of Ca2+. Sequential infusions of 
AGEPC or LPC, and phenylephrine, indicate that each of these agents mobilizes Ca2+ from the same 
intracellular source. The efflux of Ca2+ was not observed in the presence of indomethacin or bromophenacyl 
bromide, or when the liver was perfused with low-Ca2+-containing (25 jum) media. Other physiological 
responses, such as changes in respiration, glucose output and portal pressure, were also inhibited under these 
conditions. The results suggest that the Ca2+-flux changes and other responses are mediated by prostaglandins 
produced and released within the liver, possibly by cell types other than hepatocytes.
INTRODUCTION
Apart from its established role in mediating in­
flammatory and allergic reactions, the phosphoglyceride 
AGEPC (platelet-activating factor) has been shown to 
have powerful effects on liver metabolism. In particular 
it has been reported that AGEPC elicits marked changes 
in vasoconstriction, oxygen consumption and glyco- 
genolysis in the perfused rat liver (Shukla et al., 1983; 
Buxton et al., 1984, 1986; Fisher et al., 1986). Although 
these effects of AGEPC on liver have been well 
characterized the mechanism by which such actions are 
mediated is not known. Of especial relevance are the 
findings that AGEPC does not elicit any respiratory 
and glycogenolytic effect in isolated hepatocytes (Fisher 
et al., 1984). Although the reason for this is not clear, 
Buxton et al. (1986) and Fisher et al. (1986) have 
suggested that the respiratory and glycogenolytic 
responses in the perfused liver are secondary effects 
brought about by vasoconstriction of the vasculature 
system within the liver, and consequently a decreased 
oxygen supply to heptocytes. This conclusion was partly 
based on a previous finding by these workers that the 
actions of AGEPC do not involve Ca2+-flux movements 
in hepatocytes or the perfused liver, and hence that 
AGEPC induces glycogenolysis by a mechanism different 
from that of the Ca2+-mobilizing agents (Fisher et al., 
1984; Buxton et al., 1984).
In view of reports that AGEPC can lead to an increase 
in the cytosolic Ca2+ concentration in platelets (Hallam 
et al., 1984), and can influence 45Ca2+ movements in
cultured vascular endothelial cells (Brock & Gimbrone, 
1986), and since the action of AGEPC has been shown 
to be dependent on extracellular Ca2+ (Buxton et al., 
1984, 1986), it seemed important to re-examine the issue 
of the action of AGEPC on whole-liver Ca2+-flux 
changes. In this work we have used a Ca2+-selective 
electrode to study the effects of AGEPC and lysophos- 
phatidylcholine (LPC) administration on Ca2+ changes 
in the perfused rat liver. We also examined the effects 
of indomethacin (an inhibitor of cyclo-oxygenase) and 
bromophenacyl bromide (BPB, an inhibitor of phospho­
lipase A2) on the responses induced by AGEPC and LPC. 
We find that AGEPC and LPC each induce significant 
net Ca2+-flux changes, and that these changes, together 
with the physiological responses of respiration, vaso­
constriction and glycogenolysis, are all significantly 
inhibited by these inhibitors. These data provide strong 
evidence that cyclo-oxygenase products may be involved 
in mediating Ca2+-flux changes and associated physio­
logical responses by these agents.
METHODS
Male Wistar strain rats weighing 280-350 g and 
having free access to food were used for all experiments. 
The rats were anaesthetized with sodium pentobarbitone 
(50 mg/kg body wt.), and the livers were perfused at a 
flow rate of 35 ml/min with Krebs-Henseleit (1932) 
bicarbonate buffer containing 1.3mM-CaCl2 as des­
cribed in Reinhart et al. (1982). Measurement of
Abbreviations used: AGEPC, ‘acetylglyceryl ether phosphorylcholine’ (l-0-hexadecyl-2-acetyl-.vn-glycero-3-phosphocholine, platelet-activating 
factor); LPC, lysophosphatidylcholine; BPB, bromophenacyl bromide.
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perfusate Ca2+, oxygen and glucose concentrations was 
carried out exactly as described by Reinhart et al. (1982) 
and Altin & Bygrave (1985). Hepatic vasoconstriction 
was determined by measuring the portal pressure as 
reflected by the level of buffer in an open capillary (4 mm 
diameter) at the inflow to the liver. The basal portal 
pressure was 3.5±0.3 mmHg; in this system an increase 
in pressure of 10 mmHg corresponded to a decrease in 
flow rate of approx. 13.7 ml/min at constant pressure. 
Stock solutions of AGEPC (0.7 mM) and LPC (17.5 mM) 
were made up in Krebs-Henseleit buffer containing 10% 
(w/v) fatty acid-free bovine serum albumin, and were 
infused into the portal vein at the appropriate rates by 
pump-driven infusion syringe. Indomethacin and BPB 
were dissolved in dimethyl sulphoxide and then admin­
istered by addition to the perfusion medium containing 
0.1% albumin. The final concentration of dimethyl sul­
phoxide was < 0.02%. Under these conditions neither 
dimethyl sulphoxide nor albumin had any significant 
effect on the action of the agents being studied.
AGEPC (1 -0-hexauecy 1-2-acetyl-s/i-glycero-3- 
phosphocholine), L-a-LPC (type I, from egg yolk), 
L-a-lysophosphatidylethanolamine (type I from egg 
yolk), L-a-phosphatidylcholine (type III-E from egg 
yolk), synthetic L-a-LPC (palmitoyl and stearoyl forms), 
phenylephrine and indomethacin were all obtained from 
Sigma Chemical Co., St. Louis, MO, U.S.A. BPB was 
obtained from Aldrich Chemical Co., Milwaukee, WI, 
U.S.A. All other reagents were of analytical grade.
RESULTS
Ca2 + -flux changes induced by the administration of 
AGEPC to the perfused rat liver
Although the action of AGEPC on hepatic vaso­
constriction, respiration and glycogenolysis in the 
perfused rat liver has been studied in some detail (Shukla 
et al., 1983; Buxton et al., 1984, 1986), it appears that 
similar studies on the action of this substance on 
Ca2+-flux movements in liver are lacking. Fig. 1 shows 
that the administration of AGEPC (100 nM) induces a 
rapid efflux of Ca2+ from the liver, as measured with the 
Ca2+-selective electrode; also, the maximum rate and 
the total net amount of Ca2+ efflux are dependent on the 
concentration of AGEPC infused. The amount of Ca2+ 
efflux was close to maximal (120-140 nmol/g of liver; 
maximum rate of efflux was approx. 180 nmol/min per g 
of liver) at an AGEPC concentration of 100 nM. This 
amount is quantitatively similar to that induced by the 
a-adrenergic agonist phenylephrine (Reinhart et al., 
1982; Altin & Bygrave, 1985). Although the maximum 
rate and total amount of Ca2+ efflux are much less at the 
lower AGEPC concentrations (Fig. 1), measurable 
changes in perfusate [Ca2+] were induced at AGEPC 
concentrations as low as 0.1 nM (results not shown). 
These results suggest that AGEPC does elicit Ca2+-flux 
movements in liver, and hence, contrary to the 
conclusions of Buxton et al. (1984), suggest that a 
mobilization of Ca2+ may be involved in triggering the 
glycogenolytic response that is induced by this agent.
Inhibition by indomethacin and BPB of AGEPC-induced 
Ca2+ fluxes and physiological responses
Of possible relevance to the mechanism of action of 
AGEPC is the finding that inhibitors of the arachidonate 
cascade can inhibit the glycogenolytic and vasocon-
100 nM
10 n M  —
y 1 nM
AGEPC
20 25
Perfusion time (min)
Fig. 1. Ca2 + -flux changes induced by the administration of 
AGEPC to the perfused rat liver
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3 mM-Ca2+ as outlined in the 
Methods section. After a pre-perfusion period of 20 min, 
AGEPC was infused into the portal vein as indicated by
the arrows. The continuous (----- ), broken (------ ) and
dotted (••••) traces represent Ca2+-selective-electrode 
recordings of the perfusate Ca2+ concentration after the 
infusion of AGEPC at concentrations of 100, 10 and 1 nM 
respectively. Each trace is a representative obtained from 
four separate experiments.
strictive effects of AGEPC in the perfused rat liver 
(Mendlovic et al., 1984). Because prostaglandins have 
been implicated in the transport of Ca2+ in some systems 
(see, e.g., Karmazyn, 1986; Fukuo et al., 1986), it was 
decided to explore the possibility that these products of 
cyclo-oxygenase activity may be involved in mediating 
also the Ca2+-flux changes (and other physiological 
responses) induced by AGEPC. The data in Figs. 2(a), 
2(b), 2(c) and 2(d) show respectively the changes in 
perfusate concentrations of Ca2+, oxygen and glucose, 
and also the change in portal pressure induced by the 
administration of 10nM-AGEPC to the perfused liver. 
The data in Fig. 2 also show the effect of a 15 min 
pre-administration of indomethacin (20 //m). The results 
provide evidence of a marked (>  80%) inhibition of all 
four AGEPC-induced responses by 20 //M-indomethacin. 
This strongly suggests that cyclo-oxygenase products, 
presumably prostaglandins, are involved in mediating 
the Ca2+-flux changes and the other three physiological 
responses that are observed. It is noteworthy that a 
15 min pre-infusion of BPB (50//m) also inhibited the 
responses to a similar extent (results not shown). 
However, it is relevant to point out that, whereas 
indomethacin did not affect the responses induced by 
administration of phenylephrine, in this instance BPB 
inhibited the action of phenylephrine by approx. 50% 
(not shown).
Comparison of the effects of LPC with those of 
AGEPC
For several reasons it seemed relevant to study the 
effect of LPC in the perfused rat liver. Firstly, the basic 
molecular structures of AGEPC and LPC are similar. 
Secondly, LPC can be produced intracellularly and 
extracellularly by mechanisms including the action of 
phospholipase A, on phosphatidylcholine, and in plasma 
(by the action of the enzyme phosphatidylcholine-choles-
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Fig. 2. Effect of AGEPC administration on net Ca2 + -flux 
changes, oxygen consumption, glucose output and portal 
pressure, and the inhibition of these responses by 
indomethacin
Rat livers were perfused with Krebs-Henseleit medium 
containing 1.3 mM-Ca2+. The perfusate Ca2+ and oxygen 
concentrations were monitored continuously with the 
Ca2+-selective electrode and oxygen electrode respectively. 
At the indicated times the portal pressure was recorded, 
and samples of the effluent perfusate were collected for 
determination of glucose. Other details are outlined in the 
Methods section. After a pre-perfusion period of 20 min, 
AGEPC (10 nM) was infused into the portal vein for 
10 min, as indicated by the arrows. The continuous curves 
in (a), (b), (c) and (d) show the AGEPC-induced change 
in the perfusate Ca2+, oxygen and glucose concentrations 
and portal pressure respectively. The dotted curves in (a), 
(b), (c) and (d ) show the corresponding changes induced 
by AGEPC in experiments in which indomethacin (20 fiM) 
was pre-administered for 15 min (beginning at 5 min of 
perfusion) and thereafter for the remainder of the 
experiment. In each instance the Ca2+ and oxygen traces 
are representative of between four and six independent 
experiments. The results for glucose concentration and 
portal pressure are means of four separate experiments; 
s.e.m. values have been omitted for clarity, but +0.04 mM 
for glucose, and ±0.7 mmHg for portal pressure, was 
never exceeded.
terol acyltransferase), where the LPC is believed to be 
transported by albumin for uptake and utilization by 
cells (Feilding et al., 1972; Burrier & Brecher, 1986). 
Moreover, the above studies indicated an involvement of
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Fig. 3. Effect of LPC administration on net Ca2 + -flux changes, 
oxygen consumption, glucose output and portal pressure, 
and the inhibition of these responses by indomethacin
The continuous curves in (a), (b), (c) and (d ) show the 
changes in the perfusate Ca2+, oxygen and glucose 
concentrations and portal pressure respectively induced by 
the administration of LPC (50 /im) to the perfused rat liver. 
In each instance the corresponding dotted curve represents 
the result obtained in the presence of 20 /^M-indomethacin. 
Liver perfusions and other experimental details, except 
that, where indicated, 50 /^m-LPC was used instead of 
AGEPC, were exactly as described in the legend to Fig. 2.
the arachidonate cascade in the mechanism of action of 
AGEPC.
Preliminary experiments suggested that, in the con­
centration range 1-100 /i m , the magnitude of the 
responses induced by LPC was correspondingly similar 
to those induced by AGEPC at concentrations in the 
range 0.1-100 nM. Moreover, the changes in the 
concentrations of perfusate Ca2+, oxygen and glucose 
and the increase in portal pressure induced by the 
administration of 50 //m-LPC are shown in Figs. 3(a), 
3(b), 3(c) and 3(d) respectively. The data indicate clearly 
that LPC (50 //m) induces significant changes in all four 
parameters studied. Although the magnitude of the 
Ca2+-flux response induced by LPC was concentration- 
dependent and was only just detectable at 1-5 /^ m-LPC 
(results not shown), the response induced was near- 
maximal at 50 //m-LPC. In this instance LPC induced a
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Fig. 4. Effect of LPC administration on oxygen consumption, and the dose-response curve of the effect of LPC on hepatic port al 
pressure
Rat livers were perfused with Krebs-Henseleit bicarbonate medium containing 1.3 mM-Ca2+. After a pre-perfusion period of 
15 min, LPC was administered for a period of 5 min (arrows). The curves in (a) represent the oxygen response obtained from
separate experiments in which the concentration of LPC administered was 10 jum (••••), 25 fiu (------ ) or 50 /m (----- ). Each
result is a representative of at least three independent experiments. (b) shows the dose-response curve for the effect of LPC 
on the maximum change in portal pressure that is induced during the first 5 min of LPC administration in experiments of the 
type shown in (a). Each point represents the mean + s.E.M. for three separate pressure measurements conducted at each 
concentration of LPC.
net efflux of Ca2+ (100-150 nmol/g of liver; maximum 
rate of efflux approx. 170nmol/min per g of liver), 
followed by a smaller extent of Ca2+ influx (see Fig. 3a). 
The general shape of the oxygen response changed 
considerably with increasing concentrations of LPC. In 
the concentration range 1-10 / / m , LPC stimulated 
oxygen uptake in a transient manner, whereas, at 
concentrations of around 20 jum and above, the oxygen 
response was biphasic, showing first a stimulation and 
then an inhibition of oxygen uptake (see Fig. 4a). At LPC 
concentrations of 1-10 //m, glucose output was sustained 
for the duration of PLC infusion (results not shown). 
However, at concentrations above about 20 //M, the 
maximum rate of glucose output increased rapidly, to 
high values initially, and then returned rapidly to 
near-basal values even while the LPC was still being 
infused (see, e.g., Fig. 3c). The data in Fig. 3(d) show 
that LPC also induced an increase in portal pressure. 
This increase was sustained for the period of LPC 
administration and was concentration-dependent (see 
Fig. 4b).
Comparison of the effects induced by AGEPC (see 
Fig. 2 of the present work; also Buxton et al., 1984, 1986) 
with those induced by LPC (Fig. 3) suggests that the 
main differences are in the dose-response curve (LPC 
active at a 1000-fold higher concentration than AGEPC), 
and in the ability of LPC to induce a more sustained 
effect on vasoconstriction and inhibition of oxygen 
uptake (cf. Figs. 3 and 4) at near-maximal concentrations 
of each agent. The responses induced by LPC are also 
inhibited by a 15 min pre-administration of indomethacin 
(Fig. 3) or 50 //m-BPB (results not shown). As with 
AGEPC (Fig. 2), these results suggest that cyclo­
oxygenase products are involved in eliciting the responses 
induced by LPC (Fig. 3).
The source o f C a2+ mobilized by AG EPC and LPC
Our finding that AGEPC and LPC administration to 
the perfused rat liver results in an efflux of Ca2+ (Figs. 1 
and 2) raises the question of the source of this Ca2+. In
order to study this, a higher concentration of AGEPC 
(100 nM) was used in the following experiments to ensure 
near-maximal Ca2+ efflux. The data in Fig. 5(a) show that 
a 4 min pre-administration of 100 nM-AGEPC results 
in abolition of the Ca2+-efflux response induced by a 
subsequent infusion of 5 //M-phenylephrine. Conversely, 
Fig. 5(b) shows that a prior administration of 5 // m - 
phenylephrine, which is known to lead to a depletion of 
the hormone-sensitive pool of Ca2+ (Reinhart et al., 
1982), results in an almost total inhibition of the Ca2+ 
efflux induced by subsequent infusion of AGEPC. These 
results suggest that the major component of Ca2+ 
mobilized by AGEPC originates from the same intra­
cellular source as the Ca2+ that is mobilized by 
phenylephrine. Hence, since it is thought that in liver 
phenylephrine mobilizes Ca2+ from the endoplasmic 
reticulum in hepatocytes (reviewed by Reinhart et al., 
1984; Williamson et al., 1985; Exton, 1985), it would 
appear that the main component of the Ca2+ efflux 
response induced by AGEPC (Figs. 1, 2a and 5) is due 
also to an efflux of Ca2+ from this source.
Two further features of the Ca2+ mobilization induced 
by AGEPC may be noted. Firstly, although AGEPC and 
phenylephrine appear to mobilize Ca2+ from the same 
intracellular source, the Ca2+ mobilization induced by 
AGEPC is inhibitable by 20 //M-indomethacin, whereas 
that induced by phenylephrine is not inhibitable by this 
substance (Fig. 5c). This would suggest that cyclo­
oxygenase products are involved in the release of Ca2+ 
from hepatocytes. Secondly, the mobilization of Ca2+ by 
phenylephrine is unaffected by lowering of [Ca2+] in the 
perfusion medium from 1.3 mM (physiological) to 25 /m  ; 
however, the mobilization of Ca2+ induced by AGEPC 
is abolished under these conditions (Fig. 5d). This 
suggests that an adequate extracellular [Ca2+] is crucial 
for the mobilization of Ca2+ by AGEPC to occur, and 
therefore may explain the failure of Buxton et al. (1984) 
to detect any AGEPC-induced Ca2+ fluxes in their 
system, in which the extracellular Ca2+ concentration 
was only 50 /*m. Essentially identical results were
1987
Cai2+ fluxes induced by platelet-activating factor in liver
AGEPC
t AGEPC f
.E - 3 0
+ Indo
I AGEPC
Ä 50
I AGEPC ( I Phen
20 25 30 35
Perfusion time (min) ,
Fig. 5. Effect of sequential additions of AGEPC and phenyl­
ephrine on the Ca2 +-efflux response
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium, and the perfusate Ca2+ concentration was 
continuously monitored with the Ca2+-selective electrode 
as previously described. At 20 min and 25 min of 
perfusion, respectively, AGEPC (100 nM) and phenyl­
ephrine (Phen; 5 //m) were administered as indicated by the 
arrows. The resulting Ca2+-flux response is shown in (a). 
The Ca2+-flux response induced when the order of AGEPC 
and phenylephrine administration was reversed is shown 
in (b). AGEPC and phenylephrine infusions in (c) were 
similar to (a), except that 20 /^M-indomethacin was 
administered at 5 min of perfusion and thereafter for the 
remainder of the experiment. (d ) shows the Ca2+ response 
induced by the infusion of AGEPC for 4 min, followed by 
phenylephrine for 4 min as indicated; however, in this 
instance the Ca2+ concentration of the perfusion medium 
was changed from 1.3 mM- to 25 /m-Ca2+ at 20 min of 
perfusion. Each trace is a representative obtained from 
three separate experiments.
obtained when 50 //m-LPC was used instead of AGEPC 
(results not shown).
DISCUSSION
The first major conclusion from this work is that, 
provided that there is an adequate concentration of
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external Ca2+, AGEPC is able to induce significant 
Ca2+-flux changes in the perfused rat liver. This offers an 
explanation why in previous reports AGEPC did not 
lead to any significant Ca2+-flux changes in this system 
(Buxton et a i, 1984). As a consequence of this, current 
models for the mechanism by which AGEPC elicits its 
effects in liver (see, e.g., Buxton et al., 1984, 1986; Fisher 
et ai, 1986) may need to be revised.
The second major point is that LPC administration to 
the perfused rat liver elicits responses, including Ca2+-flux 
changes, oxygen uptake, glucose output and hepatic 
vasoconstriction, which are similar to those induced by 
AGEPC. This previously has not been reported. Because 
it has been demonstrated that LPC can induce cell lysis 
at high concentrations (Weltzien, 1979), it was important 
to establish that any irreversible damage to hepatocytes 
under these conditions had not occurred. Our obser­
vations that, at concentrations up to 50 fiM, repeated 
short administrations ( <5mi n )  of LPC lead to a 
repetition of the responses, and that a subsequent 
administration of the a-agonist phenylephrine induces a 
normal type of response if administered after a suitable 
rest period (results not shown), strongly suggest that 
under these conditions little irreversible damage had 
occurred.
It is possible that LPC may interact with receptors on 
the plasma membrane, perhaps through low-affinity 
interaction with receptors for AGEPC. Alternatively, the 
action of LPC may be brought about by a less specific 
effect on the ion-permeability properties of the plasma 
membrane (Weltzien, 1979). It is noteworthy however, 
that similar concentrations of phosphatidylcholine and 
L-a-lysophosphatidylethanolamine from egg yolk were 
without effect, whereas synthetic L-a-LPC (palmitoyl or 
stearoyl forms) were both active in the present system 
(results not shown). Despite obvious similarities between 
the responses induced by LPC and those induced by 
AGEPC, some differences are apparent. These include a 
difference in the dose-response [cf. Fig. 4(b) of the 
present work with Fig. 4 in Fisher et al. (1986)], a more 
sustained vasoconstrictive effect and inhibition of oxygen 
uptake during LPC administration (Fig. 3), and a 
decreased susceptibility to desensitization upon subse­
quent administrations, by comparison with AGEPC 
(results not shown).
An important feature of the responses induced by 
AGEPC and LPC is their sensitivity to inhibition by BPB 
and indomethacin. This argues strongly for an involve­
ment of phospholipase A2 and the production of 
prostaglandins in eliciting the responses. Of potential 
relevance to this work are the findings that cultured 
Kupfifer and endothelial cells from rat liver sinusoids 
produce significant amounts of prostaglandins and other 
eicosanoids when stimulated by agents such as AGEPC, 
arachidonic acid, phorbol ester and zymosan (Birmelin & 
Decker, 1984; Dieter et al., 1986; Schlayer et al., 1986). 
By contrast, hepatocytes are more likely to be involved 
in the degradation rather than in the synthesis of 
prostaglandins (Decker, 1985; Tran-Thi et al., 1986). In 
the light of these considerations, the present results 
suggest that the responses induced by the administration 
of AGEPC and LPC to the liver may be due to an 
interaction of these agents with cell types other than the 
parenchymal cells. The possible involvement of cell types 
other than hepatocytes in the action of AGEPC 
previously had been proposed by Mendlovic et al. (1984).
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In essence, these findings could well explain the inability 
of AGEPC to induce any glycogenolytic effect in isolated 
hepatocytes (Fisher et al., 1984).
Consistent with this notion also are the findings 
(Charest et al., 1985) that AGEPC does not stimulate 
inositol trisphosphate formation, or an increase in 
cytoplasmic [Ca2+] in isolated hepatocytes. Moreover, 
our present observation that AGEPC does not induce 
any sizeable amount of Ca2+ efflux from the perfused 
liver at low perfusate Ca2+ (Fig. 5d) supports these 
findings. On the other hand, this does not support the 
observations by Shukla et al. (1983) and Fisher et al. 
(1984) that AGEPC stimulates the breakdown of 
phosphatidylinositol 4,5-bisphosphate in isolated hepato­
cytes. A further implication of the present work is that 
extracellular Ca2+ is important in the production of 
prostaglandins. Since phospholipase A2 is a Ca2+- 
dependent enzyme, and since treatment of Kupffer cells 
and endothelial cells with the Ca2+-ionophore A23187 is 
sufficient to activate the arachidonate cascade (Dieter 
et al., 1986), it seems that the much decreased ability of 
AGEPC to stimulate responses in liver at low perfusate 
[Ca2+] can be explained.
In regard to the mechanism of action of AGEPC, 
Buxton et al. (1986) and Fisher et al. (1986) have 
proposed that the glycogenolytic effects of AGEPC are 
brought about indirectly by a decreased oxygen supply 
induced by vasoconstriction. Because both AGEPC and 
LPC induce a release of Ca2+ from the same source as 
that mobilized by the a-agonist phenylephrine, it seems 
to us more likely that glycogenolysis is triggered by the 
release of this Ca2+, perhaps by the interaction of 
cyclo-oxygenase products with hepatocytes through 
receptors that are themselves linked to the breakdown of 
phosphoinositides.
On the basis of the evidence presented, we propose the 
following model to explain the observed AGEPC- and 
LPC-induced responses. Clearly, central to this is that 
AGEPC and LPC elicit various responses in the perfused 
rat liver by a mechanism that involves the cyclo­
oxygenase pathway. The data are consistent with a 
general model in which AGEPC and LPC in liver 
interact primarily on eicosanoid-producing cells, such as 
Kupffer cells and endothelial cells. The nature of this 
interaction is unknown at present, but could involve the 
breakdown of phosphoinositides in these cells such that 
there is an increase in cytosolic [Ca2+] and an activation 
of phospholipase A2, as has been reported for the action 
of AGEPC on platelets (Billah & Lapetina, 1983). The 
eicosanoid products released, in particular the prosta­
glandins, then could interact both with hepatocytes, 
producing Ca2+-flux changes, a stimulation of oxygen 
uptake and glycogenolysis, and also with the vasoactive 
cells that are involved in affecting hepatic vasocon­
striction. The nature of the interaction between the 
prostaglandins and the parenchymal cells of the liver is 
not known, but may itself involve the breakdown of 
phosphoinositides by a mechanism similar to that which 
occurs in the action of Ca2+-mobilizing hormones (Creba
et al., 1983; Berridge, 1984; Charest et al., 1985). VVe 
acknowledge, however, that a direct proof for t he 
existence of this mechanism awaits further investigation.
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Section B.4
Prostaglandin F2a and the thromboxane A2 analogue ONO-11113 stimulate
Ca2+ fluxes and other physiological responses in rat liver.
Further evidence that prostanoids may be involved in the action of arachidonic acid and
platelet-activating factor.
(Altin & By grave, 1988)
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Prostaglandin F2a and the thromboxane A2 analogue 
ONO-11113 stimulate Ca2+ fluxes and other physiological 
responses in rat liver
Further evidence that prostanoids may be involved in the action of arachidonic acid and 
platelet-activating factor
Joseph G. ALTIN and Fyfe L. BYGRAVE
Department of Biochemistry, Faculty of Science, The Australian National University, Canberra, A.C.T. 2601, Australia
The administration of prostaglandin F2a (PGF2J  and the thromboxane A2 analogue, ONO-11113, to rat 
livers perfused with media containing either 1.3 mM- or 10 //M-Ca2+ was followed by a stimulation of Ca2+ 
efflux, changes in 0 2 uptake and glucose output, and increase in portal pressure. The responses elicited by 
5 //m-PGF.^ were similar to those induced by the a-adrenergic agonist phenylephrine. At both 1.3 mM and 
10 //m extracellular Ca2+, PGF2a induced Ca2+ efflux (70-90 nmol/g of liver), probably from the same source 
as that released by phenylephrine. Prostaglandin D2 (5 / / m ) and prostaglandin E2 (5 jum) also induced 
responses, but these were generally much smaller (<  30%) than those induced by PGF2a. Similarly to 
vasopressin and other Ca2+-mobilizing hormones, PGF^ also interacted synergistically with glucagon (and 
cyclic AMP) in stimulating Ca2+ influx both in the perfused liver and in isolated hepatocytes. By comparison 
with phenylephrine and PGF2j, ONO-11113 was much more potent in inducing vasoconstriction, and, at 
concentrations of 10-200 nM, induced a different pattern of changes in Ca2+ flux, respiration and 
glycogenolysis. There was first a rapid efflux of Ca2+ (45-60 nmol/g of liver), followed by a smaller Ca2+ 
influx, and a further release of Ca2+ (approx. 90 nmol/g of liver) when ONO-11113 was removed. 
Respiration was first stimulated but then markedly inhibited. At concentrations less than 5 nM, ONO-11113 
induced a sustained stimulation of Oz uptake and a more prolonged efflux of Ca2+, with less Ca2+ efflux 
occurring upon the removal of the agent. Glycogenolysis followed a pattern which was similar to the Ca2+ 
response. Co-administration of glucagon did not potentiate Ca2+ influx by ONO-11113, but the action of 
ONO-11113 was inhibited (50 %) by a few minutes’ prior administration of 10 nM-vasopressin. The 
vasoconstrictive action of ONO-11113 was synergistically potentiated by the co-administration of 
phenylephrine. Since the actions of arachidonic acid, platelet-activating factor and lysophosphatidylcholine 
in liver were recently found to be cyclo-oxygenase-sensitive, the results provide strong evidence that at least 
PGF2i and thromboxane A2 may be involved in mediating the action of these agents.
INTRODUCTION
Recent work suggests that eicosanoids, metabolites 
generally associated with an inflammatory response, may 
be produced by different cell types from liver (e.g. 
Kupffer and endothelial cells in culture) after exposure to 
an appropriate stimulus (Birmelin & Decker, 1984; 
Dieter et al., 1986; Schlayer et al., 1986). Although there 
are strong indications that eicosanoids may be taken up 
and metabolized by hepatocytes (Decker, 1985; Tran- 
Thi et al., 1986), and that specific receptors may exist on 
the surface of hepatocytes for the binding or transport of 
leukotrienes (Uehara et al., 1983) and prostaglandins 
(Smigel & Fleischer, 1974, 1977; Okamura & Terayama, 
1977; Okumura et al., 1987), as yet it is unclear as to 
whether these receptors have a specific role in regulating 
liver function. There are reports which suggest that the 
administration of prostaglandins of the E-series to the 
perfused rat liver (DeRubertis et al., 1974) and to 
isolated hepatocytes (Bronstad & Christoffersen, 1981;
Abbreviation used: PG, prostaglandin.
Brass et al., 1984; Brass & Garrity, 1985) can modulate 
the effects of other hormones such as glucagon and 
adrenaline by inhibiting the hormone-induced accumu­
lation of cyclic AMP. It appears, nonetheless, that 
relatively little is known about the mechanism of action 
of these and other prostanoids in liver.
Products of cyclo-oxygenase activity have been impli­
cated in the action of arachidonic acid (Dieter et al., 
1987^,6; Altin & Bygrave, 19876) and of platelet­
activating factor (Mendlovic et al., 1984; Buxton et al., 
1984; Garcia-Sainz & Hernandez-Sotomayor, 1985; 
Altin et al., 1987) in the perfused rat liver. Such action 
includes a stimulation of Ca2+-flux changes, 0 2 uptake, 
glucose output and an increase in portal pressure (see 
references above). In order to establish which prosta­
glandins might be involved in mediating these responses, 
we have examined in this work the effects of administering 
prostaglandin D2 (PGD2), prostaglandin E2 (PGE2), 
prostaglandin F2a (PGF2a), and a stable analogue of 
thromboxane A2 (ONO-11113) to the perfused rat liver.
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The data obtained provide new information about the 
mechanism of action of prostanoids in liver. It appears 
that the action of PGF2a is mediated by a mechanism 
similar to that of other Ca2+-mobilizing hormones, 
whereas the action of ONO-11113 seems likely to involve 
a different mechanism. The possible involvement of these 
prostanoids in mediating some of the actions of 
arachidonic acid and platelet activating factor in liver is 
discussed.
METHODS 
Liver perfusions
Male Wistar-strain rats of weight 280-350 g and fed 
ad libitum were anaesthetized with sodium pento­
barbitone (50 mg/kg body wt.). After dissection, the 
livers were perfused in a non-recirculating mode with 
Krebs-Henseleit (1932) bicarbonate medium equilibrated 
with 0 2/C 0 2 (19:1) and containing 1.3mM-Ca2+ as 
described previously (Reinhart et al., 1982). After 
a 15-20 min pre-perfusion period, hormones and 
prostanoids were administered at the specified con­
centration by an appropriate infusion with a pump- 
driven syringe. The concentrations of 0 2 and Ca2+ in the 
outflowing perfusate was monitored continuously with a 
Clark-type oxygen electrode and a Ca2+-selective elec­
trode (Radiometer F2112), respectively, as described by 
Reinhart et al. (1982) and Altin & Bygrave (1985). Where 
indicated, portal pressure was determined by measuring 
the level of buffer in an open glass capillary (2 mm 
diameter) connected to the inflow canula into the portal 
vein; the basal portal pressure was 3.4 + 0.3 mmHg. 
Also, for some experiments, appropriate samples of the 
perfusate were collected for glucose determination by the 
glucose oxidase method (Reinhart et al., 1982).
Stock solutions of phenylephrine, vasopressin, 
glucagon and PGF2a were made up in Krebs-Henseleit 
medium, whereas those of PGD2, PGE2 and throm­
boxane- A2 analogue ONO-11113 were made in dimethyl 
sulphoxide. The final concentration of dimethyl 
sulphoxide when used as a solvent was less than 0.05 % 
(v/v). All solutions were stored frozen at —20 °C.
Preparation of hepatocytes
Hepatocytes were prepared by a modification of the 
methods described by Berry & Friend (1969) and Barritt 
et al. (1981). After 10 min of low-Ca2+ perfusion, the 
liver was perfused for 6-8 min with medium containing 
1.3mM-Ca2+ plus collagenase (0.03%, w/v). The liver 
was dispersed and then incubated for a further 10 min in 
the same medium in a 250 ml conical flask kept at 37 °C 
and shaken at 100 cycles/min in a water-bath shaker. 
Cell clumps were removed by filtering with a nylon mesh 
(0.2 mm grid), and the cell suspension was washed twice 
by gentle centrifugation (50 g for 1 min), aspirating away 
the supernatant, and resuspending of the cell sediment 
in ice-cold Krebs-Henseleit bicarbonate medium. A 
final wash was carried out with complete minimum 
essential Eagle’s medium containing 1.3 mM free Ca2+ and 
20 mM-Hepes buffer, pH 7.4, but without Phenol Red. 
The cells were resuspended in this medium (30 mg of 
cells/ml), dispensed into 1 ml portions, and incubated 
for 15 min at 37 °C before addition of any agonist. All 
incubations were carried out with constant shaking and 
gassing with 0 2/C 0 2 (19:1). For all experiments cells
were used within 1 h of preparation. Cell viability, as 
judged by the exclusion of Trypan Blue, always exceeded 
90%.
For determination of the total cell calcium, at the 
appropriate time the cells were immediately placed in an 
Eppendorf tube and centrifuged for 10-15 s to pellet the 
cells. The supernatant was quickly removed and the cell 
protein was precipitated with ice-cold 2 m-HC104 to 
extract calcium. The precipitate was pelleted, and a 
suitable sample of the supernatant was used for calcium 
determination by atomic-absorption spectroscopy.
Chemicals and materials
PGD2, PGE2, PGF2a, phenylephrine, [Arg8]vaso- 
pressin, glucagon, dibutyryl 3/,5,-cyclic AMP (here­
after ‘cyclic AM P’), collagenase (type IV), fatty-acid- 
free bovine serum albumin and the glucose assay kit 
(510-A) were all obtained from Sigma Chemical Co., St. 
Louis, MO, U.S.A. The stable analogue of thromboxane 
A2, 9,11 -epithio-11,12-methano-thromboxane A2, was 
generously given by Ono Pharmaceutical Co., Higashiku, 
Osaka, Japan. Percoll and density-marker beads were 
obtained from Pharmacia Fine Chemicals, Uppsala, 
Sweden. Ca2+-selectrode membranes (F2112) and filling 
solution S43316 were obtained from Radiometer, Copen­
hagen, Denmark. Other chemicals used were of analytical 
grade.
RESULTS
Preliminary experiments indicated that, of the three 
prostaglandins tested, PGF2a was by far the most active. 
The data in Fig. 1(a) show the Ca2+-flux changes induced 
by the administration of PGF2a (5 /im) to the liver perfused 
with media containing either 10 jnu (dotted curve) or 
1.3 mM (continuous curve) free Ca2+. The administration 
of PGF2a induces a significant efflux of Ca2+ from the 
liver (70-90 nmol/g of liver) which is taken up when the 
agent is removed. Although the time of onset of Ca2+ 
efflux is slower (approx. 15 s), and the net amount of 
Ca2+ efflux is less, the overall pattern of the response is 
similar to that induced by 2 /tM-phenylephrine (see Fig. 
la, and Reinhart et al., 1982; Altin & Bygrave, 1985). 
The administration of PGF2a is also accompanied by a 
stimulation of whole-tissue respiration and glucose 
output, and an increase in portal pressure, as shown in 
Figs. 1(6), 1(c) and 1(d) respectively. By contrast, the 
administration of PGE2 induced a relatively small effect 
(<  30%) by comparison with PGF2a, and the adminis­
tration of PGD2 induced responses that were only just 
detectable (see Fig. 1). It is noteworthy that the action of 
PGF2a was similar to that of phenylephrine, in that both 
agents induced a Ca2+ efflux and less-sustained physio­
logical responses even when the perfusate Ca2+ con­
centration was lowered to 10 /im.
Intracellular source of Ca2+ mobilized by PGF2a
The data in Fig. 1(a) suggest that PGF2a may induce 
its effects by inducing a release of Ca2+ from intracellular 
stores. It was therefore of interest to establish whether 
the Ca2+ release induced by PGF2a originates from the 
same intracellular source as that mobilized by other 
Ca2+-mobilizing agents, such as phenylephrine (see, e.g., 
Reinhart et al., 1982, 1984; Exton, 1985; Williamson 
et al., 1985). The data in Fig. 2(a) show that Ca2+ 
efflux induced by the administration of PGF2a is much
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Fig. 1. Effect of PGD>, PGE2 and PGF2a administration on 
Ca2*-flux changes, 0 2 consumption, glucose output and 
portal pressure in the perfused rat liver
Livers were perfused with Krebs-Henseleit bicarbonate
medium containing UmM-Ca2* (------) or 10//M-Ca2"
(-------; lowered from 1.3 mM to 10 //M at 10 min of
perfusion and thereafter for the remainder of the 
experiment) as detailed in the Methods section. Separate 
experiments were conducted in which, after a pre-perfusion
period of 15 min, PGD2 ( ----- , A) PGE2 (••••,  O) or
PGF2a (------, • ; -------, O) (each at 5 /i\i) was infused for
5 mm as indicated by the arrows. Then 20 min later 
phenylephrine (Phe; 2 //m) was infused as shown. The 
induced Ca2+ and 0 2 responses, as monitored with the 
Ca2+-sensitive electrode and oxygen electrode respectively, 
are shown in (a) and (b). The associated glucose response 
and changes in portal pressure are shown in (c) and (d ) 
respectively, where each point is the result of a measure­
ment carried out at the indicated time (see the Methods 
section for further details). For clarity, the data for the 
effects of PGD2 and PGE2 at 10 fiu perfusate Ca2+ were 
not included, but all responses induced were smaller than 
those induced at 1.3 mM-Ca2*. Each trace is a representative 
of those obtained from three separate experiments. The 
data for glucose and portal pressure represent mean values 
obtained from the three experiments; s.e.m . values were 
omitted for clarity, however, ±0.03 mM for glucose and 
±0.2 mmHg for portal pressure was never exceeded. For 
clarity, the data obtained with PGD2 and PGE2 are not 
presented beyond the 25 min time point.
decreased after the depletion of the intracellular hor­
mone-sensitive pool of Ca2+ by phenlephrine. Similarly, 
the administration of PGF2a diminishes the subsequent
Perfusion time (min)
Fig. 2. Effect of sequential infusion of PGF2a and phenylephrine 
on Ca2* efflux
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3mM-Ca2+. At 15 min of perfusion 
phenylephrine (Phe; 5 fiu) and then PGF2a (5 /tm) were 
each infused for 5 min as indicated. The Ca2+ response 
induced is shown in (a); (b) shows the Ca2+ response 
obtained from a similar experiment in which the order of 
PGF2a and phenylephrine administration was reversed. 
Each trace is a representative of three experiments 
performed independently.
efflux of Ca2+ induced by phenylephrine. These results 
therefore suggest that PGF2a mobilizes Ca2+ from the 
same intracellular source as does phenylephrine.
Effect of glucagon co-administration on the Ca2+-flux 
changes induced by PGD2, PGE2 and PGF2a
To determine whether the cyclic-AMP-producing 
hormone glucagon could alter the pattern of Ca2+-flux 
change induced by the prostaglandins (compare with the 
effect of glucagon on the responses induced by other 
Ca2+-mobilizing agents: Morgan et al., 1983; Mauger 
et al., 1985; Poggioli et al., 1986; Altin & Bygrave, 1986, 
1987a), experiments were conducted in which both 
glucagon and prostaglandins were co-administered. The 
data in Fig. 3(b) show the Ca2+ responses induced by the 
co-administration of glucagon (10 nM) with PGD2, 
PGE2 or PGF2a (each at 5 jum) 4 min later. By com­
parison with Fig. 3(a), which shows a small efflux of 
Ca2+ induced by the administration of PGF2a alone, the 
co-administration of glucagon (10 nM) and 5 //M-PGF2a 
resulted in a large stimulation of Ca2+ influx. 
The amount of Ca2+ influx that was induced (approx. 
1000 nmol of Ca2+/g of liver) with these concentrations 
of glucagon and PGF2a is quantitatively similiar to that 
induced by the co-administration of glucagon with 2 jum- 
phenylephrine under otherwise identical experimental 
conditions (see Fig. 3 and Table 1). It is noteworthy that, 
when co-administered with glucagon, PGF2a induced
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Fig. 3. Comparison of the Ca2 -flux response induced by the co- 
administration of glucagon with PG D ,, PGE,, PGF2i, or 
with phenylephrine
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3mM-Ca2", and the perfusate Ca2" 
concentration was monitored continuously with a Ca2"- 
selective electrode. The traces in (a) represent the Ca2" 
response obtained from separate experiments in which
phenylephrine (2 ftm; ----- ) or PGD, (----- ), PGE, (••••)
or PGF^ (-------), each at 5 //M, was infused for the time
indicated by the arrows. Similarly, the Ca2" response 
obtained in separate experiments in which the infusion of 
phenylephrine, PGD,, PGE, and PGF2;( was preceded by a 
4 min infusion of 10 nM-glucagon (Glu), which was then 
co-administered with each agent is shown in (6). At this 
concentration, the administration of glucagon induced a 
small efflux of Ca2" during the first 3-4 min (see Fig. 36), 
but did not itself induce any net stimulation of Ca2" influx 
when administered for the 9 min period (results not 
shown). Essentially identical results (not shown) were 
obtained when 200/^M-cyclic AMP was administered 
instead of glucagon. Each trace is a representative of three 
or four independent experiments.
significant influx of Ca2+ even at a concentration of 
0.2 / m  (Table 1). By contrast, the co-administration of 
glucagon only slightly potentiated the Ca2+ response 
induced by PGD2 and PGE2 (each at 5 //m) (see Fig. 2 
and Table 1), a result consistent with the smaller effect of 
these prostaglandins on Ca2+-flux movements, glyco- 
genolysis and respiration, when administered alone (see 
Fig. 1). In all instances, similar results were obtained 
when 200 /<M-cyclic AMP was used in place of glucagon.
Cell type and the intracellular sink for the Ca2+ influx
The change in the total cell calcium content induced by 
the administration of the different prostaglandins and 
phenylephrine, with or without glucagon, is shown in 
Table 2. By comparison with Fig. 3 and Table 1, the 
increase in calcium content (approx. 800 nmol/g wet wt. 
of cells) induced by the addition of these agents to
Table 1. Stimulation of net Ca2" influx in the perfused rat liver 
by the co-administration of glucagon with PG D ,, 
PGE,, PGF2j or phenylephrine
The Table gives the net amount and maximum rate of 
Ca2" influx induced by the co-administration of 10 nM- 
glucagon and PGD,, PGE, and PGF2i, or phenylephrine. 
The maximum rate of influx was calculated from the 
maximum deflection of the pen in the Ca2" trace, and the 
net amount of Ca2" influx from the area above the curve 
in the Ca2" influx response. Liver perfusions and other 
details are exactly as described in the legend to Fig. 3(6). 
Each value represents the mean + s.E.M. obtained from 
three to five independent experiments.
Ca2" influx
Maximum rate
Addition Net amount (nmol/min
of glucagon plus (nmol/g of liver) per g of liver)
PGD, (5 //m) None detected No change
PGE, (5 //M) 52 + 8 23 + 5
PGF2a: (0.2 //m) 112 + 9 50 + 4
(1 /<M) 470 + 65 157 + 22
(5//M) 1 105+130 324 + 46
Phenylephrine (2 //m) 1030+128 320 + 38
Table 2. Effect of the co-addition of glucagon with PGD,, 
PGE, or PGF2:i (each at 5 /«m), or with phenylephrine 
(2 //m), on the total calcium content of isolated 
hepatocytes
Cells were incubated with glucagon for 4 min and then for 
a further 5 min with the agent indicated below. After 
harvesting, the cells were then assayed for calcium content. 
See the Methods section and the text for further details. 
Each value represents the mean + s.E.M . obtained from five 
or six experiments performed independently. No significant 
change was induced by PGD2 or PGE2, or when glucagon 
alone was present.
Total calcium content
Additions (nmol/g wet wt. of cells)
Control (no additions) 1800+180
Glucagon plus PGF2a 2564+ 170
Glucagon plus phenylephrine 2592+190
isolated hepatocytes shows a similar pattern to that 
which is induced in the perfused rat liver. Because the 
proportion of parenchymal to non-parenchymal cells is 
increased in this preparation as compared with the intact 
liver, the data suggest that the principal action of PGF2a 
is on hepatocytes themselves. Also, the similarity of the 
response induced by PGF2a to that induced by phenyl­
ephrine when each is co-administered with glucagon 
provides further evidence for a common mechanism of 
action.
The large stimulation of Ca2+ influx induced by the co­
administration of glucagon and PGF2a raises the question 
of the intracellular sink for this Ca2+. To examine this, 
liver subfractionation studies were conducted to deter-
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mine the location of the Ca2+ taken up after the co­
administration of glucagon and PGF2a to the perfused 
liver. Although in these experiments glucagon and 
PGF2a were co-administered for only 5 min (as in Fig. 3), 
the studies were carried out exactly as described 
previously for locating the intracellular sink for the Ca2+ 
influx after the co-administration of glucagon and 
vasopressin (see Altin & Bygrave, 1986). The data 
indicate that, whereas the calcium content of plasma- 
membrane- and endoplasmic-reticulum-enriched frac­
tions increased by 30-50%, the calcium content of the 
fractions enriched in mitochondria increased approx. 10- 
fold, each with respect to control fractions obtained 
from livers treated with glucagon only (results not 
shown). This suggests that the mitochondria are the sink 
for the Ca2+ influx that is observed, a feature similar to 
that reported for the Ca2+ uptake induced by the co­
administration of glucagon with vasopressin (Altin & 
Bygrave, 1986).
Effect of ONO-11113, a stable analogue of 
thromboxane A2, on Ca2+-flux changes, respiration, 
glycogenolysis and vasoconstriction
Since the response induced by each of the prosta­
glandins examined in this work could not account for 
some of the responses induced by platelet-activating 
factor and lysophosphatidylcholine, it was decided to 
study the possible action of the cyclo-oxygenase metab­
olite thromboxane A2 on physiological responses in liver. 
Because thromboxane A2 is unstable, we used the stable 
analogue ONO-11113. Fig. 4 shows that the adminis­
tration of 20 nM-ONO-11113 to the liver perfused with 
media containing 1.3mM-Ca2+ induces rapid biphasic 
Ca2+-flux changes. The infusion of ONO-11113 induced 
a rapid efflux of Ca2+ during the first 40-50 s, corres­
ponding to 45-60 nmol/g of liver. The onset of Ca2+ 
efflux occurred at about 8 s, and the maximum rate of 
efflux (approx. 200 nmol/min per g of liver) was reached 
after about 30 s of ONO-11113-administration. This was 
followed by a spontaneous influx of Ca2+ (30-40 nmol/ 
g of liver), which reached a maximum rate of around 
55 nmol Ca2+/min per g of liver after approx. 1 min of 
ONO-11113 administration. These effects were accom­
panied first by a small transient stimulation, and then by 
a rapid and sustained inhibition, of 0 2 uptake (Fig. Ab). 
Also, there was a transient pulse of glucose release, and 
a marked and sustained increase in portal pressure (see 
Figs. 4c and Ad). The removal of ONO-11113 was 
followed by a transient efflux of Ca2+ (approx. 90 nmol/ 
g of liver), a relief of respiratory inhibition, with perhaps 
a slight stimulation of 0 2 uptake, a transient stimulation 
of glucose output, and a return to basal portal pressure 
(see Fig. 4). Although dependent also on the concen­
tration of ONO-11113 used (results not shown), all these 
responses were considerably decreased (inhibited by 
30-70%) by perfusion with media containing low 
(10 fim) Ca2+ (see broken curves in Fig. 4). This suggests 
that the presence of extracellular Ca2+ is important for the 
full expression of the action of ONO-11113.
Whereas the pattern of responses shown in Fig. 4 was 
typical of the responses induced by ONO-11113 at 
concentrations of 10-200 nM, a different pattern of Ca2+- 
flux change, respiratory and glycogenolytic responses 
was induced by ONO-11113 at concentrations below 
about 5 nM. For example, Fig. 5(a) shows that 2.5 nM- 
ONO-11113 induces a more prolonged Ca2+ efflux and
.5 0  +200
+ 400
15 20 25 30
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Fig. 4. Effect of the administration of the thromboxane A2 
analogue, ONO-11113, on Ca2+-flux changes, 0 2 con­
sumption, glucose output and portal pressure in the 
perfused rat liver
Livers were perfused with Krebs-Henseleit bicarbonate
medium containing 1.3mM-Ca2+ (------) or 10/tM-Ca2+
(-------; lowered from 1.3 mM to 10 fiM at 10 min of
perfusion and thereafter for the remainder of the experi­
ment) as detailed in the Methods section. After a pre­
perfusion period of 15 min, ONO-11113 (20 nM) was 
infused for 5 min as indicated by the arrows. The induced 
changes in perfusate Ca2+, 0 2 and glucose, and portal 
pressure, are shown in (a), (b), (c) and (d ) respectively. 
Other details are exactly as described in the legend to Fig.
1. Each trace is a representative of those obtained from 
three to five separate experiments. The glucose data 
represent mean values; s .e .m . values were omitted for 
clarity, however, + 0.04mM was never exceeded.
glucose output during its administration. In this instance 
a net stimulation of Ca2+ influx occurs only when the 
agent is removed. Comparison with Fig. 4 shows that 
ONO-11113 induced a moderate increase in portal 
pressure and a sustained stimulation of 0 2 uptake (see 
Fig. 56). Also, the stimulation of Ca2+ efflux and glucose 
output, upon the removal of ONO-11113 and coincident 
with the relief of vasoconstriction, were considerably 
decreased at the lower ONO-11113 concentrations, when 
the increase in portal pressure stimulated by ONO-11113 
was much less (Fig. 5). This suggests that severe 
vasoconstriction and associated inhibition of respiration 
induced during the administration of higher ONO-11113 
concentrations may be interfering with the quantitative 
output of Ca2+ and glucose (cf. Figs. 4 and 5).
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Perfusion time (min)
Fig. 5. Effect of the administration of low concentrations of 
ONO-11113 on Ca2+ fluxes, 0 2 uptake, glucose output 
and portal pressure
Rat livers were perfused exactly as described in the legend 
to Fig. 4, except that media containing 1.3 mM-Ca2+ were
used throughout all experiments. The Ca2+ (------) and
glucose ( • )  responses induced by a 5 min administration 
of ONO-11113 (2.5 nM, arrowed) are shown in (a).
Similarly, the associated changes in 0 2 uptake (------) and
portal pressure ( ♦ )  are shown in (b). Other details are 
exactly as in the legend to Fig. 4.
Dose-response for the action of ONO-11113 on 
physiological responses, and the effect of including 
bovine serum albumin in the perfusion medium
Because at concentrations above 10 nM ONO-11113 
induced responses both during and immediately after its 
administration, it seemed important to take into account 
both these effects in determining the dose-response. 
Thus Fig. 6(a) shows the total Ca2+ efflux and glucose 
output induced during, and 5 min after, a 5 min 
administration of different concentrations of ONO- 
11113. The increases in portal pressure induced by the 
administration of different concentrations of ONO- 
11113 are shown in Fig. 6(b). From the shape of the 
curves it is clear that ONO-1111 has very potent effects 
on Ca2+ efflux, glucose output and vasoconstriction. 
Near-maximal effects for each of these responses were 
induced at 20 nM-ONO-11113 (Fig. 6). It was noted, 
however, that the co-administration of bovine serum 
albumin had a pronounced moderating effect on the 
action of ONO-11113 (see Fig. 6 b). The inclusion of 
0.03% bovine serum albumin in the perfusion medium 
resulted in a shift in the dose-response curve by 
approximately an order of magnitude to the right (results 
not shown).
Effect of glucagon co-administration on the Ca2+ 
response induced by ONO-11113
The observation that ONO-11113 induces a mobiliza­
tion of Ca2+ led us to investigate whether its mechanism 
of action, at least with respect to Ca2+ mobilization, is
8.0 3
[ONO-11113] (nM)
Albumin in perfusion medium (%)
0 0.05 0.10 0.15
[ONO-11113] (nM)
Fig. 6. Dose-response for the stimulation of Ca2+ efflux, glucose 
output and portal pressure by ONO-11113
Perfusion details are exactly as described in the legend to 
Fig. 4, except that Krebs-Henseleit bicarbonate medium 
containing 1.3mM-Ca2+ was used throughout all experi­
ments, and the concentration of ONO-11113 administered 
was varied as indicated. In (a) each point ( # )  represents 
the total amount of Ca2+ efflux induced both during and 
5 min after a 5 min ONO-11113 administration. Similarly 
each point (O) represents the total glucose output induced 
by ONO-11113 during the same period. In (b) each point 
( ♦ )  represents the maximum increase in portal pressure 
that is induced during the 5 min administration of ONO- 
11113 at the specified concentration. Data for each point 
within a curve were obtained from separate experiments 
conducted at the indicated concentration of ONO-11113. 
Also in (b) the points (O ) represent the maximum increase 
in portal pressure that is induced during a 5 min 
administration of 20 mM-ONO-11113, but for which the 
specified amount of bovine serum albumin was pre­
administered for 5 min and thereafter continuously 
administered. Each point is the mean + s.E.M. of three to 
six experiments performed independently.
similar to that of other Ca2+-mobilizing agents. The data 
in Fig. 7(a) show that, under conditions where ONO- 
11113 is presumed to release intracellular Ca2+ (see Fig. 
7), the co-administration of glucagon does not lead to 
any stimulation of Ca2+ influx (cf. glucagon plus PGF2a 
and glucagon plus phenylephrine, Fig. 3). By contrast, 
despite the vasoconstriction induced by ONO-11113 
under these conditions, phenylephrine was still capable 
of stimulating Ca2+ influx (Fig. 7a). This suggests that the 
mechanism of action of ONO-11113 in eliciting Ca2+
1988
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Fig. 7. Effect of the co-administration of glucagon with ONO- 
11113, phenylephrine or vasopressin on Ca2* flux changes 
and portal pressure
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3mM-Ca2+, and the perfusate Ca2+ 
concentration was monitored continuously with a Ca2+- 
selective electrode. At 16 min of perfusion, glucagon (Glu;
10 nM) and 4 min later ONO-11113 (2.5 nM), and 5 min 
later phenylephrine (Phe; 2 / m )  were all co-infused until
25 min of perfusion. The Ca2+ trace (------) and the changes
in portal pressure ( • )  are shown in (a). Similarly, the 
Ca2+ and portal-pressure responses obtained in separate 
experiments in which vasopressin (Vaso; 10 nM) was 
infused in place of phenylephrine are shown in (6). 
Essentially identical results were obtained when 200 f i M -  
cyclic AMP was administered instead of glucagon (results 
not shown). Data for each Ca2+ trace and portal pressure 
are representative of three experiments performed inde­
pendently.
efflux is different from that of phenylephrine and 
PGF2a. Because the amount of Ca2+ influx induced 
by phenylephrine was decreased to approx. 40 % in the 
presence of ONO-11113, it would seem that ONO- 
11113-induced vasoconstriction was interfering with 
phenylephrine-induced Ca2+ influx. Although the prior 
administration of glucagon had only a slight inhibitory 
effect on the vasoconstrictive action of ONO-11113, 
subsequent infusion of phenylephrine resulted in a 
synergistic stimulation of portal pressure (Fig. la). This 
synergism occurred also when ONO-11113 and phenyl­
ephrine was administered without glucagon (results not 
shown). That vasoconstriction interfered with Ca2+ 
influx is also suggested by the fact that, when vasopressin 
was administered in place of phenylephrine, there was no 
synergistic increase in portal pressure, and Ca2+ influx 
was more sustained (Fig. lb). It was noteworthy that, in 
the absence of glucagon, a few minutes’ prior adminis­
tration of 10 nM-vasopressin alone inhibited all responses 
induced by a subsequent co-administration of ONO- 
11113 (results not shown).
D IS C U S S IO N
The first major finding from this work relates to the 
ability of PGF2a to induce Ca2+-flux changes, a stimu­
lation of respiration and glycogenolysis, and vaso­
constriction when administered to the liver perfused with 
media containing either high (1.3 mM) or low (10 /um) 
concentrations of Ca2+. It appears that such action of 
PGF2a in liver has not yet been reported.
This work also reveals that the action of PGF2a has a 
number of features in common with that of the so-called 
Ca2+-mobilizing hormones. Firstly, PGF2a appears to 
release Ca2+ from the same intracellular source as that 
mobilized by phenylephrine, since a pre-administration 
of phenylephrine abolishes the Ca2+ efflux induced by a 
subsequent administration of PGF2a. Secondly, PGF2a 
and glucagon (or cyclic AMP) interact synergistically in 
stimulating Ca2+ influx both in the perfused rat liver and 
in isolated hepatocytes. This influx is dependent on the 
concentration of PGF2a, with 5 /^M-PGF2a inducing 
essentially the same amount of Ca2+ influx as that 
induced by a near-maximal concentration of phenyl­
ephrine. Thirdly, the mitochondria are the intracellular 
sink for the Ca2+ taken up, as determined by the Ca2+ 
content of fractions obtained by a Percoll-density 
gradient subfractionation of liver after co-administration 
of glucagon and PGF2a. These findings also suggest that 
PGF2a elicits its effects by interacting with parenchymal 
cells in liver.
The action of Ca2+-mobilizing agents is known to 
involve a mobilization of Ca2+ that occurs as a 
consequence of a receptor-mediated breakdown of 
phosphoinositides and the generation of second mes­
sengers (Creba et al., 1983; Joseph et al., 1984; Berridge, 
1984; Charest et al., 1985). To our knowledge there are 
no reports of PGF2a inducing phosphatidylinositide 
breakdown in liver parenchyma. It is noteworthy, 
however, that PGF2a has been shown to have growth- 
factor-like action on neonatal-rat hepatocytes in culture 
(Armato & Andreis, 1983), to stimulate phospha- 
tidylinositol turnover and accumulation of 1,2-diacyl- 
glycerol in resting 3T3 Swiss cells (Macphee et al., 1984), 
to stimulate the production of inositol phosphates in 
cultured rat mesangial cells (Mene et al., 1987), and to 
stimulate phosphatidylinositol 4,5-bisphosphate hydro­
lysis and a mobilization of intracellular Ca2+ in bovine 
luteal cells (Davis et al., 1987). These actions of PGF2a 
are consistent with our present results, which suggest that 
in liver the action of PGF2a is mediated by a mechanism 
similar to that of other Ca2+-mobilizing agents.
Although PGE2 was considerably more effective than 
PGD2 in inducing Ca2+ movements and a stimulation of 
respiration and glycogenolysis, both prostaglandins in 
our system induced only small effects on these responses, 
especially when compared with the magnitude of those 
induced by PGF2a. Because hepatocytes have been 
shown to possess receptors for PGD2 and PGE2, and 
since both of these prostaglandins are known to be 
produced by non-parenchymal liver cells (e.g. Kupffer 
cells) in culture (Decker, 1985), it would seem that the 
principal role of these prostaglandins in regulating liver 
metabolism may be different from that of the Ca2+- 
mobilizing hormones. In this regard it may be relevant 
that E-series prostaglandins have been reported to inhibit 
cyclic-AMP-dependent and cyclic-AMP-independent 
hormone-stimulated glycogenolysis in isolated hepato-
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cytes (Brass & Garrity, 1985). In our system a prior 
administration of glucagon or cyclic AMP led to a small 
but significant stimulation of Ca2+ efflux upon subsequent 
administration of PGD., or PGE2 (see Fig. 3). The 
mechanism for this is not clear.
Our data indicate that the thromboxane analogue 
ONO-11113 is very active in its ability to stimulate 
physiological responses in the perfused rat liver (see Fig. 
5). Such action was also reported by Fisher et al. (1987), 
who carried out their studies with the structurally 
different analogue U-46619. A significant difference in 
action between these two compounds appears to be that 
the potency of ONO-11113 is at least an order of 
magnitude greater than that of U-46619 (cf. Fig. 6 of 
present work with Fig. 2 of Fisher et al., 1987). Similarly, 
the principal differences between the action of ONO- 
11113 and PGF2a, as far as we can judge, are the greater 
potency of ONO-11113 in inducing vasoconstriction, a 
different pattern of Ca2+, respiratory and glycogenolytic 
response, and the inability of glucagon to potentiate 
Ca2+ influx induced by ONO-11113. The manner in 
which bovine serum albumin is able to moderate the 
action of ONO-11113 is not known, but could involve 
the binding of ONO-11113 to albumin or some inter­
ference effect of the albumin on the interaction of ONO- 
11113 with the thromboxane receptor. In support of this 
is our observation that the bovine serum albumin effect 
could be overcome by increasing the concentration of 
ONO-11113 (results not shown).
As pointed out by Fisher et al. (1987), it is possible 
that the respiratory and glycogenolytic effects of throm­
boxane analogues in liver occur secondarily to vaso­
constriction, especially in view of the fact that severe 
vasoconstriction can be expected to lead to ischaemia 
within the liver tissue. Such action may well explain the 
observed inhibition of tissue respiration, and conse­
quently a stimulation of glycogenolysis, by an increase in 
AMP within hepatocytes themselves (Hers, 1976; Hems 
& Whitton, 1980). It is also noteworthy, however, that 
whereas no Ca2+-flux changes were reported by Fisher 
et al. (1987), who studied the action of U-46619, the 
action of ONO-11113 is associated with marked Ca2+-flux 
movements in liver perfused with media containing a 
physiological concentration (1.3 m M )  of Ca2+ (see Figs. 5 
and 6). We cannot exclude the possibility that some 
component of the Ca2+ movement induced by ONO- 
11113 may result from the direct action of ONO-11113 
on smooth-muscle cells within the hepatic vasculature or 
other cell types within the liver. Alternatively, this may 
also involve a release of Ca2+ from pools within 
the extracellular space that is associated with the 
parenchymal cells of the liver (Claret-Berthon et al., 
1977). Owing to the magnitude of the Ca2+ efflux that is 
induced (Fig. 6a), and the fact that the mobilization of 
such appears to be temporally related to the stimulation 
of glycogenolysis (see Figs. 4 and 5), we believe that the 
major component of the Ca2+ efflux induced by ONO- 
11113 is due to a mobilization of Ca2+ from hepatocytes, 
or at least must be in close communication with the 
cytoplasmic free Ca2+ concentration of hepatocytes. It 
may be possible that the Ca2+ release induced by ONO- 
11113 occurs as a consequence of hypoxia and the 
associated increases in intracellular AMP (or other 
metabolites) within hepatocytes, similar to the reported 
stimulation of glycogenolysis which can occur under 
these conditions. Such an effect of hypoxia on Ca2+ efflux
from hepatocytes has yet to be demonstrated, however. 
Our measurements of the time of onset of Ca2+ efflux and 
vasoconstriction suggest that the onset of Ca2+ efflux 
may occur just before vasoconstriction. It is clear, 
therefore, that the mechanism by which ONO-11113 and 
perhaps other thromboxane A2 analogues stimulate Ca2+ 
-flux changes in the perfused rat liver will need to be 
clarified, before the glycogenolytic action of these agents 
can be attributed solely to their ability to induce hypoxia.
A final major point arising from this work is that the 
results presented support our proposal that the action of 
arachidonic acid (Dieter et al., 1987a, 6; Altin & Bygrave, 
19876), platelet-activating factor and lysophospha- 
tidylcholine (Altin et al., 1987) are mediated by eico- 
sanoids produced and released by different cell types 
within the liver. The responses induced by PGF2a, 
including its interaction with glucagon, are similar to 
those induced by the administration of arachidonic acid 
(Altin & Bygrave, 19876). On the other hand, conditional 
upon the concentrations used, the responses induced by 
ONO-11113 share many features with those induced by 
the administration of platelet-activating factor and 
lysophosphatidylcholine (see Altin et al., 1987). Since the 
actions of arachidonic acid, platelet-activating factor 
and lysophosphatidylcholine are all sensitive to inhibition 
by indomethacin, it would seem that the principal action 
of arachidonic acid in liver is mediated mainly by the 
generation of PGF2a, whereas the actions of platelet­
activating factor and lysophosphatidylcholine are medi­
ated mainly by the generation of thromboxane A2. We 
do not eliminate the possibility that these agents may, in 
addition, have some direct action on liver cells. However, 
because arachidonic acid is the precursor of both PGF2a 
and thromboxane A2, and the responses induced by 
arachidonic acid and ONO-11113 are different (cf. this 
work with Dieter et al., 19876; Altin & Bygrave, 19876), 
it appears that, in the main, exogenously administered 
arachidonic acid is metabolized by different pathways, or 
perhaps by cell types different from those that are 
responsible for the activation of cyclo-oxygenase activity 
by platelet-activating factor and lysophosphatidylcholine 
(Altin et al., 1987a). According to this model, PGF2a 
released from such cells would interact with hepatocytes, 
eliciting physiological responses by a mechanism similar 
to that of Ca2+-mobilizing hormones (i.e. by interacting 
with receptors linked to the breakdown of phospho- 
inositides). The vasoactive response seen when PGF2a is 
administered might be attributable also to an interaction 
with smooth-muscle cells. Also, the thromboxane A2 
produced could interact with vasoactive cells and possibly 
hepatocytes, inducing vasoconstriction and a stimulation 
of other responses by mechanisms which are not yet fully 
understood. This interpretation presumes that the con­
centrations of prostaglandins used in these experiments 
are comparable with those that may be generated locally 
within the liver. To our knowledge no estimate of local 
concentrations has yet been made, however.
In this work we have related the action of arachidonic 
acid and platelet-activating factor to that of PGF2a and 
of thromboxane A2. Clearly these will be only a fraction 
of the total spectrum of eicosanoids which could be 
generated in liver and modulate its metabolism, con­
sequent to the exposure to agents such as arachidonic 
acid, lysophosphatidylcholine and platelet-activating 
factor. We therefore consider that the full effects of these 
agonists in liver can only be understood when the
1988
Prostaglandin-induced responses in liver 685
com posite effects, interactions and concentrations o f  all 
the active m etabolites produced are taken into account.
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Section B.5
The Ca2+-mobilizing actions of vasopressin and angiotensin differ from those 
of the a-adrenergic agonist phenylephrine in the perfused rat liver.
(Altin & Bygrave, 1985)
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The Ca2+-mobilizing actions of vasopressin and angiotensin differ 
from those of the «-adrenergic agonist phenylephrine in the 
perfused rat liver
Joseph G. ALTIN and Fyfe L. BYGRAVE*
Department of Biochemistry, Faculty of Science, The Australian National University, Canberra, A.C.T. 2601, Australia
A Ca2+-sensitive electrode was used to study net Ca2+-flux changes induced by the administration of 
phenylephrine, vasopressin and angiotensin to the perfused rat liver. The studies reveal that, although the 
Ca2+ responses induced by vasopressin and angiotensin are similar, they are quite different from the Ca2+ 
fluxes induced by phenylephrine. The administration of phenylephrine is accompanied by a stimulation of 
a net amount of Ca2+ efflux (140 nmol/g of liver). A re-uptake of a similar amount of Ca2+ occurs only 
after the hormone is removed. In contrast, the administration of vasopressin or angiotensin to livers perfused 
with 1.3 mM-Ca2+ induces the release of a relatively small amount of Ca2+ (approx. 40 nmol/g of liver) during 
the first 60 s. This is followed by a much larger amount of Ca2+ uptake (70-140 nmol/g of liver) after 1-2.5 min 
of hormone administration, and a slow efflux or loss of a similar amount of Ca2+ over a period of 6-8 min. 
At lower concentrations of perfusate Ca2+ (less than 600 / / m ) these hormones induce only a net efflux of 
the ion. These results suggest that at physiological concentrations of extracellular Ca2+ the mechanism by 
which a-adrenergic agonists mobilize cellular Ca2+ is different from that involving vasopressin and 
angiotensin. It seems that the hormones may have quite diverse effects on Ca2+ transport across the plasma 
membrane and perhaps organellar membranes in liver.
INTRODUCTION
It is well established that the interaction of a number 
of hormones, neurotransmitters and other external 
stimuli with appropriate cell-surface receptors in many 
tissues rapidly mobilize Ca2+ so as to increase the 
cytoplasmic Ca2+ concentration and thereby stimulate 
numerous Ca2+-sensitive physiological responses. Such 
mobilization of Ca2+ appears to involve the generation 
of one or more intracellular signals, among which inositol 
1,4,5-trisphosphate (reviewed by Berridge, 1984; Berridge 
& Irvine, 1984) and possibly polyamines (Koenig et al., 
1983) appear to be candidates.
In the liver tissue, the above-mentioned phenomena 
have been examined in the main with the Ca2+-mobilizing 
agents, a-adrenergic agonists, vasopressin and angioten­
sin. In this regard, it seems to be assumed that each of 
the receptors for these agents is multi-functional, in that 
they form part of a common general transducing 
mechanism for the mobilization of intracellular Ca2+ (see, 
e.g., Exton, 1981; Morgan et al., 1983; Berridge, 1984; 
Reinhart et al., 1984b,c). To our knowledge, however, 
no systemic study has been undertaken to compare in any 
detail the Ca2+-fiux response induced by a-adrenergic 
agonists, vasopressin and angiotensin. Furthermore, it 
appears that progress towards a better understanding of 
the mechanism of action of these hormones is at present 
hindered by conflicting evidence in at least two areas: 
namely, the source or subcellular compartmentation of 
the intracellular calcium that is mobilized, and the extent 
to which extracellular Ca2+ is involved in triggering the 
effects of the hormones under physiological conditions 
(Reinhart et al., 1982, 1984/?; Mauger et al., 1984; Shears
& Kirk, 1984a,b). Also, evidence is appearing to suggest 
that the mechanism of signal transduction for a-adrenergic 
agonists is not the same as that of the vasopressin 
peptides (see, e.g., Dehaye et al., 1981; Corveva et al., 
1984; Huerta-Bahena & Garcia-Sainz, 1985). If the 
assumption is correct that all three receptor types form 
part of a general transducing mechanism, it is reasonable 
to predict that the Ca2+ responses induced by each would 
indeed be similar.
We have examined this assumption in the present 
paper. Specifically, we have used the sensitive Ca2+- 
selective-electrode technique, previously employed in this 
laboratory (Reinhart et al., 1982), to compare the abilities 
of phenylephrine (an a r adrenergic agonist), vasopressin 
and angiotensin to induce changes in Ca2+ fluxes in 
perfused rat liver over a range of perfusate Ca2+ 
concentrations. Our data provide clear evidence that, 
although the pattern of Ca2+ mobilization induced by 
vasopressin is similar to but not identical with that 
by angiotensin, it is quite different from that induced by 
phenylephrine. The implications this could have for the 
commonality of the mechanism by which these hormones 
lead to a rise in the cytosolic Ca2+ concentration, and 
hence to the triggering of physiological responses induced 
by the hormones in the perfused rat liver (and probably 
other tissues), are discussed.
EXPERIMENTAL 
Animals and perfusions
Male Wistar-strain albino rats weighing 230-270 g and 
having free access to food were used for all experiments.
* To whom reprint requests should be addressed.
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Rats were anaesthetized with sodium pentobarbitone 
(50 mg/kg body wt.) and the livers perfused with 
Krebs-Henseleit (1932) bicarbonate buffer equilibrated 
with 0 2/C 0 2 (19:1) as described previously (Reinhart 
et al., 1982). All livers were pre-perfused for 15 min with 
media containing 1.3 m M  added CaCl2 at 35 °C and at a 
flow rate of 3.5 ml/min per g wet wt. of liver. In many 
experiments Ca2+ was infused by means of an infusor 
pump directly into the cannula feeding the portal vein to 
facilitate rapid change of perfusate Ca2+.
Perfusate Ca2+ determinations
For most experiments the perfusate Ca2+ concentration 
was continuously monitored exactly as described pre­
viously (Reinhart et al., 1982). A Radiometer F2112 
Ca2+-selective electrode was placed into a small flow­
through chamber, close to the liver, and coupled to a 
Radiometer K801 (Ag/AgCl) reference electrode via an 
agarose/KCl salt bridge. Signal amplification was 
achieved by connecting both electrodes to an Orion 
model 90! microprocessor ion analyser set to the 
grounded-solution mode. Output was channelled through 
a bucking-voltage device (Madeira, 1975) to a Spectra- 
Physics SP4100 computing integrator which was pro­
grammed to display changes in the perfusate Ca2+ 
concentration (peak height) and the total amounts of 
Ca2+ taken up or extruded by the liver (integration mode). 
Further details are described by Reinhart et al. (1982). In 
the present work the electrical background noise was 
decreased even further than was accomplished previously 
(Reinhart et al., 1982) by increasing the conductivity of 
the salt bridge connecting the electrodes, more extensive 
shielding of all signal leads and the cabinet surrounding 
the perfusion system, and by using an R-C filter to by-pass 
extraneous electrical noise pick-up by the electrode 
system.
Perfusate glucose and oxygen determinations
Glucose release by the liver was determined by the 
glucose oxidase/peroxidase method as previously descri­
bed (Reinhart et al., 1982). Oxygen consumption by the 
liver was calculated from the difference between influent 
and effluent oxygen concentrations measured with a 
Clark-type oxygen electrode modified for a flow-through 
mode of operation.
Chemicals and materials
Phenylephrine, [Arg8]vasopressin, [Val5]angiotensin 
and the glucose assay kit were obtained from Sigma. 
Ca2+-selective electrode membranes (F2112) and filling 
solution S43316 were obtained from Radiometer, 
Copenhagen, Denmark. Other chemicals used were of 
analytical grade.
Expression of data
All experiments were performed at least three times. 
Where indicated, data are expressed as means ± s .e .m . for 
the numbers of independent experiments described.
RESULTS
Further characterization of Ca2 + -flux changes associated 
with phenylephrine action in the perfused rat liver
Studies of the action of Ca2+-mobilizing hormones can 
be exploited to considerable advantage in the perfused rat 
liver, especially since the induced Ca2+-flux changes can
2 min
Perfusion time (min)
J  120
c 160
Duration of phenylephrine stimulation (min)
Fig. 1. Effect of varying the time of phenylephrine administration 
on Ca24 fluxes in perfused rat liver
Livers were perfused with Krebs-Henseleit buffer contain­
ing 1.3 m M  added Ca2+ as described in the Experimental 
section. After a 15 min equilibration period, livers were 
then infused with phenylephrine (2.0 //M final concn.) for 
various times between 15 s and 10 min (arrowed). 
Sufficient time (approx. 5 min) was allowed between pulses 
to let Ca2+ influx proceed to completion. A representative 
trace of only the first four pulses is shown for clarity in (a). 
The data in each curve of (b) were obtained from 
experiments similar to those shown in (a). The amount of 
Ca2+ efflux that occurred with each pulse of phenylephrine 
is expressed as a function of the duration of each pulse. The 
data were obtained from experiments conducted at 1.3 mM  
( • ) ,  300 /im (O) and 50 / / m  (♦ )  perfusate Ca2+ respectively. 
For experiments conducted at 50 /im- and 300 /^M-Ca2+,
1.3 mM-Ca24 was infused only during the first 10 min of the 
pre-perfusion. The liver was then perfused for 5 min at 
the lower Ca2+ concentration before the administration 
of phenylephrine. In these experiments, each pulse of 
phenylephrine was followed by a 5 min infusion of
1.3 mM-Ca24 (and another 5 min perfusion at the lower 
Ca2+ concentration) to replenish the hormone-sensitive 
pool of Ca2+. Data are means + S.E.M. for three to five 
independent experiments.
be continuously and precisely monitored over a range of 
extracellular (perfusate) Ca2+ concentrations from zero to 
1.3 m M  (Reinhart et al., 1982, 19846). Also, it is possible 
with this system to infuse the hormone or agent for any 
specific time and thereby assess not only the Ca2+-flux
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changes associated with the triggering ‘on’ of the system 
but also those that occur when infusion of the agent is 
terminated.
In the first part of this work and as a necessary prelude 
to the data to be presented below, we have used this 
system to examine further two features of phenylephrine- 
induced Ca2+ fluxes not previously characterized in 
perfused rat liver, namely the time of phenylephrine 
administration required to induce maximal responses at 
different Ca2+ concentrations, and the consequence of 
varying the time between repetitive administrations of the 
a-agonist.
Duration of phenylephrine administration required to 
induce maximal Ca2+ efflux
Fig. 1 (a) shows a representative Ca2+-selective-electrode 
trace of the Ca2+ response obtained when phenylephrine 
was administered to the liver for specific times of between 
15 s and 10 min duration. Clearly, the longer the duration 
of the phenylephrine pulse, the greater the amount of 
Ca2+ effluxed. The maximum rate of Ca2+ efflux, 
70-100 nmol of Ca2+/min per g of liver, is achieved with 
a phenylephrine pulse of 40-50 s duration. The relation 
between the duration of phenylephrine administration 
and the amount of Ca2+ effluxed is shown in Fig. 1(6): 
at 1.3 mM extracellular Ca2+ the amount of Ca2+ effluxed 
reaches a maximum (140 nmol of Ca2+/g of liver) after 
3 min of phenylephrine stimulation. By this time, all net 
Ca2+ movement out of the liver is complete, and 
prolonging the hormone stimulation does not result in 
any further Ca2+ efflux.
When similar experiments were carried out but with 
300 / / m  and 50 jtm perfusate Ca2+, efflux of the ion was 
not complete until 4-5 min of phenylephrine infusion at 
300 / / m  extracellular Ca2+, and 6-8 min of phenylephrine 
infusion at 50//M extracellular Ca2+ (Fig. 16). In 
conducting these experiments and those in Fig. 2 (see 
below), it was necessary to infuse 1.3 mM-Ca2+ for 
approx. 5 min after each hormone challenge. This was 
done to accelerate the refilling of the hormone-sensitive 
intracellular Ca2+ pool. The data in Fig. 1(6) also suggest 
that, when the duration of phenylephrine stimulation 
exceeds about 3 min, the amount of Ca2+ effluxed from 
the liver perfused with media containing low Ca2+ (50 ju,m) 
is 10-15% greater than the amount of Ca2+ effluxed from 
the liver perfused with media containing 1.3 mM-Ca2+ 
under otherwise similar experimental conditions.
Variation of the time between consecutive administrations 
of phenylephrine
The representative Ca2+-selective-electrode trace 
shown in Fig. 2(a) provides an indication of two things. 
First it shows that a longer interval between consecutive 
pulses of phenylephrine allows more Ca2+ to be taken up. 
Secondly it shows that, if the second pulse is administered 
early enough, it interferes with the Ca2+-inflow response 
associated with the first pulse. More specifically, the data 
in Fig. 2(a) indicate that, with 1.3 mM extracellular Ca2+, 
the maximum rate of Ca2+ influx that occurs between two 
consecutive 5-min pulses of phenylephrine is 40-50 nmol 
of Ca2+/min per g of liver, and that this is achieved when 
the second pulse of the agonist is administered at least 
40-50 s after the first.
In Fig. 2(6) the amount of Ca2+ taken up by the liver 
is expressed as a function of the time interval between the 
administration of two consecutive phenylephrine pulses.
-  1.29
“  1.28
Perfusion time (min)
E 100
< 20 “V ♦
Time between phenylephrine pulses (min)
Fig. 2. Phenylephrine-induced Ca2+ response obtained when the 
time between two consecutive pulses of hormone is varied
Livers were perfused with Krebs-Henseleit buffer contain­
ing 1.3 mM-Ca2+ as described in the Experimental section. 
After a 15 min equilibration period, phenylephrine (2 //.m ) 
was infused for 5 min (arrowed). The Ca2+-selective 
electrode trace (a) shows the changes in perfusate Ca2+ 
obtained when the time interval between two consecutive 
5 min pulses of phenylephrine was varied between 30 s and 
10 min. Each pair of pulses was followed by a ‘rest period’ 
of approx. 5 min to permit refilling of the hormone-sensitive 
Ca2+ pool. Only the response corresponding to the first two 
pairs of pulses is shown for clarity. (6) shows the amount 
of Ca2+ influx that occurs as a function of the time between 
the two consecutive phenylephrine administrations indica­
ted on the axis. These data were derived from experiments 
of the type shown in (u), conducted at ( • )  1.3 mM-, (O) 
300 //M - and (♦ )  50//M-Ca2+ respectively. Details for the 
perfusions carried out at 50 /im and 300 jum extracellular 
Ca2+ are exactly as described in Fig. 1(6). The data are 
means+ S.E.M. for three to five independent experiments.
It can be deduced that at 1.3 mM extracellular Ca2+ the 
uptake response is essentially complete within 4-5 min of 
hormone removal. Similarly it can be deduced that at 
50 n m extracellular Ca2+ less than 50% of the hormone- 
sensitive pool is refilled by 5 min of phenylephrine 
removal; in this instance the maximum rate of Ca2+ influx 
was estimated to be 10-15 nmol of Ca2+/min per g of 
liver. For 300 / / m extracellular Ca2+, the values are 
intermediate. These data thus indicate that at sub-
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Perfusion time (min)
Fig. 3. Comparison of the Ca2+-flux response in perfused rat liver induced by phenylephrine, vasopressin and angiotensin at different 
concentrations of extracellular Ca2 +
Livers were perfused with Krebs-Henseleit buffer containing ( a )  50 ju m - ,  (b ) 300 f i M - ,  (c) 650 / /m- and ( d )  1.3mM-Ca2+ 
respectively. For the experiments conducted at 50 /i m - , 300 j u m - and 650 jiM-Ca2+, the extracellular Ca2+ concentration was 
maintained at 1.3 mM for the first 10 min of the 15 min equilibration period by infusion from a stock solution; this was followed 
by a 5 min perfusion at the lower Ca2+ concentration. In each experiment phenylephrine (2 jum, A), vasopressin (10 nM, B) or 
angiotensin II (10 nM, C) was infused for 6 min as indicated by the arrows. Each trace is a representative result from four to 
six independent experiments.
physiological concentrations of extracellular Ca2+ the 
removal of phenylephrine is followed by a lower 
maximum rate of Ca2+ uptake by the liver compared with 
that which occurs at 1.3 mM extracellular Ca2+, and hence 
that under these conditions a much longer time is 
required to refill the hormone-sensitive pool of Ca2+.
Comparison of the Ca2+ fluxes induced by phenylephrine, 
vasopressin and angiotensin
The Ca2+ response obtained when maximally effective 
doses of phenylephrine, vasopressin or angiotensin are 
infused to livers at perfusate Ca2+ concentrations of 
50 //M, 300 j u m , 650 j u m  or 1.3 mM is shown in Fig. 3. In 
each situation the agent was infused twice, each for 6 min, 
with an intervening recovery interval of 10 min. These 
conditions differ from those used in an earlier study 
(Reinhart et al., 1982) in that they allow for the Ca2+ 
efflux and influx responses to be near-fully expressed at 
both high and low extracellular Ca2+ concentrations and 
allow time for the depleted agonist-sensitive pools of Ca2+ 
to be refilled (see Fig. 2).
The traces in Fig. 3(A) outline the apparent trend by 
which infusing the first pulse of phenylephrine induces a 
smaller net amount of Ca2+ efflux as the extracellular 
Ca2+ concentration is increased, i.e. although the peak 
height is approximately the same for all four responses, 
the area under the curve diminishes. A second trend is 
evident in Fig. 3(A); as the perfusate Ca2+ concentration 
is increased, so do the rate and extent of Ca2+ inflow after
removal of the hormone. In these experiments, and 
consistent with the information in Fig. 2, recovery is 
near-maximal even when the external Ca2+ concentration 
is only 600 j u m  and occurs within approx. 6 min of 
terminating the administration of the agonist. Adminis­
tration of a second pulse of the agonist produces a 
similar response to the first at perfusate Ca2+ concentra­
tions of 600//M and 1.3 mM. At 50 j u m  perfusate Ca24, 
however, a different response is consistently observed. It 
exhibits a characteristic multi-peaked shape that is less 
evident at 300 //M extracellular Ca2+. Approximately the 
same amount of Ca2+ is effluxed as in the first Ca2+ 
response. Attempts to link individual peaks with indi­
vidual intracellular Ca2+ pools by using inhibitors of 
mitochondrial respiration were attempted, but proved 
unsuccessful.
Experiments like those described for phenylephrine 
(Fig. 3A) were carried out also with vasopressin being 
administered in place of the a-agonist. Data in Fig. 3(B) 
show that the Ca2+ responses differ in several key 
respects. The first major difference is that, after the initial 
pulse of vasopressin, increases in the external net Ca2+ 
concentration diminish far more significantly as the 
perfusate Ca2+ concentration increases. Together with 
this, a spontaneous influx of the ion occurs at 1.3 mM 
perfusate Ca2+, after some 40 s, when only approx. 
40 nmol of Ca2+/g of liver has effluxed. This is complete 
by approx. 4 min; a trend towards this situation is ap­
parent even at 650 j u m  perfusate Ca2+. The second major
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Fig. 4. Effect of varying the time of vasopressin and angiotensin 
administration on the Ca2+ response
Livers were perfused with Krebs-Henseleit buffer contain­
ing 1.3 mM-Ca2+. After a 15 min pre-perfusion period, 
vasopressin (10 nM) infusion was begun as indicated by 
the arrow. The traces shown indicate the Ca2+ response 
obtained from separate experiments in which vasopressin
was administered for 15 s ( ........), 30 s (------- ) and 45 s
(------) respectively. Each trace is representative of three
independent experiments conducted for each duration of 
hormone administration. Changes in perfusate Ca2+ were 
measured with the Ca2+-selective electrode. An essentially 
identical result was obtained with angiotensin (10 nM) 
instead of vasopressin.
difference of note is that, consequent to termination of 
vasopressin infusion, no clear evidence of Ca2+ influx 
(rate < 15 nmol/min per g of liver) is observed for any 
concentration of perfusate Ca2+. The third major 
difference is that the Ca2^  response to the second pulse 
of vasopressin administration is much less than the first 
in all instances except at 1.3 mM perfusate Ca2+. At 50 / / m 
perfusate Ca2+, vestiges of the multi-peaked trace seen 
after phenylephrine infusion are apparent. In other 
experiments (results not shown) it was found that at 
1.3 mM perfusate Ca2+ the spontaneous Ca2+-flux 
changes seen with the pulse of vasopressin could be 
induced a second time only when the recovery period 
between consecutive pulses was about 40 min or longer.
The above sequence of experiments was repeated, this 
time with angiotensin in place of phenylephrine (Fig. 3C). 
In general the Ca2+ responses are similar to those induced 
by vasopressin. The major points of differences between 
angiotensin and vasopressin are the sharper Ca2+-efflux 
peaks at all concentrations of perfusate Ca2+, and the 
occurrence of the spontaneous re-influx of Ca2+ at lower 
perfusate Ca2+ concentrations.
Other features of the Ca2+ response induced by 
vasopressin and by angiotensin
At both 50 [iu and 1.3 mM extracellular Ca2+, the onset 
of the Ca2+-flux changes induced by vasopressin occurs 
after 10 ± 1 s and 11 ± 1 s, respectively, of administration 
(results not shown). The onset of these responses is thus
3  1.30
I  1.26
fc 1.24
3  200
E 0.6
6  g 0.2
Perfusion time (min)
Fig. 5. Effect of vasopressin on perfusate Ca2+ concentration, 
oxygen uptake and glucose release in the perfused rat liver
Livers were perfused with Krebs-Henseleit buffer contain­
ing 1.2 mM-Ca2+. After the first 15 min of pre-perfusion, 
vasopressin (10 nM) was infused as indicated (arrowed). 
The Ca2+-selective electrode trace of the perfusate Ca2+ 
concentration is shown in (a) and the concurrent changes 
in the perfusate oxygen and glucose concentration are 
shown in (b) and (c) respectively. Oxygen was measured 
with a Clark-type oxygen electrode; glucose was measured 
in samples of perfusate collected at 15 s and 30 s intervals. 
Other details are as stated in the Experimental section. 
Each trace in (a) and (b) is representative of six to eight 
independent experiments. The data in (c) are the means of 
three independent experiments; s.e.m . values were always 
less than 0.03 mM and have been omitted for clarity.
4-5 s slower than the onset of those induced by 
phenylephrine under identical experimental conditions 
(Reinhart et al., 1982). Similar conclusions had been 
reached previously by Charest et al. (1983), studying the 
ability of vasopressin and a-adrenergic agonists to induce 
increases in cytoplasmic Ca2+ in rat hepatocytes.
The effect of varying the time of vasopressin 
administration to the liver perfused with media containing 
1.3 mM extracellular Ca2+ is shown in Fig. 4. The data 
show that a maximal change in the Ca2+ response is 
achieved when vasopressin is administered for only 45 s. 
Shorter times of hormone administration, however, result 
in a decrease in the amount of spontaneous Ca2+ uptake 
that occurs after the administration of the first pulse and 
results also in a decrease in the total net amount of Ca2+ 
efflux associated with subsequent short vasopressin pulses 
(results not shown). Essentially similar results were 
obtained with angiotensin.
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Correlation with glucose output and oxygen uptake
Because the Ca2+ response induced by vasopressin at
1.3 mM extracellular Ca2+ was different from that induced 
by phenylephrine, it seemed important to examine the 
effects of vasopressin on other physiological responses, 
such as, oxygen uptake and glucose output. The data in 
Figs. 5(a), 5(6) and 5(c) show the vasopressin-induced 
Ca2+, oxygen-uptake and glucose-output responses 
respectively. The oxygen-uptake response induced by 
vasopressin (Fig. 5b) returned slowly to the pre-stimulated 
value, even while the hormone was still being infused. 
This result is quite unlike the stimulation of oxygen 
uptake induced by phenylephrine at 1.3 mM extracellular 
Ca2+, which is sustained for the duration of hormone 
administration (see Reinhart et al., 1982). In contrast with 
the transient nature of the Ca2+ and oxygen responses 
induced by vasopressin, the stimulation of glucose out­
put by vasopressin (Fig. 5c) appeared sustained for 
the duration of vasopressin stimulation. On removal of the 
hormone, however, the return of glucose output to 
the basal value was not as rapid as observed with 
phenylephrine (see Reinhart et al., 1982). Again the 
pattern of responses induced by angiotensin was similar 
to that of vasopressin (results not shown).
DISCUSSION
In the light of the findings reported in this paper, we 
suggest that certain aspects of the mechanism of action 
of Ca2+-mobilizing hormones may need to be revised, at 
least as they relate to liver tissue. The Ca2+-selective 
electrode used in the present study revealed differences in 
the action of phenylephrine, vasopressin and angiotensin 
in inducing Ca2+ fluxes in the perfused rat liver over a 
range of perfusate Ca2+ concentrations from 50 //m to
1.3 mM.
The data on Ca2+-flux changes in the intact liver 
obtained with phenylephrine as stimulus (Fig. 3 A) extend 
that obtained previously (Reinhart et al., 1982). Clearly, 
in the course of a prolonged pulse of the agonist, a precise 
amount of Ca2+ is released from the liver. As long as the 
agonist continues to be infused, the liver remains depleted 
of this Ca2+. Removal of the agonist then triggers the 
re-uptake of the same amount of Ca2+ that previously had 
been released. This sequence can be repeated as many as 
25 times (Reinhart et al., 1982) provided that the 
perfusate Ca2+ concentration is greater than approx. 
50 //M and sufficient time is allowed for the depleted 
intracellular Ca2+ pool(s) to refill (the present work; and 
see Morgan et al., 1982). These features have been 
observed in qualitative terms also by Sies et al. (1983) and 
by Morgan et al. (1982); unfortunately, though, and as 
recognized by Sies et al. (1983), the large electrical noise 
background in their traces did not permit a quantitative 
analysis of the Ca2+-flux changes. A similarly large scatter 
exists in the data presented by Morgan et al. (1982), who 
measured changes in extracellular Ca2+ by atomic 
absorption spectroscopy in a perfusate Ca2+ concentration 
of 1 mM. The accumulated errors involved in measuring 
changes of several /^ m Ca2+ when the perfusate Ca2+ 
concentration is greater than about 300 jum previously led 
us to abandon this particular experimental approach 
(J. G. Altin & F. L. Bygrave, unpublished work).
The major point arising out of the present work is that 
administration of vasopressin and angiotensin to livers 
perfused with 1.3 mM-Ca2+ induces Ca2+-flux changes
which, in several respects, are quite different from those 
observed after phenylephrine administration (Figs. 3B 
and 3C). First, a much smaller quantity of Ca2+ is 
released from the liver; this is soon followed by a 
spontaneous uptake of the ion even while the hormone 
is still being infused. A similar difference between 
vasopressin and phenylephrine in inducing a Ca2+ 
response is present in the data of Sies et al. (1983). In their 
experiments, Morgan et al. (1982) observed no difference 
between the effects of the two hormones on Ca2+ fluxes 
in the perfused rat liver and concluded that they have 
similar mechanisms of action. A second important 
difference between the actions of phenylephrine and those 
of vasopressin and angiotensin in the rat liver perfused 
with 1.3 mM-Ca2+ is that, within the time course of one 
experiment (<  60 min), a second pulse of the hormone 
fails to elicit the same response as observed with the initial 
pulse (see Fig. 3).
This work raises a number of questions concerning the 
mechanism of action of Ca2+-mobilizing hormones in 
liver. Firstly, the spontaneity of the Ca2+ influx observed 
when vasopressin or angiotensin is infused into the intact 
liver, and the subsequent inability of these hormones to 
induce a second response (see also Breant et al., 1981), 
is of interest. In this regard, there now is good evidence 
that a further action of Ca2+-mobilizing hormones, in 
addition to mobilizing intracellular Ca2+ (reviewed by 
Reinhart et al., 19846; Williamson et al., 1985) is to 
induce inward movement of the ion (Barritt et al., 1981; 
Blackmore et al., 1984; Mauger et al., 1984) and an 
increase in the rate of plasma-membrane Ca2+ cycling 
(Reinhart et al., 1984a). The present work in fact shows 
that phenylephrine, vasopressin and angiotensin differ 
in their ability to stimulate a net inward movement of 
Ca2+. Whether Ca2+ channels (see, e.g., Taylor et al., 
1985) and/or specific interactions between these and the 
various hormone receptors are involved remains to be 
clarified. Furthermore, the possible effects of these 
hormones on the plasma-membrane Ca2+-activated 
ATPase (Lin et al., 1983; Prpic et al., 1984) also requires 
clarification (Epping & Bygrave, 1984).
Another question that arises out of this work is the 
relation between the observed Ca2+-flux changes and the 
physiological responses as reflected in the increased 
glucose production and oxygen uptake (Fig. 5). Although 
we did not measure changes in cytoplasmic Ca2+ in this 
work, Charest et al. (1983) have shown with rat 
hepatocytes that vasopressin induces an increase in such 
Ca2+. Clearly it will be important to attempt to measure 
changes in cytoplasmic Ca2+ in the intact perfused rat 
liver.
The third question relates to the nature of the signal(s) 
generated by these hormones at the plasma membrane. 
It has been reported by several laboratories (Burgess 
etal., 1984; Thomas et al., 1984; Berridge, 1984; Berridge 
& Irvine, 1984) that the purported (common) signal 
generated by each of these hormones is inositol 
1,4,5-trisphosphate; this appears to induce a release of 
Ca2+ from only non-mitochondrial sources (see, e.g., 
Shears & Kirk, 19846), and thus presumably from 
endoplasmic reticulum (Burgess et al., 1984; Prentki et 
al., 1984; Dawson & Irvine, 1984; Hirata et al., 1984; 
Joseph et al., 1984). However, the present work, showing 
that the pattern of Ca2+ mobilization induced by 
phenylephrine is different from that induced by vasopres­
sin and angiotensin, supports the idea (Dehaye et al.,
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1981) detailed by Huerta-Bahena & Garcia-Sainz (1985) 
that the nature of the signals generated by these two sets 
of hormones is different. Whether the signal(s) generated 
by these hormones have different effects on Ca2+ 
transport across the plasma membrane and/or organellar 
membranes, or whether different hormone-operated Ca2+ 
channels are involved at the plasma membrane, requires 
investigation. In this regard the intracellular fate of the 
Ca24 spontaneously taken up by the liver (Figs. 3B and 
3 0  is of especial interest.
In conclusion it would appear that the mechanism by 
wh:ch vasopressin and angiotensin mobilize Ca2+ in the 
perfused rat liver is not the same as that for a-adrenergic 
agonists, a feature that may be relevant also to other 
issues.
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Section B.6
Synergistic stimulation of Ca2+ uptake by glucagon and Ca2+-mobilizing hormones 
in the perfused rat liver. A role for mitochondria in long-term Ca2+ homeostasis.
(Altin & By grave, 1986)
Biochen. J. (1986) 238, 653-661 (Printed in Great Britain) 653
Synergistic stimulation of Ca2+ uptake by glucagon and 
C a2+-mobilizing hormones in the perfused rat liver
A role for mitochondria in long-term Ca2+ homoeostasis
Joseph G. ALTIN and Fyfe L. BYGRAVE*
Department of Biochemistry, Faculty of Science, The Australian National University, Canberra, A.C.T. 2601, Australia
A perfused liver system incorporating a Ca2+-sensitive electrode was used to study the long-term effects of 
glucagon and cyclic AMP on the mobilization of Ca2+ induced by phenylephrine, vasopressin and 
angiotensin. At 1.3 mM extracellular Ca2+ the co-administration of glucagon (10 nM) or cyclic AMP (0.2 ium) 
and a Ca2+-mobilizing hormone led to a synergistic potentiation of Ca2+ uptake by the liver, to a degree 
which was dependent on the order of hormone administration. A maximum net amount of Ca2+ influx, 
corresponding to approx. 3800 nmol/g of liver (the maximum rate of influx was 400 nmol/min per g of liver), 
was induced when cyclic AMP or glucagon was administered about 4 min before vasopressin and 
angiotensin. These changes are over an order of magnitude greater than those induced by Ca2+-mobilizing 
hormones alone [Altin & Bygrave (1985) Biochem. J. 232, 911-917], For a maximal response the influx of 
Ca2+ was transient and was essentially complete after about 20 min. Removal of the hormones was followed 
by a gradual efflux of Ca2+ from the liver over a period of 30-50 min; thereafter, a similar response could 
be obtained by a second administration of hormones. Dose-response measurements indicate that the 
potentiation of Ca2+ influx by glucagon occurs even at low (physiological) concentrations of the hormone. 
By comparison with phenylephrine, the stimulation of Ca2+ influx by vasopressin and angiotensin is more 
sensitive to low concentrations of glucagon and cyclic AMP, and can be correlated with a 20-50-fold 
increase in the calcium content of mitochondria. The reversible uptake of such large quantities of Ca2+ 
implicates the mitochondria in long-term cellular Ca2+ regulation.
INTRODUCTION
The movement of Ca2+ ions across cellular and 
organellar membranes appears to be an essential 
phenomenon that is associated with the action of many 
hormones, and other similar biological substances. Work 
on the mechanism of action of the Ca2+-mobilizing 
hormones a r adrenergic agonists, vasopressin and angio­
tensin, has shown that the receptor-mediated breakdown 
of phosphatidylinositol 4,5-bisphosphate leads to the 
production of inositol 1,4,5-trisphosphate, which appears 
to be the signal that triggers the release of Ca2+ from the 
endoplasmic reticulum (Creba et al., 1983; Berridge, 
1984; Joseph et al., 1984; Burgess et al., 1984; Charest 
et al., 1985). Although this model seems to account for 
the initial triggering of the physiological responses that 
are induced, little is known at present about the 
mechanism by which the hormones stimulate the influx 
of extracellular Ca2+ that is necessary in order to sustain 
the physiological responses that follow the depletion of 
the intracellular Ca2+ stores (Reinhart et al., 1984b,c).
We previously reported (Altin & Bygrave, 1985) that 
the actions of phenylephrine, vasopressin and angiotensin 
differ in their ability to stimulate the net movement of 
Ca2+ into the perfused liver. In particular, we presented 
evidence which suggests that, unlike phenylephrine, both 
vasopressin and angiotensin each induce a spontaneous 
net uptake of Ca2+ even while the hormone is still being
administered. In view of reports that glucagon and cyclic 
AMP can modulate the Ca2+ mobilization induced by 
Ca2+-mobilizing hormones (Morgan et al., 1983a,b; 
Cocks et al., 1984), it seemed important to examine 
whether cyclic AMP might be involved in eliciting the 
different Ca2+ flux responses that we had observed (Altin 
& Bygrave, 1985). It also has been known for some years 
that glucagon or cyclic AMP alone is able to induce a 
redistribution of Ca2+ in the perfused rat liver (Friedmann 
& Park, 1968).
In the present work we have used the Ca2+-selective 
electrode to study further the difference in the Ca2+-flux 
responses induced by phenylephrine, vasopressin and 
angiotensin, and to examine the interaction of glucagon 
(and cyclic AMP) with these hormones in stimulating 
Ca2+ uptake by the perfused rat liver. Our results show 
that the interaction of phenylephrine, vasopressin or 
angiotensin with glucagon (or exogenous cyclic AMP) 
can have profound effects on the Ca2+-flux changes that 
are induced. Furthermore, measurement of the total 
calcium content of subcellular fractions obtained by 
Percoll-density-gradient subfractionation of the liver 
after hormonal challenge show that the mitochondria are 
the sink for the Ca2+ uptake that occurs. We conclude 
that mitochondria play an important role in regulating 
long-term cellular and perhaps cytoplasmic Ca2+ concen­
trations. The physiological relevance of this in terms of 
liver metabolism is discussed.
* To whom reprint requests should be sent.
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EXPERIMENTAL 
Animals and perfusions
For all experiments male Wistar-strain albino rats 
weighing 280-350 g and having free access to food were 
used. Rats were anaesthetized with sodium pentobar­
bitone (50 mg/kg body wt), and the livers were perfused 
with Krebs-Henseleit (1932) bicarbonate buffer equili­
brated with 0 2/C 0 2 (19:1) and containing 1.3 mM added 
CaCl2. All perfusions were conducted in a non­
recirculating mode at a flow rate of 3.5 ml/min per g 
wet wt. of liver. All livers were pre-perfused for 15 min 
before the infusion of hormone. Other results are exactly 
as in Reinhart et al. (1982b).
Perfusate Ca2+ measurements
The perfusate Ca2+ concentration was monitored 
continuously with a Radiometer F2112 Ca2+-selective 
electrode in a flow-through chamber placed on the 
outflow side of the liver (Reinhart et al., 1982b). The 
electrode was coupled to a Radiometer K801 reference 
electrode via an agarose/KCl salt-bridge, and the 
combined signals were fed via an Orion microprocessor 
ion-analyser to a SP4100 computing integrator for 
recording and analysis. For other details see Altin & 
Bygrave (1985).
Liver subfractionation
This was carried out exactly as described by Reinhart 
et al. (1982a). Briefly, after termination of hormone 
infusion, the liver was perfused for 2 min with 
Krebs-Henseleit medium containing no added Ca2+ but 
instead 50 //m-EGTA, as indicated in the legend to 
Fig. 4. The liver was homogenized in a medium consist­
ing of 210 mM-mannitol, 60 mM-sucrose, lOmM-KCl, 
20 //m-EGTA and 10 mM-Hepes/KOH buffer (pH 7.4). 
A portion of the resulting homogenate (2 ml) was 
layered on a discontinuous gradient of iso-osmotic 
Percoll, and centrifuged for 30 s at 39600gav in a 
Sorvall RC-5B refrigerated centrifuge fitted with an SS-34 
rotor. In this way the homogenate was separated into ten 
distinct fractions within a total preparation time of 
6 min. Fraction 8, and fractions 1 and 2, previously have 
been shown to be enriched in mitochondria and 
endoplasmic reticulum respectively (see Reinhart et al., 
1982a). The calcium content of these fractions isolated 
from control perfused rat livers (see Fig. 4) is closely 
related to estimations of the calcium content of 
mitochondria and endoplasmic reticulum in vivo (Rein­
hart et al., 1982a, 1984a; Somlyo et al., 1985). 
Immediately after isolation, a portion of each fraction 
was used for protein determination by the method of 
Lowry et al. (1951), and the remainder was extracted 
with ice-cold 2 m-HC104, and a suitable sample of the 
supernatant was analysed for calcium by atomic- 
absorption spectroscopy.
Chemicals and materials
Phenylephrine, [Arg8]vasopressin, [Val5]angiotensin 
and dibutyryl cyclic AMP were obtained from Sigma 
Chemical Co., St. Louis, MO, U.S.A. Glucagon was 
obtained from Eli Lilly and Co., Indianapolis, IN, 
U.S.A. Percoll and density-marker beads were obtained 
from Pharmacia Fine Chemicals A.B., Uppsala, Sweden. 
Ca2+-selectrode membranes (F2112) and filling solutions 
S43316 were obtained from Radiometer, Copenhagen, 
Denmark. Other chemicals used were of analytical grade.
Expression of data
All experiments were performed at least three times. 
Where indicated, data are expressed as means± s.e.m. for 
the numbers of independent experiments described.
RESULTS
Effect of glucagon and cyclic AMP on Ca2+ mobilization 
induced by phenylephrine, vasopressin and angiotensin
Although some studies have been carried out on the 
influence of glucagon on the Ca2+ fluxes induced by 
Ca2+-mobilizing hormones, it appears that much infor­
mation still remains to be gained. The studies by Morgan 
et al. (1983a) and Mauger et al. (1985) have revealed 
some interesting aspects of the short-term effects of these 
hormones on the Ca2+ changes that are induced. 
However, our use of the perfused liver system, incor­
porating the Ca2+-selective electrode, provides a means 
of monitoring these Ca2+-flux changes over an extended 
period.
The data in Fig. 1 show typical Ca2+-selective-electrode 
traces of the Ca2+-flux changes that are induced when 
cyclic AMP is administered (a) after, (b) at the same time 
as, and (c) before, the infusion of phenylephrine, 
vasopressin and angiotensin to the perfused liver. 
Exogenous cyclic AMP was used instead of the cyclic 
AMP-producing hormone glucagon, in order to eliminate 
possible secondary effects of glucagon on the plasma 
membrane. The use of the Ca2+-selective electrode to 
monitor the response continuously over a long period of 
time (approx. 1 h) reveals several important features of 
the modulation of the hormone-induced Ca2+ response 
by cyclic AMP, which were not revealed in the earlier 
work of Morgan et al. (1983a).
First, in each instance the stimulation of Ca2+ influx is 
transient and is dependent on the order of cyclic AMP 
and hormone administration (cf. Figs, la, 1 b and lc). 
Preliminary experiments showed that near-maximal 
stimulation of Ca2+ uptake by the liver occurred when the 
infusion of cyclic AMP (0.2 mM) preceded the infusion of 
hormone by about 4 min (results not shown). The 
maximum rate of Ca2+ uptake achieved by a 4 min 
pretreatment with 0.2 mM-cyclic AMP was 380-420 
nmol/min per g of liver for both vasopressin and 
angiotensin, and 270-300 nmol/min per g of liver for 
phenylephrine (see Fig. lc and Table 1). In each of these 
situations the maximum rate of Ca2+ uptake was 
achieved after about 90 s of hormone infusion. Further­
more, the uptake response was transient but nevertheless 
dependent on the co-administration of both cyclic AMP 
and hormone, as the removal of either agent resulted in 
a cessation of Ca2+ uptake within 2-5 min (results not 
shown). By contrast, the prolonged co-administration of 
cyclic AMP and hormone resulted in an uptake response 
which was nearly complete only after about 20 min. By 
this time the net amount of Ca2+ uptake by the liver was 
3850 +330 nmol/g of liver for each of vasopressin and 
angiotensin, and 1250+ 160 nmol/g of liver for phenyl­
ephrine. These Ca2+ changes are much greater than those 
induced by the administration of Ca2+-mobilizing 
hormones alone, about 140 nmol/g of liver (see Altin & 
Bygrave, 1985). A 2 min administration of hormone 
(with 4 min pre-administration of cyclic AMP) resulted 
in an uptake of Ca2+ corresponding to only about 40% 
of these values (results not shown). The corresponding
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Fig. 1. Effect of cyclic AM P on the Ca2+ response induced by the administration of Ca2+-mobilizing hormones to the perfused liver
Livers of fed rats were perfused with Krebs-Henseleit bicarbonate medium containing 1.3 mM-Ca2+. The Ca2+ concentration 
of the effluent perfusate was monitored continuously with a Ca2+-selective electrode. See the Experimental section for further 
details. After an equilibration period of about 15 min, both cyclic AMP (0.2 mM) and a Ca2+-mobilizing hormone were 
co-administered by separate infusion syringes for the times indicated by the bold and the thin arrowed bars respectively. The
traces show the Ca2+ response that is induced by the co-ac"».inistration of cyclic AMP with vasopressin (10 nM) (-------),
angiotensin (10 nM) (......... ) or phenylephrine (2 j u m ) (••••).  The traces in (a), (b ) and (c) represent experiments for which the
infusion of vasopressin, angiotensin or phenylephrine was commenced 4 min before, at the same time as, or 4 min after, the 
infusion of cyclic AMP, respectively. Because a non-recirculating perfusion system was used, pen deflection above an imaginary 
baseline at 1.28 mM-Ca2+ represents Ca2+ efflux, whereas deflection of the pen below the baseline represents Ca2+ influx. Each 
trace is a representative of three to five experiments performed independently. Differences between the Ca2+ influx induced by 
phenylephrine and that induced by vasopressin and angiotensin became less obvious, whereas the Ca2+ response induced by 
vasopressin and angiotensin was essentially unchanged, when glucagon (10 nM) was used instead of cyclic AMP.
Table 1. Maximum rates of Ca2+ influx and Ca2+ efflux, and the corresponding net amounts of Ca2+ influx and Ca2+ efflux, induced 
by the co-administration of cyclic AM P (0.2 mM) and maximal doses of vasopressin, angiotensin and phenylephrine
Liver perfusions were conducted exactly as described in the legend to Fig. 1. The Table gives the magnitude of the Ca2+-flux 
changes that are induced after the first cycle of hormone administration and hormone removal in each Ca2+-selective-electrode 
trace in Figs. 1(a), 1(6) and 1(c). The maximum rate of Ca2+ influx or Ca2+ efflux was calculated from the maximum deflection 
of the pen from the baseline, and the maximum net amount of Cs2+ influx and Ca2+ efflux was computed from the areas above 
or below the relevant section of curve, respectively. Values are means+ S.E.M. for three to five independent experiments. Values 
in parentheses show the maximum rates, in nmol/min per g of liver; the s .e .m . is omitted for clarity, but was always less than 
10% .
Order of administration 
of agents
Influx Efflux
(nmol of Ca2+/g  of liver) (nmol of Ca2+/g  of liver)
Cyclic AMP before vasopressin 
Vasopressin with cyclic AMP 
Vasopressin before cyclic AMP
3850 + 330 (395) 
2350 + 240 (250) 
1170+150 (160)
1470 + 250 (112) 
1300+180 (76) 
690 + 90 (52)
Cyclic AMP before angiotensin 
Angiotensin with cyclic AMP 
Angiotensin before cyclic AMP
3985 + 350 (408) 
2755 + 235 (286) 
1860 + 214 (190)
2150 + 210 (140) 
1790+ 105 (113) 
1160+ 120 (95)
Cyclic AMP before phenylephrine 
Phenylephrine with cyclic AMP 
Phenylephrine before cyclic AMP
1250+160 (284) 1330+145 (90)
540 + 38 (66 ) 312 + 26 (51)
307 + 26 (86 ) 180+18 (43)
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average maximum change in perfusate Ca2+ concentra­
tions was approx. 120 fiM for vasopressin and angiotensin. 
These changes are greater than those described in the 
experiments of Morgan et al. (1983a), where the average 
change in perfusate Ca2+ concentration was measured to 
be 70 fiM.
As shown in Figs. 1 (b) and 1(c) and Table 1, both the 
maximum rates and the net amounts of Ca2+ uptake were 
considerably decreased, to about 70% and 40%, when 
cyclic AMP was administered at the same time as, or 
4 min after, the hormones, respectively. It is relevant that 
administration of cyclic AMP alone induced only a 
relatively small amount of Ca2+ efflux (<  50 nmol/g of 
liver), sometimes followed by a smaller amount of Ca2+ 
influx (<  15 nmol/g of liver). Similar results were ob­
tained by using glucagon (10 nM) instead of cyclic AMP; 
however, with glucagon both the net amount and the 
maximum rate of Ca2+ influx tended to be 10-15% 
greater, probably owing to the higher intracellular cyclic 
AMP concentrations that are generated (results not 
shown). These data thus suggest that glucagon and its 
second messenger, cyclic AMP, interact synergistically 
with Ca2+-mobilizing hormones in stimulating Ca2+ up­
take by the liver. A similar conclusion was reached by 
Mauger et al. (1985), who studied the stimulation of 
45Ca2+ uptake by hepatocytes. Further, our results clearly 
demonstrate that the degree of stimulation is dependent 
on the temporal relationship between the hormone- 
receptor interaction and the cyclic-AMP-triggered events 
that may be involved. Also, the ability of cyclic AMP plus 
phenylephrine to stimulate Ca2+ influx is only about 
30-40% of that of cyclic AMP plus vasopressin, and
cyclic AMP plus angiotensin, under otherwise identical 
experimental conditions (see Fig. 1 and Table 1).
A second important feature of the Ca2+ response 
induced by the co-administration of cyclic AMP with 
phenylephrine, vasopressin or angiotensin is that the 
Ca2+-uptake phase of the response (which lasts for about 
20 min for a prolonged administration of hormones) is 
followed by a more gradual efflux of Ca2+ from the liver 
once the hormones are removed. Both the time over 
which the Ca2+ effluxes, and the maximum rate at which 
the efflux occurs, appear to be dependent on the amount 
of Ca2+ previously accumulated. For a prolonged 
stimulation by cyclic AMP plus hormone (20 min), which 
results in a large uptake of Ca2+ (approx. 3850 nmol/g 
of liver with vasopressin and angiotensin, for example), 
the maximum rate of Ca2+ efflux is 90-140 nmol/min per 
g of liver (see Fig. 1 and Table 1). This decreases to less 
than 20 nmol/min per g of liver 30 min after removal of 
the stimulus. At this time a similar Ca2+-uptake response 
again can be induced by hormone administration, 
suggesting that, insofar as Ca2+ uptake is concerned, no 
permanent liver damage has occurred (see Fig. 1). It is 
also noteworthy that the time taken to reach a maximum 
rate of Ca2+ efflux after the removal of stimulation differs 
with each hormone: about 2 min for cyclic AMP plus 
phenylephrine, 6-10 min for cyclic AMP plus angiotensin, 
and 10-15 min for cyclic AMP plus vasopressin. This 
suggests that the characteristic effect of each hormone 
continues to be registered by the liver for some 
considerable time after the removal of hormone 
stimulation.
Despite the characteristic differences in the time
Vasopressin
/  Angiotensin 
Phenylephrine
400
Vasopressin
Angiotensin
Phenylephrine
—log{[Hormone] (m )} —log{[Glucagon] (m )(
Fig. 2. Dose-response: effect of varying the concentration of Ca2+-mobilizing hormone (a) or glucagon (6) on the maximum rate of 
Ca2+ influx
Liver perfusions were conducted as described in the legend to Fig. 1. At 10 min of perfusion, vasopressin, angiotensin or 
phenylephrine was infused for 2 min. This was done to avoid the spontaneous influx of Ca2+ that is normally observed with 
a prior administration of these hormones (Altin & Bygrave, 1985). At 25 min of perfusion, glucagon was infused at the 
concentration indicated. At 29 min of perfusion (4 min later), vasopressin, angiotensin or phenylephrine was also infused. The 
perfusate Ca2+ concentration was continuously monitored with a Ca2+-selective electrode as previously described. Each point 
denotes the maximum rate of Ca2+ uptake that is induced at the different concentrations of either Ca2+-mobilizing hormone 
(a) or glucagon (b ). For all the points in (a), a maximal dose of glucagon (10 nM) was used; conversely, for all points in (b ) 
maximal doses of vasopressin and angiotensin (10 nM) and phenylephrine (2 f i u )  were used. In experiments where phenylephrine 
was used, the specific a 2-adrenergic receptor antagonist yohimbine (5 / i m ) was co-infused with glucagon for 4 min before the 
infusion of phenylephrine to inhibit a 2-receptor binding. Each point represents the mean + s.E.M. of three to six independent 
experiments conducted at each particular concentration of hormone.
1985
Synergistic action of glucagon and Ca2+-mobilizing hormones
Cyclic jV
t AMP
-1 0 0
^Cyclic AMP
Perfusion time (min)
Fig. 3. Effect of the successive infusion of two different 
Ca2+-mobilizing hormones on the Ca2+-uptake response 
potentiated by cyclic AMP
Livers of fed rats were perfused with Krebs-Henseleit 
bicarbonate medium containing 1.3 mM-Ca2+. The per­
fusate Ca2+ concentration was monitored continuously 
with a Ca2+-selective electrode. At 16 min of perfusion, 
cyclic AMP (10 m M ) was administered by infusion syringe, 
as indicated by the bold line. At 20 min and 22 min of 
perfusion, vasopressin (V; 10 nM) and phenylephrine (P;
10 fiM) were also infused, as indicated by the broken and 
thin lines respectively. The resulting trace of the Ca2+ 
response is shown in (a). The trace in (b) shows the Ca2+ 
response for a similar experiment in which the order of 
infusion of vasopressin and angiotensin was reversed. 
Each trace is a representative of three independent 
experiments. Almost identical results were obtained when 
angiotensin (10 nM ) was used instead of vasopressin.
required to reach the maximum rate of Ca2+ efflux after 
the removal of hormone stimulation, these results appear 
to suggest that the extrusion of Ca2+ continues for the 
period of time necessary to re-establish the initial 
steady-state concentrations of Ca2+ before the effects of 
the hormones. It is only after this time has elapsed that 
a second response, identical with the first, can be 
induced. A tendency towards this effect can be seen after 
the second period of hormonal challenge in Figs. 1(a), 
1 (b) and 1(c). Again, similar results were obtained when 
glucagon (10 nM) was administered instead of cyclic 
AMP. These results indicate that, even after the 
co-administration of maximal doses of these hormones, 
the liver has a capacity for regulating the Ca2+-transport 
processes necessary to re-establish a basal level of 
physiological response and metabolic activity once the 
hormones are removed.
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Dose-response of the synergistic stimulation of Ca2 + 
influx by glucagon and Ca2+-mobilizing hormones
In order to gain evidence as to whether the 
potentiation by glucagon (and cyclic AMP) of the 
Ca2+-uptake response induced by phenylephrine, vaso­
pressin and angiotensin could be of physiological 
significance, dose-response measurements were carried 
out. The data in Fig. 2 show the maximum rate of Ca2+ 
uptake that is induced by phenylephrine, vasopressin and 
angiotensin as a function of the concentration of these 
hormones (Fig. 2a), or the concentration of glucagon 
(Fig. 2b). Each concentration point represents a separate 
experiment in which glucagon (at the specified concen­
tration) was administered 4 min before the infusion of 
phenylephrine, vasopressin or angiotensin.
Two features can be seen from the dose-response 
curves in Fig. 2. Firstly, the potentiation of Ca2+ influx 
by glucagon occurs at physiological concentrations of 
the hormone (0.1-0.01 nM). Secondly, vasopressin and 
angiotensin appear to be more sensitive to low 
concentrations of glucagon (and presumably cyclic 
AMP) than is phenylephrine in stimulating Ca2+ uptake. 
Further confirmation of the second effect is shown in Fig. 
3(b), which shows that, after pre-treatment with a 
submaximal concentration of cyclic AMP (2 /im), both 
vasopressin and angiotensin can elicit further uptake of 
Ca2+ by the liver after the administration of a maximal 
dose of phenylephrine (10 fiM). However, phenylephrine 
is incapable of inducing further Ca2+ uptake if it is 
administered after the administration of either vaso­
pressin or angiotensin (Fig. 3a).
The sink for the spontaneous influx of Ca2+ stimulated by 
vasopressin and angiotensin
Our previous finding that the administration of 
vasopressin and angiotensin to the perfused rat liver 
leads to a spontaneous net uptake of Ca2+ (Altin & 
Bygrave, 1985), and also that glucagon and cyclic AMP 
can potentiate this response (Morgan et al., 1983a; the 
present work), raises the question of the intracellular 
‘sink’ for this Ca2+, especially since such large amounts 
of the ion appear to be mobilized. The data in Fig. 4 show 
the total calcium content of each of eight subcellular 
fractions obtained by Percoll-density-gradient subfrac­
tionation of the liver. Comparison of the calcium content 
of fractions obtained from control (Fig. 4a) and 
hormone-treated animals (Figs. 4b and 4c) indicates that 
the greatest change in calcium content that is induced by 
the hormones occurs in fraction 8. This fraction 
previously has been shown (Reinhart et al., 1982a) to 
contain the highest proportion of the total cytochrome c 
oxidase activity, a marker enzyme for mitochondria. This 
result thus provides evidence that the Ca2+ influx 
stimulated by the hormones (see Fig. 1) leads to an 
accumulation of Ca2+ by the mitochondria, and is 
consistent with the findings by Morgan et al. (1983a), 
who conducted similar measurements on hormone-treated 
hepatocytes.
It is pertinent to point out that, although the calcium 
content of mitochondria from hormone-treated liver 
(approx. 50 nmol/mg of protein) is higher than the 
16 nmol/mg of protein obtained by Morgan et al. 
(1983a), we believe that this is still an underestimate. This 
is because at such high calcium contents it can be 
expected that there will be calcium loss from the
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Fig. 4. Calcium content of subcellular fractions prepared from perfused rat liver after the administration of glucagon and 
vasopressin
Livers were perfused with Krebs-Henseleit medium, the 1.3 mM-Ca2+ being infused separately into the portal cannula by 
infusion syringe. At 15 min and 19 min of perfusion respectively, glucagon (10 n\t) and vasopressin (10 nM) were also infused.
At 39 min of perfusion the infusion of both hormones and 1.3mM-Ca2+ was terminated and immediately replaced with 
50 //m-EGTA (see Reinhart et al., 1984a). After exactly 2 min the liver was excised and rapidly homogenized and then 
fractionated on a single-step Percoll gradient as indicated in the Experimental section. Of the ten fractions obtained (see 
Reinhart et al., 1982a), fractions 1 and 2, and fractions 9 and 10, were each combined for convenience. All fractions were then 
assayed for calcium content by atomic-absorption spectroscopy; the results are shown in (c). The column marked 1H ’ represents 
the calcium content of the homogenate before fractionation. The results for the calcium contents of the liver fractions obtained 
from the corresponding control and glucagon-treated liver are shown in (a) and (6) respectively. The calcium content of 
fractions obtained from vasopressin-treated liver was not significantly different from that of control liver (results not shown).
It should be noted that, although the amount of calcium/mg of protein in fraction 7, and fractions 9 and 10 combined, is 
relatively large (probably because of contamination with mitochondria), the total amount of calcium in these fractions is small, 
owing to their low protein content (see Reinhart et al., 1982a). The results are means+ S.E.M. for three independent experiments.
mitochondria during the isolation procedure itself, 
especially since the isolation medium contained 
20 //m-EGTA. On the basis of the amount of Ca2+ uptake 
shown in Table 1, and assuming 60 mg of mitochondrial 
protein/g wet wt. of liver and that most of the Ca2+ taken 
up is accumulated by mitochondria, our results suggest 
that the calcium content of mitochondria from hormone- 
treated liver could be as high as 60-70 nmol/mg of 
protein. Since the calcium content of mitochondria from 
control liver appears to be around 1-2 nmol/mg of 
protein (Reinhart et al., 1984a; Somlyo et al., 1985), we 
conclude that in the perfused liver the synergistic action 
of glucagon (of cyclic AMP) with either vasopressin or 
angiotensin can lead to an increase in the calcium 
content of mitochondria to a value representing some 
20-50 times that of control mitochondria.
In order to demonstrate the involvement of mito­
chondria in sinking the hormone-induced Ca2+ uptake 
in situ, we have examined the effect of respiratory-chain 
inhibitors on the Ca2+-uptake response. The trace in Fig. 
5(a) shows that the infusion of NaN3 (5 miw) is followed 
by a net release of approx. 200 nmol of Ca2+/g  of liver, 
presumably from the mitochondria. This Ca2+ is then 
taken up when the NaN3 is removed. The co­
administration of NaN3 (5 m M )  with glucagon does not 
significantly affect the NaN3-induced Ca2+ release (Fig. 
5b). However, subsequent administration of either 
vasopressin or angiotensin, with or without glucagon 
pre-treatment, results in a complete abolition of the net 
uptake of Ca2+ that is normally associated with the 
administration of these hormones (cf. Figs. 1 and 5). As 
judged by manometric pressure measurements, there 
were no significant vasodilatory effects of the infusion of 
NaN3. Similar results, but with slightly less effect, were 
obtained with antimycin A (5 /im); however, the use of 
NaN3 in these experiments was more convenient, as it is 
water-soluble and its effects seemed to be rapidly 
reversed once its infusion was terminated. Although a 
possible inhibitory effect of these inhibitors on Ca2+ 
transport across the plasma membrane, or secondary 
effects owing to the possible lowering of cellular ATP 
concentrations, cannot be eliminated, these results are 
nevertheless consistent with the findings of Morgan et al. 
(1983a) using the mitochondrial inhibitors oligomycin, 
carbonyl cyanide m-chlorophenylhydrazone and anti­
mycin A in isolated hepatocytes, and also with the 
fractionation studies detailed above, which implicate the 
mitochondria as the sink for the observed influx of Ca2+.
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Fig. 5. Effect of N aN3 on the Ca2 +-uptake response induced by 
the co-administration of glucagon and a Ca2+-mobilizing 
hormone
Perfusions were conducted as described in the legend to 
Fig. 1. At 15 min of perfusion, NaN3 (5 m M )  was infused 
for the times indicated by the bold lines. The resulting trace 
of the Ca2+ response, obtained with the Ca2+-selective 
electrode, is shown in (a). The trace in (b) shows the Ca2+ 
response obtained when NaN3 was co-administered with 
maximal concentrations of glucagon (10 nM;  thin line; G), 
followed by vasopressin (10 n M ;  broken line; V) 5 min 
later. Each trace is a representative of three independent 
experiments.
DISCUSSION
The present work demonstrates that glucagon, and its 
intracellular messenger cyclic AMP, can exert quite 
profound effects on the Ca2+-flux changes induced by 
Ca2+-mobilizing hormones in the intact liver perfused 
with 1.3mM-Ca2+. Although some evidence for the 
potentiation of the effects of Ca2+-mobilizing hormones 
by glucagon and cyclic AMP has previously been 
reported (Friedmann & Park, 1968; Morgan et al., 
1983a), hitherto it appears that no detailed studies of the 
combined effects of these hormones on long-term 
Ca2+-flux changes have been conducted. The perfused rat 
liver is an ideal system for such studies, as it allows for 
an integrated approach to many facets of Ca2+ 
mobilization and hormone action in near-physiological 
conditions. The data obtained with the Ca2+-selective 
electrode (Fig. 1) show the magnitude and the temporal 
relationship of the Ca2+ fluxes that occur after the 
combined administration of cyclic AMP (or the 
cyclic-AM P-producing hormone, glucagon) and the 
Ca2+-mobilizing hormones phenylephrine, vasopressin 
and angiotensin. Several important features of the
combined effect of these hormones on Ca2+ fluxes that 
were not previously reported are revealed.
The first observation relates to the magnitudes of the 
maximum net amount, and maximum net rate, of Ca2+ 
uptake that occurs after the administration of both 
cyclic-AMP-dependent and Ca2+-mobilizing hormones. 
These Ca2+ changes are over an order of magnitude 
greater than the Ca2+-flux changes induced by phenyl­
ephrine, vasopressin and angiotensin alone, approx. 
140 nmol/g of liver (see Reinhart et al., 19826; Altin & 
Bygrave, 1985). The results clearly demonstrate the 
importance of ‘communication’ between the cyclic 
AMP-dependent and Ca2+-dependent pathways under 
physiological conditions where it is conceivable that both 
cyclic AMP-dependent and Ca2+-mobilizing hormones 
can be present simultaneously.
The possible relevance of these effects in vivo is evi­
dent from the dose-response curves in Fig. 2, which show 
that the effects are apparent even at physiological con­
centrations of glucagon and Ca2+-mobilizing hormones 
(Buhler et al., 1978). More importantly, the dose- 
response curves, together with the finding that maximal 
concentrations of phenylephrine, vasopressin and angio­
tensin display different abilities to induce Ca2+ influx 
when co-administered with a relatively low concentration 
of cyclic AMP (10 /im) (Fig. 5), appear to suggest that the 
difference in the ability of these hormones to induce Ca2+ 
influx when administered alone (Altin & Bygrave, 1985) 
may be due to a greater sensitivity to endogenous cyclic 
AMP of the specific events triggered by vasopressin and 
angiotensin. It is envisaged that such events may involve 
the phosphorylation of the Ca2+ transporter or Ca2+ 
channel across the plasma membrane by some cyclic 
AMP-dependent protein kinase(s) (Vargas et al., 1982; 
Reuter, 1983; Bean et al., 1984; Mauger et al., 1984).
Differences in the ability of phenylephrine, vasopressin 
and angiotensin to stimulate Ca2+ influx (see Figs. 1 and 
5) are less evident when glucagon (10 nM) is administered 
instead of cyclic AMP in the range lO/^M-O^mM 
(results not shown). However, since the intracellular 
cyclic AMP concentrations generated by glucagon 
(10 nM) through activation of adenylate cyclase are 
above the range, it can be presumed that, under these 
conditions, the binding of phenylephrine to oq-adrenergic 
receptors is further enhanced (Morgan et al., 1984). It is 
therefore possible that the observed differences may be 
associated with a greater number o f ‘active’ receptors for 
vasopressin and angiotensin on the liver cell plasma 
membrane, and consequently, the ability for these 
hormones to induce a greater stimulation of phospho- 
inositide breakdown, a larger accumulation of inositol 
1,4,5-trisphosphate (Lynch et al., 1985), or a higher 
increase in the cytosolic Ca2+ concentration (Charest 
et al., 1985; Binet et al., 1985), by comparison with 
phenylephrine. A direct involvement of phosphoinositide 
breakdown, or any metabolite thereof, in the stimulation 
of Ca2+ influx has yet to be demonstrated, however. 
Alternatively, the differences may be more directly linked 
to individual differences in the nature of the hormone- 
receptor interaction that is involved between phenyl­
ephrine, vasopressin and angiotensin and their specific 
receptors, perhaps involving specific hormone-operated 
Ca2+ channels (Berridge, 1982). This area requires 
further investigation.
Another finding from the present work is that the 
order of administration of glucagon (or cyclic AMP) and
Vol. 238
660 J. G. Altin and F. L. Bygrave
a Ca2+-mobilizing hormone can significantly affect both 
the maximum net rate and the maximum net amount of 
Ca2+ influx that is induced. Although no dependence on 
the order of addition was observed in the work of 
Morgan et al. (1983a), our results appear to be consistent 
with the more recent work by Mauger et al. (1985), which 
suggests that the initial rate of 45Ca2+ uptake by 
hepatocytes is less when vasopressin is added 1 min 
before glucagon than when vasopressin and glucagon are 
added at the same time. Since the dependence of Ca2+ 
influx in the order of hormone addition occurs even when 
exogenous cyclic AMP is used instead of glucagon (Fig. 
1, the present work), it seems that the effect is not due to 
the inhibition of glucagon-induced cyclic AMP accumu­
lation by vasopressin (see Morgan et al., 1983/)), but 
instead is probably related to the sequential phosphoryl­
ation steps that may be involved in the stimulation of 
Ca2+ transport across the plasma membrane.
The correlation of Ca2+-flux changes with an increase 
in the calcium content of fractions enriched in mito­
chondria obtained by Percoll-density-gradient subfrac­
tionation of the liver after hormonal challenge strongly 
indicates that the Ca2+ taken up by the liver is 
accumulated by the mitochondria, a conclusion consistent 
with that of Morgan et al. (1983a). The data also are 
consistent with previous observations from our and other 
laboratories that the administration of glucagon in vivo 
to rats, or to the perfused rat liver, greatly enhances the 
ability of the subsequently isolated mitochondria to 
retain Ca2+ (Hughes & Barritt, 1978; Prpic et al., 1978; 
Andia-Waltenbaugh et al., 1978, 1981; Prpic & Bygrave, 
1980; Taylor et al., 1980).
Mauger et al. (1985), who studied the stimulation of 
45Ca2+ uptake induced by the combined addition of 
glucagon and Ca2+-mobilizing hormones using isolated 
hepatocytes, concluded that plasma-membrane Ca2+ 
channels are the principal sites affected. Morgan et al. 
(1983a) have suggested that the mitochondrial membrane 
is the likely control point for the Ca2+ influx stimulated 
by glucagon and Ca2+-mobilizing hormones, since the 
Ca2+ uptake can be abolished by inhibitors of mitochon­
drial respiration. Our work indicates that the prolongation 
of the uptake response is dependent on the continued 
presence of both glucagon (or cyclic AMP) and a 
Ca2+-mobilizing hormone (results not shown). Since the 
hormones are known to interact with receptors at the 
plasma membrane which also contain the necessary 
transporters to permit the entry of Ca2+, it appears to us 
that the plasma membrane would be the least energy­
demanding control point to regulate the influx of Ca2+. 
However, our data show that a prolonged stimulation 
with these hormones results in a transient decrease in the 
rate of Ca2+ influx, which decays even while the 
hormones are still being administered (Fig. 1). This may 
be an indication that, under these conditions, the 
calcium content of the mitochondria has reached 
saturation. We therefore argue that both the plasma 
membrane and the mitochondrial membrane are involved 
in regulating the Ca2+-uptake response.
A final important aspect of the present work relates to 
the magnitude of Ca2+ taken up by the mitochondria in 
the intact liver. Stimulation with near-maximal concen­
trations of glucagon (or cyclic AMP) and a Ca2+- 
mobilizing hormone results in a 20-60-fold increase in 
mitochondrial calcium content (to approx. 60 nmol/mg 
of mitochondrial protein; see Fig. 4). Whether this
increase is relevant to the activation of mitochondrial- 
matrix enzymes (Denton & McCormack, 1985; McCor­
mack, 1985a,/)) remains to be established. This appears 
to be the first time that mitochondria have been shown 
to accumulate such large amounts of Ca2+ in a reversible 
manner in the intact liver, while at the same time 
maintaining (or recovering) apparent full integrity of 
mitochondrial and cellular function. These findings thus 
seem to be important in many pathological states 
involving calcification. Hence, as well as its usefulness in 
the study of the ways in which cells regulate mitochondrial 
Ca2+ fluxes in vivo, it appears that this could be a useful 
system with which to study the ability of mitochondria 
to tolerate Ca2+ reversibly in conditions of cellular 
toxicity that are associated with cellular necrosis or cell 
death.
This work was supported by a Ph.D Scholarship to J.G.A. 
and a grant to F. L. B. from the National Health and Medical 
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Section B.7
Ca2+ uptake stimulated by the synergistic action of glucagon and Ca2+-mobilizing
agents in the perfused rat liver occurs through the activation of 
a unidirectional Ca2+ influx pathway.
(Altin & Bygrave, 1987d)
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The mechanism by which the synergistic action of glucagon and the
2+ 2+Ca -mobilizing hormone vasopressin induces Ca uptake was studied by
45 2+ 2+using both Ca and a Ca -selective electrode in  the perfused ra t liv e r .
The co-administration of glucagon and vasopressin was accompanied by a
unidirectional uptake of 45Ca2+ by the liv e r ;  the bulk of th is  45Ca2+ was
accumulated by the mitochondria. This suggests that the main e ffect of
2+these hormones is  to activate a Ca in flu x  pathway, rather than to in h ib it
2+ 2+ 2+Ca extrusion by the Ca -ATPase. The e fflu x  of Ca taken up following
the co-administration of glucagon and phenylephrine was inh ib ited  by the
presence of phenylephrine alone, but was not s ig n if ic a n tly  affected by the
presence of glucagon alone. Contrary to suggestions that glucagon can 
2+in h ib it  the Ca -ATPase, these resu lts suggest tha t glucagon (at
2+ 2+concentrations up to I mM) does not a ffect Ca e fflu x  via the Ca -ATPase.
© 1987 Academic Press, Inc.
The principal action of glucagon in l iv e r  generally has been 
attributed to the activation of physiological responses mediated by a rise  
in in tra ce llu la r cyc lic  AMP (1-3). However, a number of recent reports
*To whom correspondence should be addressed.
Abbreviations: EGTA, ethyleneglycol-b is(ß -amino ethyl ether) N,N'-tetra 
acetic acid; Hepes, N-2-hydroxyethyl piperazine-M'-2-ethanesul phonic acid; 
Butyl PBD, 2 -(4 'te rt.-B u ty l phenyl)-5 -(4"-b iphenyly l)-l,3 ,4 -oxid iazo le .
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2 +suggest that glucagon also can e l ic i t  changes in cellular Ca (4) that
2+lead to increases in the cytosolic Ca concentration which are not too
2+dissimilar to those induced by the so-called Ca -mobilizing hormones
(5 ,6 ).  More recently, glucagon (and its  messenger cAMP) has been reported
2+ 2+ to act synergistically with Ca -mobilizing agents in stimulating Ca
uptake by hepatocytes (7-9) and the perfused liver (7,10). Interpretation
2+ 2+of these data is made d i f f ic u l t  because Ca efflux and Ca influx are
2+thought to occur via separate transport systems which constitute a Ca
transport cycle across the plasma membrane (11). In this regard there are
2+ 2+suggestions that glucagon may inhibit the Ca -ATPase ( i . e .  Ca efflux
2+mechanism) (12-14); and that as well as stimulating Ca influx, the
2+Ca -mobilizing agents phenylephrine, vasopressin and angiotensin also may 
2+inhibit the Ca -ATPase (15,16). The question arises then, as to whether
2+the synergism observed with glucagon and Ca -mobilizing agents in
2+ 2+ stimulating net Ca influx, is due to an inhibition of Ca efflux, or to
2+an activation of unidirectional Ca influx, or a combination of both.
In this work we have examined this question by studying the uptake
of ^5Ca^+ in the perfused rat l iv e r ,  and its  distribution into subcellular
fractions obtained therefrom, induced as a consequence of glucagon and
2+vasopressin co-administration. In addition, we have used the Ca ^-selective
electrode to investigate the effects of terminating either glucagon or
2+phenylephrine administration, separately, on the efflux of the Ca that is
accumulated following the co-administration of the hormones. Our results
2+suggest that the net Ca influx induced by the co-administration of 
2+glucagon and Ca -mobilizing agents occurs principally through an 
activation of a unidirectional Ca2+ influx pathway.
METHODS
Rats of weight 250-350g were used for all experiments. They were 
anaesthetized with sodium pentobarbitone (50mg/Kg body weight) and after 
dissection the livers were perfused with Krebs-Henseleit bicarbonate medium 
containing 1.3mM Ca2+ as described in (17). Similarly, perfusate Ca2+ 
measurements were carried out using a Ca2+-selective electrode as described 
previously (17,18). For some experiments 45caCl2 (final specific activ ity
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approx. 0.5x105 d.p.m./ml) was, infused in to  the portal vein fo r the period 
indicated. A fter a 2 min perfusion of the liv e r with Krebs-Henseleit medium 
containing no added Ca2+ 4>ut instead 50yM EGTA, the liv e r  was rap id ly  
homogenized in a medium consisting of 210 mM-mannitol, 60mM-sucrose, 10 
mM-KCl, 20 nM-EGTA and 10 mM-Hepes/KOH buffer (pH 7.4), and then 
sub-fractionated using a procedure u t i l iz in g  Percoll density gradients as 
described in (19). For ra d io a c tiv ity  measurement, a 50y 1 sample of each 
frac tion  was added to s c in t i l la t io n  v ia ls  containing 10ml of s c in t i l la n t  (6 
g of Butyl PBD in 400ml of 2-methoxyethanol and 600ml of toluene); the 
rad ioac tiv ity  was counted on a Beckman LS-2800 liq u id  s c in t i l la t io n  
counter. g
Phenylephrine, [Arg°]-vasopressin and glucagon were obtained from 
Sigma Chemical Co., U.S.A. 45CaCl2 was obtained from Amersham. A ll other 
reagents were of analytical grade. Each resu lt is a representative from at 
least 3 independent experiments.
RESULTS
Recent work has shown that the co-administration of glucagon and a
Ca2+-mobilizing agent to isolated hepatocytes (8,9), or to the perfused ra t
2+l iv e r  (10), leads to a synergistic potentiation of Ca uptake. In order to
2+establish whether the net uptake of Ca occurs through the activa tion  of
2+ 45 2+an in flu x  pathway or through in h ib itio n  of Ca -e ff lu x , Ca was
administered to the perfused liv e r  fo r a 5 min period. During th is  time the
in flu x  of Ca2+ induced by the co-administration of glucagon and vasopressin
45 2+reached a maximum (see Fig. la ) . The subcellular d is trib u tio n  of Ca
accumulated as a consequence of the 5 min 4^Ca2+ infusion is  shown in Fig.
lc . By comparison with control experiment in which only glucagon was
administered (Fig. lb ) , i t  can be seen that the co-administration of
45 2+glucagon and vasopressin induces a large accumulation of Ca by the
liv e r .  Since the rate at which extrace llu la r 45Ca2+ is  exchanged with
in tra c e llu la r exchangeable 40Ca2+ is  essentia lly constant during the f i r s t
10-15 min (20), i t  follows that the hormone-induced increase in
accumulation of 4^Ca2+ by the liv e r  during the 5 min infusion of 4^Ca2 ,
2+re fle c ts  p rinc ipa lly  the unid irectional inward movement of Ca . These
resu lts  suggest, therefore, that the main effect of the co-administration
2+of glucagon and vasopressin is  to activate the Ca in flu x  pathway.
In lig h t of reports which suggest tha t glucagon may in h ib it  the
Ca2+-ATPase (12-14), and in  an attempt to establish more c lea rly  the
2+particu la r ro le of glucagon (or i t s  messenger cAMP) and the Ca -m obilizing
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Fig. 1. The e ffec t of glucagon and vasopressin co-administration on the 
uptake of extrace llu la r 45ca2+ by the perfused ra t l iv e r .  Livers 
were perfused with Krebs-Henseleit bicarbonate medium and the 
perfusate Ca^* concentration was monitored with a Ca2+-selective 
electrode as outlined in the Methods. For the f i r s t  25 min of 
perfusion 1.3mM CaCl was administered by infusion syringe. 
Glucagon (lOnM, th ick line ) followed by vasopressin (lOnM, th in 
lin e ) were infused at 15 and 19 min of perfusion, respectively. At 
20 min of perfusion a trace amount of 45CaCl2 (specific  a c tiv ity  
approx. 0.5x105 d.p.m./ml, dotted line ) was infused fo r a period 
of 5 min. Immediately after the infusion of ^5CaC12* the infusion 
of 1.3nM CaCl 2 was terminated and replaced by 50mM EGTA fo r a 
period of 2 min. After th is  time (27 min of perfusion) the liv e r  
was rap id ly homogenised and subfractionated on Percoll density 
gradients. The sequence of events described including the 
Ca2+-selective  electrode trace preceding the fractionation  is  
shown in (a). The rad io a c tiv ity  in each of the 10 subc'ellular 
fractions (fractions 1 and 2, and 9 and 10 were combined fo r 
convenience) plus homogenate (H) was counted to 2% accuracy. Other 
d e ta ils  are exactly as described in the Methods. The d is tribu tion
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O ,
agents in e lic it in g  the in flu x  of Ca that is observed, experiments were
conducted to see whether e ither glucagon alone, or phenylephrine alone,
2+could in h ib it  in s itu  the e fflu x  of previously accumulated Ca . The data
2+in Fig. 2(a) show the Ca response induced by the co-administration of
glucagon plus phenylephrine. I t  can be seen that e fflu x  of the accumulated 
2+Ca occurs only when the hormones are removed. This is  shown by an upward
2+deflection of the pen above the baseline. The Ca e fflu x  response obtained 
when the administration of glucagon, or phenylephrine, is  prolonged beyond 
the period of hormone co-administration is shown in Fig. 2(b) and (c), 
respectively. In Fig. 2(b) i t  can be seen that removal of phenylephrine is  
su ffic ien t to allow the e fflu x  of Ca to proceed. However, Fig. 2(c) shows
that the removal of glucagon is  not su ffic ien t to permit the e fflu x  of such
2+ 2+ 2+Ca . Since the e fflu x  of Ca is  presumed to occur via the Ca extrusion
2+mechanism involving the Ca -ATPase, and since the presence of glucagon
does not s ig n ifica n tly  a ffect th is  e fflux a fte r removing phenylephrine
(Fig. 2b), the results suggest that at least at th is  concentration (lOnM)
2+glucagon alone does not s ig n if ic a n tly  in h ib it the Ca -ATPase. This is  also
2+supported by the fact that no net Ca in flu x , but instead a small e fflu x  
2 +of Ca (approx. 40nmol/g of l iv e r)  was observed during the 4 min 
pre-administration of glucagon.
2+In contrast, i t  can be seen that the Ca -m obilizing agent
2+phenylephrine in h ib its  the e fflu x  of previously accumulated Ca under
other wise identica l experimental conditions (Fig. 2c). I t  can be
2+concluded, therefore, that phenylephrine may in h ib it  Ca e fflu x , or
2+a lte rna tive ly , lead to an equivalent stimulation of Ca in flu x  such that
2+ 2+ no net Ca changes occur. Though the onset of Ca e fflu x  is  slower
of 45ca2+ i °  fractions obtained from experiments in which glucagon 
alone was administered (control) is shown in (b); this was not 
significantly different from that obtained when vasopressin alone 
was used instead of glucagon (no shown). The distribution of 
45Ca2+ in fractions obtained from experiments in which glucagon 
and vasopressin were co-administered is shown in (c) .  The results 
are means ± S.E.M. of 3 separate experiments.
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Fig. 2. The e ffect of glucagon, and phenylephrine, separately on the 
e fflu x  of Ca^+ previously taken up fo llow ing the co-administration 
of glucagon and phenylephrine. Livers were perfused with 
krebs-Henseleit bicarbonate medium containing 1.3mM Ca2+ , and the 
perfusate was monitored continuously with a Ca2+ -selective 
electrode (see Methods section). A fter a pre-perfusion period of 
15 min glucagon (lOnM, th ick lines) and 4 min la te r phenylephrine 
(2uM, th in  lines) were co-infused as indicated. Trace (a) shows 
the Ca^+ response obtained when both glucagon and phenylephrine 
are removed simultaneously. The response obtained when the 
administration of e ithe r glucagon, or phenylephrine, was continued 
fo r a period of 5 min beyond the period of co-administration is 
shown in (b) and (c), respective ly. Each trace is  a representative 
of between 3 and 5 experiments performed independently.
following the removal of vasopressin (see r e f .  10), s imilar results were 
obtained when vasopressin was used instead of phenylephrine (data not 
shown).
DISCUSSION
The present work shows that the co-administration of glucagon and
2+Ca -mobilizing agents to the perfused ra t  l iv e r  leads to a synergistic
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2+ 2+stimulation of unid irectional Ca in flu x . Hence the Ca in flu x  induced by
2+the synergistic action b f glucagon and Ca -m obilizing agents (7-10) occurs
2+mainly through the activation of a specific Ca in flu x  pathway, and not
2+ 2+through the in h ib itio n  bf the Ca e fflu x  mechanism, the Ca -ATPase. This
conclusion is  consistent with that of Poggioli et al . (9) who carried out
k ine tic  studies using ^Ca^+ in isolated hepatocytes. Furthermore, our 
45 2+ 2+studies using Ca in conjunction with the Ca -se lective  electrode and
subsequent subcellular fractionation  of the liv e r  tissue, supports recent
2+findings that mitochondria are the sink fo r the Ca taken up (7,10).
45 2+Moreover, the present studies using Ca fo r only a short period of time 
2+during Ca in flu x  minimizes the p o s s ib ility  that the observed increase in
2+the mitochondrial calcium content is  due to the uptake of Ca by 
mitochondria during iso la tion .
The second find ing made in th is  work re lates to the in a b il ity  of
glucagon (lOnM) to in h ib it  the e fflu x  of previously accumulated Ca from
the liv e r .  This resu lt does not agree with recent reports that d irect
in teraction  of glucagon with plasma membrane vesicles leads to an
in h ib itio n  of Ca -ATPase (12-14). However, i t  is  pertinent to note that in
th e ir  studies these workers used glucagon concentrations some 100 to
1000-fold higher than those used in the present work, and those which have
been shown previously to maximally activate phosphorylase kinase. In our
system using the perfused ra t liv e r  the administration of glucagon (lyM,
fo r 8 min) did not induce any s ign ifican t net uptake of Ca by the liv e r .
The administration of glucagon (10yM, fo r 8 min) induced only a re la tive ly
small amount of Ca uptake (approx. 150nmol/g of l iv e r ,  data not shown),
by comparison with the 4000nmol/g of liv e r  taken up when both hormones are
co-administered (10). I t  appears, therefore, that although glucagon alone
at very high concentrations (10mM) may lead to some in h ib itio n  of the 
2+Ca -ATPase, th is  in h ib itio n  is un like ly to account fo r the synergistic 
2+e ffec t on Ca in flu x  that is  observed when glucagon is  co-administered 
2+with a Ca -mobilizing agent. This synergism is  near-maximal at much lower
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concentrations of glucagon (approx. lOnM) and occurs when exogenous cyclic
AMP is used instead of glucagon (8-10). Lotersztajn et al . (14 ),  however,
2 +report no e ffec t  of cyclic AMP on the Ca -ATPase in th e ir  system. C learly,
we cannot rule  out the p o ss ib il i ty  that these differences are a ttr ibu tab le
to the d if fe r in g  experimental systems used.
2+That Ca -mobilizing agents l ike  phenylephrine, may in h ib i t  the
2+ 2+Ca ATPase in situ is suggested by the fact that Ca e f f lu x  is not
observed unti l  the agents are removed. This is consistent with observations
of others where treatment of the perfused l iv e r  (16) and hepatocytes (15)
2+with these agents leads to a slight inh ib it ion  of the Ca -ATPase in
subsequently isolated plasma membrane vesicles. I t  should be pointed out,
however, that phenylephrine, vasopressin and angiotensin, each have been 
2+shown to stimulate Ca 'cycling' across the plasma membrane, the e ffec tive
inward component of this corresponding to a maximum decrease in perfusate
Ca concentration of approximately 20pM (11). Thus i f  under these
conditions the e ff lu x  component of this  cycle is close to saturation, the
24-observed inh ib it ion  of the net e ff lux  of previously accumulated Ca by 
phenylephrine can also be explained in terms of an activation of a s im il ia r  
rate of Ca2+ in f lu x .
In conclusion, these results suggest that an in h ib it io n  of the
2+
Ca -ATPase is  not the principal mechanism by which the synergistic action
2+ ?4-of glucagon and Ca -mobilizing agents stimulate Ca in f lu x .  Instead i t  
24-seems that Ca in flux  is fa c i l i t a te d  through the activation of a specific
24- 24-Ca influx pathway. The characterization of the Ca transporter(s) i t s e l f
is an area that requires further investigation.
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Section B.8
The influx of Ca2+ induced by the administration of glucagon and Ca2+-mobilizing 
agents to the perfused rat liver could involve at least two separate pathways.
(Altin & Bygrave, 1987a)
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The influx of Ca2+ induced by the administration of glucagon and 
Ca2+-mobilizing agents to the perfused rat liver could involve at 
least two separate pathways
Joseph G. ALTIN and Fyfe L. BYGRAVE* 
Department of Biochemistry, Faculty of Science, Australian National University, Canberra, A.C.T. 2601, Australia
The Ca2+-mobilizing actions of ADP, ATP and epidermal growth factor (EGF) and their interaction with 
glucagon were studied in a perfused liver system incorporating a Ca2+-selective electrode. ADP (1-100 /ym), 
ATP (1-100 fiM) and EGF (10-50 nM) all induced a net efflux, followed by a net uptake of Ca2+ in the intact 
liver. The co-administration of glucagon (or of cyclic AMP) with these agents resulted in a synergistic 
potentiation of the Ca2+ uptake response in a way which resembles the synergism observed when glucagon 
is administered with phenylephrine, vasopressin or angiotensin [Altin & Bygrave (1986) Biochem J. 238, 
653-661]. The inability of diltiazem, verapamil and nifedipine to inhibit the Ca2+-influx response suggests 
that the stimulation of Ca2+ influx does not occur through voltage-sensitive Ca2+ channels. By contrast, the 
synergistic effects of glucagon in the stimulation of Ca2+ influx are inhibited by 10 mM-neomycin, and a 
lowering of the extracellular pH to 6.8. Simultaneous measurements of perfusate Ca2+ and pH changes 
suggest that the Ca2+ influx response is not mediated by a Ca2+/H + exchange. The inability of neomycin and 
low extracellular pH to inhibit the refilling of the hormone-sensitive pool of Ca2+, after the administration 
of Ca2+-mobilizing agents alone, provides evidence for the existence in liver of at least two Ca2+-influx 
pathways, or mechanisms for regulating Ca2+ influx.
INTRODUCTION
The mechanism by which Ca2+-mobilizing hormones 
(a-adrenergic agonists, vasopressin and angiotensin) 
signal the mobilization of intracellular Ca2+, and 
consequently a triggering of Ca2+-dependent physio­
logical responses in liver tissue, now can be explained 
in terms of a receptor-mediated breakdown of phospho- 
inositides in the plasma membrane. This event has been 
shown to generate the intracellular messenger inositol 
trisphosphate into the cytoplasm, and consequently a 
release of Ca2+ from the endoplasmic reticulum (Creba 
e ta i ,  1983; Berridge, 1984; Burgess et al., 1984). It is also 
generally acknowledged that, once the intracellular 
hormone-sensitive stores of Ca2+ have been depleted, 
extracellular Ca2+ is required to sustain the hormone- 
induced physiological responses (Reinhart et al., 
1984a,c). This suggests that part of the action of the 
Ca2+-mobilizing hormones is to stimulate an influx of 
Ca2+ into the cell (Barritt et al., 1981; Reinhart et al.,
19846). However, although the mechanism by which 
Ca2+-mobilizing hormones stimulate the influx of Ca2+ 
has been the subject of much investigation in recent years 
(Mauger et al., 1984, 1985; Poggioli et al., 1985), 
hitherto, it seems that the mechanism by which this occurs 
remains to be clarified.
Among the suggested mechanisms for the way in 
which hormones stimulate Ca2+ influx is by inhibition of 
the Ca2+-efflux pump, or in effect the Ca2+-ATPase (Lin 
et al., 1983; Prpic et al., 1984; Lotersztajn et al., 1985), 
and the activation of specific Ca2+-influx channels, which
may be either voltage-sensitive (Glossmann et al., 1982; 
Levitan et al., 1983; Reuter, 1983; Nayler & Horowitz, 
1983) or hormone-operated (Berridge, 1982). More 
recently, it has been shown that glucagon and its 
messenger cyclic AMP can act synergistically with 
phenylephrine, vasopressin and angiotensin in the 
stimulation of Ca2+ influx (Morgan et al., 1983; Mauger 
et al., 1985; Poggioli et al., 1986; Altin & Bygrave, 1986). 
Since the magnitude of this influx is much greater, and 
therefore more readily measurable than that which 
occurs after the administration of Ca2+-mobilizing 
agents alone, this has provided a useful system with 
which to study the properties of the Ca2+ influx 
mechanism.
In this work we have used the perfused rat liver 
incorporating a Ca2+-selective electrode to study further 
the properties of the Ca2+-influx pathway that is 
stimulated by the synergistic action of glucagon (or cyclic 
AMP) and Ca2+-mobilizing agents in the perfused rat 
liver. More specifically, we have studied the effects of 
glucagon on the Ca2+-mobilizing action of ADP, ATP 
and epidermal growth factor (EGF), to determine 
whether the synergism in stimulating Ca2+ influx that 
occurs with glucagon and phenylephrine, vasopressin 
and angiotensin (Altin & Bygrave, 1986) occurs also with 
other Ca2+-mobilizing agents whose receptors are 
purportedly linked to the breakdown of phospho- 
inositides. We have examined also the effects of diltiazem, 
verapamil, nifedipine and neomycin, and a change in the 
extracellular pH, on the Ca2+-influx response. Our 
results provide evidence for the existence of at least two
Abbreviation used: EGF, epidermal growth factor.
* To whom reprint requests should be addressed.
Vol. 242
44 J. G. Altin and F. L. Bygrave
separate mechanisms for regulating Ca2+ influx. The 
possible significance of this in the mechanism of action 
of the Ca2+-mobilizing agents is discussed.
EXPERIMENTAL 
Animals and perfusions
For all experiments male Wistar-strain albino rats 
weighing 280-350 g and fed ad libitum were used. The 
rats were anaesthetized with sodium pentobarbitone 
(50 mg/kg body wt.), and the livers were perfused with 
Krebs-Henseleit (1932) bicarbonate buffer equilibrated 
with 0 2/C 0 2 (19:1) and containing 1.3 mM added CaCl2. 
The perfusions were conducted in a non-recirculating 
mode at a flow rate of 3.5 ml/min per g wet wt. of liver. 
For each experiment the liver was first pre-perfused for 
15 min before the infusion of any hormone or Ca2+- 
channel blocker, which was administered by a pump- 
driven infusion syringe. Owing to a significant change in 
the pH of the Krebs-Henseleit bicarbonate medium on 
addition of neomycin, the neomycin was not adminis­
tered by infusion syringe, but was added directly to the 
medium and the pH was stabilized to 7.4 with NaOH 
before the experiment. Other details are exactly as 
described in Reinhart et al. (1982).
Perfusate Ca2+ and pH measurements
The perfusate Ca2+ concentration was monitored 
continuously with a Radiometer F2112 Ca2+-selective 
electrode in a flow-through chamber placed on the 
outflow side of the liver (Reinhart et al., 1982). The 
electrode was coupled to a Radiometer K801 reference 
electrode via an agarose-KCl salt-bridge, and the 
combined signals were fed via an Orion microprocessor 
ion-analyser to a SP4100 computing integrator for 
recording and analysis; for other details see Altin & 
Bygrave (1985). For some experiments the perfusate pH 
was also monitored. The pH electrode was inserted in a 
flow-through chamber and placed on the outflow side of 
the Ca2+-electrode chamber; the pH signal was fed to a 
Radiometer PM84 pH-meter and a Rikadenki model 
B-341 chart recorder.
Chemicals and materials
Phenylephrine, [Arg8]vasopressin, [Val5]angiotensin, 
ATP, ADP, EGF, dibutyryl cyclic AMP, verapamil, 
diltiazem, nifedipine and neomycin sulphate were all 
obtained from Sigma Chemical Co., St. Louis, MO, 
U.S.A. Glucagon was obtained from Eli Lilly and Co., 
Indianapolis, IN, U.S.A. Except for nifedipine, which 
was dissolved in ethanol, all these agents were dissolved 
in Krebs-Henseleit buffer for infusion into the liver. The 
pH electrode (Gk2401c) and pH-meter model PM84, and 
Ca2+-selective electrode membranes (F2112) and filling 
solutions (S43316), were obtained from Radiometer, 
Copenhagen, Denmark. Other chemicals used were of 
analytical grade.
Expression of data
All the traces presented are a representative from at 
least three independent experiments. Where indicated, 
data are expressed as means ± s.e.m. for the numbers of 
independent experiments described.
RESULTS
Effect of glucagon (and cyclic AMP) on the Ca2 + 
mobilization induced by ADP, ATP and EGF
We previously reported that, at physiological concen­
trations of extracellular Ca2+ (1.3 mM), the co-adminis­
tration of glucagon (or cyclic AMP) and phenylephrine, 
vasopressin or angiotensin leads to a synergistic 
potentiation of Ca2+ uptake by the perfused liver, and 
consequently an increase in the calcium content of 
mitochondria (Altin & Bygrave, 1986). In order to 
characterize further the mechanism(s) involved in 
mediating this influx of Ca2+, it seemed important to 
establish whether such synergism also occurs when 
glucagon (or cyclic AMP) is co-administered with other 
agents such as ADP, ATP and EGF, whose actions have 
been linked to the mobilization of Ca2+ in liver (Thor 
et al., 1984; Staddon & McGivan, 1985; Charest et al., 
1985a; Taylor et al., 1985a). Such information could 
indicate whether the synergism is specific for the actions 
of phenylephrine, vasopressin and angiotensin, or 
whether this is a more general property which is shared 
with other agents that induce a mobilization of cellular 
Ca2+ through a receptor-mediated breakdown of 
phosphoinositides, and a production of the second 
messengers inositol 1,4,5-trisphosphate and diacyl- 
glycerol (Berridge, 1984).
The data in Figs. 1(a), (b) and (c) represent 
Ca2+-selective-electrode recordings of the perfusate Ca2+ 
concentration obtained when ADP, at concentrations of 
1 / M ,  10 ju .M  and 100//M respectively, was administered 
either alone, or co-administered after a 4 min pre­
infusion of a maximal concentration of glucagon (10 nM). 
It is noteworthy that the administration of ADP alone 
induces a pattern of Ca2+-flux changes which is 
dependent on the particular concentration used. The 
response induced by 100 //m-A D P (Fig. lc), for example, 
represents a net efflux of approx. 60 nmol/g of liver 
during the first 1 min. This is followed by a net uptake 
of Ca2+ (approx. 350 nmol/g of liver) during the next 
5 min of ADP administration, and an efflux of a similar 
amount of Ca2+ when the ADP is removed. This 
response is similar to that induced by 10 nM-vasopressin 
and 10 nM-angiotensin (see Altin & Bygrave, 1985). 
Moreover, the administration of glucagon 4 min before 
ADP results in a synergistic potentiation of Ca2+ uptake 
(approx. 4200 nmol/g of liver over a period of about 
20 min) to an extent which is also similar to that 
observed after co-administration of glucagon with either 
vasopressin or angiotensin (see Altin & Bygrave, 1986). 
Similarly, the amount of Ca2+ that was influxed is also 
effluxed slowly over a period of about 30 min. A notable 
difference between the Ca2+ response induced by the 
co-administration of glucagon and ADP (100 //m), instead 
of glucagon and either vasopressin (10 nM) or angiotensin 
(10 nM), is that the maximum rate of Ca2+ efflux after the 
removal of the stimuli is achieved much more rapidly 
(approx. 1 min, by comparison with about 10 min; cf. 
Altin & Bygrave, 1986). Although slightly less effective at 
1//M and IOjM-M concentrations, ATP administration 
induced essentially identical results (results not shown).
The data in Fig. 1(d) indicate firstly that the 
administration of EGF (10 nM) alone to the perfused 
liver is associated with relatively small Ca2+-flux changes 
(5-10 nmol/g of liver), and secondly that the Ca2+-influx 
phase of the response is also susceptible to potentiation
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Fig. 1. Ca2+ response induced by the administration of ADP, 
ATP and EGF, and the potentiation of Ca2+ uptake by 
the administration of glucagon to the perfused rat liver
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3mM-Ca2+. A Ca2+-selective elec­
trode as outlined in the Experimental section was used to 
monitor continuously the Ca2+ concentration of the 
outflowing perfusate. After an equilibration period of 
about 15 min, ADP was infused into the portal vein by 
infusion syringe for the period indicated by the thin lines. 
After a subsequent rest period of about 15 min, glucagon 
(10 nM, bold line) was also infused for 4 min, and then 
both glucagon and ADP were co-administered by separate 
infusions for a period of 20 min. The Ca2+-selective- 
electrode traces in (a), (b ) and (c) represent separate 
experiments for which the ADP concentration was 1 / i m ,
10 /i m  and 100 //M  respectively. Though slightly less 
effective at \ / i m  and 10//M concentrations, essentially 
dentical results were obtained when ATP was used 
nstead of ADP. The trace in (d ) shows the Ca2+ response 
or a similar experiment for which EGF (10 nM thin 
continuous line, or 50 nM thin broken line) was used 
nstead of ADP. Each trace is a representative of at least 
:hree independent experiments.
b) glucagon. At the highest concentration of EGF tested 
(5) nM), the co-administration of glucagon and EGF was 
associated with an efflux of approx. 10 nmol/g of liver 
during the first 1 min. This was followed by an influx of 
approx. 200 nmol/g of liver during the next 4 min, and 
ar efflux of a similar amount of Ca2+ after removal of the 
stmuli. Although the response induced by glucagon and 
EGF (Fig. 1 d) is much smaller than that induced by the 
other Ca2+-mobilizing agents, the shape of the response, 
ard its synergism with glucagon, are two features which 
are similar to those observed for ADP and ATP (Fig. 1 a, 
1/ and lc) and phenylephrine, vasopressin and angio­
tensin (see Fig. 1 in Altin & Bygrave, 1986).
Efect of diltiazem, verapamil and nifedipine on Ca2 + 
influx induced by glucagon and Ca2 + -mobilizing agents
There is much evidence to suggest that the organic 
compounds verapamil, diltiazem and nifedipine are
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effective in inhibiting the flux of Ca2+ through voltage- 
sensitive Ca2+ channels in excitable tissues (see, e.g., 
Nayler & Horowitz, 1983; Towart & Schramm, 1984). 
Work by Taylor et al. (19856) has provided some 
evidence for the existence of voltage-sensitive Ca2+ 
channels also in rat liver. Another report (Joseph et al., 
1985) describes an inhibition of hormone-induced influx 
of Ca2+ in hepatocytes by high concentrations (500 /zm) 
of diltiazem. The use of these compounds in the perfused 
rat liver, coupled with the measurement of changes in the 
perfusate Ca2+ concentration with the Ca2+-selective 
electrode, thus provides a convenient method to 
determine whether the Ca2+-influx pathway synergisti- 
cally stimulated by the co-administration of glucagon 
and a particular Ca2+-mobilizing agent occurs through 
voltage-sensitive Ca2+-channels.
The data in Fig. 2 show that the infusion of diltiazem 
(100 /i m ) 8 min before the onset of the Ca2+-influx 
response did not significantly affect the influx of Ca2+ 
associated with the re-filling of the hormone-sensitive
-1 0 0
-1 5 0
10 20 30 40 50 60
Perfusion time (min)
Fig. 2. Effect of the Ca2+ antagonist diltiazem on Ca2+ influx 
induced by the co-administration of glucagon and 
Ca2 +-mobilizing agents
Perfusions of rat livers and measurements of the perfusate 
Ca2+ concentrations were conducted as described in the 
legend to Fig. 1. After a pre-perfusion period of 14 min for 
equilibration, phenylephrine (2 /i m ) was administered for 
4 min (thin broken line; Phe). Subsequently, at 20 min of 
perfusion, glucagon (10 nM, thick lines; Glu) and 4 min 
later vasopressin (10 nM, thin lines; Vaso) were co­
administered by separate infusion syringes for the times 
indicated. The associated Ca2+ response is shown by the
continuous trace (------). Trace (-------) shows the Ca2+
response obtained from an experiment in which diltiazem 
(100 / i m ) was also infused at 10 min of perfusion. Each 
trace is a representative of three independent experiments. 
Similar results were obtained with verapamil (10 /zm) and 
nifedipine (5 jum) instead of diltiazem. At these concentra­
tions the three Ca2+ antagonists were also without 
significant effect in inhibiting the Ca2+ influx induced by 
the co-administration of glucagon with angiotensin 
(10 nM), ADP (100 j iM) ,  ATP (100 /i m ) or EGF (50 nM), 
instead of vasopressin. Diltiazem (100 //m) and verapamil 
(10 jum) inhibited the Ca2+ influx induced by the 
co-administration of glucagon and phenylephrine (2 jum) 
by approx. 50% (results not shown); it seems, however, 
that this may be due to an interaction of these antagonists 
with the oq-receptor (see, e.g., Nayler & Horowitz, 1983).
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store(s) after the removal of phenylephrine (2 /im). In 
addition, the influx of Ca2+ associated with a subsequent 
co-administration of glucagon and vasopressin was 
affected only slightly (< 20%  inhibition, see Fig. 2). 
Similar results also were obtained when glucagon was 
co-administered with phenylephrine, angiotensin, ADP, 
ATP and EGF, instead of vasopressin (results not 
shown). Infusion of verapamil (10 /im ) or nifedipine 
(5 fiu) similarly did not influence Ca2+ influx (results not 
shown). Although the concentrations of the Ca2+ 
antagonists used were several times higher than those 
normally used to inhibit Ca2+ influx in excitable tissues, 
significant inhibition of the Ca2+-influx response 
(>  50%) could be achieved only by using very high 
concentrations of diltiazem (250 //m), verapamil (50 /tm) 
and nifedipine (40 //m). It seems unlikely, however, that 
this inhibition is due to some specific effect of these 
agents on the Ca2+-influx pathway itself, but instead may 
be due to toxic effect(s) or interference with hormone- 
receptor binding. In support of this is the observation 
that the administration of such high concentrations of 
diltiazem and verapamil alone was accompanied by a 
stimulation of respiration, and that after a period of 
continued administration of these compounds 
(10-20 min) the liver became progressively less responsive 
to hormone stimulation, even after an equivalent ‘rest’ 
period. We conclude therefore that nominal concentra­
tions of diltiazem, verapamil and nifidepine have little, if 
any, effect on Ca2+ influx in this system, and hence that 
the principal Ca2+-influx mechanism(s) that is involved 
must be different from the voltage-sensitive Ca2+ 
channels that exist in excitable tissues.
Effect of neomycin on the synergistic stimulation of 
Ca2 + influx by glucagon and Ca2 +-mobilizing agents
As a first step towards elucidating the mechanism by 
which the synergistic action of glucagon and Ca2+- 
mobilizing agents stimulate Ca2+ influx into the liver cell, 
it seemed important to define more clearly the 
particular event (associated with the hormone-receptor 
interaction) that may be involved in supporting the 
stimulation of Ca2+ influx in the presence of glucagon or 
cyclic AMP (Mauger et al., 1985; Altin & Bygrave, 
1986). A crucial issue is thus to determine whether the 
interaction of a Ca2+-mobilizing agent with its receptor, 
alone, without the action of phospholipase C, is 
sufficient to allow the Ca2+-influx pathway to be 
stimulated by cyclic AMP. This information could 
indicate whether direct coupling exists between the 
hormone-receptor complex and the Ca2+ transporters 
themselves in the plasma membrane, or whether 
phosphoinositide breakdown or some metabolite that 
arises from this is required to activate the Ca2+-influx 
pathway. Of potential relevance to this are the findings 
that neomycin, and related aminoglycoside antibiotics 
such as gentamycin, which are known to block neuro­
muscular transmission, are potent inhibitors of phospho­
inositide hydrolysis in nerve and skeletal muscle (Van 
Rooijen & Agranoff, 1985; Vergara et al., 1985; Shute & 
Smith, 1985). Although neomycin has been reported also 
to inhibit the action of phospholipase C in erythrocytes 
in vitro (Downes & Michell, 1981), it was decided to see 
whether this compound influences Ca2+ fluxes in the 
perfused rat liver.
The data in Fig. 3(b) show the effect of neomycin
(10 mM) on the Ca2+ response induced by the adminis­
tration of vasopressin (10 nM), phenylephrine (2 //m) and 
glucagon (10 nM) plus vasopressin. Relative to the 
control (Fig. 3a), the continuous administration of 
neomycin (commenced at 10 min of perfusion) inhibited 
the spontaneous uptake of Ca2+ that is normally 
associated with the administration of vasopressin alone. 
Moreover, the Ca2+ influx induced by a subsequent 
co-administration of glucagon and vasopressin was 
inhibited by approx. 90% (cf. Figs. 3a and 3b). At these 
concentrations neomycin did not inhibit, but instead 
slightly increased (by 20-40%), the Ca2+ efflux associated 
with the administration of phenylephrine alone, and the 
Ca2+ uptake that is induced following its removal (see 
Fig. 3; also Altin & Bygrave, 1985). The inhibition of the 
glucagon- and vasopressin-induced Ca2+ influx by 
neomycin is maintained only for as long as the infusion 
of neomycin is continued, as the removal of neomycin 
from the perfusion medium during such hormone 
administration is followed rapidly by a stimulation of 
Ca2+ uptake by the liver (results not shown). The 
dose-response curve for the inhibition of Ca2+ influx by 
neomycin is shown in Fig. 3(c); the half-maximal 
effective dose of neomycin was approx. 3 mM.
These results suggest that neomycin (10 mM) is 
effective in inhibiting the influx of Ca2+ induced by the 
administration of glucagon and vasopressin, apparently 
without any inhibition of the influx of Ca2+ that occurs 
to replenish the hormone-sensitive calcium store(s) when 
a Ca2+-mobilizing agent (e.g. phenylephrine) is removed 
after a single hormone administration. The existence of 
at least two separate mechanisms for regulating Ca2+ 
influx is thus implied. At a concentration of 10 mM or 
below, the administration of neomycin was not followed 
by any significant mobilization of Ca2+ or stimulation of 
respiration; further, there were no signs of toxicity, as the 
liver remained responsive to Ca2+-mobilizing agents for 
the duration of the experiment (around 80 min). A 
similar inhibition of Ca2+ influx by neomycin was 
observed when glucagon (or cyclic AMP, 200 jum) was 
co-administered with phenylephrine, angiotensin, ATP, 
ADP and EGF (results not shown).
Dependence of the Ca2+ influx on extracellular pH
The observation that agents which increase intra­
cellular pH (e.g. nupercaine and NH4+) can lead to 
an increase in Ca2+ influx in the perfused rat liver 
(Friedmann, 1972), and that extracellular pH can affect 
the Ca2+ content of isolated hepatocytes after the 
separate administration of glucagon, vasopressin and 
angiotensin, has led to the suggestion that a Ca2+/H + 
exchange mechanism may exist in liver (Friedmann, 
1972; Kraus-Friedmann et al., 1982; Blackmore et al., 
1984). In order to explore this possibility, it therefore 
seemed important to study the synergism that exists 
between glucagon and Ca2+-mobilizing agents as a 
function of the extracellular pH and to monitor 
simultaneously the associated changes in both the Ca2+ 
concentration and the pH of the outflowing perfusate.
The data in Figs. 4(a), 4(b) and 4(c) show the perfusate 
Ca2+ and pH changes that occur after the co­
administration of glucagon and vasopressin to livers 
perfused with media of pH 6.8, 7.4 and 8.0 respectively. 
Also, Fig. 5 shows the corresponding amount of Ca2+ 
uptake by the liver that is induced by this administration
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Fig. 3. Effect of neomycin on Ca2+ influx induced by the co-administration of glucagon and Ca2+-mobilizing agents
Livers were perfused with Krebs-Henseleit bicarbonate medium containing 1.3 mM-Ca2+, and the Ca2+ concentration of the 
perfusate was continuously monitored with a Ca2+-selective electrode as previously described. At 15 min and 35 min of 
perfusion, respectively, maximal doses of vasopressin (10 nM, thin line; V) and phenylephrine (2 / /m , thin broken line; P) were 
each separately infused for a period of 5 min, as indicated. At 55 min of perfusion, after an intervening ‘rest’ period, glucagon 
(10 nM, thick line; G) and 4 min later, vasopressin (10 nM; V) were co-administered for a period of 20 min. Trace (a) shows the 
associated Ca2+ response induced by the administration of the hormones. The result for a similar experiment in which neomycin 
(10 mM, thick broken line) was continuously infused commencing at 10 min of perfusion is shown in (b). The dose-response 
curve for the inhibition of Ca2+ influx by neomycin is shown in (c). Each point represents the Ca2+ uptake that occurs when 
glucagon and vasopressin are co-administered for a period of 20 min. Each trace in (a) and (b) is a representative of three 
independent experiments; each point in (c) represents the mean + s.E.M. of between three and five independent experiments. The 
infusion of neomycin resulted in a similar inhibition of Ca2+ influx when glucagon was co-administered with phenylephrine, 
angiotensin, ADP, ATP and EGF.
of hormones when the extracellular pH is varied from 6.8 
to 8.0. The pH of the perfusion medium was altered by 
varying the concentration of bicarbonate in the range 
7-75 mM. By comparison with the Ca2+ influx that occurs 
at the physiological pH of 7.4, at extracellular pH below
7.4 the synergistic effects of the hormones on Ca2+ influx 
were inhibited, whereas at extracellular pH above 7.4 the 
synergism was enhanced (see Figs. 4 and 5). Also, when 
the extracellular pH was below 7.80 + 0.05, no significant 
net uptake of Ca2+ (<  20 nmol/g of liver) was induced 
by the administration of glucagon (or cyclic AMP) alone. 
However, at extracellular pH above 7.80, administration 
of glucagon (or exogenous cyclic AMP) alone was 
sufficient to stimulate extensive Ca2+ uptake by the liver; 
the co-administration of vasopressin further potentiated 
this effect (see Fig. 4c). These differences in hormone 
action (i.e. synergism versus glucagon alone) are 
highlighted in Fig. 5. The reason for the abrupt change 
in Ca2+ influx induced by glucagon around pH 7.8 was 
not pursued further in this study. In contrast with the 
pattern displayed by the synergistic effect of glucagon, 
the Ca2+ influx induced by the removal of a Ca2+- 
mobilizing agent (e.g. phenylephrine, when administered 
alone) was not significantly affected by a lowering of the 
extracellular pH to 6.8 (see Fig. 4a). Also, by comparison 
with the Ca2+ efflux observed at an extracellular pH of
7.4 (Fig. 4b), vasopressin and phenylephrine administered 
alone induced a significantly greater amount of Ca2+ 
efflux (approx. 100% increase) at extracellular pH 6.8,
but induced a smaller amount of Ca2+ efflux (40% 
decrease) at an extracellular pH of 8.0 (cf Figs. 4a, 4b, 
and 4c).
Another important feature of the data in Fig. 4 is that, 
at the extracellular pH of 6.8, 7.4 and 8.0, the total 
decrease in perfusate pH that occurs after the co­
administration of glucagon and vasopressin is no larger 
than the decrease that occurs after the administration of 
vasopressin alone. This result suggests that the influx of 
Ca2+ is not associated with any increase in the efflux of 
H+. Similar results could be obtained if the pH of the 
perfusion medium was adjusted by using HC1 instead of 
by altering the bicarbonate concentration. In addition, 
the Ca2+ influx and pH responses induced by the 
co-administration of glucagon and phenylephrine, angio­
tensin, ADP, ATP or EGF displayed a similar sensitivity 
to changes in extracellular pH (results not shown).
DISCUSSION
The first major observation revealed in the present 
work concerns the ability of ATP, ADP and EGF to 
induce net Ca2+ changes in the intact liver. Although 
ADP and ATP (Charest et al., 1985a; Sistare et al., 1985; 
Staddon & McGivan, 1985) and EGF (Moolenaar et al., 
1984, 1986) have been reported to increase cytosolic Ca2+ 
concentration in isolated cells, with techniques using 
quin2, to our knowledge no detailed studies of the effects 
of these agents have been conducted in the intact tissue.
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Fig. 4. Dependence of Ca2 + influx on extracellular pH
Livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3 mM-Ca2+ for the first 10 min. 
Thereafter, the perfusions were conducted either with the 
same medium (bicarbonate concentration 28 mM, pH 7.4), 
or with medium for which the bicarbonate concentration 
was changed to some pre-determined value between 7 and 
75 mM, and the corresponding buffered pH of the medium 
was in the range 6.8-8.0. The perfusate was continuously 
monitored for changes in Ca2+ concentration and pH with 
a Ca2+-selective electrode and a pH-electrode respectively, 
as detailed in the Experimental section. After an 
additional equilibration period of 5 min to allow stabiliza­
tion of the pH, vasopressin (10 nM, thin line; V), 
phenylephrine (2 jum, thin broken line; P), and glucagon 
(10 nM, bold line; G) plus vasopressin, were separately 
infused as indicated. The traces in (a), (b) and (c) represent 
the Ca2+ responses induced by the administration of these 
hormones when the pH of the perfusion medium was 6.8, 
7.4 and 8.0 respectively. In each instance the broken trace 
shows the associated hormone-induced changes in perfu­
sate pH. Each Ca2+ and pH trace is a representative of 
three or four independent experiments conducted at the 
indicated pH.
In addition, hitherto, there has been no evidence to 
suggest that glucagon (or cyclic AMP) can interact 
synergistically with these agents in the stimulation of Ca2+ 
influx. Thus, unlike the findings of Charest et al. (1985a), 
which suggest that ADP and ATP stimulate Ca2+ efflux 
only, our data demonstrate that ADP, ATP and EGF all 
induce a net efflux, followed by a net influx, of Ca2+ 
(albeit small for low concentrations of these agents; see 
Fig. 1). Further, Thor et al. (1984) observed no effect of 
1 mM-ADP on the accumulation of Ca2+ in hepatocytes. 
Our data also show that glucagon (and cyclic AMP) can
Glu + Vaso . •
6.8 7.1 7.4 7.7 8.0
pH of perfusion medium
Fig. 5. Effect of extracellular pH on the net uptake of Ca2 + 
induced by the co-administration of glucagon with 
vasopressin
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium for the first 10 min. Thereafter, perfusions were 
conducted either with the same medium (28 mM- 
bicarbonate, pH 7.4), or with a medium of different pH in 
the range 6.8-8.0. This was achieved by changing the 
bicarbonate concentration exactly as described in the 
legend to Fig. 4. Maximal doses of glucagon (Glu; 10 nM) 
and vasopressin (Vaso; 10 nM) were separately infused at 
15 and 19 min of perfusion respectively, and both 
hormones were then co-administered for a period of 
20 min. • ,  Total net amount of Ca2+ uptake by the liver 
that is induced during this period in an experiment 
conducted at the indicated pH; O, net amount of Ca2+ 
uptake that is induced in a similar experiment for which 
glucagon, alone, was administered for the 24 min period. 
Each point is the mean ± s .e .m . of three to five experiments 
performed independently.
interact synergistically with ADP, ATP and EGF in the 
stimulation of Ca2+ influx. This potentiation closely 
resembles the synergism observed by the co-adminis­
tration of glucagon with phenylephrine, vasopressin or 
angiotensin (cf. Fig. 1 of present work with Fig. 1 of 
Altin & Bygrave, 1986).
Work by Charest et al. (1985a) suggests that the action 
of ATP and ADP in hepatocytes is linked with the 
breakdown of phosphoinositides, probably through 
interaction with P2-purinergic receptors. Although there 
are suggestions that EGF receptors may also be linked 
to phosphoinositide breakdown in some tissues (Sawyer 
& Cohen, 1981; Berridge, 1984), work by Taylor et al. 
(1985a) was unable to detect an EGF-linked breakdown 
of phosphoinositides in liver. In this regard it is 
noteworthy that the present results show that, even at 
concentrations of 50 nM (270 ng/ml), EGF was the least 
effective of the agonists tested in stimulating Ca2+ influx 
when co-administered with glucagon (see Fig. 1 d). Also,
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phenylephrine, which has been shown to be less effective 
than either vasopressin or angiotensin in inducing 
phosphoinositide breakdown and accumulation of ino­
sitol trisphosphate (Lynch et al., 1985; Charest et al., 
1985/?), has been shown also to be less effective in 
inducing Ca2+ influx when co-administered with cyclic 
AMP to the perfused rat liver (see Altin & Bygrave,
1986). It therefore appears that there is some association of 
the ability of a Ca2+-mobilizing agent to induce 
phosphoinositide breakdown with its ability to interact 
synergistically with glucagon (or cyclic AMP) in the 
stimulation of Ca2+ influx.
It was of considerable interest to observe that 
neomycin (10 mM) can inhibit the synergistic effects of 
glucagon and Ca2+-mobilizing agents stimulating Ca2+ 
influx (see Fig. 2), but not the uptake of Ca2+ associated 
with the re-filling of the hormone-sensitive pool of Ca2+. 
The precise site(s) of action of neomycin were not 
established in this work, but there are suggestions that 
neomycin may inhibit the action of phospholipase C 
by binding to the phosphoinositides in the plasma 
membrane (Schibeci & Schacht, 1977; Downes & 
Michell, 1981). Further, a direct effect of neomycin on 
the Ca2+-influx pathway cannot be eliminated. That 
neomycin at these concentrations does not significantly 
interfere with hormone-receptor binding is suggested by 
the observation that neomycin had a similar effect on the 
Ca2+ influx induced by all the Ca2+-mobilizing agents 
tested, and that its presence did not significantly alter the 
Ca2+-efflux response or a stimulation of whole-tissue 
respiration, an associated physiological response (results 
not shown).
Because we have yet to establish that in the perfused 
rat liver the main effect of neomycin is to inhibit the 
action of phospholipase C, we cannot argue too strongly 
at present for an involvement of the second messengers 
inositol trisphosphate and diacylglycerol (or some 
metabolite produced from these) in the regulation of 
Ca2+ influx. However, the possibility for such an 
involvement had previously been proposed by Michell 
(1975), who studied the effects of Ca2+-mobilizing 
hormones on phosphoinositol hydrolysis.
Another important finding made in the present work 
relates to the inability of nominal concentrations of 
diltiazem, verapamil and nifedipine to inhibit the Ca2+ 
influx that occurs after the administration of Ca2+- 
mobilizing agents with or without glucagon pre­
treatment, or the influx associated with the refilling of the 
hormone-sensitive pool of Ca2+ after the removal of 
agents such as phenylephrine, ADP (100 /m) or ADP 
(100 jum) (which induce a more pronounced uptake of 
Ca2+). This suggests that voltage-sensitive Ca2+ channels 
of the type known to exist in excitable tissues (e.g. heart) 
are unlikely to be involved in mediating either of the two 
separate components of Ca2+ influx that are observed. 
Although this is inconsistent with the findings of 
Blackmore et al. (1984) and Joseph et al. (1985), we argue 
that in their experiments these workers used concen­
trations of these agents which in some cases was more 
than an order of magnitude higher than the established 
effective doses in excitable tissues; in our hands toxic 
effects of these agents became apparent at much lower 
concentrations than were used.
Finally, the present work shows that the Ca2+-influx 
mechanism that is synergistically stimulated by the 
co-administration of glucagon and Ca2+-mobilizing
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agents is pH-sensitive: inhibited by low extracellular pH 
(pH 6.8), but potentiated by extracellular pH above 7.4. 
This agrees with the pH-dependence of hormonally 
induced Ca2+ influx previously reported by Blackmore 
et al. (1984). Moreover, our observation that the decrease 
in perfusate pH that occurs after the co-administration 
of glucagon and vasopressin was slightly less at pH 6.8, 
where no net Ca2+ influx was apparent (see Fig. 4), could 
argue for some Ca2+/H + exchange mechanism. However, 
since the total decrease in pH was less than that induced 
by the administration of vasopressin alone, it seems that 
one would need to postulate that glucagon (or cyclic 
AMP) is able to couple the extrusion of H+ with the 
influx of Ca2+. Taking into account the magnitude of the 
perfusate Ca2+ and H+ changes that occur (and taking 
into consideration that the pH change is buffered), and 
assuming that the stoichiometry of the putative exchange 
mechanism to be one Ca2+ for two H+ ions, our 
calculations suggest that the component of pH change 
that may be coupled to Ca2+ influx can account for only 
about 20-30% of the changes in the perfusate Ca2+ 
concentration that are observed. We therefore conclude 
that under these conditions the principal component of 
the Ca2+ influx that is induced by the administration of 
these hormones must occur by a mechanism which is 
different from a simple Ca2+/H + exchange.
Thus, although we cannot as yet speculate as to the 
nature of the Ca2+-influx pathway that is stimulated by 
the action of glucagon and Ca2+-mobilizing agents, the 
observations made in this work imply that at least two 
separate mechanisms exist for regulating Ca2+ influx in 
liver. The one that is neomycin- and pH-sensitive 
appears not to involve a simple Ca2+/H + exchange, but 
may be regulated by a common mechanism which is 
dependent on cyclic AMP (perhaps involving cyclic 
AMP-dependent phosphorylation), phosphoinositide 
breakdown and intracellular pH. The other Ca2+-influx 
mechanism, which is neomycin-, pH- and voltage- 
insensitive, appears to regulate the uptake of Ca2+ 
associated with the refilling of the intracellular hormone- 
sensitive stores of Ca2+ after the removal of Ca2+- 
mobilizing agents. Although it may be possible that this 
may reflect Ca2+ uptake by the endoplasmic reticulum 
from the passive entry of Ca2+ into the cell, it is clear that 
a better understanding of this and the pH-sensitive cyclic 
AMP-dependent regulatory mechanism described, and a 
characterization of the Ca2+ transporters themselves, 
require further investigation.
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Section B.9
Phosphatidic acid and arachidonic acid each interact synergistically with glucagon 
to stimulate Ca2+ influx in the perfused rat liver.
(Altin & Bygrave, 1987c)
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Phosphatidic acid and arachidonic acid each interact 
synergistically with glucagon to stimulate Ca2+ influx 
in the perfused rat liver
Joseph G. ALTIN and Fyfe L. BYGRAVE
Department of Biochemistry, Faculty of Science, The Australian National University, Canberra, A.C.T. 2601, Australia
The administration of phosphatidic acid to rat livers perfused with media containing either 1.3 mM- or 
10//M-Ca2+ was followed by a stimulation of Ca2+ efflux, Oa uptake and glucose output. The responses 
elicited by 100 /iM-phosphatidic acid were similar to those induced by the a-adrenergic agonist phenylephrine. 
Contrary to suggestions that phosphatidic acid acts like a Ca2+-ionophore, no net influx of Ca2+ was detected 
until the phosphatidic acid was removed. Sequential infusions of phenylephrine and phosphatidic acid 
indicate that the two agents release Ca2+ from the same intracellular source. The co-administration of 
glucagon (or cyclic AMP) and phosphatidic acid, and also of glucagon and arachidonic acid, led to a 
synergistic stimulation of Ca2+ uptake of the liver, a feature similar to that observed after the co­
administration of glucagon and other Ca2+-mobilizing hormones [Altin & Bygrave (1986) Biochem. J. 238, 
653-661]. A notable difference, however, is that the synergistic stimulation of Ca2+ uptake induced by the 
co-administration of glucagon and arachidonic acid was inhibited by indomethacin, whereas that induced 
by glucagon and phosphatidic acid, or glucagon and other Ca2+-mobilizing agents, was not. The results 
suggest that the synergistic action of glucagon and arachidonic acid in stimulating Ca2+ influx is mediated 
by prostanoids, but that of glucagon and phosphatidic acid is evoked by a mechanism similar to that of 
Ca2+-mobilizing agents.
INTRODUCTION
Until recently, neither phosphatidic acid nor arachi­
donic acid has been implicated in the mechanism of 
receptor-induced Ca2+ mobilization, at least in the 
perfused rat liver, although each may be produced either 
directly or indirectly as a consequence of a receptor- 
induced activation of phospholipase C and phospho­
lipase A2 respectively. Exogenously added phosphatidic 
acid has been reported to increase cellular Ca2+ and to 
evoke various physiological responses in cells (e.g. Barritt 
et al., 1981; Ohsako & Deguchi, 1981). These effects 
often have been explained in terms of the findings that 
phosphatidic acid displays Ca2+-ionophoretic properties 
in some systems (Tyson et al., 1976; Putney et al., 1980; 
Serhan et al., 1981; Harris et al., 1981). This has led to 
suggestions that phosphatidic acid may be involved in 
mediating the influx of Ca2+ induced by Ca2+-mobilizing 
hormones (e.g. Putney et al., 1980; Harris et al., 1981). 
More recently, however, Moolenaar et al. (1986) have 
reported that, in human A341 carcinoma cells, phospha­
tidic acid elicits its effects by triggering the breakdown of 
phosphoinositides and releasing Ca2+ from intracellular 
stores, and not by stimulating Ca2+ influx. On the other 
hand, although it is well established that arachidonic 
acid can be metabolized to eicosanoids in many cell types 
(for reviews, see Decker, 1985; Needleman et al., 1986), 
other reports suggest that arachidonic acid also has a 
potency similar to that of inositol 1,4,5-trisphosphate in 
releasing Ca2+ from the endoplasmic reticulum in 
permeabilized pancreatic-islet cells (Wolf et al., 1986), 
and is able to mobilize cellular Ca2+ in rat islets of 
Langerhans (Metz et al., 1987). In addition, we have 
shown that the administration of exogenous arachidonic 
acid to the perfused rat liver induces vasoconstriction,
Ca2+-flux changes and glycogenolysis (Dieter et al., 
m ia ,b ) .
Ca2+-mobilizing agents such as phenylephrine, vaso­
pressin, angiotensin, ADP, ATP and epidermal growth 
factor have been shown to interact synergistically with 
glucagon in stimulating Ca2+ uptake by the perfused rat 
liver (Altin & Bygrave, 1986, 1987). It therefore seemed 
important to test the possibility that in this system 
phosphatidic acid and arachidonic acid might similarly 
interact with glucagon (or cyclic AMP). We have 
examined this question in the present work, and report 
that phosphatidic acid and arachidonic acid each 
interacts synergistically with glucagon in stimulating 
Ca2+ influx by the perfused rat liver. In contrast with the 
influx of Ca2+ induced by glucagon and phosphatidic 
acid (and other Ca2+-mobilizing agents), which is 
unaffected by indomethacin, that induced by the co­
administration of glucagon and arachidonic acid is 
inhibited by this agent. This suggests that the mode of 
action of phosphatidic acid is similar to that of other 
Ca2+-mobilizing hormones, but that the effects of 
arachidonic acid are mediated by products of cyclo­
oxygenase.
METHODS AND MATERIALS
Male Wistar-strain rats (body wt. 280-350 g) fed ad 
libitum were used for all experiments. The rats were 
anaesthetized with sodium pentobarbitone (50 mg/kg) 
and the livers were perfused with Krebs-Henseleit (1932) 
bicarbonate medium, equilibrated with 0 2/C 0 2 (19:1), 
containing 1.3 mM-Ca2+ as described in Reinhart et al. 
(1982a). The perfusate Ca2+ and 0 2 concentrations were 
monitored continuously with a Ca2+-selective electrode
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and a Clark-type oxygen electrode respectively, exactly 
as described previously (Reinhart et al., 1982a; Altin & 
Bygrave, 1985). After a pre-perfusion period of 15-20 
min, hormones and/or phosphatidic acid or arachidonic 
acid were administered at the specified concentrations by 
appropriate infusions with a pump-driven syringe for the 
period indicated in the Figures. Stock solutions of 
hormones were made up in Krebs-Henseleit medium, 
whereas phosphatidic acid and arachidonic acid were 
each made up in Krebs-Henseleit medium containing 
10% (w/v) fatty acid-free bovine serum albumin and 
sonicated for 2-3 min at 37 °C. Indomethacin (20 jum) 
was dissolved in dimethyl sulphoxide and then 
administered by addition to perfusion medium containing 
also 0.1% (w/v) bovine serum albumin. Under these 
conditions the presence of bovine serum albumin (final 
concn. < 0.03 %) and dimethyl sulphoxide (final concn. 
< 0.02% v/v) did not induce any significant Ca2+-flux 
change, nor alter significantly the responses induced by 
Ca2+-mobilizing agents. For some experiments the 
samples of the effluent perfusate were collected for 
glucose determination by the glucose oxidase method as 
described by Reinhart et al. (19826).
Chemicals and materials
Natural L-a-phosphatidic acid from egg yolk, synthetic 
L-a-phosphatidic acid (dipalmitoyl, dilauroyl and di- 
stearoyl forms), arachidonic acid, glucagon, phenyl­
ephrine, [Arg8]vasopressin, [Val5]angiotensin, dibutyryl 
cyclic AMP, indomethacin, bovine serum albumin and 
the glucose assay kit (510-A) were all obtained from 
Sigma Chemical Co., St. Louis, MO, U.S.A. All other 
chemicals were of analytical grade.
RESULTS
Effect of phosphatidic acid administration on Ca2+-flux 
changes, respiratory and glycogenolytic responses
Previous studies on the effect of phosphatidic acid on 
Ca2+ fluxes in isolated cells have provided conflicting 
results. For example, Barritt et al. (1981) reported that 
phosphatidic acid stimulates the net influx of Ca2+ in 
isolated hepatocytes, but more recently Moolenaar et al. 
(1986) have reported that phosphatidic acid stimulates 
Ca2+ efflux in human A341 cells. To our knowledge, no 
effect of phosphatidic acid on Ca2+-flux movements in 
the perfused rat liver has yet been reported. As a prelude 
to studying possible synergistic actions of phosphatidic 
acid and glucagon, it therefore seemed relevant to 
examine first the effects of phosphatidic acid administered 
alone on Ca2+-flux changes and other physiological 
responses in the perfused rat liver.
Figs. 1(a), 1(6) and 1(c) show respectively the Ca2+, 
0 2 and glucose responses induced by administering 
100/^M-phosphatidic acid to the liver perfused with 
media containing either 1.3 mM- or 10/^M-Ca2+. At the 
higher extracellular Ca2+ concentration, phosphatidic 
acid induces a transient efflux of Ca2+ from the liver 
(120-150 nmol/g of liver). No net influx of Ca2+ can be 
detected until phosphatidic acid is removed. Moreover, 
Figs. 1(6) and 1(c) respectively, show that the phospha­
tidic acid-induced changes in 0 2 uptake and glucose 
output remain stimulated for the time during which the 
compound is administered. It is noteworthy that 
phosphatidic acid induces Ca2+ efflux even when the
-2 0 0
-1 0 0
Perfusion time (min)
Fig. 1. Effect of phosphatidic acid administration on Ca2+-flux 
changes, 0 2 consumption and glucose output in the 
perfused rat liver
Livers were perfused with Krebs-Henseleit bicarbonate
medium containing 1.3 mM-Ca2+ (------) or 10//M-Ca2+
(------- ; lowered from 1.3 mM to 10/tM at 10 min of
perfusion and thereafter for the remainder of the ex­
periment) as detailed in the Methods and materials section. 
After a pre-perfusion period of 15 min, phosphatidic acid 
(PA; 100 //m; bold horizontal line) was infused for 5 min 
as indicated by the arrows; 20 min later phenylephrine 
(Phe; 2 //M, thin horizontal line) was also infused as 
shown. The induced Ca2+ and 0 2 responses, as monitored 
with the Ca2+-sensitive electrode and oxygen electrode 
respectively, are shown in (a) and (6). The associated 
glucose response is shown in (c), where each point is the 
result of a glucose determination carried out on a sample 
of the effluent perfusate collected at the indicated time. 
The traces are representative of those obtained from three 
separate experiments. The glucose data represent mean 
values; s.e.m. values were omitted for clarity, but 
+ 0.03 mM was never exceeded.
extracellular Ca2+ concentration is lowered to 10 jum. In 
these experimental conditions the respiratory and glyco­
genolytic responses are transient (see Figs. 16 and lc). 
These data suggest that the influx of extracellular Ca2+ is 
not required for triggering the induced respiratory and 
glycogenolytic effects, but that phosphatidic acid elicits 
these effects by releasing Ca2+ from intracellular stores.
The data in Fig. 2(a) show that the pre-administration 
of phenylephrine (5 jum) results in a marked decrease in 
the Ca2+ efflux induced by phosphatidic acid. Also, the 
data in Fig. 2(6) show that the pre-administration of 
phosphatidic acid (150 / / m ) markedly decreases the efflux 
of Ca2+ induced by phenylephrine. These results suggest 
that the Ca2+ release induced by phosphatidic acid 
originates from the same intracellular source as that
1987
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Fig. 2. Effect of sequential infusion of phosphatidic acid and 
phenylephrine on Ca2+ efflux
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3 mM-Ca2+. At 15 min of perfusion, 
phenylephrine (Phe; 5 / /m ; thin horizontal line) and then 
phosphatidic acid (PA; 150 / /m , bold line) were each 
infused for 5 min as indicated. The Ca2+ response induced 
is shown in (a). Fig. 2(b) shows the Ca2+ response obtained 
from a similar experiment in which the order of adminis­
tration of phosphatidic acid and phenylephrine was 
reversed. Each trace is a representative of three experiments 
performed independently.
mobilized by phenylephrine, and hence that in this 
system phosphatidic acid elicits its effects by a mechanism 
which mimics that of other Ca2+-mobilizing agents.
Specificity of phosphatidic acids in inducing 
physiological responses
Moolenaar et al. (1986) reported differences in the 
abiity of different phosphatidic acids to induce a 
physiological response in human A431 carcinoma cells. 
We therefore decided to compare the effects of natural 
phosphatidic acid (from egg yolk) with those of different 
synthetic phosphatidic acids in the perfused rat liver. In 
oui system, synthetic dipalmitoyl phosphatidic acid and 
synthetic dioleoyl phosphatidic acid elicited respiratory 
anc glycogenolytic effects which were 30-50 % (the Ca2+ 
flu;, changes induced were less than 10%) of those 
induced by a similar concentration of natural phospha­
tide acid from egg yolk (results not shown). Also, 
syrthetic dilauroyl phosphatidic acid elicited small effects 
only after it was removed whereas synthetic distearoyl 
phosphatidic acid elicited no detectable change in any of 
the responses studied. Such variation in the ability of 
these agents to elicit a response suggests that there is 
corsiderable specificity for the particular type of fatty 
acii chains in the phosphatidic acid molecule.
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Fig. 3. Comparison of the Ca2+-flux response induced by the 
co-administration of glucagon with phosphatidic acid, 
arachidonic acid or phenylephrine
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3 m\t-Ca2+, and the perfusate Ca2+ 
concentration was monitored continuously with a Ca2+- 
selective electrode. The traces in (a) represent the Ca2+ 
response obtained from separate experiments in which
phenylephrine (Phe; 2 / m ; ------), phosphatidic acid (PA;
150 / M ; ------) or arachidonic acid (AA; 200 /im ; • • • •)
was infused for the time indicated by the arrows. Similarly, 
the Ca2+ response obtained in separate experiments in 
which the infusion of phosphatidic acid, arachidonic acid 
and phenylephrine was preceded by a 4 min infusion of 
10 nM-glucagon, which was then co-administered with 
each agent, is shown in (b). At this concentration the 
administration of glucagon induced only a small efflux of 
Ca2+ during the first 3-4 min, but did not itself induce any 
net stimulation of Ca2+ influx when administered for the 
9 min period (results not shown). Essentially identical 
results (not shown) were obtained when 200 //M-cyclic 
AMP was administered instead of glucagon. Each trace is 
a representative of four or five experiments performed 
independently.
Ability of glucagon to potentiate phosphatidic acid- and 
arachidonic acid-induced Ca2+ influx
Data presented above (Figs. 1 and 2) establish that 
exogenous phosphatidic acid has properties similar to 
those of other Ca2+-mobilizing hormones. Moreover, we 
have shown that the administration of arachidonic acid 
induces Ca2+-flux changes and other physiological 
responses in the perfused rat liver (Dieter et al., 1987a,/;). 
Because glucagon has been found to interact syner- 
gistically with Ca2+-mobilizing agents in stimulating Ca2+ 
influx in isolated hepatocytes (Morgan et al., 1983; 
Mauger et al., 1985; Poggioli et al., 1986), and in the 
perfused liver (Altin & Bygrave, 1986, 1987), we 
conducted experiments to determine whether such
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Fig. 4. Dose-response for the stimulation of Ca2+ influx by the 
co-administration of glucagon with phosphatidic acid or 
with arachidonic acid
Experiments were conducted exactly as described in the 
legend to Fig. 3(b), except that the concentrations of 
phosphatidic acid and arachidonic acid were varied. For 
each experiment the total net amount of Ca2+ influx, as 
represented by the area above the curve constituting the 
Ca2+-influx response, was determined. Each point re­
presents the net amount of Ca2+ influx obtained from 
separate experiments conducted at the indicated concen­
tration of phosphatidic acid (PA; O) and arachidonic acid 
(AA; • ) .  Each point is the mean + s.E.M . of either three or 
four independent experiments conducted at the indicated 
concentration.
synergism could be observed also with glucagon and 
phosphatidic acid, or glucagon and arachidonic acid. 
Fig. 3(a) shows the Ca2+-flux response induced by the 
administration of phosphatidic acid, arachidonic acid, 
and phenylephrine, when each was administered alone. 
By comparison, the effect of a 4 min pre-administration 
of 10 nM-glucagon is shown in Fig. 3(6). In each instance 
the administration of 10 nM-glucagon leads to a 
synergistic stimulation of Ca2+ uptake by the liver upon 
subsequent administration of 150 //M-phosphatidic acid, 
200 /rM-arachidonic acid or 2 //M-phenylephrine. Under 
these conditions, glucagon itself did not stimulate any 
net influx of Ca2+ when administered alone for the 9 min 
period (results not shown). The Ca2+ response induced 
by the co-administration of glucagon and phenylephrine 
was described previously (Altin & Bygrave, 1986) and is 
included here for comparison. The Ca2+ influx induced 
by the co-administration of glucagon and arachidonic 
acid was essentially complete after 5 min. However, the 
rate of Ca2+ influx induced by glucagon and phosphatidic 
acid (and also that induced by glucagon and phenyl­
ephrine) was approx. 60 % of maximal at 5 min of co­
Table 1. Stimulation of Ca2+ influx by the co-administration o f  
glucagon with phosphatidic acid, arachidonic acid or 
phenylephrine
The Table gives the net amount and maximum rate of 
Ca2+ influx induced by the co-administration of 10 nM- 
glucagon and near-maximal concentrations of phospha­
tidic acid (150/<m), arachidonic acid (200/tm) or phenyl­
ephrine (2 //m). The maximum rate of influx was calculated 
from the maximum deflection of the pen in the Ca2+ trace, 
and the net amount of Ca2+ influx from the area above the 
curve in the Ca2+-influx response. Liver perfusions and 
other details are exactly as described in the legend to 
Fig. 3(6). Each value represents the mean + s.E.M . of three 
or four independent experiments.
Ca2+ influx
Maximum
Net amount rate (nmol/
(nmol/g of min per g
Additions liver) of liver)
Glucagon + phosphatidic acid 1170+130 358 + 35
Glucagon + arachidonic acid 484 + 42 202 + 24
Glucagon + phenylephrine 1050+118 326 + 38
administration, and the rate then decreased rapidly 
(within 1-2 min) when the stimuli were removed (Fig. 3). 
In each instance removal of the stimuli was subsequently 
followed by a slower efflux of Ca2+ over a period of 
20-25 min. Although the magnitude of the Ca2+ influx 
and the minimal dose required to elicit the effect are 
different for each agent, the Ca2+-flux response is 
qualitatively similar to that induced by glucagon and 
phenylephrine (Fig. 3), and glucagon and other Ca2f- 
mobilizing agents such as vasopressin, angiotensin, 
ADP, ATP and epidermal growth factor (Altin & 
Bygrave, 1986, 1987).
The dose-response curves for the stimulation of Ca2+ 
uptake by glucagon and phosphatidic acid, and glucagon 
and arachidonic acid, are shown in Fig. 4. With 10 nM- 
glucagon, near-maximal stimulation of Ca2+ influx 
occurs at 150 //M-phosphatidic acid and 200 /m- 
arachidonic acid. The net amount of Ca2+ uptake, and 
the maximum rate of Ca2+ influx that is observed after 
the administration of these concentrations of phospha­
tidic acid and arachidonic acid, are given in Table 1 for 
comparison with phenylephrine. It is noteworthy that the 
Ca2+ response induced by the co-administration of 
glucagon and phosphatidic acid, or glucagon and 
phenylephrine, could be repeated by a second adminis­
tration of these agents after a rest period of 20-25 min. 
However, the Ca2+-influx response induced by glucagon 
and arachidonic acid was refractory, in that a second 
administration of the agents 20-30 min later failed to 
elicit a similar response (results not shown). Essentially 
identical results were obtained when 200 //M-cyclic AMP 
was used instead of 10 nM-glucagon (results not 
shown).
Effect of indomethacin on the Ca2+ response induced by 
the co-administration of glucagon and arachidonic acid, 
or glucagon and phosphatidic acid
Because it is known that arachidonic acid can be 
metabolized to eicosanoids, it seemed important to test
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Fig. 5. Effect of indomethacin on the Ca2+-influx response 
induced by the co-administration of glucagon with 
phosphatidic acid, with arachidonic acid, or with phenyl­
ephrine
Rat livers were perfused with Krebs-Henseleit bicarbonate 
medium containing 1.3 mM-Ca2+, and the perfusate Ca2+ 
concentration was continuously monitored with the Ca2+- 
selective electrode as previously described. At 5 min of 
perfusion, and thereafter for the remainder of the 
experiment, the perfusion was carried out with media 
containing also 20 //M-indomethacin (see the Methods and 
materials section). At 16 and 20 min of perfusion, glucagon 
(Glu; 10 nM; broken horizontal lines) and phosphatidic 
acd (PA; 150//M; bold horizontal line) were infused as 
indicated. Subsequently, at 40 min of perfusion glucagon 
(l )nM; broken horizontal line), and 4 min later phenyl­
ephrine (Phe; 2 / /m ; thin horizontal line) were also 
acministered as indicated. The Ca2+ response induced is 
shown in (a). The Ca2+ response obtained in a similar 
experiment in which arachidonic acid (AA) was 
acministered instead of phosphatidic acid is shown in (b). 
Each trace is a representative of three independent 
experiments.
whether the cyclo-oxygenase inhibitor indomethacin 
coud prevent the synergistic effects of glucagon and 
arachidonic acid (and perhaps glucagon and phospha­
tidic acid, or glucagon and phenylephrine) in stimulating 
Ca2' uptake by the liver. Figs. 5(a) and 5(6) show that a 
15 nin pre-treatment with 20 /cM-indomethacin results in 
a complete inhibition of the Ca2+ response induced by 
the :o-administration of glucagon and arachidonic acid. 
However, the Ca2+ influx response induced by the co- 
adrrinistration of glucagon and phosphatidic acid, and 
glucagon and phenylephrine, is not significantly affected 
by indomethacin (inhibition approx. 10%). These data 
suggest that cyclo-oxygenase products are the active 
metabolites in mediating the synergistic stimulation of 
Ca2f influx by glucagon and arachidonic acid. The data
also indicate, by contrast, that such products are unlikely 
to be involved in the stimulation of Ca2+ influx that is 
induced by the co-administration of glucagon and 
phosphatidic acid, or glucagon and phenylephrine (see 
Fig. 5). Similarly, indomethacin failed to prevent Ca2+ 
influx induced by the synergistic action of glucagon with 
vasopressin and angiotensin instead of phenylephrine 
(results not shown).
D IS C U S S IO N
This work has shown that the administration of 
exogenous phosphatidic acid induces Ca2+ efflux, and 
stimulates 0 2 uptake and glucose output in the perfused 
rat liver. These effects, which are observed at both 1.3 mM 
and 10 fiM extracellular Ca2+, are consistent with 
reports that phosphatidic acid induces glycogenolytic 
effects in isolated hepatocytes (Barritt et al., 1981) and 
physiological responses in other cells (Salmon & 
Honeyman, 1980; Harris et al., 1981; Ohsako & Deguchi, 
1981). The results are not consistent, however, with 
reports that phosphatidic acid fails to stimulate glyco- 
genolysis in cultured rat hepatocytes (Osugi et al.,
1984) .
It has been reported that phosphatidic acid stimulates 
Ca2+ influx in cells in a Ca2+-ionophoretic-like action 
(Putney et al., 1980; Serhan et al., 1981; Harris et al., 
1981; Ohsako & Deguchi, 1981). In the perfused liver, 
however, the net effect of phosphatidic acid is to induce 
Ca2+ efflux, most probably from the same intracellular 
stores as that released by the a-adrenergic agonist 
phenylephrine and other Ca2+-mobilizing hormones (see 
Fig. 2). It is noteworthy also that Holmes & Yoss (1983) 
failed to observe Ca2+ influx induced by phosphatidic 
acid, albeit in phosphatidylcholine-containing membrane 
vesicles. Our result is also in agreement with the 
observation that at early times phosphatidic acid induces 
a loss of 45Ca2+ from isolated hepatocytes pre­
equilibrated with the radioisotope (Barritt et al., 1981). 
Moreover, our data suggest that the action of phospha­
tidic acid with respect to mobilization of Ca2+ and the 
induction of respiratory and glycogenolytic effects in 
liver is similar to that of phenylephrine, an agent known 
to induce its effects by releasing Ca2+ through the 
breakdown of phosphoinositides and the generation of 
inositol 1,4,5-tris-phosphate (reviewed by Reinhart et al., 
1984; Berridge, 1984; Exton, 1985; Williamson et al.,
1985) . The data presented thus give support to the 
findings by Moolenaar et al. (1986) that phosphatidic 
acid induces Ca2+ efflux and the breakdown of phospho­
inositides in human A431 carcinoma cells.
It is not yet clear whether phosphatidic acid is acting 
through some receptors on the surface of the plasma 
membrane, or whether it enters the cell and activates 
phospholipase C directly, as proposed by Moolenaar 
et al. (1986). It is noteworthy, however, as also reported 
by Moolenaar et al. (1986), that natural phosphatidic acid 
from egg yolk is the most active of the phosphatidic acids 
tested.
The second major point arising from the present work 
concerns the ability of phosphatidic acid and of 
arachidonic acid each to interact synergistically with 
glucagon to stimulate Ca2+ influx. To our knowledge, no 
such action has yet been reported. The general pattern of 
the induced Ca2+-influx response is similar to that evoked 
by the co-administration of glucagon and other Ca2+-
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mobilizing agents (cf. this work with Altin & Bygrave, 
1986, 1987). However, the potency of phosphatidic acid 
differs from that of arachidonic acid in inducing Ca2+ 
influx when each is co-administered with glucagon (see 
Fig. 4), and the maximum amount of Ca2+ influx that is 
induced also differs between the two acids (Fig. 3 and 
Table 1).
Our finding that phosphatidic acid induces Ca2+ efflux 
even at low extracellular [Ca2+] (Figs. 1 and 2 of the 
present work), supports the observations that phospha­
tidic acid induces its effects by stimulating the breakdown 
of phosphoinositides (Moolenaar et al., 1986). We 
therefore suggest that the synergistic action of glucagon 
and phosphatidic acid in stimulating Ca2+ influx need not 
involve phosphatidic acid itself, but that the Ca2+ influx 
is probably regulated by a mechanism similar to that 
which exists between cyclic AMP and other Ca2+- 
mobilizing agents which are known to stimulate phospho- 
inositide metabolism. The particular aspect of phospho- 
inositide metabolism involved in regulating Ca2+ influx 
remains to be determined, although there is evidence for 
a possible involvement of inositol 1,3,4,5-tetrakis- 
phosphate, a metabolite of inositol 1,4,5-trisphosphate 
(Irvine & Moor, 1986). We are mindful, on the other 
hand, that phosphatidic acid is rapidly produced as a 
consequence of the activation of receptors linked with 
the breakdown of phosphoinositides and mobilization of 
cellular Ca2+ (Berridge, 1984; Godfrey & Putney, 1984; 
Seyfred & Wells, 1984), and that the temporal accumu­
lation of phosphatidic acid in the plasma membrane of 
hepatocytes stimulated with vasopressin (Seyfred & 
Wells, 1984) correlates well with the onset of Ca2+ influx 
that is observed in the presence of glucagon or cyclic 
AMP (see Altin & Bygrave, 1986).
A further and significant feature of the synergistic 
interaction of glucagon and arachidonic acid in stimu­
lating Ca2+ influx is its sensitivity to the cyclo-oxygenase 
inhibitor indomethacin (Fig. 5). This suggests that 
arachidonic acid itself is not the active agent that 
interacts with glucagon (or cyclic AMP) to stimulate 
Ca2+ influx. Rather, it would seem that metabolites of 
cyclo-oxygenase activity are involved in mediating this 
effect. By contrast, under otherwise identical conditions 
the synergistic stimulation of Ca2+ influx induced by the 
co-administration of glucagon and phosphatidic acid, or 
glucagon and other Ca2+-mobilizing agents, is essentially 
unaffected by indomethacin (see Fig. 5). This therefore 
suggests that products of cyclo-oxygenase are unlikely to 
be involved in eliciting the synergistic effects induced by 
these agents.
Because the liver parenchyma are thought not to be 
significant producers of prostanoids (Decker, 1985; 
Tran-Thi et al., 1986), it would seem that the action of 
arachidonic acid in liver may involve the production of 
prostanoids by cell types other than hepatocytes. We 
envisage that such prostanoids, once released from these 
cells, could interact with hepatocytes through receptors 
that are themselves linked to the breakdown of phospho­
inositides and a mobilization of cellular Ca2+, in a 
manner that is similar to that induced by Ca2+-mobilizing 
hormones (Creba et al., 1983; Berridge, 1984). The 
synergism that exists between glucagon and arachidonic 
acid (Fig. 3) could then be explained by a mechanism 
analogous to that which exists between glucagon and the 
Ca2+-mobilizing hormones. This notion is consistent 
with our proposal that the physiological responses
induced by arachidonic acid and zymosan (Dieter et al., 
1987a,6) and platelet-activating factor (Altin et al., 1987) 
are mediated by prostanoids produced and released by 
different cell types within the liver.
Thus the present work has shown that both 
phosphatidic acid and arachidonic acid, metabolites that 
are produced as a consequence of the activation of a 
number of different receptors, themselves elicit Ca2+-flux 
changes and physiological responses when administered 
exogenously to the perfused rat liver. Our data are 
consistent with the effects of arachidonic acid being 
mediated by products of cyclo-oxygenase, whereas those 
of phosphatidic acid appear to be induced by a 
mechanism similar to that of other Ca2+-mobilizing 
agents. The particular product(s) of cyclo-oxygenase 
involved in mediating the effects of arachidonic acid, and 
the mechanism by which phosphatidic acid seemingly 
stimulates phosphoinositide breakdown, remain to be 
determined.
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Action of calcium-mobilizing stimuli in the perfused rat liver.
(Bygrave etal., 1987)
Action of calcium-mobilizing stimuli 
in the perfused rat liver
F.L. BYGRAVE, J.G. ALTIN, P. DIETER AND A. KARJALAINEN
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In recent years many laboratories have begun to invest much effort in order 
to understand how certain hormones and other related agents act on various 
tissues to bring about changes in calcium ion (Ca2+) fluxes and the associated 
metabolic responses. In this paper we discuss overall aspects of some of these 
issues and focus, in keeping with the theme of this conference and of our own 
current research interests, on the information that has been gained from 
studies with the intact perfused rat liver. We hope to make it clear in this article 
that while this experimental system is seemingly complex, a considerable body 
of useful information can be gained from it, especially in respect of stimuli- 
induced cellular calcium movement.
THE MULTIPLICITY OF AGENTS THAT INDUCE CALCIUM FLUX 
CHANGES IN LIVER
Influence of vasopressin, angiotensin and a-adrenergic agonists
Early work by several groups detected changes in Ca2+ movements in both 
the perfused rat liver and in hepatocytes following administration of the 
hormones vasopressin, angiotensin or a-adrenergic agonists (this information 
has been reviewed in references 1-4). The pattem and quantities of such 
fluxes induced, by for example, phenylphrine administration to the perfused 
rat liver, is illustrated by the data shown in Figure 7.1. We have incorporated 
into this experimental system a sensitive Ca2*-selective electrode which pro­
vides a means of continuously measuring quite small changes in the perfusate 
Ca2+ even when the background Ca2+ concentration is as high as 
1.3 mmol/15’6. The sensitivity of the system is such that a change of less than 
1 fjinol/1 Ca2+ can be readily detected. The data show that seconds after 
phenylephrine administration, the Ca2+ concentration in the perfusate rises 
steeply and transiently, reflecting a net loss of Ca2+ from the liver. When the 
agonist is removed, the equivalent amount of Ca2+ that was initially lost, is
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Figure 7.1 Calcium fluxes induces by the a-adrenergic agonist phenylephrine in the perfused rat 
liver. For experimental details see references 5 and 6
allowed to enter the liver across the plasma membrane (see later). A large 
body of evidence now suggests that the initial intracellular ‘pool’ of this 
mobilized Ca2+ is within the endoplasmic reticulum and not the mito­
chondria.
A somewhat different pattern of Ca2+ mobilization is observed when 
vasopressin and angiotensin are each administered (Figure 7.2). In these 
circumstances a smaller efflux of Ca2+ occurs and, prior to removal of the 
hormone, there is a spontaneous influx of quite large quantities of the ion7' 9. 
These differences are not as evident if^M P or the*AMP-generating hormone 
glucagon is administered prior to eacn of the three above-mentioned stimuli6.
Role of glucagon
As shown in Figure 7.3, when*AMP is administered some 2-4 minutes prior 
to vasopressin, angiotensin of a-adrenergic agonists, initially a rather small 
efflux of Ca2+ occurs. This is immediately followed by a spontaneous uptake 
of the ion which lasts for about 20 minutes when near-maximal concentrations 
of the hormones are used9. The extent of Ca2+ taken up in this way is 
quite massive, amounting to almost 4000//mol/g of liver for vasopressin 
and angiotensin and about 1200nmol/g for phenylephrine. As observed in 
experiments conducted with hepatocytes7-8, the concentrations of glucagon 
and Ca2+-mobilizing hormones required to mobilize the ion are in the physio­
logical range (~0.1-0.01 nmol/1, and thus are of potential significance.
Two other features of this phenomenon are also of interest. The first is the 
finding that mitochondria are the intracellular ‘sink’ for the accumulated 
Ca2+. Indeed we have been able to estimate that under these conditions, the 
mitochondrial Ca2+ concentration can increase to around 50 nmol/mg of 
mitochondrial protein or more, i.e. some 40-fold more than that of the 
‘control’ mitochondria9. Removal of the hormone, even after 20 minutes of
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Figure 7.2 Calcium fluxes induced by vasopressin and angiotensin in the perfused rat liver. For 
further details see reference 6
administration, leads to an efflux of the accumulated Ca2+ over a subsequent 
period of some 30 minutes. A second hormone pulse can then induce a further 
massive Ca2+ influx. This provides strong indications that the mitochondria, 
and the whole liver for that matter, have suffered no ill effects despite the 
massive amount of Ca2+ accumulated by these organelles. In this context, 
and of particular interest, is the nature and cellular location of the changes 
which have occurred to allow such massive amounts of Ca2+ movement 
without inducing damage to the mitochondria. Some argue that the site of 
alteration is primarily at the mitochondrion7, whilst others consider it occurs 
at the plasma membrane8. Our own view is that it could be a combination of 
both9.
Another noteworthy feature of this synergistic phenomenon is that the 
influx of Ca2+ induced by glucagon and each of the Ca2+-mobilizing hor-
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mones is blocked by neomycin (an inhibitor of phospholipase C action in 
some tissues), but not by nominal concentrations of the Ca2+ channel blockers 
verapamil, niphedipine or diltiazem10.
Effects of ADP, ATP, epidermal growth factor, phosphatidic acid 
and arachidonic acid
The ability of glucagon preadministration to induce an increase in apparent 
sensitivity of the liver to inward Ca2+ flux described above, provides a means 
for determining what other agents are also able to induce Ca2+ influx in this 
experimental system. Data in Figures 7.4 and 7.5 show that, besides the Ca2+-
- 1 6 0
tOLU
Perfusion time (min)
Figure 7.4 Ability o f ADP, ATP and epidermal growth factor to induce calcium fluxes in the 
perfused rat liver. For further details see reference 10. The ADP concentrations were I, 10 and 
I00|rmol/l, respectively in (aH e). The EGF concentrations were 10 (thin continuous line) or 50 
nmol/1 (thin broken line)
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Figure 7.5 Ability o f phosphatidic acid and arachidonic acid to induce calcium fluxes in the 
perfused rat liver. For further details see references 11 and 12. AA and PA concentrations were 
150/anol/l
mobilizing hormones, ADP, ATP, epidermal growth factor, phosphatidic 
acid and arachidonic acid also induce large Ca2+ influx following prior 
glucagon administration10-12. In these instances too, the influx proceeds into 
the mitochondria without producing apparent damage to the liver. It is 
relevant that most of these agents are reported to induce phosphatidylinositol 
breakdown13,14, a point that suggests common features in terms of their 
mechanism of action.
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Eicosanoid-induced calcium mobilization in the perfused rat liver
As is widely known, the liver is a relatively complex organ consisting of 
several cell types—hepatocytesj Kupfler, enothelial, fat storing and smooth 
muscle15. In assessing the responses observed in this laboratory in the whole 
organ to various stimuli, it became important to attempt to assess if possible 
the contribution of each cell type. For instance it is thought that only Kupfler 
and endothelial cells produce and release eicosanoids following their exposure 
for example to zymosan and arachidonic acid16. Hepatocytes on the other 
hand, perhaps through receptors on their plasma membranes, may respond 
to these compounds. We have approached this question by studying the 
effects of a variety of stimuli in combination with different inhibitors of 
eicosanoid formation.
Influence of latex beads, zymosan and arachidonic acid
The effects of the phagocytosable material zymosan and latex beads on the 
perfusate Ca2+ are shown in Figure 7.6. No significant responses are induced 
by latex beads, but zymosan, after being administered for approximately 1 
minute, induces Ca2* efflux although to a lesser extent than occurs with 
phenylephrine; this is followed immediately, and while the agent is still being 
infused, by a spontaneous influx of the ion11. Upon removal of the zymosan, 
Ca2+ efflux ensues. The pattern of Ca2+ mobilization induced by arachidonic
—  Phe
♦100
« J  o >
CL o>
P e r f u s i o n  T i m e  ( m i n )
Figure 7.6 Ability of phagocytosable material to promote calcium fluxes in the perfused rat 
liver. For further details see reference 11. Zymosan and latex particles were infused at l50//g/ml
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acid administration (see also Figure*7.5), is similar to that induced by phen­
ylephrine, in that Ca2+ efflux occurs initially, is transient, and is followed by 
an influx of the ion once the acid is removed.
Further information about the responses were obtained by assessing the 
effects of the inhibitors indomethacin which blocks cyclo-oxygenase activity, 
bromophenacyl bromide (BPB), which blocks phospholipase A2 activity and 
nordihydroguaiaretic acid (NDGA) which blocks lipo-oxygenase activity171*. 
Figure 7.7 shows that indomethacin does not influence phenylephrine- 
induced Ca2+ responses, but by contrast, totally blocks that induced by 
arachidonic acid. The efflux component of the zymosan-induced response is 
stimulated and the influx component is inhibited by indomethacin. The effects 
of NDGA and of BPB are to inhibit by about 50% all of the responses, but 
possible non-specific effects cannot be ruled out as these compounds also 
inhibit phenylephrine-induced responses. The first and obvious conclusion to 
be made from these experiments is that in the perfused rat liver, the mech­
anism of action of phenylephrine is different from that of zymosan and 
arachidonic acid in inducing the Ca2+ responses. It would seem that the latter 
two agents probably induce eicosanoid production in Kupffer and endothelial 
cells (but not hepatocytes) which after their release, could in turn interact 
with hepatocytes to induce the observed responses. It is unclear at this stage 
why the Ca2+ flux changes induced by zymosan differ from those induced by 
arachidonic acid.
Effect of prostaglandins
In other studies so far unpublished, we have pursued the question of the 
nature of the eicosanoids produced from arachidonic acid metabolism that 
might be responsible for the indomethacin-sensitive Ca2+ flux response. Our 
experiments indicate that prostaglandins D2 and E2 are without significant 
effect, but that prostaglandin F2a administration leads to a Ca2+ flux response 
similar to that of arachidonic acid12. A further relevant point is that the 
synergism mentioned above of glucagon and Ca2* -mobilizing agents, which 
leads to massive Ca2+ inflow, also occurs with either arachidonic acid12 or 
prostaglandin F^ administered in place of the Ca2*-mobilizing agents.
Effects of platelet-activating factor and lysophosphatidylcholine
The phosphoglyceride acetyl glycerly ether phosphorylcholine, known as 
platelet activating factor (PAF) has powerful effects on liver metabolism, 
particularly in inducing vasoconstriction, changes in respiration and in gly- 
cogenolysis in the perfused rat liver, but apparently not in isolated hepa­
tocytes19-20. Its action is reportedly dependent on external Ca2+. Because of 
this knowledge and since its mechanism of action is unclear, we have examined 
its effects on Ca2+ fluxes in the perfused rat liver. Administration to the liver 
of PAF at concentrations as low as 0.1 nmol/1 induces Ca2* efflux21. This and 
other responses measured concurrently (oxygen uptake, glucose output and
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Figure 7.7 Effect of the cyclo-oxygenase inhibitor indomethacin on calcium fluxes in the perfused 
rat liver induced by (a) phosphatidic aqd (PA) or (b) arachidonic acid (AA). For further details 
see reference 12. The perfusions in both (a) and (b) were carried out in the presence of 20^mol/l 
indomethacin
vasoconstriction) arc all significantly inhibited by indomethacin (Figure 7.8) 
suggesting that the observed responses are also mediated by products of 
cyclo-oxygenase activity. The similarity of these responses to those induced 
by ONO-11113, the stable analogue of thromboxane-A2, is noteworthy and 
is a current line of study in this laboratory.
We have also examined the responses induced by the structurally related 
compound lysöphosphatidylcholine21, which can be produced intracellularly 
by the action of phospholipase A2 on phosphatidylcholine and extracellularly 
by the action of phosphatidylcholine-cholesterol acyltransferase. Data in 
Figure 7.9 show that the lysophosphatidylcholine-induced responses bear a 
remarkable similarity to those induced by PAF. Near-maximal effects are 
observed around 50^mol/l, and detectable responses are observed as low as 
5 /imol/1. These effects were also inhibited by indomethacin. Other noteworthy 
features of these responses to lysophosphatidylcholine, are their sensitivity
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Figure 7.8 Calcium fluxes induced by platelet activating factor in the perfused rat liver. For 
further details see reference 21. The concentration of PAF(AGEPC) was io nmol/1. Experiments 
were carried out in the absence (continuous lines) or presence (dotted lines) of 20/imol/l 
indomethacin
to indomethacin, the commonality with phenylephrine of the source of intra­
cellular Ca2+, and the absence of Ca2+ efflux when the external Ca2+ con­
centration is lowered to around 25//mol/1. Moreover, similar concentrations 
of phosphatidylcholine and of lysophosphatidylethanolamine from egg yolk 
are without effect.
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These studies thus reveal an involvement of prostanoid production in 
eliciting the responses in the perfused rat liver to the agents zymosan, arach- 
idonic acid, platelet activating factor and lysophosphatidylcholine. The 
nature of the interactions which occur between prostaglandins and hepa- 
tocytes is not clear but may involve phosphatidylinositol breakdown in a 
manner similar to that which occurs in the action of Ca2+-mobilizing agents.
Nature of the plasma membrane Ca-influx pathway
It will be apparent from the above that an increasing variety of stimuli are 
now being revealed that induce, directly or indirectly, the influx of Ca2 + into 
liver. The membrane across which this influx occurs, in the main, is the plasma 
membrane of hepatocytes. We consider hepatocytes to be the particular cell 
type into which Ca2+ moves because these occupy such a large volume of the 
total cell population of the liver and because they contain the bulk of the 
liver mitochondria into which the ion moves.
What is obviously important to consider now is the nature of the ‘message’ 
that signals the stimulation of Ca2+ entry at the plasma membrane, and the 
pathway by which such entry is gained to the cell interior. As it turns out, 
little information about the nature of the message(s) is available at present, 
though some recent reports suggest that products of phosphatidylinositol 
metabolism could be involved22-24.
Information about the entry (influx) pathway is so far mainly confined to 
kinetic studies on the perfused liver10-25,26 and intact hepatocytes22-27. However, 
an important revelation of this information, already gained is that more than 
one mechanism or pathway may exist whereby the ion enters10-28.
In recent experiments (Bygrave, Karjalainen and Altin, manuscript in prep­
aration) we have been examining Ca2+ uptake by plasma membrane vesicles 
isolated from liverk Our studies detect the existence of a pathway for uptake 
which occurs independently oT ATP and that may reflect one of the entry 
points. The data point to a pathway involving a specific protein(s) and not 
one that simply involves for example a non-specific change in ion permeability 
of the membrane.
CONCLUDING COMMENTS
A major intent of this communication has been to draw attention to the large 
body of information that can be gained about stimuli-induced Ca2+ fluxes 
through studies with the intact perfused rat liver. Fundamental to this is the 
obvious need to be able to sensitively measure small changes in the perfusate 
Ca2+ concentration, irrespective of the concentration of extracellular Ca2+.
In the first place the ability of glucagon (or cAMP) to potentiate agonist- 
induced Ca2+ influx was used to assess the range and variety of stimuli which 
stimulate Ca2+ entry. Those that are synergistic with glucagon (vasopressin, 
angiotensin, a-adrenergic agonists, ADP, ATP, epidermal growth factor, 
phosphatidic acid and prostaglandin F2a, probably all do so via a mechanism
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Figure 7.9 Calcium fluxes induced by lysophosphatidylcholine in the perfused rat liver. For 
further details see reference 21. The concentration o f LPC was 50//mol/1. Experiments were 
carried out in the absence (continuous lines) or presence (dotted lines) o f 20//m ol/l indomethacin
which ultimately is common to all stimuli and that could involve products of 
phosphatidylinositol metabolism in the hepatocytes. Similarly a case can be 
mounted that thromboxane-A2, generated by the action o f platelet activating
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factor and lysophosphatidylcholine, accounts for the responses induced by 
these latter two compounds.
Second, we showed that by administering phagocytosable material and 
vasoconstrictive agents, it is possible to obtain information about the inter­
action of other cell types, such as Kupfler cells and smooth muscle cells with 
hepatocytes.
Third and finally, all o f the data focus on the hepatocyte plasma membrane 
Ca2+ inflow mechanism. We now need to understand the molecular nature 
of the stimuli or signals which regulate Ca:* influx through the pathway(s) 
involved. This latter area is now ripe for study utilizing the techniques of 
molecular biology.
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Section B .ll
A water-soluble derivative of prazosin prazosinamine hydrochloride 
[l-(4'-amino-6',7'-dimethoxyquinazoline-2'-YL)-4-(6"-aminohexanoyl) 
piperazine hydrochloride], reversibly inhibits the calcium-mobilizing action of 
o(.y adrenergic agonists in the perfused rat liver.
(Armarego et al., 1987)
Biochemical Pharmacology. Vol. 36. No. 10. pp. 1583-1588. 1987. 
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Abstract—A newly-synthesized derivative of prazosin, prazosinamine hydrochloride, was examined for 
its ability to antagonize the interaction of the Oi-adrenergic agonist phenylephrine with liver cells. Using 
a Ca2~-selective electrode to measure changes in perfusate Ca2+ concentration, prazosinamine was found 
to be as effective as prazosin in inhibiting the phenylephrine-induced efflux of Ca2+ from the perfused 
liver. Maximal and half-maximal inhibition occurred at 150 nM and 25 nM prazosinamine, respectively. 
Prazosinamine appears to share the 0 -^specificity of prazosin, but has other unique and desirable
adrenergic receptor studies in perfused tissues. The molecule can also be readily coupled to other 
ligands.
properties, its soiuointy in aqueous media is about tnree orders oi magnitude mgner tnan tnat ot 
prazosin. Also, its antagonistic effects are rapid in onset, and are reversed within seconds of terminating 
its infusion into the liver. These attributes seem to make this agent more useful than prazosin for
The study of many receptor-specific physiological 
responses that are induced by hormones has been 
furthered by a knowledge of the specificity of a 
particular hormone for a particular receptor. Syn­
thetic receptor-specific antagonists such as dihydro- 
ergocryptine, prazosin and yohimbine, have been 
useful for characterizing the different adrenergic 
receptors in a variety of tissues including the nervous 
system, heart and liver [1-4]. In particular, the ability 
of these agents to distinguish between the different 
alpha-adrenergic binding sites has led to a sub­
division of these receptors into the arr type, whose 
activation has been associated with the mobilization 
of cellular Ca2+ and the triggering of physiological 
responses [5-7]; and the ar2-type, whose activation 
elicits an inhibition of adenylate cyclase activity 
[7,8].
To date most work on the characterization of 
alpha-adrenergic receptors has been conducted util­
izing various radioligands, both agonists and antag­
onists, in competitive-binding type studies using 
plasma membrane preparations [9—11], or for relat­
ing the agonist-receptor binding with the physio­
logical responses that are induced in isolated cells 
[5,12]. These studies have been invaluable for deter­
mining the affinity of a ligand for a particular recep­
tor, and for elucidating the responses that are associ­
ated with the activation of particular receptor types. 
However, the demonstration that the action of these
t Address for correspondence.
agents is observable in the intact organ, such as the 
perfused liver [13,14] is perhaps a clearer dem­
onstration that the particular receptor-agonist inter­
action studied can be of both physiological and phar­
macological importance.
In this paper we report that a newly-synthesized 
water-soluble derivative of prazosin (prazosinamine 
hydrochloride — see structural formula in Fig. 1) has 
a^-adrenergic specificity, and is effective in inhibiting 
the mobilization of Ca2+, and therefore other associ­
ated physiological responses such as respiration and 
glycogenolysis [13,14], that are induced by the 
administration of the ori-agonist phenylephrine to 
the perfused rat liver. Moreover, in contrast to pra­
zosin, the antagonistic effects of prazosinamine are 
rapid in onset, and rapidly reversed, once the agent 
is removed. It seems that these attributes may render 
the use of this compound preferable to prazosin 
for receptor-related studies, especially in perfused 
tissues.
EXPERIMENTAL
Animals and perfusions. Male Wistar-strain albino 
rats weighing between 280 and 350 g and fed ad 
libitum were used in all experiments. The rats were 
anaesthetized with sodium pentobarbitone (50 mg/ 
kg body wt), and the livers perfused with Krebs- 
Henseleit bicarbonate buffer [15] equilibrated with 
0 2/C 0 2 (19:1) and containing 1.3 mM added CaCl2. 
All perfusions were conducted in a non-recirculating
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( a )
Fig. 1. Comparison of the structure of prazosin hydrochloride (a), with that of prazosinamine hydro­
chloride (b).
mode at a flow rate of 3.5 ml/min/g of wet liver. 
At the start of each experiment the liver was pre­
perfused for 15-20 min before the infusion of any 
agonist or antagonist. Other details are exactly as 
described in [14].
Perfusate Ca2+ measurements. The perfusate Ca2+ 
concentration was monitored continuously with a 
Radiometer F2112 Ca2+-selective electrode in a flow­
through chamber placed on the outflow side of the 
liver [14]. The electrode was coupled to a Radio­
meter K801 reference electrode via an agarose-KCl 
salt-bridge, and the combined signals were fed via 
an Orion microprocessor ion-analyzer to a SP4100 
computing integrator for recording and analysis. For 
other details see [16].
Chemicals and materials. Phenylephrine, [Arg8] 
vasopressin, and [Val5] angiotensin were obtained 
from the Sigma Chemical Co. St Louis, MO. 
Prazosin hydrochloride was obtained from Pfizer, 
Brooklyn, NY. - Prazosinamine hydrochloride, a 
derivative of prazosin, was synthesized as detailed 
below. With the exception of prazosin which was 
dissolved in distilled water, all these agents were 
dissolved in Krebs-Henseleit buffer for infusion into 
the liver. Ca2+-selective electrode membranes 
(F2112) and filling solutions S43316 were obtained 
from Radiometer, Copenhagen, Denmark. Other 
chemicals used were of analytical grade.
Synthesis o f  prazosinamine hydrochloride [l-(4'- 
amino - 6' - 7' - dimethoxyquinazolin - 2' - yl) - 4 - (6" - 
aminohexanoyl)piperazine hydrochloride] (Fig. lb). 
6-Benzyloxycarbonylaminohexanoic acid [10.6 g, 
1 mol, prepared in 90% yield as described for 
benzyloxycarbonylglycine [17], had m.p. 56-57° 
(Found: C, 63.1; H, 7.5; N, 5.3, C14H19N 0 4 requires 
C, 63.4; H, 7.2; N, 5.3%), and the p.m.r. (200 MHz) 
spectrum in CDC13 (Me4Si, 6 O) has 6 1.34 (m, 2H, 
4-C//2), 1.46 (m, 2H, 3-CH2), 1.61 (m, 2H, 5-CH2), 
2.29 (t , 2H, 2-CH2), 3.12 (m, 2H, 6-CH2), 5.08 (s,
2H, PhCtf2), 5.24 (/, 1H, NH), 7.33 (s, 5H, C6Hs) 
and 10.4 (brs, 1H, C 0 2//)ppm] in methylene chlor­
ide (160 ml) was treated with dicyclohexyl-car- 
bodiimide (13.5 g, 1.6 mol) and stirred for 1 hr. The 
solid (dicyclohexylurea) that separated was filtered 
off, and dry pentachlorophenol (10.6 g, lm ol), in 
methylene chloride (160 ml) was added to the filtrate 
and the mixture was stirred for 30 min. This solution 
was placed in a syringe and added slowly (30 min, 
through a SUBA seal) to a filtered solution of anhy­
drous piperazine (16.8 g, 5 mol.) in methylene chlor­
ide (400 ml) which had been standing over molecular 
sieves (44 g, Linde, type 4A) for 2 hr, and the mixture 
was stirred overnight. All operations up to this point 
were carried out with the exclusion of moisture. The 
large amount of white dicyclohexylurea was filtered 
off, the filtrate was evaporated to 70 ml and the 
further amount of urea that separated was filtered 
off. The filtrate was diluted with methylene chloride 
(200 ml) and the solution was washed with 0.1 M 
sodium hydroxide (3 x 100 ml, to remove free pip­
erazine and neutral material, e.g. the 1,4-disub- 
stituted piperazine) and extracted with 0.5 M hydro­
chloric acid (5 x 50 ml). The acidic extract was 
adjusted to pH 10.5-11.0 with 2M sodium hydrox­
ide, saturated with solid sodium chloride and the 
oil that separated was extracted with chloroform 
(5 x 100 ml). The dried (Na2S 0 4) extract was evap­
orated and the residual oil was kept under vacuum 
(0.1 mm Hg) overnight in the presence of P2Os and 
NaOH. The i.r. spectrum of the oil, l-(6'-benzyloxy- 
carbonylaminohexanoyl)piperazine (4.12 g, 31%) 
had ymax (film) 1635 (amide CO), 1715 (ester CO) 
and 3320 (NH) cm-1, and p.m.r (200 MHz) spectrum 
in CDC13 [(CH3)4Si, <5 Oppm] had <5 1.35 (t , 2H, 4'- 
CH2), 1.52 (m, 2H, 3'-CH2), 1.60 (m, 2H, 5'-CH2), 
2.30(t, 2H, C //2CON), 2.47 (br m, 1H, piperazine- 
NH), 2.81 (m 4H, piperazine-3-C//2), 3.15 (m, 2H, 
CONHC//2), 3.40 (t, 2H, piperazine-2-C//2), 3.59
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(t, 2H, piperazine-2-C/f2), 5.10 (5 , 2H, PhC//20), 
5.52 (r, 1H, CON//CH2) and 7.35 (s, 5H, C6/ /5)ppm 
indicated that it was better than 90% pure.
The oily benzyloxycarbonylhexanoylpiperazine 
(4.12 g, 1.1 mol) and 2-chloro-6,7-dimethoxyquin- 
azolinyl-4-amine [2.64 g, lmol, m.p.> 300° decomp, 
prepared in eight steps from veratraldehyde accord­
ing to procedures similar to those used by Althuis 
and Hess [18] and Armarego and Reece [19] for 
preparing related 2-chloroquinazolinyl-4-amines 
(Found: C, 50.0; H, 4.1; N, 17.1. C10H 10ClN3O2 
requires C, 50.1; H, 4.2; N, 17.5%)] in isoamyl 
alcohol (55 ml) was boiled under reflux for 4 hr and 
set aside overnight. The mixture was cooled in ice 
and dry ether (80 ml) was added. The l-(4'-amino- 
6' ,7' - dimethoxyquinazolin - 2' - yl) - 4 - (6" - benzyl- 
oxycarbonylaminohexanoyl)piperazine (5.48 g, 
93%) that separated was collected, recrystallised 
from methanol and dried. It had m.p. 145-147° 
(effervescence) and its i.r. spectrum had ymax (KBr) 
1600 (C-N), 1640 (br, amide CO), 1700 (ester CO) 
and 3500 (NH) cm-1, and the p.m.r. (90 MHz) spec­
trum in [(CD3)2SO; Me4Si, <5 O) at 55° had <5 1.38 
(1hr m, 6H, 3", 4" and 5" CH2), 3.82 (s 3H, 6' or 7' 
OC//3), 3.87 (5 , 3H, 7' or OC//3), 7.25 (s, 5H, 
Q H 5), 7.33 (5 , 1H, quinazoline-5'-//), 7.65 (s, 1H, 
quinazoline-8'-//) and 8.60 (s , 1H, N //C 02)ppm. 
(Found: C, 62.7; H, 7.4; N, 14.7. C28H36N60 5 
requires C, 62.7; H, 6.8; N, 14.9%).
The preceding benzyloxyquinazoline (2.5 g) was 
dissolved in boiling methanol (100 ml), diluted 
further with methanol (50 ml) and cooled. Pall- 
adium-on-charcoal (50%, 2.5 g) was added to the 
solution followed by three drops of 7 M methanolic 
hydrogen chloride (not more, otherwise a solid sep­
arates) and shaken with hydrogen at 720mm Hg and 
25° for 18 hr. The p.m.r. spectrum of an aliquot 
indicated that hydrogenolysis was complete, i.e. the 
benzylic protons were absent. The catalyst was fil­
tered off and the filtrate treated with 7 M methanolic 
hydrogen chloride (0.5 ml) and evaporated to a small 
volume. Dry ether was added and l-(4'-amino-6',7'- 
dimethoxyquinazolin - 2' - yl) - 4 - (6" - amino - 
hexanoyl)piperazine hydrochloride (1.94 g, 73%), 
m.p.> 210° (effervescence, slow heating) separated. 
It gave one spot on t.l.c. (RfO.45, on Merck Kieselgel 
60F254 in butan-l-ol:acetic acid water: 10:3:7) 
(Found: C, 42.4; H, 6.8; N, 14.5; Cl, 15.6. 
QoHsoNöO^ 2.5HC1.4.1H20  requires C, 42.3; H, 
7.2; N, 14.8; Cl, 15.6%). The i.r. spectrum had ymax 
(KBr) 1600 (amide CO) and 3500 (v br, NH) cm-1, 
and the p.m.r. (200 MHz) spectrum in D20  (sodium 
3-trimethylsilylpropanesulphonate, <5 O) had <5 1.55 
(m, 2H, 4"-CH2), 1.80 (m, 4H, 3" and 5"-CH2), 2.62 
(t, 2H, 2"-CH2), 3.12 (t, 2H, 6"-CH2), 3.80 (s, 3H, 
6' or l'-OCHf), 3.87 (7' or 6'-CO//3), 6.60 (s, 1H, 
quinazoline-5'-H), 6.84 (5 , 1H, quinazoline-8'-H) 
ppm but the piperazine protons are under the broad 
base of the OCH3 singlets.
I.r. spectra were measured on a Pye Unicam 
SP1050 spectrometer and p.m.r. spectra were 
measured on Jeol FX90Q (90MHz) and Varian 
XL200E (200MHz) n.m.r spectrometers at ambient 
temperatures unless otherwise stated.
Expression of data. All experiments were per­
formed at least three times. Where indicated, data
are expressed as means ± SEM for the number of 
independent experiments described.
RESULTS
Comparison of the effects of prazosin with those of 
prazosinamine in antagonizing the efflux of Ca2+ 
induced by the a^-agonist phenylephrine
It seems well established that the action of arr  
adrenergic agonists (e.g. phenylephrine) in liver is 
mediated by a mobilization of both intracellular and 
extracellular Ca2+ which leads to an increase in the 
cytosolic Ca2+ concentration, and consequently, a 
triggering of many Ca2+-dependent physiological 
responses (reviewed in [20—23]). Like the action of 
other Ca2+-mobilizing hormones, the binding of the 
^-adrenergic agonist phenylephrine to its specific 
receptor on the plasma membrane appears to be 
associated with the breakdown of phosphoinositides 
in the membrane that generate the second messenger 
inositol 1,4,5-trisphosphate, which appears to be 
involved in the release of Ca2+ from the endoplasmic 
reticulum [24-26]. The release of this intracellular 
hormone-sensitive pool of Ca2+ is accompanied by a 
concomitant net efflux of Ca2+ from the liver over 
a period of 3-4 min until the pool is depleted [14]. 
This pool is replenished from the extracellular Ca2+ 
pool once the agonist is removed. Although many 
workers (for example [5,12,27]) have correlated the 
degree of hormonal stimulation with the activation of 
glycogen phosphorylase, a Ca2+-dependent enzyme 
involved in glycogenolysis, it seems that, at least in 
the early stages, the extent of hormone activation 
can be correlated with the amount of intracellular 
Ca2+ that is effluxed from the liver. Hence, the use 
of a Ca2+-selective electrode to monitor the Ca2+ 
fluxes that are induced by the administration of an 
^-specific agonist or antagonist to the perfused rat 
liver, provides a convenient means to study the abil­
ity of agents like prazosinamine to antagonize agon­
ist-receptor binding, and consequently, the associ­
ated Ca2+ flux response.
The Ca2+-selective electrode trace in Fig. 2(a) 
shows the Ca2+ flux changes that are induced by the 
administration of a maximal dose of phenylephrine 
(2 pM) to the liver perfused with Krebs-Henseleit 
medium containing 1.3 mM Ca2+. This results in a 
net efflux of approximately 140 nmol Ca2+/g of liver 
(see also [14,16]). The re-uptake of a similar amount 
of Ca2+ occurs when the agent is removed. A 5 min 
pre-infusion of prazosin (200 nM) results in a com­
plete inhibition of the Ca2+ efflux response induced 
by a subsequent administration of phenylephrine 
(see Fig. 2b). Also, it can be seen that there is no 
significant reversal of this effect even after 30 min of 
terminating the infusion of prazosin. This suggests 
that the binding of prazosin to the site where it 
antagonizes the interaction of phenylephrine with 
the ^-receptor is irreversible over this time period, 
thus making any further addition of the agonist or 
antagonist futile.
Comparison of Fig. 2(b) and 2(c) shows that the 
prazosin derivative prazosinamine (200 nM) is as 
effective as prazosin (200 nM) in antagonising the 
interaction of phenylephrine with the arj-receptor. 
It is noteworthy that preliminary experiments had
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Perfusion time (min)
Fig. 2. Comparison of the antagonistic effects of prazosin 
(b), with those of prazosinamine (c), on the efflux of Ca2+ 
induced by the administration of phenylephrine to the 
perfused rat liver. Livers of fed rats were perfused with 
Krebs-Henseleit bicarbonate medium containing 1.3 mM 
Ca2+. After an equilibration period of 15-20 min agonists 
and antagonists were infused into the portal vein by infusion 
syringe for the times indicated by the arrows. The effluent 
perfusate was monitored continuously with a Ca2+-selective 
electrode as described in the experimental section. Trace 
(a) shows the Ca2+-response induced by separate infusions 
of maximal concentrations of phenylephrine (2 flM., thin 
line), and either vasopressin or angiotensin (each at 10~8 M, 
thin broken line), for the times indicated. The result for a 
similar experiment in which prazosin (0.2 juM, bold line) 
was infused prior to the first pulse of phenylephrine is 
shown in (b). Similarly, trace (c) shows the Ca2+ response 
obtained by infusing prazosinamine (0.2 juM, bold broken 
line) instead of prazosin. Each trace is a representative of 
between three and four experiments performed indepen­
dently.
shown that the full effect of prazosinamine on the 
efflux of Ca2+ induced by the infusion of phenyl­
ephrine can be observed with only a 15 sec pre- 
administration of the agent (see Fig. 2b). This con­
trasts the use of prazosin where a 3-5 min pre­
administration seems to be required to elicit com­
plete inhibition of the Ca2+ efflux response (data 
not shown). From the Ca2+ flux changes that are 
observed (Fig. 2c) it seems clear that inhibition of 
agonist-receptor binding is maintained only for as 
long as the infusion of prazosinamine is continued. 
The termination of prazosinamine infusion results in 
a rapid onset of the Ca2+ efflux response that is 
normally induced by phenylephrine; the amount of 
Ca2+ effluxed is essentially the same as the control
(Fig. 2a). Also, the time delay between the removal 
of the antagonist and the onset of the Ca2+ efflux 
response induced by the presence of phenylephrine 
(<10sec), is not significantly different from that 
which occurs before the onset of Ca2+ efflux fol­
lowing the administration of phenylephrine alone. 
Hence, unlike the antagonism by prazosin which 
is essentially irreversible, the antagonistic effect of 
prazosinamine is rapidly reversed within seconds of 
terminating its infusion. As a consequence of this 
the Ca2+ response can be repeated many times, by 
subsequent prazosinamine and phenylephrine 
administrations, during the course of one 
experiment.
Concentration-dependence o f the inhibition o f pheny­
lephrine-induced Ca2+ efflux by prazosinamine
The ability of different concentrations of prazo­
sinamine to inhibit phenylephrine-induced Ca2+ 
efflux from the perfused liver is shown in Fig. 3. 
Each point on the curve represents the net amount of 
Ca2+ efflux induced by the infusion of phenylephrine 
2 min after the infusion of prazosinamine at the 
specified concentration. It can be seen that the maxi­
mal and half-maximal effective doses of prazo­
sinamine was approx. 150 nM, and 25 nM, respect-
-Loo,,, [Prazosinamine] (M)
Fig. 3. Concentration-dependence of the antagonism of 
phenylephrine-induced Ca2+ efflux by prazosinamine. Liver 
perfusions were conducted as described in the legend to 
Fig. 2. After a pre-perfusion period of 15 min, repeated 
infusions of prazosinamine and phenylephrine were made. 
Each point on the curve represents the net amount of Ca2+ 
that is effluxed from the liver following the infusion of a 
maximal concentration of phenylephrine (2 /zM), 2 min 
after the infusion of a specified concentration of prazosin­
amine. The infusions of both prazosinamine and phenyl­
ephrine was continued until no further Ca2+ was being 
effluxed. For the purposes of measuring the amount of Ca2+ 
efflux, a rest period of at least 10 min was allowed between 
the termination of prazosinamine and phenylephrine 
infusion, and any subsequent addition of these agents. 
Perfusion times were not permitted to run beyond 60 min; 
only the results of experiments for which the infusion of 
phenylephrine alone (after 60 min of perfusion) gave the 
usual amount of Ca2+ efflux, were used. Each point is 
the mean ± SEM of between four and six independent 
experiments performed at the specified concentrations of 
prazosinamine.
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ively. These concentrations are similar to those 
required for inhibition of phenylephrine-induced 
Ca2+ efflux by prazosin (data not shown). It should 
be noted, however, that the time required for the 
association of prazosin (0.2 nM) with its binding site 
to reach equilibrium in isolated plasma membranes 
appears to be around 15-20 min [12]. Since inhibition 
of Ca2+ efflux by prazosinamine seems to occur more 
rapidly than when prazosin is used (data not shown) 
it is clear that a direct comparison of the effective 
concentrations must also take into account these 
differences in kinetics. Using the equation of Cheng 
and Prusoff [28], the apparent dissociation constant 
for the inhibition of phenylephrine-induced Ca2+ 
efflux by prazosinamine was calculated to be approxi­
mately 1.2 nM.
DISCUSSION
The major point revealed in this study is that 
prazosinamine, a newly-synthesized water-soluble 
derivative of the arj-specific antagonist prazosin, has 
antagonistic properties similar to prazosin as judged 
by its ability to inhibit the phenylephrine-induced 
efflux of Ca2+ in the perfused rat liver. The inhibition 
appears to be specific for the a^-receptor since the 
Ca2+ response induced by other Ca2+-mobilizing hor­
mones such as vasopressin and angiotensin seems 
unaffected by a pre-administration of even high doses 
(1 pM) of prazosinamine (see also Fig. 2b, c). 
Although the effective concentrations of prazo­
sinamine for maximal and half-maximal inhibition of 
the Ca2+-efflux response induced by phenylephrine, 
are similar to the concentrations of prazosin required 
for a corresponding inhibition of Ca2+-efflux (Fig. 
2b, c) or glucose output [13], our results show that 
prazosinamine has other desirable properties which 
are not shared with prazosin.
Firstly, the solubility of prazosinamine is much 
higher than that of prazosin. The solubility of pra­
zosin was determined empirically for these experi­
ments and was found to be approx. 350 juM; however, 
the solubility of prazosinamine was found to be in 
excess of 1 M. The higher solubility of prazosinamine 
is attributed to the additional highly basic aliphatic 
amino group (pKaca. 10.5) attached to the piperazine 
moiety of the prazosin molecule by five methylene 
groups and an amide function, which are expected 
to make the molecule charged and polar, and hence 
more hydrophilic. At physiological pH, i.e. ca.7, 
prazosinamine (estimated pA"a>7.5) must contain a 
high proportion (> 76%) of the diprotonated species 
(c/Fig. 2b; pKa of 2,4-diaminopyrimidine is 7.23 and 
a fused benzene ring, and alkyl groups on the 2- 
amino group are all base strengthening by at least
0.3 pKa units [29]) and the rest exist as the species 
protonated on the aliphatic group. Prazosinamine 
behaves like a detergent in aqueous solution because 
it froths on shaking.
Another characteristic property of prazosinamine 
is its ability to rapidly reverse its inhibition of pheny­
lephrine-induced Ca2+-efflux, once its infusion is ter­
minated. It thus appears that the prazosinamine mol­
ecule is able to dissociate itself from the ^-specific 
binding site much more rapidly than prazosin. The 
removal of Ca2+-efflux inhibition was apparent only
seconds after terminating prazosinamine infusion, 
though no significant reduction of inhibition by pra­
zosin was apparent 30 min after its removal. The 
reason for this is not clearly understood, but its seems 
likely that it could be related to the greater solubility 
of prazosinamine in the aqueous perfusate.
Finally, we suggest that the attributes of high 
solubility, and reversible nature of the a^-specific 
antagonism exhibited by prazosinamine, may make 
this the compound of choice in pharmacological stud­
ies on adrenergic receptors. This is especially so in 
studies involving perfused tissues where it is expected 
that many separate administrations of agonist and 
antagonist are desired during the one experiment. 
Furthermore, preliminary experiments have shown 
that prazosinamine can be readily coupled to immu­
nogenic molecules like hemocyanin, and to a 
Sepharose-4B matrix. This suggests that the com­
pound can also be used to raise anti-idiotypic anti­
bodies against the orr receptor, and to produce an 
affinity column for the purification of these receptors.
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With regard to agents whose actions in liver appear to be mediated primarily through an interaction 
with non-parenchymal cells, it seems that further work to substantiate the existence of the model 
presented in this work will need to establish several things: firstly, that the various stimulating agents 
lead to the production of eicosanoids within the intact liver tissue, and secondly, the levels of particular 
eicosanoids produced by a particular stimulating agent within different regions of the liver. It would be 
especially important to establish the levels of eicosanoids that may be generated in the vicinity of 
hepatocytes under various stimulating conditions. This may be difficult because many of these products 
(eg. TXA2  and PGI2 ) have a relatively short half-life. Another area not dealt with in this work 
concerns the possibility that many eicosanoids, both prostanoids and products of lipoxygenase, may act 
in concert to elicit various responses. This presumably applies to the fact that prostanoids and 
lipoxygenase products may be produced simultaneously by stimulating agents such as zymosan, 
arachidonic acid, PAF, lysolecithin and phorbol esters. The interaction between various eicosanoids is 
an area that requires further study.
Another area that remains to be addressed concerns the specificity of the inhibitors indomethacin 
and bromophenacyl bromide, used to study the action of various stimulating agents in the perfused rat 
liver. A paper infrequently quoted in the recent literature (Northover, 1977), has been noted which 
suggests that indomethacin, an established inhibitor of cyclo-oxygenase (Vane, 1971), may inhibit 
contraction of most types of venous and arterial vascular smooth muscle, and may also alter the 
permeability properties of the vascular endothelial wall. This is thought to occur through the ability of 
indomethacin to interfere with or antagonize the biological actions of Ca2+ in these cells (Northover,
1977). At high concentrations (above 100 pM) indomethacin has been reported to inhibit the activity 
of protein kinases (Goueli & Ahmed, 1980). Whatever the effect of indomethacin in these cells, the 
compound does not significantly inhibit uptake of Ca2+ by the perfused rat liver induced by the 
synergistic action of glucagon and Ca2+-mobilizing agents (Altin & Bygrave, 1987c). Such uptake 
has been shown to occur predominantly in hepatocytes (Mauger et al., 1985; Altin & Bygrave, 1986; 
Poggioli et al., 1986; Altin & Bygrave, 1988). Because endothelial and/or smooth muscle cells may be 
important in bringing about vasoconstriction and redistribution of blood flow within the liver, it is 
possible that the observed inhibitory effects of indomethacin on the action of agents such as PAF [and 
perhaps also lysolecithin (Altin et al., 1987b)] whose actions are accompanied by marked vasoactive 
effects, may be due to an inhibition of the vasoconstriction and associated responses (Buxton et al., 
1986; Fisher et al., 1986; Hill & Olson, 1987), rather than through an inhibition of prostanoid 
production. That is, it is possible that PAF and lysolecithin may act directly on the vasoactive cells 
themselves. Since PAF has been reported to stimulate prostanoid production in cultured Kupffer cells 
(Dieter et al., 1986) and endothelial cells (Schlayer et al., 1986) from liver however, and since a number
of these prostanoids [eg. P G F ^  , PGE2  and analogues of TXA2 (Buxton et al., 1987; Fisher et al.,
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1987; Haussinger et al., 1987b; Altin & Bygrave, 1988)] have been shown to induce responses in the 
perfused liver, it seems likely also that at least part of the action of PAF could be mediated by 
eicosanoid production. Clearly therefore, in light of the reported effect of indomethacin on vascular 
tissue, it seems that the particular contribution of each of the two mechanisms to explain the action of 
PAF and possibly similar agents in the perfused rat liver (ie. a direct effect of the agents on vasoactive 
cells, or an indirect effect on vasoactive cells and hepatocytes due to eicosanoid production and release 
by sinusoidal cells) is an area that awaits further clarification.
A further aspect of this study is that much of the evidence presented indicates that the effects of 
sinusoidal cells can be inhibited by inhibitors of phospholipase-A2, of the cyclo-oxygenase pathway,
and possibly of Ca2+ channels. Assuming that these inhibitors do not significantly effect responses in 
hepatocytes therefore, their use provides a means of identifying in the perfused liver those stimulating 
agents whose actions are largely dependent on an intact hepatic vasculature (and which therefore may 
mediate their actions primarily through an interaction with non-parenchymal cells), and those that 
mediate their effects by interacting specifically or primarily with hepatocytes.
In relation to the action of Ca2+-mobilizing agonists on the parenchymal cells, it seems well 
established that the action of these can be understood largely in terms of a receptor-mediated hydrolysis 
of phosphoinositides in the plasma membrane of hepatocytes, which generates second messengers for 
the activation of protein kinase C (diacylglycerol), the mobilization of intracellular Ca2+ (IP3), and
most probably signals for the regulation of Ca2+ influx across the plasma membrane. Whilst some 
progress has been made towards an understanding of the mechanism of activation of protein kinase C 
and the release of intracellular Ca2+ from the endoplasmic reticulum, it is clear from the preceding 
discussion that the mechanism by which Ca2+-mobilizing agonists stimulate Ca2+ influx across the 
plasma membrane remains to be elucidated. Current evidence suggests that the sustained increase in 
cytosolic Ca2+ levels induced by hormones, involve a stimulation of unidirectional Ca2+ influx, rather 
than an inhibition of the Ca2+ efflux via the Ca2+-ATPase. However, a possible role of the ATPase in 
eliciting this effect has not yet been eliminated. Recent evidence suggests that the pathway for 
hormonal stimulation of Ca2+ inflow is probably different to that of the basal Ca2+ influx which 
occurs in resting cells (Hughes et al., 1986b; Altin & Bygrave, 1987a). The recent detection and 
preliminary characterization of some of the properties of this Ca2+ inflow system in rat liver plasma 
membranes (Bygrave et al., unpublished) has provided a system with which to further characterize this 
basal Ca2+ transport process in vitro. This may provide a system by which the Ca2+ transporter can be 
labelled and isolated when a suitable label has been found. Such studies should provide invaluable 
information concerning the way cells regulate cytosolic Ca2+ levels in both resting and
hormone-stimulated cells.
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With regard to the hormonally-stimulated influx of Ca2+ in liver, there are suggestions that the 
regulation of Ca2+ influx occurs via the breakdown of phosphoinositides in the plasma membrane, 
rather than by direct interaction of the hormone-receptor complex with the Ca2+ transporters 
themselves. A characterization of the Ca2+ flux changes induced by different Ca2+-mobilizing agonists 
suggests that the agonists differ in their ability to stimulate net Ca2+ influx. For example, vasopressin 
and angiotensin have a greater capacity to stimulate Ca2+ influx by comparison with phenylephrine. 
All Ca2+-mobilizing agonists tested (except ONO-11113 which probably mediates its effects by 
interaction with non-parenchymal cells, see Altin & Bygrave, 1988) stimulate Ca2+ influx 
synergistically in the presence of cyclic AMP or the cyclic AMP-producing hormone glucagon. In all 
instances however, the net rate of Ca2+ efflux in the early stages of agonist action exceeds that of Ca2+ 
influx, as reflected by a net loss of Ca2+ from the liver, suggesting that the rate of onset of the Ca2+ 
influx response is slower than the release of intracellular Ca2+. The stimulation of net Ca2+ influx by 
Ca2+-mobilizing agonists, both in the presence or absence of cyclic AMP, appears to be related to their 
ability to stimulate phosphoinositide hydrolysis. Agents like vasopressin and angiotensin, which lead 
to a greater production of IP3 and diacylglycerol, also induce a greater net influx of Ca2+ by comparison 
with other agents like phenylephrine. It remains to be established however, whether IP3, IP4, 
phosphatidic acid or some other metabolite of PIP2 hydrolysis is directly involved in the regulation of
Ca2+ influx. The synergistic effects of cyclic AMP in stimulating Ca2+ influx by Ca2+-mobilizing 
agonists should provide a useful system for further studies on the regulation of Ca2+ influx. In 
particular, it would seem that the development of techniques for manipulating or controlling the 
production of these and other metabolites by hormones, or for introducing these into intact hepatocytes 
in which cyclic AMP levels have been raised, would provide a powerful means to identify those 
metabolites which are important in the regulation of Ca2+ influx. To some extent the current lack of 
knowledge in this area is due to a lack of specific inhibitors for PIP2 hydrolysis, for the metabolism of
inositol phosphates, and for the hormone-stimulated Ca2+ transport process itself. In this regard the 
development and/or identification of more specific agents in this area is likely to be very fruitful, and 
may be considered to be a necessary step towards a better understanding of the regulation of Ca2+ influx 
by hormones and also towards the identification, isolation and characterization in molecular terms, of 
the Ca2+ transporter itself.
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